assay_id,assay_subcellular_fraction,assay_organism,description,relationship_type,assay_type,confidence_score,curated_by,src_id,src_assay_id,chembl_id,cell_id,bao_format,tissue_id,variant_id
7524,,Rattus norvegicus,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL618647,,BAO_0000218,2113.0,
7525,,Rattus norvegicus,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,N,A,1,Intermediate,1,,CHEMBL618648,,BAO_0000218,2113.0,
7526,,Rattus norvegicus,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL618649,,BAO_0000218,2113.0,
7527,,Rattus norvegicus,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL618650,,BAO_0000218,2107.0,
7528,,Rattus norvegicus,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,N,A,1,Intermediate,1,,CHEMBL618651,,BAO_0000218,2107.0,
7529,,Rattus norvegicus,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL876497,,BAO_0000218,2107.0,
7530,,Rattus norvegicus,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL618652,,BAO_0000218,2048.0,
7531,,Rattus norvegicus,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,N,A,1,Intermediate,1,,CHEMBL618653,,BAO_0000218,2048.0,
7532,,Rattus norvegicus,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL618654,,BAO_0000218,2048.0,
7533,,Rattus norvegicus,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,N,A,1,Intermediate,1,,CHEMBL618655,,BAO_0000218,,
7534,,Rattus norvegicus,Compound was tested for solubility in water,N,A,1,Intermediate,1,,CHEMBL618656,,BAO_0000218,,
7535,,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),U,P,0,Intermediate,1,,CHEMBL618657,,BAO_0000100,,
7536,,Rattus norvegicus,Solubility was determined,N,A,1,Intermediate,1,,CHEMBL618658,,BAO_0000218,,
7537,,Rattus norvegicus,solubility in water (ug/mL) at 37 degree C.,N,A,1,Intermediate,1,,CHEMBL618659,,BAO_0000218,,
7538,,Rattus norvegicus,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,N,A,1,Intermediate,1,,CHEMBL618660,,BAO_0000218,,
7539,,Rattus norvegicus,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,N,A,1,Intermediate,1,,CHEMBL618661,,BAO_0000218,,
7540,,Rattus norvegicus,Half life in rats,N,A,1,Intermediate,1,,CHEMBL873807,,BAO_0000218,,
7541,,Rattus norvegicus,Half life in Dawley rat,N,A,1,Intermediate,1,,CHEMBL618662,,BAO_0000218,,
7542,,Rattus norvegicus,Half life period after 3 mg/kg iv administration,N,A,1,Intermediate,1,,CHEMBL618663,,BAO_0000218,,
7543,,Rattus norvegicus,Half life period after 3 mg/kg iv administration in rat,N,A,1,Intermediate,1,,CHEMBL618664,,BAO_0000218,,
7544,,Rattus norvegicus,Half life period after 3 mg/kg iv administration in the rat,N,A,1,Intermediate,1,,CHEMBL618665,,BAO_0000218,,
7545,,Rattus norvegicus,Half life period in female Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL876498,,BAO_0000218,,
7546,,Rattus norvegicus,Half life period in rat,N,A,1,Intermediate,1,,CHEMBL618666,,BAO_0000218,,
7547,,Rattus norvegicus,Half-life in rats was determined,N,A,1,Intermediate,1,,CHEMBL620440,,BAO_0000218,,
7548,,Rattus norvegicus,Half-life in rats with metabolic oxidation,N,A,1,Intermediate,1,,CHEMBL620441,,BAO_0000218,,
7549,,Rattus norvegicus,Half-life in rats,N,A,1,Intermediate,1,,CHEMBL620442,,BAO_0000218,,
7550,,Rattus norvegicus,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL620443,,BAO_0000218,,
7551,,Rattus norvegicus,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL620444,,BAO_0000218,,
7552,,Rattus norvegicus,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL620445,,BAO_0000218,,
7553,,Rattus norvegicus,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL620446,,BAO_0000218,,
7554,,Rattus norvegicus,Biological half-life measured in plasma of rat,N,A,1,Intermediate,1,,CHEMBL620447,,BAO_0000218,1969.0,
7555,,Rattus norvegicus,Biological half-life measured in plasma of rat; 22-25,N,A,1,Intermediate,1,,CHEMBL621129,,BAO_0000218,1969.0,
7556,,Rattus norvegicus,Biological half-life measured in plasma of rat; 9-16,N,A,1,Intermediate,1,,CHEMBL621130,,BAO_0000218,1969.0,
7557,,Rattus norvegicus,Compound was evaluated for its half life when administered intravenously in rat,N,A,1,Intermediate,1,,CHEMBL873808,,BAO_0000218,,
7558,,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,N,A,1,Intermediate,1,,CHEMBL876598,,BAO_0000218,,
7559,,Rattus norvegicus,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL621131,,BAO_0000218,,
7560,,Rattus norvegicus,Half life (T1/2) after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL621132,,BAO_0000218,,
7561,,Rattus norvegicus,Half life of compound after iv administration of 20 mg/kg dose in rat,N,A,1,Intermediate,1,,CHEMBL621133,,BAO_0000218,,
7562,,Rattus norvegicus,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,A,1,Expert,1,,CHEMBL621312,,BAO_0000218,,
7563,,Rattus norvegicus,Half life of compound was determined in rat,N,A,1,Intermediate,1,,CHEMBL621313,,BAO_0000218,,
7564,,Rattus norvegicus,Half life of compound was determined in rat blood,N,A,1,Intermediate,1,,CHEMBL621314,,BAO_0000218,178.0,
7565,,Rattus norvegicus,Half life at 1 mg/kg was determined in rat,N,A,1,Intermediate,1,,CHEMBL621315,,BAO_0000218,,
7566,,Rattus norvegicus,Half life at 10 mg/kg was determined in rat,N,A,1,Intermediate,1,,CHEMBL621316,,BAO_0000218,,
7567,,Rattus norvegicus,Half life in rats,N,A,1,Intermediate,1,,CHEMBL621317,,BAO_0000218,,
7568,,Rattus norvegicus,Half life in rats in hours,N,A,1,Intermediate,1,,CHEMBL621318,,BAO_0000218,,
7569,,Rattus norvegicus,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,A,1,Intermediate,1,,CHEMBL621319,,BAO_0000218,,
7570,,Rattus norvegicus,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL621377,,BAO_0000218,,
7571,,Rattus norvegicus,Half life was determined,N,A,1,Intermediate,1,,CHEMBL621378,,BAO_0000218,,
7572,,Rattus norvegicus,Half life after i.v. administration,N,A,1,Intermediate,1,,CHEMBL876599,,BAO_0000218,,
7573,,Rattus norvegicus,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,N,A,1,Intermediate,1,,CHEMBL621379,,BAO_0000218,,
7574,,Rattus norvegicus,Half life in rat plasma,N,A,1,Intermediate,1,,CHEMBL621380,,BAO_0000218,1969.0,
7575,,Rattus norvegicus,Half life in rat plasma; Not detected,N,A,1,Intermediate,1,,CHEMBL621381,,BAO_0000218,1969.0,
7576,,Rattus norvegicus,Half life in rats,N,A,1,Intermediate,1,,CHEMBL618515,,BAO_0000218,,
7577,,Rattus norvegicus,Half life period of compound was determined after peroral administration,N,A,1,Intermediate,1,,CHEMBL618516,,BAO_0000218,,
7578,,Rattus norvegicus,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,N,A,1,Intermediate,1,,CHEMBL618517,,BAO_0000218,,
7579,,Rattus norvegicus,Half life period in rat,N,A,1,Intermediate,1,,CHEMBL618518,,BAO_0000218,,
7580,,Rattus norvegicus,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,A,1,Intermediate,1,,CHEMBL618519,,BAO_0000218,,
7581,,Rattus norvegicus,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,A,1,Intermediate,1,,CHEMBL618698,,BAO_0000218,,
7582,,Rattus norvegicus,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,N,A,1,Intermediate,1,,CHEMBL618862,,BAO_0000218,,
7583,,Rattus norvegicus,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL618863,,BAO_0000218,,
7584,,Rattus norvegicus,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,N,A,1,Intermediate,1,,CHEMBL618864,,BAO_0000218,,
7585,,Rattus norvegicus,Half life time in rat the dose of 2 mg/kg,N,A,1,Intermediate,1,,CHEMBL618865,,BAO_0000218,,
7586,,Rattus norvegicus,Half-life 24 hr after 10 mg/kg iv administration in rats,N,A,1,Intermediate,1,,CHEMBL618866,,BAO_0000218,,
7587,,Rattus norvegicus,Half-life 24 hr after 2 mg/kg iv administration in rats,N,A,1,Intermediate,1,,CHEMBL618867,,BAO_0000218,,
7588,,Rattus norvegicus,Half-life consistent with the observed metabolic steady state in rats,N,A,1,Intermediate,1,,CHEMBL875828,,BAO_0000218,,
7589,,Rattus norvegicus,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,A,1,Intermediate,1,,CHEMBL618868,,BAO_0000218,,
7590,,Rattus norvegicus,Half-life for oxidative metabolic stability was determined using male human,N,A,1,Intermediate,1,,CHEMBL618869,,BAO_0000218,,
7591,,Rattus norvegicus,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",N,A,1,Intermediate,1,,CHEMBL618870,,BAO_0000218,,
7592,,Rattus norvegicus,Half-life in rat plasma,N,A,1,Intermediate,1,,CHEMBL618871,,BAO_0000218,1969.0,
7593,,Rattus norvegicus,Half-life in rat plasma was determined,N,A,1,Intermediate,1,,CHEMBL618872,,BAO_0000218,1969.0,
7594,,Rattus norvegicus,Half-life in rats was determined,N,A,1,Intermediate,1,,CHEMBL873816,,BAO_0000218,,
7595,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,U,A,0,Autocuration,1,,CHEMBL618873,,BAO_0000218,,
7596,,,Area under curve after oral dose of 0.1 mg//kg,U,A,0,Autocuration,1,,CHEMBL621602,,BAO_0000019,,
7597,,,Area under curve after oral dose of 0.3 mg/kg,U,A,0,Autocuration,1,,CHEMBL621603,,BAO_0000218,,
7598,,,Area under curve after oral dose of 1 mg/kg,U,A,0,Autocuration,1,,CHEMBL621604,,BAO_0000218,,
7599,,,Area under curve after oral dose of 10 mg/kg,U,A,0,Autocuration,1,,CHEMBL621605,,BAO_0000218,,
7600,,,Area under curve after oral dose of 23.4 mg/kg,U,A,0,Autocuration,1,,CHEMBL621606,,BAO_0000218,,
7601,,,Area under curve after oral dose of 3 mg/kg,U,A,0,Autocuration,1,,CHEMBL621607,,BAO_0000218,,
7602,,,Area under curve after oral dose of 3.87 mg/kg,U,A,0,Autocuration,1,,CHEMBL621608,,BAO_0000218,,
7603,,,Area under curve was determined,U,A,0,Autocuration,1,,CHEMBL621609,,BAO_0000019,,
7604,,,Area under curve at a dose of 10 mg/kg,U,A,0,Autocuration,1,,CHEMBL621610,,BAO_0000218,,
7605,,Rattus norvegicus,Area under curve was determined; ND=No data,N,A,1,Intermediate,1,,CHEMBL621611,,BAO_0000218,,
7606,,Rattus norvegicus,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,A,1,Intermediate,1,,CHEMBL621612,,BAO_0000218,,
7607,,Rattus norvegicus,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,A,1,Intermediate,1,,CHEMBL622308,,BAO_0000218,,
7608,,Rattus norvegicus,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,A,1,Intermediate,1,,CHEMBL622309,,BAO_0000218,,
7609,,Rattus norvegicus,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,N,A,1,Intermediate,1,,CHEMBL622310,,BAO_0000218,,
7610,,Rattus norvegicus,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,A,1,Intermediate,1,,CHEMBL622311,,BAO_0000218,,
7611,,Rattus norvegicus,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,N,A,1,Intermediate,1,,CHEMBL622312,,BAO_0000218,,
7612,,Rattus norvegicus,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,A,1,Intermediate,1,,CHEMBL622931,,BAO_0000218,,
7613,,Rattus norvegicus,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,N,A,1,Intermediate,1,,CHEMBL622932,,BAO_0000218,,
7614,,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,A,1,Intermediate,1,,CHEMBL622736,,BAO_0000218,1969.0,
7615,,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,A,1,Intermediate,1,,CHEMBL622737,,BAO_0000218,1969.0,
7616,,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,A,1,Intermediate,1,,CHEMBL622738,,BAO_0000218,1969.0,
7617,,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,N,A,1,Intermediate,1,,CHEMBL622739,,BAO_0000218,1969.0,
7618,,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,A,1,Intermediate,1,,CHEMBL622740,,BAO_0000218,1969.0,
7619,,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,N,A,1,Intermediate,1,,CHEMBL622741,,BAO_0000218,1969.0,
7620,,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,A,1,Intermediate,1,,CHEMBL622742,,BAO_0000218,1969.0,
7621,,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,N,A,1,Intermediate,1,,CHEMBL622743,,BAO_0000218,1969.0,
7622,,Mus musculus,AUC in mice,N,A,1,Intermediate,1,,CHEMBL622744,,BAO_0000218,1969.0,
7623,,,Area under curve was measured from the graph obtained from concentration Vs time,U,A,0,Autocuration,1,,CHEMBL624134,,BAO_0000019,,
7624,,,Area under curve value of compound per hour after oral administration,U,A,0,Autocuration,1,,CHEMBL624135,,BAO_0000019,,
7625,,Rattus norvegicus,Area under curve was determined after oral administration in rats,N,A,1,Intermediate,1,,CHEMBL624136,,BAO_0000218,,
7626,,Rattus norvegicus,Area under curve was determined after oral administration in rats; No data,N,A,1,Intermediate,1,,CHEMBL624137,,BAO_0000218,,
7627,,Rattus norvegicus,Area under curve was determined after oral administration in rats;No data,N,A,1,Intermediate,1,,CHEMBL624320,,BAO_0000218,,
7628,,Canis lupus familiaris,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,A,1,Intermediate,1,,CHEMBL624321,,BAO_0000218,,
7629,,Rattus norvegicus,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL624322,,BAO_0000218,,
7630,,Rattus norvegicus,Area under curve was determined for the compound after iv dose of 5.06 in rats,N,A,1,Intermediate,1,,CHEMBL624323,,BAO_0000218,,
7631,,Rattus norvegicus,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL624324,,BAO_0000218,,
7632,,Rattus norvegicus,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL624325,,BAO_0000218,,
7633,,Rattus norvegicus,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL624326,,BAO_0000218,,
7634,,Rattus norvegicus,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL624327,,BAO_0000218,,
7635,,Rattus norvegicus,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL624328,,BAO_0000218,,
7636,,Canis lupus familiaris,Area under curve was determined in Dogs after peroral administration,N,A,1,Intermediate,1,,CHEMBL627848,,BAO_0000218,,
7637,,Rattus norvegicus,Area under curve was determined in Rats after peroral administration,N,A,1,Intermediate,1,,CHEMBL627849,,BAO_0000218,,
7638,,Rattus norvegicus,Area under curve was determined in carotid blood of rat when administered intradermally,N,A,1,Intermediate,1,,CHEMBL627850,,BAO_0000218,,
7639,,Rattus norvegicus,Area under curve was determined in portal blood of rat when administered intradermally,N,A,1,Intermediate,1,,CHEMBL627851,,BAO_0000218,,
7640,,Mus musculus,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL627852,,BAO_0000218,,
7641,,Mus musculus,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL627853,,BAO_0000218,,
7642,,Mus musculus,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,A,1,Intermediate,1,,CHEMBL627854,,BAO_0000218,,
7643,,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL627855,,BAO_0000218,,
7644,,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),N,A,1,Intermediate,1,,CHEMBL627856,,BAO_0000218,,
7645,,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL875339,,BAO_0000218,,
7646,,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),N,A,1,Intermediate,1,,CHEMBL627857,,BAO_0000218,,
7647,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL627858,,BAO_0000218,2106.0,
7648,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627859,,BAO_0000218,178.0,
7649,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627860,,BAO_0000218,955.0,
7650,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627019,,BAO_0000218,948.0,
7651,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627020,,BAO_0000218,2107.0,
7652,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627021,,BAO_0000218,2048.0,
7653,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627022,,BAO_0000218,2385.0,
7654,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627023,,BAO_0000218,,
7655,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627024,,BAO_0000218,2106.0,
7656,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627025,,BAO_0000218,2046.0,
7657,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627026,,BAO_0000218,2113.0,
7658,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627027,,BAO_0000218,178.0,
7659,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627028,,BAO_0000218,955.0,
7660,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627029,,BAO_0000218,948.0,
7661,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627030,,BAO_0000218,2113.0,
7662,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627031,,BAO_0000218,2107.0,
7663,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627032,,BAO_0000218,2048.0,
7664,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627033,,BAO_0000218,2385.0,
7665,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627034,,BAO_0000218,,
7666,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627035,,BAO_0000218,2106.0,
7667,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627036,,BAO_0000218,2046.0,
7668,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL875340,,BAO_0000218,178.0,
7669,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627037,,BAO_0000218,948.0,
7670,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627038,,BAO_0000218,2113.0,
7671,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627039,,BAO_0000218,2107.0,
7672,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL627040,,BAO_0000218,2385.0,
7673,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL624663,,BAO_0000218,2106.0,
7674,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL625963,,BAO_0000218,2046.0,
7675,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL876799,,BAO_0000218,955.0,
7676,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL626133,,BAO_0000218,2048.0,
7677,,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,N,A,1,Intermediate,1,,CHEMBL626134,,BAO_0000218,,
7678,,Rattus norvegicus,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL626135,,BAO_0000218,,
7679,,Rattus norvegicus,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL626136,,BAO_0000218,,
7680,,Rattus norvegicus,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,N,A,1,Intermediate,1,,CHEMBL626137,,BAO_0000218,,
7681,,Rattus norvegicus,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL626138,,BAO_0000218,,
7682,,Rattus norvegicus,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL626139,,BAO_0000218,,
7683,,Rattus norvegicus,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL626140,,BAO_0000218,,
7684,,Rattus norvegicus,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL626141,,BAO_0000218,,
7685,,Rattus norvegicus,C24h in rat p.o. at 20 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL626142,,BAO_0000218,,
7686,,Rattus norvegicus,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL627930,,BAO_0000218,2385.0,
7687,,Rattus norvegicus,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,N,A,1,Intermediate,1,,CHEMBL627931,,BAO_0000218,2385.0,
7688,,Rattus norvegicus,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL627932,,BAO_0000218,2385.0,
7689,,Rattus norvegicus,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL627933,,BAO_0000218,2106.0,
7690,,Rattus norvegicus,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,N,A,1,Intermediate,1,,CHEMBL627934,,BAO_0000218,2106.0,
7691,,Rattus norvegicus,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,N,A,1,Intermediate,1,,CHEMBL627935,,BAO_0000218,2106.0,
7692,,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL627936,,BAO_0000218,178.0,
7693,,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL627937,,BAO_0000218,178.0,
7694,,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL627938,,BAO_0000218,178.0,
7695,,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,N,A,1,Intermediate,1,,CHEMBL627939,,BAO_0000218,178.0,
7696,,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL627940,,BAO_0000218,178.0,
7697,,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL627941,,BAO_0000218,178.0,
7698,,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL876800,,BAO_0000218,178.0,
7699,,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL627942,,BAO_0000218,178.0,
7700,,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL627943,,BAO_0000218,178.0,
7701,,Rattus norvegicus,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,N,A,1,Intermediate,1,,CHEMBL627944,,BAO_0000218,178.0,
7702,,Rattus norvegicus,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,N,A,1,Intermediate,1,,CHEMBL627945,,BAO_0000218,178.0,
7703,,Rattus norvegicus,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,N,A,1,Intermediate,1,,CHEMBL628584,,BAO_0000218,178.0,
7704,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA at 15 min,N,A,1,Intermediate,1,,CHEMBL628585,,BAO_0000218,178.0,
7705,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,N,A,1,Intermediate,1,,CHEMBL628586,,BAO_0000218,178.0,
7706,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA at 30 min,N,A,1,Intermediate,1,,CHEMBL628587,,BAO_0000218,178.0,
7707,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,N,A,1,Intermediate,1,,CHEMBL628588,,BAO_0000218,178.0,
7708,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,N,A,1,Intermediate,1,,CHEMBL628589,,BAO_0000218,178.0,
7709,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,N,A,1,Intermediate,1,,CHEMBL625304,,BAO_0000218,178.0,
7710,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL625305,,BAO_0000218,178.0,
7711,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,N,A,1,Intermediate,1,,CHEMBL625306,,BAO_0000218,178.0,
7712,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,N,A,1,Intermediate,1,,CHEMBL625307,,BAO_0000218,178.0,
7713,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,N,A,1,Intermediate,1,,CHEMBL625308,,BAO_0000218,178.0,
7714,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL627740,,BAO_0000218,178.0,
7715,,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,N,A,1,Intermediate,1,,CHEMBL627741,,BAO_0000218,178.0,
7716,,Rattus norvegicus,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL627742,,BAO_0000218,178.0,
7717,,Rattus norvegicus,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,N,A,1,Intermediate,1,,CHEMBL627743,,BAO_0000218,178.0,
7718,,Rattus norvegicus,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,N,A,1,Intermediate,1,,CHEMBL627744,,BAO_0000218,178.0,
7719,,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL627745,,BAO_0000218,10000001.0,
7720,,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL627746,,BAO_0000218,10000001.0,
7721,,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL627747,,BAO_0000218,10000001.0,
7722,,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,N,A,1,Intermediate,1,,CHEMBL876810,,BAO_0000218,10000001.0,
7723,,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL627748,,BAO_0000218,10000001.0,
7724,,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL627749,,BAO_0000218,10000001.0,
7725,,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL627750,,BAO_0000218,10000001.0,
7726,,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL618728,,BAO_0000218,10000001.0,
7727,,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL618729,,BAO_0000218,10000001.0,
7728,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA at 15 min,N,A,1,Intermediate,1,,CHEMBL618730,,BAO_0000218,10000001.0,
7729,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,N,A,1,Intermediate,1,,CHEMBL618731,,BAO_0000218,10000001.0,
7730,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA at 30 min,N,A,1,Intermediate,1,,CHEMBL618732,,BAO_0000218,10000001.0,
7731,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,N,A,1,Intermediate,1,,CHEMBL618733,,BAO_0000218,10000001.0,
7732,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,N,A,1,Intermediate,1,,CHEMBL618734,,BAO_0000218,10000001.0,
7733,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,N,A,1,Intermediate,1,,CHEMBL618735,,BAO_0000218,10000001.0,
7734,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,N,A,1,Intermediate,1,,CHEMBL876602,,BAO_0000218,10000001.0,
7735,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL618736,,BAO_0000218,10000001.0,
7736,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,N,A,1,Intermediate,1,,CHEMBL618737,,BAO_0000218,10000001.0,
7737,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,N,A,1,Intermediate,1,,CHEMBL618738,,BAO_0000218,10000001.0,
7738,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,N,A,1,Intermediate,1,,CHEMBL618739,,BAO_0000218,10000001.0,
7739,,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL618740,,BAO_0000218,10000001.0,
7740,,Rattus norvegicus,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL618741,,BAO_0000218,10000001.0,
7741,,Rattus norvegicus,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,N,A,1,Intermediate,1,,CHEMBL618742,,BAO_0000218,10000001.0,
7742,,Rattus norvegicus,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,N,A,1,Intermediate,1,,CHEMBL618743,,BAO_0000218,10000001.0,
7743,,Rattus norvegicus,Half-life from rat plasma at a single oral dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL618744,,BAO_0000218,1969.0,
7744,,Rattus norvegicus,Half-life in male rat,N,A,1,Intermediate,1,,CHEMBL618745,,BAO_0000218,,
7745,,Rattus norvegicus,Half-life in rat after peroral administration at 10 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL620479,,BAO_0000218,,
7746,,Rattus norvegicus,Half-life in rat after peroral administration at 5 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL620480,,BAO_0000218,,
7747,,Rattus norvegicus,Half-life in rat at a dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL620481,,BAO_0000218,,
7748,,Rattus norvegicus,Half-life was evaluated in rats,N,A,1,Intermediate,1,,CHEMBL620482,,BAO_0000218,,
7749,,Rattus norvegicus,Half-life was measured in rat,N,A,1,Intermediate,1,,CHEMBL876603,,BAO_0000218,,
7750,,Rattus norvegicus,Half-life period for the compound was determined in rats at 50 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL620483,,BAO_0000218,,
7751,,Rattus norvegicus,Half-life period in rats after intravenous administration at 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL620484,,BAO_0000218,,
7752,,Rattus norvegicus,Half-life period in rat at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL620485,,BAO_0000218,,
7753,,Rattus norvegicus,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL620486,,BAO_0000218,,
7754,,Rattus norvegicus,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",N,A,1,Intermediate,1,,CHEMBL620487,,BAO_0000218,,
7755,,Rattus norvegicus,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",N,A,1,Intermediate,1,,CHEMBL620488,,BAO_0000218,,
7756,,Rattus norvegicus,Half-life time in rat the dose of 2 mg/kg,N,A,1,Intermediate,1,,CHEMBL620489,,BAO_0000218,,
7757,,Rattus norvegicus,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,N,A,1,Intermediate,1,,CHEMBL620490,,BAO_0000218,,
7758,,Rattus norvegicus,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,N,A,1,Intermediate,1,,CHEMBL620491,,BAO_0000218,,
7759,,Rattus norvegicus,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,A,1,Intermediate,1,,CHEMBL876604,,BAO_0000218,1969.0,
7760,,Rattus norvegicus,Oral half life was determined,N,A,1,Intermediate,1,,CHEMBL620492,,BAO_0000218,,
7761,,Rattus norvegicus,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",N,A,1,Intermediate,1,,CHEMBL620493,,BAO_0000218,,
7762,,Rattus norvegicus,Pharmacokinetic property (t1/2) in rat,N,A,1,Intermediate,1,,CHEMBL620494,,BAO_0000218,,
7763,,Rattus norvegicus,Plasma elimination half-life was determined,N,A,1,Intermediate,1,,CHEMBL620495,,BAO_0000218,1969.0,
7764,,Rattus norvegicus,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,A,1,Intermediate,1,,CHEMBL620496,,BAO_0000218,1969.0,
7765,,Rattus norvegicus,Plasma half life was observed after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL620497,,BAO_0000218,1969.0,
7766,,Rattus norvegicus,Plasma half-life was determined,N,A,1,Intermediate,1,,CHEMBL620498,,BAO_0000218,1969.0,
7767,,Rattus norvegicus,Plasma half-life following oral administration in Fisher rats,N,A,1,Intermediate,1,,CHEMBL620499,,BAO_0000218,1969.0,
7768,,Rattus norvegicus,Plasma half-life in rat,N,A,1,Intermediate,1,,CHEMBL620500,,BAO_0000218,1969.0,
7769,,Rattus norvegicus,Plasmatic Half-life after intravenous administration to rat,N,A,1,Intermediate,1,,CHEMBL873809,,BAO_0000218,1969.0,
7770,,Rattus norvegicus,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,A,1,Intermediate,1,,CHEMBL620501,,BAO_0000218,,
7771,,Rattus norvegicus,Terminal half life after intravenous administration (1 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL620502,,BAO_0000218,,
7772,,Rattus norvegicus,Terminal half life in Rat at a oral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL620503,,BAO_0000218,,
7773,,Rattus norvegicus,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,A,1,Intermediate,1,,CHEMBL620504,,BAO_0000218,,
7774,,Rattus norvegicus,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL876605,,BAO_0000218,,
7775,,Rattus norvegicus,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL620505,,BAO_0000218,,
7776,,Rattus norvegicus,plasma half life was observed after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL873811,,BAO_0000218,1969.0,
7777,,Rattus norvegicus,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,A,1,Expert,1,,CHEMBL624016,,BAO_0000218,,
7778,,Rattus norvegicus,Half life of compound determined in rat,N,A,1,Intermediate,1,,CHEMBL624017,,BAO_0000218,,
7779,,Rattus norvegicus,Mean residence time determined in rat,N,A,1,Intermediate,1,,CHEMBL624018,,BAO_0000218,,
7780,,Rattus norvegicus,Plasma half life determined in rat,N,A,1,Intermediate,1,,CHEMBL624019,,BAO_0000218,,
7781,,Rattus norvegicus,Compound was evaluated for Tmax in brain after intravenous administration in male rats,N,A,1,Intermediate,1,,CHEMBL624020,,BAO_0000218,955.0,
7782,,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter maximum time period,N,A,1,Intermediate,1,,CHEMBL624201,,BAO_0000218,,
7783,,Rattus norvegicus,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL872528,,BAO_0000218,,
7784,,Rattus norvegicus,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624202,,BAO_0000218,,
7785,,Rattus norvegicus,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624203,,BAO_0000218,,
7786,,Rattus norvegicus,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624350,,BAO_0000218,,
7787,,Rattus norvegicus,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL621320,,BAO_0000218,,
7788,,Rattus norvegicus,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,A,1,Intermediate,1,,CHEMBL621321,,BAO_0000218,,
7789,,Rattus norvegicus,Maximum time (Tmax) required to reach Cmax in rats,N,A,1,Intermediate,1,,CHEMBL621322,,BAO_0000218,,
7790,,Rattus norvegicus,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL621323,,BAO_0000218,,
7791,,Rattus norvegicus,Maximum time of clearance of compound in rats after peroral administration,N,A,1,Intermediate,1,,CHEMBL621324,,BAO_0000218,,
7792,,Rattus norvegicus,Maximum time at the dose of 2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL621325,,BAO_0000218,,
7793,,Rattus norvegicus,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL875837,,BAO_0000218,1969.0,
7794,,Rattus norvegicus,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL621326,,BAO_0000218,1969.0,
7795,,Rattus norvegicus,Tmax in Guinea pig (PO dose),N,A,1,Intermediate,1,,CHEMBL621327,,BAO_0000218,,
7796,,Rattus norvegicus,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",N,A,1,Intermediate,1,,CHEMBL621328,,BAO_0000218,,
7797,,Rattus norvegicus,Pharmacokinetic parameter (Tmax) in rat,N,A,1,Intermediate,1,,CHEMBL621329,,BAO_0000218,,
7798,,Rattus norvegicus,Pharmacokinetic parameter (Tmax) was estimated,N,A,1,Intermediate,1,,CHEMBL621330,,BAO_0000218,,
7799,,Rattus norvegicus,Pharmacokinetic property (Tmax) in rat,N,A,1,Intermediate,1,,CHEMBL621331,,BAO_0000218,,
7800,,Rattus norvegicus,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,A,1,Intermediate,1,,CHEMBL621332,,BAO_0000218,,
7801,,Rattus norvegicus,T max in Rat at a oral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL621333,,BAO_0000218,,
7802,,Rattus norvegicus,T max was determined at 10 mg/kg po dose in rats,N,A,1,Intermediate,1,,CHEMBL621334,,BAO_0000218,,
7803,,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),N,A,1,Intermediate,1,,CHEMBL621335,,BAO_0000218,,
7804,,Canis lupus familiaris,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,N,A,1,Intermediate,1,,CHEMBL621336,,BAO_0000218,,
7805,,Rattus norvegicus,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,N,A,1,Intermediate,1,,CHEMBL621337,,BAO_0000218,,
7806,,Canis lupus familiaris,Area under curve was measured after i.v. administration into Beagle dog.,N,A,1,Intermediate,1,,CHEMBL621338,,BAO_0000218,,
7807,,Canis lupus familiaris,Area under curve was measured after iv administration into Beagle dog,N,A,1,Intermediate,1,,CHEMBL875838,,BAO_0000218,,
7808,,Canis lupus familiaris,Area under curve was measured after po administration into Beagle dog,N,A,1,Intermediate,1,,CHEMBL621339,,BAO_0000218,,
7809,,Canis lupus familiaris,Area under curve was measured after po administration into Beagle dog.,N,A,1,Intermediate,1,,CHEMBL621340,,BAO_0000218,,
7810,,,Area under curve was measured at peroral dose of 3 mg/kg,U,A,0,Autocuration,1,,CHEMBL621341,,BAO_0000218,,
7811,,,Area under curve was measured by using concentration Vs time,U,A,0,Autocuration,1,,CHEMBL621342,,BAO_0000019,,
7812,,,Area under curve was measured by using concentration Vs time; not tested,U,A,0,Autocuration,1,,CHEMBL621343,,BAO_0000019,,
7813,,Mus musculus,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),N,A,1,Intermediate,1,,CHEMBL621344,,BAO_0000218,,
7814,,Mus musculus,Area under curve(AUC) was measured in mice after oral administration.,N,A,1,Intermediate,1,,CHEMBL621345,,BAO_0000218,,
7815,,,Area under curve(AUC) value of the compound,U,A,0,Autocuration,1,,CHEMBL621346,,BAO_0000019,,
7816,,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,U,A,0,Autocuration,1,,CHEMBL621347,,BAO_0000218,,
7817,,Canis lupus familiaris,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,N,A,1,Intermediate,1,,CHEMBL621348,,BAO_0000218,,
7818,,,Area under curve(carotid artery) was determined by the availability in blood,U,A,0,Autocuration,1,,CHEMBL621349,,BAO_0000019,178.0,
7819,,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,U,A,0,Autocuration,1,,CHEMBL621350,,BAO_0000019,178.0,
7820,,,Area under curve(carotid artery) was determined by the availability in blood; No data,U,A,0,Autocuration,1,,CHEMBL875839,,BAO_0000019,178.0,
7821,,,Area under curve(portal vein) was determined by the availability in blood,U,A,0,Autocuration,1,,CHEMBL620211,,BAO_0000019,178.0,
7822,,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,U,A,0,Autocuration,1,,CHEMBL620212,,BAO_0000019,178.0,
7823,,,Area under curve(portal vein) was determined by the availability in blood; No data,U,A,0,Autocuration,1,,CHEMBL620213,,BAO_0000019,178.0,
7824,,Macaca mulatta,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,A,1,Intermediate,1,,CHEMBL620214,,BAO_0000218,1969.0,
7825,,Macaca mulatta,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,A,1,Intermediate,1,,CHEMBL620215,,BAO_0000218,1969.0,
7826,,Macaca mulatta,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL620216,,BAO_0000218,1969.0,
7827,,Canis lupus familiaris,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",N,A,1,Intermediate,1,,CHEMBL620888,,BAO_0000218,1969.0,
7828,,Canis lupus familiaris,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",N,A,1,Intermediate,1,,CHEMBL620889,,BAO_0000218,1969.0,
7829,,,Area under plasma concentration vs time curve observed in rats for 0-3 h,U,A,0,Autocuration,1,,CHEMBL620890,,BAO_0000019,1969.0,
7830,,Rattus norvegicus,Area under plasma time curve determined in male rat,N,A,1,Intermediate,1,,CHEMBL620891,,BAO_0000218,1969.0,
7831,,,Area under the MAP curve measured over 5 min.,U,A,0,Autocuration,1,,CHEMBL620892,,BAO_0000019,,
7832,,Mus musculus,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,N,A,1,Intermediate,1,,CHEMBL621079,,BAO_0000218,,
7833,,Mus musculus,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,N,A,1,Intermediate,1,,CHEMBL621080,,BAO_0000218,,
7834,,Canis lupus familiaris,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL621081,,BAO_0000218,,
7835,,Cricetinae,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL621082,,BAO_0000218,,
7836,,Rattus norvegicus,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL621083,,BAO_0000218,,
7837,,Canis lupus familiaris,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,N,A,1,Intermediate,1,,CHEMBL621084,,BAO_0000218,,
7838,,Canis lupus familiaris,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,N,A,1,Intermediate,1,,CHEMBL621085,,BAO_0000218,,
7839,,Canis lupus familiaris,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,N,A,1,Intermediate,1,,CHEMBL621086,,BAO_0000218,,
7840,,Canis lupus familiaris,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,A,1,Intermediate,1,,CHEMBL621087,,BAO_0000218,,
7841,,Canis lupus familiaris,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),N,A,1,Intermediate,1,,CHEMBL622607,,BAO_0000218,,
7842,,Canis lupus familiaris,Serum AUC in marmosets (IV dose),N,A,1,Intermediate,1,,CHEMBL622608,,BAO_0000218,,
7843,,,Area under the curve after intravenous administration at a dose of 10 umol/kg,U,A,0,Autocuration,1,,CHEMBL624481,,BAO_0000019,,
7844,,,Area under the curve after intravenous administration at a dose of 2 umol/kg,U,A,0,Autocuration,1,,CHEMBL624482,,BAO_0000019,,
7845,,,Area under the curve after intravenous administration at a dose of 4 umol/kg,U,A,0,Autocuration,1,,CHEMBL624483,,BAO_0000019,,
7846,,,Area under the curve after intravenous administration at a dose of 40 umol/kg,U,A,0,Autocuration,1,,CHEMBL624484,,BAO_0000019,,
7847,,,Area under the curve after intravenous administration at a dose of 5 umol/kg,U,A,0,Autocuration,1,,CHEMBL624485,,BAO_0000019,,
7848,,Rattus norvegicus,Area under the curve for fumarate salt was evaluated in F344 Rats.,N,A,1,Intermediate,1,,CHEMBL624486,,BAO_0000218,,
7849,,,Area under the curve for the compound was calculated.,U,A,0,Autocuration,1,,CHEMBL624487,,BAO_0000019,,
7850,,,Area under the curve in concentration/ time,U,A,0,Autocuration,1,,CHEMBL624488,,BAO_0000019,,
7851,,Rattus norvegicus,Area under the curve administered intraintestinal in rats.,N,A,1,Intermediate,1,,CHEMBL624489,,BAO_0000218,,
7852,,Rattus norvegicus,Area under the curve administered intravenously in rats.,N,A,1,Intermediate,1,,CHEMBL625184,,BAO_0000218,,
7853,,,Area under the curve during intravenous administration,U,A,0,Autocuration,1,,CHEMBL625185,,BAO_0000019,,
7854,,,Area under the curve during intravenous administration; Not determined,U,A,0,Autocuration,1,,CHEMBL875954,,BAO_0000019,,
7855,,,Area under the curve during systemic administration,U,A,0,Autocuration,1,,CHEMBL625186,,BAO_0000019,,
7856,,,Area under the curve during systemic administration; Not determined,U,A,0,Autocuration,1,,CHEMBL625187,,BAO_0000019,,
7857,,,Area under the curve was calculated for the compound.,U,A,0,Autocuration,1,,CHEMBL625188,,BAO_0000019,,
7858,,Canis lupus familiaris,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,N,A,1,Intermediate,1,,CHEMBL625189,,BAO_0000218,,
7859,,Canis lupus familiaris,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,N,A,1,Intermediate,1,,CHEMBL625190,,BAO_0000218,,
7860,,Rattus norvegicus,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL621733,,BAO_0000218,,
7861,,Rattus norvegicus,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL621734,,BAO_0000218,,
7862,,Rattus norvegicus,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,N,A,1,Intermediate,1,,CHEMBL621735,,BAO_0000218,,
7863,,Rattus norvegicus,Clearance of the drug was measured in the plasma of rat; No data,N,A,1,Intermediate,1,,CHEMBL621736,,BAO_0000218,1969.0,
7864,,Rattus norvegicus,The pharmacokinetic parameter plasma clearance in vivo in rats,N,A,1,Intermediate,1,,CHEMBL621737,,BAO_0000218,1969.0,
7865,,Rattus norvegicus,Plasma clearance at the dose of 2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL621738,,BAO_0000218,,
7866,,Rattus norvegicus,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL622806,,BAO_0000218,,
7867,,Rattus norvegicus,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL623519,,BAO_0000218,,
7868,,Rattus norvegicus,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL623520,,BAO_0000218,,
7869,,Rattus norvegicus,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,A,1,Intermediate,1,,CHEMBL623521,,BAO_0000218,,
7870,,Rattus norvegicus,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,A,1,Intermediate,1,,CHEMBL623522,,BAO_0000218,,
7871,,Rattus norvegicus,Clearance rate in rat,N,A,1,Intermediate,1,,CHEMBL623523,,BAO_0000218,,
7872,,Rattus norvegicus,Clearance rate in rat,N,A,1,Intermediate,1,,CHEMBL623690,,BAO_0000218,,
7873,,Rattus norvegicus,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623691,,BAO_0000218,,
7874,,Rattus norvegicus,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623692,,BAO_0000218,,
7875,,Rattus norvegicus,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623693,,BAO_0000218,,
7876,,Rattus norvegicus,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623694,,BAO_0000218,,
7877,,Rattus norvegicus,Clearance of compound after iv administration of 20 mg/kg dose in rat,N,A,1,Intermediate,1,,CHEMBL623695,,BAO_0000218,,
7878,,Rattus norvegicus,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,N,A,1,Intermediate,1,,CHEMBL623696,,BAO_0000218,,
7879,,Rattus norvegicus,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,N,A,1,Intermediate,1,,CHEMBL623697,,BAO_0000218,,
7880,,Macaca mulatta,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,A,0,Intermediate,1,,CHEMBL623698,,BAO_0000218,1969.0,
7881,,Rattus norvegicus,Compound was tested for its plasma clearance rate in Sprague Dawley rats,U,A,0,Intermediate,1,,CHEMBL623699,,BAO_0000218,1969.0,
7882,,Rattus norvegicus,Mean (%CV) PK parameters for CL(mL/min/kg).,N,A,1,Intermediate,1,,CHEMBL623700,,BAO_0000218,,
7883,,Rattus norvegicus,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,N,A,1,Intermediate,1,,CHEMBL623701,,BAO_0000218,,
7884,,Rattus norvegicus,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,N,A,1,Intermediate,1,,CHEMBL623702,,BAO_0000218,1969.0,
7885,,Rattus norvegicus,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,N,A,1,Intermediate,1,,CHEMBL623703,,BAO_0000218,,
7886,,Rattus norvegicus,Plasma clearance in rat was determined,N,A,1,Intermediate,1,,CHEMBL623704,,BAO_0000218,,
7887,,Rattus norvegicus,Plasma clearance in rat after administration of 2 mg/kg iv,N,A,1,Intermediate,1,,CHEMBL623705,,BAO_0000218,,
7888,,Rattus norvegicus,Plasma clearance in rat after administration of 2 mg/kg iv,N,A,1,Intermediate,1,,CHEMBL623706,,BAO_0000218,,
7889,,Rattus norvegicus,Plasma clearance was determined,N,A,1,Intermediate,1,,CHEMBL623707,,BAO_0000218,,
7890,,Rattus norvegicus,Plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL623708,,BAO_0000218,,
7891,,Rattus norvegicus,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,N,A,1,Intermediate,1,,CHEMBL623709,,BAO_0000218,,
7892,,Rattus norvegicus,Plasma clearance in rat by iv administration,N,A,1,Intermediate,1,,CHEMBL623710,,BAO_0000218,,
7893,,Rattus norvegicus,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL623711,,BAO_0000218,,
7894,,Rattus norvegicus,Plasma clearance in rat p.o.,N,A,1,Intermediate,1,,CHEMBL623712,,BAO_0000218,,
7895,,Rattus norvegicus,Plasma clearance in rats,N,A,1,Intermediate,1,,CHEMBL623713,,BAO_0000218,,
7896,,Rattus norvegicus,Plasma clearance was determined; ND denotes no data,N,A,1,Intermediate,1,,CHEMBL623714,,BAO_0000218,,
7897,,Rattus norvegicus,Plasma clearance was determined; ND denotes not determined,N,A,1,Intermediate,1,,CHEMBL623715,,BAO_0000218,,
7898,,Rattus norvegicus,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,A,1,Intermediate,1,,CHEMBL623716,,BAO_0000218,,
7899,,Rattus norvegicus,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,A,1,Intermediate,1,,CHEMBL622980,,BAO_0000218,,
7900,,Rattus norvegicus,Plasma administration to rats,N,A,1,Intermediate,1,,CHEMBL622981,,BAO_0000218,,
7901,,Rattus norvegicus,Plasma clearance of the compound in female Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL622982,,BAO_0000218,,
7902,,Rattus norvegicus,Plasma clearance was observed after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL622983,,BAO_0000218,,
7903,,Rattus norvegicus,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,N,A,1,Intermediate,1,,CHEMBL622984,,BAO_0000218,,
7904,,Rattus norvegicus,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,N,A,1,Intermediate,1,,CHEMBL622985,,BAO_0000218,,
7905,,Rattus norvegicus,plasma clearance was observed after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL623631,,BAO_0000218,1969.0,
7906,,Rattus norvegicus,In vivo CL/F determined,N,A,1,Intermediate,1,,CHEMBL623632,,BAO_0000218,,
7907,,Rattus norvegicus,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,N,A,1,Intermediate,1,,CHEMBL623633,,BAO_0000218,1969.0,
7908,,Rattus norvegicus,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,N,A,1,Intermediate,1,,CHEMBL623634,,BAO_0000218,1969.0,
7909,,Rattus norvegicus,Compound was tested for the lower blood clearance in rat,N,A,1,Intermediate,1,,CHEMBL623635,,BAO_0000218,,
7910,,Rattus norvegicus,Evaluated for the low clearance in rat (in vivo),N,A,1,Intermediate,1,,CHEMBL621195,,BAO_0000218,,
7911,,Rattus norvegicus,Pharmacokinetic property (CLb)of the compound was determined in rat,N,A,1,Intermediate,1,,CHEMBL621196,,BAO_0000218,,
7912,,Rattus norvegicus,Rapid clearance after intravenous administration in rat was determined,N,A,1,Intermediate,1,,CHEMBL875287,,BAO_0000218,,
7913,,Rattus norvegicus,Clearance measured in rat,N,A,1,Intermediate,1,,CHEMBL621197,,BAO_0000218,,
7914,,Rattus norvegicus,Compound was evaluated for plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL621198,,BAO_0000218,1969.0,
7915,,Rattus norvegicus,Low plasma clearance was calculated in rat,N,A,1,Intermediate,1,,CHEMBL621199,,BAO_0000218,1969.0,
7916,,Rattus norvegicus,Pharmacokinetic property (Clp) in rat,N,A,1,Intermediate,1,,CHEMBL621200,,BAO_0000218,,
7917,,Rattus norvegicus,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,N,A,1,Intermediate,1,,CHEMBL621201,,BAO_0000218,,
7918,,Rattus norvegicus,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,N,A,1,Intermediate,1,,CHEMBL621202,,BAO_0000218,,
7919,,Rattus norvegicus,Plasma clearance after IV dosing at 0.5 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL621203,,BAO_0000218,,
7920,,Rattus norvegicus,Plasma clearance after IV dosing at 1 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL621204,,BAO_0000218,,
7921,,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL621205,,BAO_0000218,948.0,
7922,,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL621206,,BAO_0000218,948.0,
7923,,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL621207,,BAO_0000218,948.0,
7924,,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL621208,,BAO_0000218,948.0,
7925,,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,N,A,1,Intermediate,1,,CHEMBL621209,,BAO_0000218,948.0,
7926,,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL876484,,BAO_0000218,948.0,
7927,,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL621210,,BAO_0000218,948.0,
7928,,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL621211,,BAO_0000218,948.0,
7929,,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL621212,,BAO_0000218,948.0,
7930,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA at 15 min,N,A,1,Intermediate,1,,CHEMBL621213,,BAO_0000218,948.0,
7931,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,N,A,1,Intermediate,1,,CHEMBL621214,,BAO_0000218,948.0,
7932,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA at 30 min,N,A,1,Intermediate,1,,CHEMBL621215,,BAO_0000218,948.0,
7933,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,N,A,1,Intermediate,1,,CHEMBL621216,,BAO_0000218,948.0,
7934,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,N,A,1,Intermediate,1,,CHEMBL621217,,BAO_0000218,948.0,
7935,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,N,A,1,Intermediate,1,,CHEMBL621218,,BAO_0000218,948.0,
7936,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL621219,,BAO_0000218,948.0,
7937,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,N,A,1,Intermediate,1,,CHEMBL621220,,BAO_0000218,948.0,
7938,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,N,A,1,Intermediate,1,,CHEMBL621221,,BAO_0000218,948.0,
7939,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,N,A,1,Intermediate,1,,CHEMBL621222,,BAO_0000218,948.0,
7940,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL621223,,BAO_0000218,948.0,
7941,,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,N,A,1,Intermediate,1,,CHEMBL876485,,BAO_0000218,948.0,
7942,,Rattus norvegicus,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL621224,,BAO_0000218,948.0,
7943,,Rattus norvegicus,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,N,A,1,Intermediate,1,,CHEMBL621225,,BAO_0000218,948.0,
7944,,Rattus norvegicus,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,N,A,1,Intermediate,1,,CHEMBL621226,,BAO_0000218,948.0,
7945,,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL621227,,BAO_0000218,2113.0,
7946,,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL621228,,BAO_0000218,2113.0,
7947,,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL621229,,BAO_0000218,2113.0,
7948,,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,N,A,1,Intermediate,1,,CHEMBL621230,,BAO_0000218,2113.0,
7949,,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,A,1,Intermediate,1,,CHEMBL621231,,BAO_0000218,2113.0,
7950,,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL621232,,BAO_0000218,2113.0,
7951,,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL621233,,BAO_0000218,2113.0,
7952,,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL621234,,BAO_0000218,2113.0,
7953,,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,A,1,Intermediate,1,,CHEMBL621235,,BAO_0000218,2113.0,
7954,,Rattus norvegicus,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL621236,,BAO_0000218,2113.0,
7955,,Rattus norvegicus,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,N,A,1,Intermediate,1,,CHEMBL621237,,BAO_0000218,2113.0,
7956,,Rattus norvegicus,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,N,A,1,Intermediate,1,,CHEMBL876486,,BAO_0000218,2113.0,
7957,,Rattus norvegicus,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,N,A,1,Intermediate,1,,CHEMBL622436,,BAO_0000218,160.0,
7958,,Rattus norvegicus,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,N,A,1,Intermediate,1,,CHEMBL622437,,BAO_0000218,160.0,
7959,,Rattus norvegicus,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,N,A,1,Intermediate,1,,CHEMBL622438,,BAO_0000218,160.0,
7960,,Rattus norvegicus,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,N,A,1,Intermediate,1,,CHEMBL622439,,BAO_0000218,2107.0,
7961,,Rattus norvegicus,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,N,A,1,Intermediate,1,,CHEMBL622440,,BAO_0000218,2107.0,
7962,,Rattus norvegicus,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,N,A,1,Intermediate,1,,CHEMBL622441,,BAO_0000218,2107.0,
7963,,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL622442,,BAO_0000218,2107.0,
7964,,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL622443,,BAO_0000218,2107.0,
7965,,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL622444,,BAO_0000218,2107.0,
7966,,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL622445,,BAO_0000218,2107.0,
7967,,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,A,1,Intermediate,1,,CHEMBL622446,,BAO_0000218,2107.0,
7968,,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL622447,,BAO_0000218,2107.0,
7969,,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL622448,,BAO_0000218,2107.0,
7970,,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,A,1,Intermediate,1,,CHEMBL622449,,BAO_0000218,2107.0,
7971,,Rattus norvegicus,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,N,A,1,Intermediate,1,,CHEMBL622450,,BAO_0000218,2107.0,
7972,,Rattus norvegicus,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,N,A,1,Intermediate,1,,CHEMBL622451,,BAO_0000218,2107.0,
7973,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA at 15 min,N,A,1,Intermediate,1,,CHEMBL622452,,BAO_0000218,2107.0,
7974,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,N,A,1,Intermediate,1,,CHEMBL622453,,BAO_0000218,2107.0,
7975,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA at 30 min,N,A,1,Intermediate,1,,CHEMBL622454,,BAO_0000218,2107.0,
7976,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,N,A,1,Intermediate,1,,CHEMBL622455,,BAO_0000218,2107.0,
7977,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,N,A,1,Intermediate,1,,CHEMBL876024,,BAO_0000218,2107.0,
7978,,Rattus norvegicus,T max was determined at 3 mg/kg po dose in rats,N,A,1,Intermediate,1,,CHEMBL622456,,BAO_0000218,,
7979,,Rattus norvegicus,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL622457,,BAO_0000218,,
7980,,Rattus norvegicus,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL622458,,BAO_0000218,,
7981,,Rattus norvegicus,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,N,A,1,Intermediate,1,,CHEMBL622459,,BAO_0000218,,
7982,,Rattus norvegicus,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,N,A,1,Intermediate,1,,CHEMBL873343,,BAO_0000218,,
7983,,Rattus norvegicus,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,N,A,1,Intermediate,1,,CHEMBL622460,,BAO_0000218,,
7984,,Rattus norvegicus,Time for maximum plasma concentration determined in rat,N,A,1,Intermediate,1,,CHEMBL622461,,BAO_0000218,1969.0,
7985,,Rattus norvegicus,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL622462,,BAO_0000218,1969.0,
7986,,Rattus norvegicus,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,N,A,1,Intermediate,1,,CHEMBL622463,,BAO_0000218,,
7987,,Rattus norvegicus,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,N,A,1,Intermediate,1,,CHEMBL622464,,BAO_0000218,,
7988,,Rattus norvegicus,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL622465,,BAO_0000218,,
7989,,Rattus norvegicus,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,N,A,1,Intermediate,1,,CHEMBL622466,,BAO_0000218,,
7990,,Rattus norvegicus,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL622467,,BAO_0000218,,
7991,,Rattus norvegicus,Time of maximum plasma concentration in rat,N,A,1,Intermediate,1,,CHEMBL622468,,BAO_0000218,1969.0,
7992,,Rattus norvegicus,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL876025,,BAO_0000218,1969.0,
7993,,Rattus norvegicus,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,A,1,Intermediate,1,,CHEMBL622469,,BAO_0000218,1969.0,
7994,,Rattus norvegicus,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,A,1,Intermediate,1,,CHEMBL622470,,BAO_0000218,1969.0,
7995,,Rattus norvegicus,Time required to reach maximum concentration (Cmax) after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL622471,,BAO_0000218,,
7996,,Rattus norvegicus,Time required to reach maximum concentration in rat plasma,N,A,1,Intermediate,1,,CHEMBL622472,,BAO_0000218,1969.0,
7997,,Rattus norvegicus,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,A,1,Intermediate,1,,CHEMBL622473,,BAO_0000218,1969.0,
7998,,Rattus norvegicus,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL624282,,BAO_0000218,1969.0,
7999,,Rattus norvegicus,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL624283,,BAO_0000218,1969.0,
8000,,Rattus norvegicus,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL624284,,BAO_0000218,1969.0,
8001,,Rattus norvegicus,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,A,1,Intermediate,1,,CHEMBL624285,,BAO_0000218,1969.0,
8002,,Rattus norvegicus,Time to reach Cmax after oral administration to rats,N,A,1,Intermediate,1,,CHEMBL624286,,BAO_0000218,,
8003,,Rattus norvegicus,Time to reach Cmax when a dose of 1 mg/kg is administered orally,N,A,1,Intermediate,1,,CHEMBL624287,,BAO_0000218,,
8004,,Rattus norvegicus,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,N,A,1,Intermediate,1,,CHEMBL624288,,BAO_0000218,,
8005,,Rattus norvegicus,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,N,A,1,Intermediate,1,,CHEMBL624289,,BAO_0000218,1969.0,
8006,,Rattus norvegicus,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL873344,,BAO_0000218,1969.0,
8007,,Rattus norvegicus,Tmax after peroral administration (10 mg/kg) was determined in rat,N,A,1,Intermediate,1,,CHEMBL619623,,BAO_0000218,,
8008,,Rattus norvegicus,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,N,A,1,Expert,1,,CHEMBL621399,,BAO_0000218,,
8009,,Rattus norvegicus,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,N,A,1,Intermediate,1,,CHEMBL621400,,BAO_0000218,,
8010,,Rattus norvegicus,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",N,A,1,Intermediate,1,,CHEMBL621401,,BAO_0000218,,
8011,,Rattus norvegicus,Tmax was determined,N,A,1,Intermediate,1,,CHEMBL621402,,BAO_0000218,,
8012,,Rattus norvegicus,Tmax was determined,N,A,1,Intermediate,1,,CHEMBL621403,,BAO_0000218,,
8013,,Rattus norvegicus,Tmax after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL621121,,BAO_0000218,,
8014,,Rattus norvegicus,Tmax after peroral administration in rats at 2.4 uM/kg,N,A,1,Intermediate,1,,CHEMBL872525,,BAO_0000218,,
8015,,Rattus norvegicus,Tmax in male rat,N,A,1,Intermediate,1,,CHEMBL621122,,BAO_0000218,,
8016,,Rattus norvegicus,Tmax in rat at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL621123,,BAO_0000218,,
8017,,Rattus norvegicus,Tmax in rat by po administration at a dose of 40 mg/kg,N,A,1,Intermediate,1,,CHEMBL621124,,BAO_0000218,,
8018,,Rattus norvegicus,Tmax in rats,N,A,1,Intermediate,1,,CHEMBL621125,,BAO_0000218,,
8019,,Rattus norvegicus,Tmax was measured in rats after peroral administration at 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL621126,,BAO_0000218,,
8020,,Rattus norvegicus,Tmax value after oral dose at a dose of 10 mg/kg in rats.,N,A,1,Intermediate,1,,CHEMBL621127,,BAO_0000218,,
8021,,Rattus norvegicus,Tmax value after administration of 20 mg/Kg oral dose in rat,N,A,1,Intermediate,1,,CHEMBL621128,,BAO_0000218,,
8022,,Rattus norvegicus,Tmax value at a dose of 10 mg/kg in male SD rats,N,A,1,Intermediate,1,,CHEMBL618263,,BAO_0000218,,
8023,,Rattus norvegicus,Tmax value at a dose of 100 mg/kg in male SD rats,N,A,1,Intermediate,1,,CHEMBL618264,,BAO_0000218,,
8024,,Rattus norvegicus,Tmax value at a dose of 50 mg/kg in male SD rats,N,A,1,Intermediate,1,,CHEMBL618265,,BAO_0000218,,
8025,,Rattus norvegicus,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,A,1,Intermediate,1,,CHEMBL618266,,BAO_0000218,1969.0,
8026,,Rattus norvegicus,time required to reach maximum concentration (Cmax) after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL618267,,BAO_0000218,,
8027,,Rattus norvegicus,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),N,A,1,Intermediate,1,,CHEMBL618450,,BAO_0000218,1088.0,
8028,,Rattus norvegicus,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),N,A,1,Intermediate,1,,CHEMBL618451,,BAO_0000218,1088.0,
8029,,Rattus norvegicus,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,A,1,Intermediate,1,,CHEMBL618452,,BAO_0000218,,
8030,,Rattus norvegicus,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,N,A,1,Intermediate,1,,CHEMBL618453,,BAO_0000218,1088.0,
8031,,Rattus norvegicus,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,N,A,1,Intermediate,1,,CHEMBL618454,,BAO_0000218,1088.0,
8032,,Rattus norvegicus,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,N,A,1,Intermediate,1,,CHEMBL618455,,BAO_0000218,1088.0,
8033,,Rattus norvegicus,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,N,A,1,Intermediate,1,,CHEMBL618456,,BAO_0000218,,
8034,,Rattus norvegicus,Compound distribution in rat tissues was determined,N,A,1,Intermediate,1,,CHEMBL618457,,BAO_0000218,,
8035,,Rattus norvegicus,Volume of distribution was evaluated in rat,N,A,1,Intermediate,1,,CHEMBL618458,,BAO_0000218,,
8036,,Rattus norvegicus,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL618459,,BAO_0000218,,
8037,,Rattus norvegicus,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL876733,,BAO_0000218,,
8038,,Canis lupus familiaris,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,N,A,1,Intermediate,1,,CHEMBL618460,,BAO_0000218,,
8039,,Rattus norvegicus,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL618461,,BAO_0000218,,
8040,,,Area under the curve was determined after oral administration (300 uM/Kg),U,A,0,Autocuration,1,,CHEMBL618462,,BAO_0000019,,
8041,,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL618463,,BAO_0000218,,
8042,,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,N,A,1,Intermediate,1,,CHEMBL618464,,BAO_0000218,,
8043,,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL618465,,BAO_0000218,,
8044,,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,N,A,1,Intermediate,1,,CHEMBL618466,,BAO_0000218,,
8045,,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL618467,,BAO_0000218,,
8046,,Rattus norvegicus,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL618468,,BAO_0000218,,
8047,,Canis lupus familiaris,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,N,A,1,Intermediate,1,,CHEMBL618469,,BAO_0000218,1969.0,
8048,,Canis lupus familiaris,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL618470,,BAO_0000218,1969.0,
8049,,,Plasma drug AUC in rat (PO dose),U,A,0,Autocuration,1,,CHEMBL618471,,BAO_0000218,,
8050,,Mus musculus,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,N,A,1,Intermediate,1,,CHEMBL618472,,BAO_0000218,,
8051,,,Area under was determined at a dose of 30 mg/kg,U,A,0,Autocuration,1,,CHEMBL618473,,BAO_0000218,,
8052,,Mustela putorius furo,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,N,A,1,Intermediate,1,,CHEMBL621699,,BAO_0000218,,
8053,,Rattus norvegicus,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,N,A,1,Intermediate,1,,CHEMBL621700,,BAO_0000218,,
8054,,Rattus norvegicus,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,N,A,1,Intermediate,1,,CHEMBL621701,,BAO_0000218,,
8055,,Mustela putorius furo,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,N,A,1,Intermediate,1,,CHEMBL621702,,BAO_0000218,,
8056,,Canis lupus familiaris,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,N,A,1,Intermediate,1,,CHEMBL621703,,BAO_0000218,,
8057,,Canis lupus familiaris,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,N,A,1,Intermediate,1,,CHEMBL621704,,BAO_0000218,,
8058,,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",N,A,1,Intermediate,1,,CHEMBL624259,,BAO_0000218,,
8059,,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",N,A,1,Intermediate,1,,CHEMBL624260,,BAO_0000218,,
8060,,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",N,A,1,Intermediate,1,,CHEMBL624430,,BAO_0000218,,
8061,,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",N,A,1,Intermediate,1,,CHEMBL624431,,BAO_0000218,,
8062,,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",N,A,1,Intermediate,1,,CHEMBL624432,,BAO_0000218,,
8063,,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",N,A,1,Intermediate,1,,CHEMBL624433,,BAO_0000218,,
8064,,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",N,A,1,Intermediate,1,,CHEMBL624434,,BAO_0000218,,
8065,,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",N,A,1,Intermediate,1,,CHEMBL624435,,BAO_0000218,,
8066,,Mus musculus,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,N,A,1,Intermediate,1,,CHEMBL618570,,BAO_0000218,,
8067,,Mus musculus,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,A,1,Intermediate,1,,CHEMBL618571,,BAO_0000218,,
8068,,Mus musculus,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,N,A,1,Intermediate,1,,CHEMBL618572,,BAO_0000218,,
8069,,Mus musculus,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,A,1,Intermediate,1,,CHEMBL618573,,BAO_0000218,,
8070,,Mus musculus,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,N,A,1,Intermediate,1,,CHEMBL619267,,BAO_0000218,,
8071,,Mus musculus,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,A,1,Intermediate,1,,CHEMBL619431,,BAO_0000218,,
8072,,Mus musculus,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,N,A,1,Intermediate,1,,CHEMBL619432,,BAO_0000218,,
8073,,Mus musculus,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,A,1,Intermediate,1,,CHEMBL619433,,BAO_0000218,,
8074,,,AUC in mice after oral dose (50 mg/kg),U,A,0,Autocuration,1,,CHEMBL619434,,BAO_0000218,1969.0,
8075,,Mus musculus,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,N,A,1,Intermediate,1,,CHEMBL619435,,BAO_0000218,1977.0,
8076,,,AUC (0-4 hr) ug/ml/h,U,A,0,Autocuration,1,,CHEMBL619436,,BAO_0000019,1969.0,
8077,,Rattus norvegicus,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,N,A,1,Intermediate,1,,CHEMBL619437,,BAO_0000218,,
8078,,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,U,A,0,Autocuration,1,,CHEMBL619438,,BAO_0000218,,
8079,,Mus musculus,Compound was evaluated for Area under curve in mice,N,A,1,Intermediate,1,,CHEMBL619439,,BAO_0000218,,
8080,,Rattus norvegicus,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,A,1,Intermediate,1,,CHEMBL619440,,BAO_0000218,,
8081,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,U,F,0,Autocuration,1,,CHEMBL619441,,BAO_0000218,,
8082,,Rattus norvegicus,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,A,1,Intermediate,1,,CHEMBL619442,,BAO_0000218,,
8083,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,U,A,0,Autocuration,1,,CHEMBL875156,,BAO_0000019,,
8084,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,U,A,0,Autocuration,1,,CHEMBL619443,,BAO_0000019,,
8085,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,U,A,0,Autocuration,1,,CHEMBL619444,,BAO_0000019,,
8086,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,U,A,0,Autocuration,1,,CHEMBL623464,,BAO_0000019,,
8087,,Mus musculus,Compound was evaluated for area under curve when administered through oral route in mouse,N,A,1,Intermediate,1,,CHEMBL623465,,BAO_0000218,,
8088,,Rattus norvegicus,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,N,A,1,Intermediate,1,,CHEMBL623466,,BAO_0000218,,
8089,,Rattus norvegicus,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,N,A,1,Intermediate,1,,CHEMBL623467,,BAO_0000218,,
8090,,Rattus norvegicus,Plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL623468,,BAO_0000218,,
8091,,Rattus norvegicus,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,A,1,Intermediate,1,,CHEMBL622660,,BAO_0000218,,
8092,,Rattus norvegicus,Plasma clearance rate in Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL622661,,BAO_0000218,,
8093,,Rattus norvegicus,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,N,F,1,Intermediate,1,,CHEMBL622662,,BAO_0000218,,
8094,,Rattus norvegicus,Pharmacokinetic property (total body clearance) in rat,N,A,1,Intermediate,1,,CHEMBL622663,,BAO_0000218,,
8095,,Rattus norvegicus,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,N,A,1,Intermediate,1,,CHEMBL622664,,BAO_0000218,,
8096,,Rattus norvegicus,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL622665,,BAO_0000218,,
8097,,Rattus norvegicus,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL622666,,BAO_0000218,,
8098,,Rattus norvegicus,Cl in rat i.v. at 2 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL621615,,BAO_0000218,,
8099,,Rattus norvegicus,Clearance of compound after intravenous administration in rats at 24 uM/kg,N,A,1,Intermediate,1,,CHEMBL621616,,BAO_0000218,,
8100,,Rattus norvegicus,Clearance was determined,N,A,1,Intermediate,1,,CHEMBL621617,,BAO_0000218,,
8101,,Rattus norvegicus,Clearance by intravenous administration of 3.4 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL621618,,BAO_0000218,,
8102,,Rattus norvegicus,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL621619,,BAO_0000218,,
8103,,Rattus norvegicus,Clearance rate after i.v. administration in rats,N,A,1,Intermediate,1,,CHEMBL621620,,BAO_0000218,,
8104,,Rattus norvegicus,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL621786,,BAO_0000218,,
8105,,Rattus norvegicus,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,A,1,Intermediate,1,,CHEMBL621787,,BAO_0000218,,
8106,,Rattus norvegicus,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,N,A,1,Intermediate,1,,CHEMBL621788,,BAO_0000218,,
8107,,Rattus norvegicus,Clearance (Cl) after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL621789,,BAO_0000218,,
8108,,Rattus norvegicus,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL621790,,BAO_0000218,,
8109,,Rattus norvegicus,Compound was tested for plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL621791,,BAO_0000218,1969.0,
8110,Microsomes,Rattus norvegicus,In vitro microsome metabolism clearance in rat was determined,N,A,1,Intermediate,1,,CHEMBL621792,,BAO_0000218,,
8111,Microsomes,Rattus norvegicus,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,N,A,1,Intermediate,1,,CHEMBL621793,,BAO_0000218,,
8112,,Rattus norvegicus,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL621794,,BAO_0000218,,
8113,,Rattus norvegicus,In vivo plasma clearance was determined,N,A,1,Intermediate,1,,CHEMBL621795,,BAO_0000218,1969.0,
8114,,Rattus norvegicus,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,N,A,1,Intermediate,1,,CHEMBL621796,,BAO_0000218,,
8115,,Rattus norvegicus,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,N,A,1,Intermediate,1,,CHEMBL621797,401.0,BAO_0000218,2107.0,
8116,,Rattus norvegicus,Pharmacokinetic property (Plasma clearance) was measured in rat,N,A,1,Intermediate,1,,CHEMBL621798,,BAO_0000218,,
8117,,Rattus norvegicus,Pharmacokinetic property (clearance) in rat i.v.,N,A,1,Intermediate,1,,CHEMBL621799,,BAO_0000218,,
8118,,Rattus norvegicus,"Plasma Clearance was evaluated in rats, iv",N,A,1,Intermediate,1,,CHEMBL621800,,BAO_0000218,,
8119,,Rattus norvegicus,Plasma clearance (in vivo) in rats was determined,N,A,1,Intermediate,1,,CHEMBL621801,,BAO_0000218,,
8120,,Rattus norvegicus,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL621802,,BAO_0000218,,
8121,,Rattus norvegicus,Plasma clearance was determined,N,A,1,Intermediate,1,,CHEMBL618596,,BAO_0000218,,
8122,,Rattus norvegicus,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL618597,,BAO_0000218,,
8123,,Rattus norvegicus,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL618598,,BAO_0000218,,
8124,,Rattus norvegicus,Plasma clearance in rats,N,A,1,Intermediate,1,,CHEMBL618599,,BAO_0000218,,
8125,,Rattus norvegicus,Plasma clearance rate determined in rat,N,A,1,Intermediate,1,,CHEMBL618600,,BAO_0000218,,
8126,,Rattus norvegicus,Plasma clearance was determined in rat,N,A,1,Intermediate,1,,CHEMBL618601,,BAO_0000218,,
8127,,Rattus norvegicus,Plasma clearance was determined,N,A,1,Intermediate,1,,CHEMBL618602,,BAO_0000218,,
8128,,Rattus norvegicus,Plasma clearance value in rat,N,A,1,Intermediate,1,,CHEMBL618603,,BAO_0000218,,
8129,,Rattus norvegicus,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,A,1,Intermediate,1,,CHEMBL618604,,BAO_0000218,2107.0,
8130,,Rattus norvegicus,Clearance in rat,N,A,1,Intermediate,1,,CHEMBL618605,,BAO_0000218,,
8131,,Rattus norvegicus,Total body clearance in rat i.v. at 2 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL618606,,BAO_0000218,,
8132,,Rattus norvegicus,Clearance of compound in rats after intravenous administration,N,A,1,Intermediate,1,,CHEMBL618607,,BAO_0000218,,
8133,,Rattus norvegicus,Clearance after iv administration to rats,N,A,1,Intermediate,1,,CHEMBL618608,,BAO_0000218,,
8134,,Rattus norvegicus,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,A,1,Intermediate,1,,CHEMBL618609,,BAO_0000218,,
8135,,Rattus norvegicus,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,A,1,Intermediate,1,,CHEMBL618610,,BAO_0000218,,
8136,,Rattus norvegicus,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,N,A,1,Intermediate,1,,CHEMBL618611,,BAO_0000218,,
8137,,Rattus norvegicus,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,A,1,Intermediate,1,,CHEMBL618612,,BAO_0000218,,
8138,,Rattus norvegicus,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,A,1,Intermediate,1,,CHEMBL618613,,BAO_0000218,,
8139,,Rattus norvegicus,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,A,1,Intermediate,1,,CHEMBL621076,,BAO_0000218,,
8140,,Rattus norvegicus,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,A,1,Intermediate,1,,CHEMBL621077,,BAO_0000218,,
8141,,Rattus norvegicus,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",N,A,1,Intermediate,1,,CHEMBL621078,,BAO_0000218,,
8142,,Rattus norvegicus,Clearance in rat,N,A,1,Intermediate,1,,CHEMBL621251,,BAO_0000218,,
8143,,Rattus norvegicus,Clearance in rat after oral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL621252,,BAO_0000218,,
8144,,Rattus norvegicus,Clearance in rat.,N,A,1,Intermediate,1,,CHEMBL621253,,BAO_0000218,,
8145,,Rattus norvegicus,Clearance rate following an oral dose of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL621254,,BAO_0000218,,
8146,,Rattus norvegicus,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,N,A,1,Intermediate,1,,CHEMBL621255,,BAO_0000218,,
8147,,Rattus norvegicus,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,N,A,1,Intermediate,1,,CHEMBL621256,,BAO_0000218,1969.0,
8148,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,N,A,1,Intermediate,1,,CHEMBL621257,,BAO_0000218,2107.0,
8149,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,N,A,1,Intermediate,1,,CHEMBL621258,,BAO_0000218,2107.0,
8150,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL621259,,BAO_0000218,2107.0,
8151,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,N,A,1,Intermediate,1,,CHEMBL621260,,BAO_0000218,2107.0,
8152,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,N,A,1,Intermediate,1,,CHEMBL876494,,BAO_0000218,2107.0,
8153,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,N,A,1,Intermediate,1,,CHEMBL621261,,BAO_0000218,2107.0,
8154,,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL621262,,BAO_0000218,2107.0,
8155,,Rattus norvegicus,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,A,1,Intermediate,1,,CHEMBL621263,,BAO_0000218,2107.0,
8156,,Rattus norvegicus,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,N,A,1,Intermediate,1,,CHEMBL621264,,BAO_0000218,2107.0,
8157,,Rattus norvegicus,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL621265,,BAO_0000218,2385.0,
8158,,Rattus norvegicus,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,N,A,1,Intermediate,1,,CHEMBL621266,,BAO_0000218,2385.0,
8159,,Rattus norvegicus,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL621267,,BAO_0000218,2385.0,
8160,,Rattus norvegicus,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL621268,,BAO_0000218,2385.0,
8161,,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,N,A,1,Intermediate,1,,CHEMBL621269,,BAO_0000218,2385.0,
8162,,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL621270,,BAO_0000218,2385.0,
8163,,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,N,A,1,Intermediate,1,,CHEMBL621271,,BAO_0000218,2385.0,
8164,,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,N,A,1,Intermediate,1,,CHEMBL621272,,BAO_0000218,2385.0,
8165,,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,N,A,1,Intermediate,1,,CHEMBL621273,,BAO_0000218,2385.0,
8166,,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,N,A,1,Intermediate,1,,CHEMBL621274,,BAO_0000218,2385.0,
8167,,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,N,A,1,Intermediate,1,,CHEMBL876495,,BAO_0000218,2385.0,
8168,,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,N,A,1,Intermediate,1,,CHEMBL621275,,BAO_0000218,2385.0,
8169,,Rattus norvegicus,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,N,A,1,Intermediate,1,,CHEMBL621276,,BAO_0000218,2385.0,
8170,,Rattus norvegicus,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,N,A,1,Intermediate,1,,CHEMBL621277,,BAO_0000218,2385.0,
8171,,Rattus norvegicus,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,N,A,1,Intermediate,1,,CHEMBL621278,,BAO_0000218,160.0,
8172,,Rattus norvegicus,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,N,A,1,Intermediate,1,,CHEMBL621279,,BAO_0000218,160.0,
8173,,Rattus norvegicus,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),N,A,1,Intermediate,1,,CHEMBL621280,,BAO_0000218,160.0,
8174,,Rattus norvegicus,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL621281,,BAO_0000218,2106.0,
8175,,Rattus norvegicus,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,N,A,1,Intermediate,1,,CHEMBL621282,,BAO_0000218,2106.0,
8176,,Rattus norvegicus,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,A,1,Intermediate,1,,CHEMBL621283,,BAO_0000218,2106.0,
8177,,Rattus norvegicus,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,N,A,1,Intermediate,1,,CHEMBL621284,,BAO_0000218,2106.0,
8178,,Rattus norvegicus,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,N,A,1,Intermediate,1,,CHEMBL621285,,BAO_0000218,2106.0,
8179,,Rattus norvegicus,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,N,A,1,Intermediate,1,,CHEMBL621286,,BAO_0000218,2106.0,
8180,,Rattus norvegicus,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,N,A,1,Intermediate,1,,CHEMBL623220,,BAO_0000218,2106.0,
8181,,Rattus norvegicus,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,N,A,1,Intermediate,1,,CHEMBL623221,,BAO_0000218,2106.0,
8182,,Rattus norvegicus,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,N,A,1,Intermediate,1,,CHEMBL876029,,BAO_0000218,2106.0,
8183,,Rattus norvegicus,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,N,A,1,Intermediate,1,,CHEMBL623222,,BAO_0000218,945.0,
8184,,Rattus norvegicus,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,N,A,1,Intermediate,1,,CHEMBL623223,,BAO_0000218,945.0,
8185,,Rattus norvegicus,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,N,A,1,Intermediate,1,,CHEMBL621445,,BAO_0000218,945.0,
8186,,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621446,,BAO_0000218,178.0,
8187,,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621447,,BAO_0000218,178.0,
8188,,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619681,,BAO_0000218,178.0,
8189,,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619682,,BAO_0000218,178.0,
8190,,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619683,,BAO_0000218,178.0,
8191,,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619684,,BAO_0000218,955.0,
8192,,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619685,,BAO_0000218,955.0,
8193,,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619686,,BAO_0000218,955.0,
8194,,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619687,,BAO_0000218,955.0,
8195,,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619688,,BAO_0000218,955.0,
8196,,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619689,,BAO_0000218,948.0,
8197,,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619690,,BAO_0000218,948.0,
8198,,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619691,,BAO_0000218,948.0,
8199,,Rattus norvegicus,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL619692,,BAO_0000218,,
8200,,Rattus norvegicus,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,N,A,1,Expert,1,,CHEMBL619693,,BAO_0000218,,
8201,,Rattus norvegicus,Vc value after IV dose at a dose of 5 mg/kg in rats.,N,A,1,Intermediate,1,,CHEMBL619694,,BAO_0000218,,
8202,,Rattus norvegicus,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,N,A,1,Intermediate,1,,CHEMBL619695,,BAO_0000218,,
8203,,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter volume of distribution,N,A,1,Intermediate,1,,CHEMBL619696,,BAO_0000218,,
8204,,Rattus norvegicus,Compound was evaluated for volume of distribution in rat,N,A,1,Intermediate,1,,CHEMBL619697,,BAO_0000218,,
8205,,Rattus norvegicus,Steady state volume distribution was determined; steady state(ss),N,A,1,Intermediate,1,,CHEMBL619698,,BAO_0000218,,
8206,,Rattus norvegicus,Steady state volume of distribution after iv administration to rats,N,A,1,Intermediate,1,,CHEMBL619699,,BAO_0000218,,
8207,,Rattus norvegicus,Steady state volume of distribution dosing at 3 mg/kg iv,N,A,1,Intermediate,1,,CHEMBL619700,,BAO_0000218,,
8208,,Rattus norvegicus,The compound was evaluated for volume of distribution in rat,N,A,1,Intermediate,1,,CHEMBL619701,,BAO_0000218,,
8209,,Rattus norvegicus,The compound was tested for volume of distribution in rat,N,A,1,Intermediate,1,,CHEMBL619702,,BAO_0000218,,
8210,,Rattus norvegicus,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,N,A,1,Intermediate,1,,CHEMBL620335,,BAO_0000218,,
8211,,Rattus norvegicus,Volume distribution (VD) after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL620336,,BAO_0000218,,
8212,,Rattus norvegicus,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,A,1,Intermediate,1,,CHEMBL620337,,BAO_0000218,,
8213,,Rattus norvegicus,Volume distribution in rat,N,A,1,Intermediate,1,,CHEMBL620520,,BAO_0000218,,
8214,,Rattus norvegicus,Volume distribution in rat,N,A,1,Intermediate,1,,CHEMBL620521,,BAO_0000218,,
8215,,Rattus norvegicus,Volume distribution in rat after peroral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL875825,,BAO_0000218,,
8216,,Rattus norvegicus,Volume distribution in rat after peroral administration at 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL620522,,BAO_0000218,,
8217,,Rattus norvegicus,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL620523,,BAO_0000218,,
8218,,Rattus norvegicus,Volume of distribution in rat.,N,A,1,Intermediate,1,,CHEMBL620524,,BAO_0000218,,
8219,,Rattus norvegicus,Volume of distribution in rat,N,A,1,Intermediate,1,,CHEMBL620525,,BAO_0000218,,
8220,,Rattus norvegicus,Volume of distribution in rat,N,A,1,Intermediate,1,,CHEMBL620526,,BAO_0000218,,
8221,,Rattus norvegicus,Volume of distribution in rat by iv administration,N,A,1,Intermediate,1,,CHEMBL620527,,BAO_0000218,,
8222,,Rattus norvegicus,Volume of distribution in rats,N,A,1,Intermediate,1,,CHEMBL620528,,BAO_0000218,,
8223,,Rattus norvegicus,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,A,1,Intermediate,1,,CHEMBL620529,,BAO_0000218,,
8224,,Rattus norvegicus,Volume distribution at the dose of 2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL620530,,BAO_0000218,,
8225,,Rattus norvegicus,Steady state volume of distribution was determined,N,A,1,Intermediate,1,,CHEMBL620531,,BAO_0000218,,
8226,,Macaca mulatta,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,A,0,Intermediate,1,,CHEMBL620532,,BAO_0000218,,
8227,,Rattus norvegicus,Compound was tested for its plasma volume distribution in Sprague Dawley rats,U,A,0,Intermediate,1,,CHEMBL620533,,BAO_0000218,,
8228,,Rattus norvegicus,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,U,A,0,Intermediate,1,,CHEMBL620534,,BAO_0000218,,
8229,,Rattus norvegicus,Mean (%CV) PK parameters for Vdss(mL/kg).,N,A,1,Intermediate,1,,CHEMBL620535,,BAO_0000218,,
8230,,Rattus norvegicus,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,N,A,1,Intermediate,1,,CHEMBL875826,,BAO_0000218,,
8231,,Rattus norvegicus,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,N,A,1,Intermediate,1,,CHEMBL620536,,BAO_0000218,,
8232,,Rattus norvegicus,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL620537,,BAO_0000218,,
8233,,Rattus norvegicus,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,N,A,1,Intermediate,1,,CHEMBL618526,,BAO_0000218,,
8234,,Rattus norvegicus,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,N,A,1,Intermediate,1,,CHEMBL618527,,BAO_0000218,,
8235,,Rattus norvegicus,Pharmacokinetic property (Vdss) in rat,N,A,1,Intermediate,1,,CHEMBL618528,,BAO_0000218,,
8236,,Rattus norvegicus,Pharmacokinetic property (vdss) was measured in rat,N,A,1,Intermediate,1,,CHEMBL618529,,BAO_0000218,,
8237,,Rattus norvegicus,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL618530,,BAO_0000218,,
8238,,Rattus norvegicus,Volume of distribution in rat,N,A,1,Intermediate,1,,CHEMBL618531,,BAO_0000218,,
8239,,Rattus norvegicus,The pharmacokinetic parameter volume of distribution in vivo in rats,N,A,1,Intermediate,1,,CHEMBL618532,,BAO_0000218,,
8240,,Rattus norvegicus,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,N,F,1,Intermediate,1,,CHEMBL618533,,BAO_0000218,,
8241,,Rattus norvegicus,Vdss in rat i.v. at 2 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL618534,,BAO_0000218,,
8242,,Rattus norvegicus,Volume distribution after intravenous administration (1 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL618535,,BAO_0000218,,
8243,,Rattus norvegicus,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL618536,,BAO_0000218,,
8244,,Rattus norvegicus,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL618537,,BAO_0000218,,
8245,,Rattus norvegicus,Volume distribution at a dose of 10 uM/kg in rat was determined,N,A,1,Intermediate,1,,CHEMBL618538,,BAO_0000218,,
8246,,Rattus norvegicus,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,A,1,Intermediate,1,,CHEMBL618539,,BAO_0000218,,
8247,,Rattus norvegicus,Volume distribution was calculated in rat,N,A,1,Intermediate,1,,CHEMBL618540,,BAO_0000218,,
8248,,Rattus norvegicus,Volume distribution was determined,N,A,1,Intermediate,1,,CHEMBL618541,,BAO_0000218,,
8249,,Rattus norvegicus,Volume of distribution after intravenous administration was evaluated in rat,N,A,1,Intermediate,1,,CHEMBL618542,,BAO_0000218,,
8250,,Rattus norvegicus,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,A,1,Intermediate,1,,CHEMBL622544,,BAO_0000218,,
8251,,Rattus norvegicus,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",N,A,1,Intermediate,1,,CHEMBL622545,,BAO_0000218,,
8252,,Rattus norvegicus,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,A,1,Intermediate,1,,CHEMBL622546,,BAO_0000218,,
8253,,Rattus norvegicus,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",N,A,1,Intermediate,1,,CHEMBL622547,,BAO_0000218,,
8254,,Rattus norvegicus,Volume of distribution in steady state was determined in rat,N,A,1,Intermediate,1,,CHEMBL622548,,BAO_0000218,,
8255,,Rattus norvegicus,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,N,A,1,Intermediate,1,,CHEMBL622549,,BAO_0000218,,
8256,,Rattus norvegicus,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,A,1,Intermediate,1,,CHEMBL622550,,BAO_0000218,,
8257,,Mus musculus,Compound was evaluated for area under curve when administered through oral route to mouse,N,A,1,Intermediate,1,,CHEMBL622551,,BAO_0000218,,
8258,,Rattus norvegicus,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,A,1,Intermediate,1,,CHEMBL622552,,BAO_0000218,,
8259,,Rattus norvegicus,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,A,1,Intermediate,1,,CHEMBL622553,,BAO_0000218,,
8260,,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,U,F,0,Autocuration,1,,CHEMBL622554,,BAO_0000218,,
8261,,Canis lupus familiaris,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,N,A,1,Intermediate,1,,CHEMBL622555,,BAO_0000218,,
8262,,Mus musculus,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL622556,,BAO_0000218,,
8263,,Mus musculus,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL622557,,BAO_0000218,,
8264,,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,N,A,1,Intermediate,1,,CHEMBL622558,,BAO_0000218,178.0,
8265,,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,N,A,1,Intermediate,1,,CHEMBL622559,,BAO_0000218,178.0,
8266,,Canis lupus familiaris,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,N,A,1,Intermediate,1,,CHEMBL622560,,BAO_0000218,,
8267,,Rattus norvegicus,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,A,1,Intermediate,1,,CHEMBL622561,,BAO_0000218,,
8268,,Rattus norvegicus,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,N,A,1,Intermediate,1,,CHEMBL622562,,BAO_0000218,,
8269,,Rattus norvegicus,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,A,1,Intermediate,1,,CHEMBL622563,,BAO_0000218,,
8270,,,Concentration of compound in Central nervous system,U,A,0,Autocuration,1,,CHEMBL622564,,BAO_0000019,,
8271,,,Concentration of compound in Central nervous system; Not detectable,U,A,0,Autocuration,1,,CHEMBL622565,,BAO_0000019,,
8272,,Mus musculus,"Concentration of diester in the blood, following oral administration in mice",N,A,1,Intermediate,1,,CHEMBL622566,,BAO_0000218,,
8273,,Mus musculus,"Concentration of monoester in the blood, following oral administration in mice",N,A,1,Intermediate,1,,CHEMBL624515,,BAO_0000218,,
8274,,Mus musculus,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,N,A,1,Intermediate,1,,CHEMBL624516,,BAO_0000218,,
8275,,,Evaluated for Pharmacokinetic property: Area under the curve,U,A,0,Autocuration,1,,CHEMBL624517,,BAO_0000019,,
8276,,Mus musculus,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,N,A,1,Intermediate,1,,CHEMBL624518,,BAO_0000218,,
8277,,Macaca fascicularis,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,N,A,1,Intermediate,1,,CHEMBL624519,,BAO_0000218,,
8278,,Macaca fascicularis,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL624520,,BAO_0000218,,
8279,,Macaca fascicularis,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL624521,,BAO_0000218,,
8280,,Macaca fascicularis,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL624522,,BAO_0000218,,
8281,,Macaca fascicularis,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL624523,,BAO_0000218,,
8282,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,A,1,Intermediate,1,,CHEMBL624409,,BAO_0000218,,
8283,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",N,A,1,Intermediate,1,,CHEMBL624410,,BAO_0000218,,
8284,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,A,1,Intermediate,1,,CHEMBL624411,,BAO_0000218,,
8285,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",N,A,1,Intermediate,1,,CHEMBL623531,,BAO_0000218,,
8286,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",N,A,1,Intermediate,1,,CHEMBL623532,,BAO_0000218,,
8287,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",N,A,1,Intermediate,1,,CHEMBL623533,,BAO_0000218,,
8288,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,A,1,Intermediate,1,,CHEMBL623534,,BAO_0000218,,
8289,,Mus musculus,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL623535,,BAO_0000218,,
8290,,Mus musculus,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL623536,,BAO_0000218,,
8291,,Mus musculus,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL623537,,BAO_0000218,,
8292,,Mus musculus,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL623538,,BAO_0000218,,
8293,,Mus musculus,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL623539,,BAO_0000218,,
8294,,Mus musculus,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,N,A,1,Intermediate,1,,CHEMBL623540,,BAO_0000218,,
8295,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",N,A,1,Intermediate,1,,CHEMBL623541,,BAO_0000218,,
8296,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",N,A,1,Intermediate,1,,CHEMBL623542,,BAO_0000218,,
8297,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",N,A,1,Intermediate,1,,CHEMBL623543,,BAO_0000218,,
8298,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",N,A,1,Intermediate,1,,CHEMBL623544,,BAO_0000218,,
8299,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",N,A,1,Intermediate,1,,CHEMBL623545,,BAO_0000218,,
8300,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",N,A,1,Intermediate,1,,CHEMBL623546,,BAO_0000218,,
8301,,Rattus norvegicus,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL623547,,BAO_0000218,1969.0,
8302,,Rattus norvegicus,High i.v. clearance in Dawley rats,N,A,1,Intermediate,1,,CHEMBL623548,,BAO_0000218,,
8303,Microsomes,Rattus norvegicus,In vitro clearance in rat liver microsomes,N,A,1,Intermediate,1,,CHEMBL623549,,BAO_0000218,2107.0,
8304,Microsomes,Rattus norvegicus,Intrinsic clearance in rat liver microsomes was determined,N,A,1,Intermediate,1,,CHEMBL623550,,BAO_0000218,2107.0,
8305,,Rattus norvegicus,Intrinsic clearance in rat hepatocytes was determined,N,A,1,Intermediate,1,,CHEMBL875276,401.0,BAO_0000218,2107.0,
8306,,Rattus norvegicus,Plasma Clearance was determined,N,A,1,Intermediate,1,,CHEMBL621872,,BAO_0000218,,
8307,,Rattus norvegicus,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,N,A,1,Intermediate,1,,CHEMBL621873,,BAO_0000218,,
8308,,Rattus norvegicus,Plasma clearance in rat.,N,A,1,Intermediate,1,,CHEMBL621874,,BAO_0000218,,
8309,,Rattus norvegicus,Plasma clearance in rats,N,A,1,Intermediate,1,,CHEMBL621875,,BAO_0000218,,
8310,,Rattus norvegicus,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,N,A,1,Intermediate,1,,CHEMBL621876,,BAO_0000218,,
8311,,Rattus norvegicus,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,N,A,1,Intermediate,1,,CHEMBL621877,,BAO_0000218,,
8312,,Rattus norvegicus,Plasma clearance was measured in rat,N,A,1,Intermediate,1,,CHEMBL621878,,BAO_0000218,,
8313,,Rattus norvegicus,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,A,1,Intermediate,1,,CHEMBL621879,,BAO_0000218,,
8314,,Rattus norvegicus,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",N,A,1,Intermediate,1,,CHEMBL621880,,BAO_0000218,1969.0,
8315,,Rattus norvegicus,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL621881,,BAO_0000218,,
8316,,Rattus norvegicus,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,A,1,Intermediate,1,,CHEMBL621882,,BAO_0000218,,
8317,,Rattus norvegicus,Total clearance at 1 mg/kg was determined in rat,N,A,1,Intermediate,1,,CHEMBL875283,,BAO_0000218,,
8318,,Rattus norvegicus,Total clearance at 10 mg/kg was determined in rat,N,A,1,Intermediate,1,,CHEMBL621883,,BAO_0000218,,
8319,,Rattus norvegicus,Clearance in rat,N,A,1,Intermediate,1,,CHEMBL621884,,BAO_0000218,,
8320,,Rattus norvegicus,Plasma clearance rate determined in rats,N,A,1,Intermediate,1,,CHEMBL621885,,BAO_0000218,,
8321,,Rattus norvegicus,Clearance of compound in rat was evaluated,N,A,1,Intermediate,1,,CHEMBL621886,,BAO_0000218,,
8322,,Rattus norvegicus,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL621887,,BAO_0000218,1969.0,
8323,,Rattus norvegicus,Pharmacokinetic property (blood clearance) in rat,N,A,1,Intermediate,1,,CHEMBL621888,,BAO_0000218,,
8324,,Rattus norvegicus,Plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL621889,,BAO_0000218,,
8325,,Rattus norvegicus,Plasma clearance in rats,N,A,1,Intermediate,1,,CHEMBL621890,,BAO_0000218,,
8326,Microsomes,Rattus norvegicus,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,N,A,1,Intermediate,1,,CHEMBL621891,,BAO_0000218,2107.0,
8327,,Rattus norvegicus,Clearance in Dawley rat,N,A,1,Intermediate,1,,CHEMBL621892,,BAO_0000218,,
8328,,Rattus norvegicus,Clearance rat,N,A,1,Intermediate,1,,CHEMBL621893,,BAO_0000218,,
8329,,Rattus norvegicus,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),N,A,1,Intermediate,1,,CHEMBL621894,,BAO_0000218,,
8330,,Rattus norvegicus,Clearance rat; Not determined,N,A,1,Intermediate,1,,CHEMBL621895,,BAO_0000218,,
8331,,Rattus norvegicus,Clearance rate was determined in rat at a dose of 1 mpk i.v.,N,A,1,Intermediate,1,,CHEMBL875284,,BAO_0000218,,
8332,,Rattus norvegicus,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,A,1,Intermediate,1,,CHEMBL618699,,BAO_0000218,,
8333,,Rattus norvegicus,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,A,1,Intermediate,1,,CHEMBL618700,,BAO_0000218,,
8334,,Rattus norvegicus,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL618701,,BAO_0000218,,
8335,,Rattus norvegicus,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,A,1,Intermediate,1,,CHEMBL876600,,BAO_0000218,1969.0,
8336,,Rattus norvegicus,Clearance of compound in rat after 1 mg/kg i.v. administration,N,A,1,Intermediate,1,,CHEMBL618702,,BAO_0000218,,
8337,,Rattus norvegicus,Compound was evaluated for Hepatic clearance in rat,N,A,1,Intermediate,1,,CHEMBL618703,,BAO_0000218,,
8338,,Rattus norvegicus,In vivo clearance after 5 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL618704,,BAO_0000218,,
8339,,Rattus norvegicus,Compound was tested for plasma clearance in rats,N,A,1,Intermediate,1,,CHEMBL618705,,BAO_0000218,1969.0,
8340,,Rattus norvegicus,Hepatic clearance after intravenous administration was evaluated in rat,N,A,1,Intermediate,1,,CHEMBL618706,,BAO_0000218,,
8341,,Rattus norvegicus,Lower clearance in rat (i.v.) at 0.5 mpk,N,A,1,Intermediate,1,,CHEMBL618707,,BAO_0000218,,
8342,,Rattus norvegicus,Pharmacokinetic parameter expressed as plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL618708,,BAO_0000218,1969.0,
8343,,Rattus norvegicus,Pharmacokinetic property (Clp) in rat,N,A,1,Intermediate,1,,CHEMBL618709,,BAO_0000218,,
8344,,Rattus norvegicus,Plasma clearance in Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL618710,,BAO_0000218,,
8345,,Rattus norvegicus,Plasma clearance (Clp) in rat,N,A,1,Intermediate,1,,CHEMBL618711,,BAO_0000218,,
8346,,Rattus norvegicus,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL618712,,BAO_0000218,,
8347,,Rattus norvegicus,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,N,A,1,Intermediate,1,,CHEMBL618713,,BAO_0000218,,
8348,,Rattus norvegicus,Plasma clearance after intravenous administration of 1 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL618714,,BAO_0000218,,
8349,,Rattus norvegicus,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,A,1,Intermediate,1,,CHEMBL618715,,BAO_0000218,,
8350,,Rattus norvegicus,Plasma clearance in rat was determined,N,A,1,Intermediate,1,,CHEMBL618716,,BAO_0000218,,
8351,,Rattus norvegicus,Plasma clearance measured in rat,N,A,1,Intermediate,1,,CHEMBL876601,,BAO_0000218,,
8352,,Rattus norvegicus,Plasma clearance was calculated in rat,N,A,1,Intermediate,1,,CHEMBL618717,,BAO_0000218,,
8353,,Rattus norvegicus,Plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL618718,,BAO_0000218,,
8354,,Rattus norvegicus,Plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL618719,,BAO_0000218,,
8355,,Rattus norvegicus,Plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL618720,,BAO_0000218,,
8356,,Rattus norvegicus,Plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL618721,,BAO_0000218,,
8357,,Rattus norvegicus,Plasma clearance in rats,N,A,1,Intermediate,1,,CHEMBL621477,,BAO_0000218,,
8358,,Rattus norvegicus,Plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL621478,,BAO_0000218,,
8359,,Rattus norvegicus,Plasma clearance was evaluated in rat,N,A,1,Intermediate,1,,CHEMBL621479,,BAO_0000218,,
8360,,Rattus norvegicus,Plasma clearance was evaluated in rat; Not tested,N,A,1,Intermediate,1,,CHEMBL621480,,BAO_0000218,,
8361,,Rattus norvegicus,Plasma clearance rate was determined for the compound in rat,N,A,1,Intermediate,1,,CHEMBL621481,,BAO_0000218,,
8362,,Rattus norvegicus,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",N,A,1,Intermediate,1,,CHEMBL621482,,BAO_0000218,,
8363,,Rattus norvegicus,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,A,1,Intermediate,1,,CHEMBL621483,,BAO_0000218,,
8364,,Rattus norvegicus,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",N,A,1,Intermediate,1,,CHEMBL621484,,BAO_0000218,,
8365,,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621485,,BAO_0000218,948.0,
8366,,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621486,,BAO_0000218,948.0,
8367,,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621487,,BAO_0000218,160.0,
8368,,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621488,,BAO_0000218,160.0,
8369,,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621489,,BAO_0000218,160.0,
8370,,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621490,,BAO_0000218,160.0,
8371,,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621491,,BAO_0000218,160.0,
8372,,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621492,,BAO_0000218,2113.0,
8373,,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621493,,BAO_0000218,2113.0,
8374,,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621494,,BAO_0000218,2113.0,
8375,,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621495,,BAO_0000218,2113.0,
8376,,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621496,,BAO_0000218,2113.0,
8377,,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621497,,BAO_0000218,2107.0,
8378,,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621498,,BAO_0000218,2107.0,
8379,,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL621499,,BAO_0000218,2107.0,
8380,,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL618634,,BAO_0000218,2107.0,
8381,,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL618635,,BAO_0000218,2107.0,
8382,,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL618636,,BAO_0000218,2048.0,
8383,,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619737,,BAO_0000218,2048.0,
8384,,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL619738,,BAO_0000218,2048.0,
8385,,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL624329,,BAO_0000218,2048.0,
8386,,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL624330,,BAO_0000218,2048.0,
8387,,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL624331,,BAO_0000218,2385.0,
8388,,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL624332,,BAO_0000218,2385.0,
8389,,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL624333,,BAO_0000218,2385.0,
8390,,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL624334,,BAO_0000218,2385.0,
8391,,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL624335,,BAO_0000218,2385.0,
8392,,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620016,,BAO_0000218,2106.0,
8393,,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620169,,BAO_0000218,2106.0,
8394,,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620170,,BAO_0000218,2106.0,
8395,,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620171,,BAO_0000218,2106.0,
8396,,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620172,,BAO_0000218,2106.0,
8397,,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620173,,BAO_0000218,945.0,
8398,,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620174,,BAO_0000218,945.0,
8399,,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620175,,BAO_0000218,945.0,
8400,,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620176,,BAO_0000218,945.0,
8401,,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620177,,BAO_0000218,945.0,
8402,,Rattus norvegicus,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620178,,BAO_0000218,2037.0,
8403,,Rattus norvegicus,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620179,,BAO_0000218,2037.0,
8404,,Rattus norvegicus,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620180,,BAO_0000218,,
8405,,Rattus norvegicus,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,N,A,1,Intermediate,1,,CHEMBL620181,,BAO_0000218,,
8406,,Rattus norvegicus,Volume of distribution of compound in rats after intravenous administration,N,A,1,Intermediate,1,,CHEMBL620182,,BAO_0000218,,
8407,,Rattus norvegicus,Volume of distribution in rat,N,A,1,Intermediate,1,,CHEMBL620183,,BAO_0000218,,
8408,,Rattus norvegicus,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,N,A,1,Intermediate,1,,CHEMBL620184,,BAO_0000218,,
8409,,Rattus norvegicus,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,A,1,Intermediate,1,,CHEMBL620185,,BAO_0000218,,
8410,,Rattus norvegicus,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,A,1,Intermediate,1,,CHEMBL620186,,BAO_0000218,,
8411,,Rattus norvegicus,Volume of distribution was determined in Dawley rat,N,A,1,Intermediate,1,,CHEMBL620187,,BAO_0000218,,
8412,,Rattus norvegicus,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL620188,,BAO_0000218,,
8413,,Rattus norvegicus,Volume of distribution was reported in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL620189,,BAO_0000218,,
8414,,Rattus norvegicus,Volumes of distribution in rat after peroral administration,N,A,1,Intermediate,1,,CHEMBL620190,,BAO_0000218,,
8415,,Rattus norvegicus,Volumes of distribution in rat after po administration,N,A,1,Intermediate,1,,CHEMBL620191,,BAO_0000218,,
8416,,Rattus norvegicus,Volumes of distribution in rat after po administration; Not determined,N,A,1,Intermediate,1,,CHEMBL620192,,BAO_0000218,,
8417,,Rattus norvegicus,Pharmacokinetic property (Volume) in rat i.v.,N,A,1,Intermediate,1,,CHEMBL620193,,BAO_0000218,,
8418,,Rattus norvegicus,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,N,A,1,Intermediate,1,,CHEMBL620194,,BAO_0000218,,
8419,,Rattus norvegicus,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",N,A,1,Intermediate,1,,CHEMBL876730,,BAO_0000218,,
8420,,Rattus norvegicus,Volume distribution in rat after oral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL620195,,BAO_0000218,,
8421,,Rattus norvegicus,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL620196,,BAO_0000218,,
8422,,Rattus norvegicus,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,A,1,Intermediate,1,,CHEMBL620197,,BAO_0000218,,
8423,,Rattus norvegicus,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,N,A,1,Intermediate,1,,CHEMBL620198,,BAO_0000218,,
8424,,Rattus norvegicus,Volume of distribution in rats,N,A,1,Intermediate,1,,CHEMBL620199,,BAO_0000218,,
8425,,Rattus norvegicus,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,N,A,1,Intermediate,1,,CHEMBL620200,,BAO_0000218,,
8426,,Rattus norvegicus,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,N,A,1,Intermediate,1,,CHEMBL620201,,BAO_0000218,,
8427,,Rattus norvegicus,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL620202,,BAO_0000218,,
8428,,Rattus norvegicus,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL620203,,BAO_0000218,,
8429,,Rattus norvegicus,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,N,A,1,Intermediate,1,,CHEMBL620204,,BAO_0000218,,
8430,,Rattus norvegicus,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL620205,,BAO_0000218,,
8431,,Rattus norvegicus,Pharmacokinetic parameter (Vss) in rat,N,A,1,Intermediate,1,,CHEMBL624664,,BAO_0000218,,
8432,,Rattus norvegicus,Pharmacokinetic property (Volume) in rat i.v.,N,A,1,Intermediate,1,,CHEMBL624665,,BAO_0000218,,
8433,,Rattus norvegicus,Pharmacokinetic property (Vss) in rat,N,A,1,Intermediate,1,,CHEMBL624666,,BAO_0000218,,
8434,,Rattus norvegicus,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,A,1,Intermediate,1,,CHEMBL624667,,BAO_0000218,,
8435,,Rattus norvegicus,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624668,,BAO_0000218,,
8436,,Rattus norvegicus,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624669,,BAO_0000218,,
8437,,Rattus norvegicus,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624670,,BAO_0000218,,
8438,,Rattus norvegicus,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624671,,BAO_0000218,,
8439,,Rattus norvegicus,Steady state volume distribution in rat,N,A,1,Intermediate,1,,CHEMBL624672,,BAO_0000218,,
8440,,Rattus norvegicus,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",N,A,1,Intermediate,1,,CHEMBL624673,,BAO_0000218,1969.0,
8441,,Rattus norvegicus,Steady state volume of distribution determined in rat,N,A,1,Intermediate,1,,CHEMBL624674,,BAO_0000218,,
8442,,Rattus norvegicus,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,A,1,Intermediate,1,,CHEMBL624675,,BAO_0000218,,
8443,,Rattus norvegicus,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,N,A,1,Intermediate,1,,CHEMBL621728,,BAO_0000218,,
8444,,Rattus norvegicus,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,N,A,1,Intermediate,1,,CHEMBL621729,,BAO_0000218,,
8445,,Rattus norvegicus,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,N,A,1,Intermediate,1,,CHEMBL621730,,BAO_0000218,,
8446,,Rattus norvegicus,Volume distribution in rat after administration of 2 mg/kg iv,N,A,1,Intermediate,1,,CHEMBL621731,,BAO_0000218,,
8447,,Rattus norvegicus,Volume distribution in rat after administration of 2 mg/kg iv,N,A,1,Intermediate,1,,CHEMBL621732,,BAO_0000218,,
8448,,Rattus norvegicus,Volume in steady state distribution value was determined,N,A,1,Intermediate,1,,CHEMBL621908,,BAO_0000218,,
8449,,Rattus norvegicus,Volume in steady state distribution value was determined; ND denotes no data,N,A,1,Intermediate,1,,CHEMBL875347,,BAO_0000218,,
8450,,Rattus norvegicus,Volume in steady state distribution value was determined; ND denotes not determined,N,A,1,Intermediate,1,,CHEMBL621909,,BAO_0000218,,
8451,,Rattus norvegicus,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,A,1,Intermediate,1,,CHEMBL621910,,BAO_0000218,,
8452,,Rattus norvegicus,Volume of distribution at steady state was evaluated in rats,N,A,1,Intermediate,1,,CHEMBL621911,,BAO_0000218,,
8453,,Rattus norvegicus,Volume of distribution at steady state was observed after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL621912,,BAO_0000218,,
8454,,Rattus norvegicus,Volume of distribution in steady state was determined in rat,N,A,1,Intermediate,1,,CHEMBL621913,,BAO_0000218,,
8455,,Rattus norvegicus,Volume of distribution in steady state was determined in rat,N,A,1,Intermediate,1,,CHEMBL621914,,BAO_0000218,,
8456,,Rattus norvegicus,Volume of distribution after i.v. administration,N,A,1,Intermediate,1,,CHEMBL621915,,BAO_0000218,,
8457,,Rattus norvegicus,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,A,1,Intermediate,1,,CHEMBL621916,,BAO_0000218,,
8458,,Mus musculus,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,A,1,Intermediate,1,,CHEMBL621917,,BAO_0000218,2107.0,
8459,,Mus musculus,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,A,1,Intermediate,1,,CHEMBL621918,,BAO_0000218,2107.0,
8460,,Mus musculus,Biodistribution of compound (oxidized form) in spleen tissue,N,A,1,Intermediate,1,,CHEMBL621919,,BAO_0000218,2106.0,
8461,,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",N,A,1,Intermediate,1,,CHEMBL621920,,BAO_0000218,2106.0,
8462,,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",N,A,1,Intermediate,1,,CHEMBL621921,,BAO_0000218,2106.0,
8463,,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,A,1,Intermediate,1,,CHEMBL622401,,BAO_0000218,2106.0,
8464,,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,A,1,Intermediate,1,,CHEMBL875348,,BAO_0000218,2106.0,
8465,,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,A,1,Intermediate,1,,CHEMBL622402,,BAO_0000218,2106.0,
8466,,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,N,A,1,Intermediate,1,,CHEMBL622403,,BAO_0000218,178.0,
8467,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,A,1,Intermediate,1,,CHEMBL622404,,BAO_0000218,178.0,
8468,,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,N,A,1,Intermediate,1,,CHEMBL622405,,BAO_0000218,955.0,
8469,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,A,1,Intermediate,1,,CHEMBL622406,,BAO_0000218,955.0,
8470,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,A,1,Intermediate,1,,CHEMBL622407,,BAO_0000218,955.0,
8471,,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,N,A,1,Intermediate,1,,CHEMBL622408,,BAO_0000218,948.0,
8472,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,A,1,Intermediate,1,,CHEMBL622409,,BAO_0000218,948.0,
8473,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,A,1,Intermediate,1,,CHEMBL622410,,BAO_0000218,948.0,
8474,,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,N,A,1,Intermediate,1,,CHEMBL622411,,BAO_0000218,2113.0,
8475,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,A,1,Intermediate,1,,CHEMBL627864,,BAO_0000218,2113.0,
8476,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,A,1,Intermediate,1,,CHEMBL627865,,BAO_0000218,2113.0,
8477,,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,N,A,1,Intermediate,1,,CHEMBL627866,,BAO_0000218,2107.0,
8478,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,A,1,Intermediate,1,,CHEMBL627751,,BAO_0000218,2107.0,
8479,,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,N,A,1,Intermediate,1,,CHEMBL627752,,BAO_0000218,2106.0,
8480,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,A,1,Intermediate,1,,CHEMBL627753,,BAO_0000218,2106.0,
8481,,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,A,1,Intermediate,1,,CHEMBL627754,,BAO_0000218,2106.0,
8482,,Mus musculus,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,N,A,1,Intermediate,1,,CHEMBL627755,,BAO_0000218,,
8483,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627756,,BAO_0000218,955.0,
8484,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627757,,BAO_0000218,955.0,
8485,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627758,,BAO_0000218,955.0,
8486,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627759,,BAO_0000218,955.0,
8487,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627760,,BAO_0000218,955.0,
8488,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627761,,BAO_0000218,955.0,
8489,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL876811,,BAO_0000218,948.0,
8490,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627762,,BAO_0000218,948.0,
8491,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627763,,BAO_0000218,948.0,
8492,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627764,,BAO_0000218,948.0,
8493,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627765,,BAO_0000218,948.0,
8494,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627766,,BAO_0000218,948.0,
8495,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627767,,BAO_0000218,2113.0,
8496,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627768,,BAO_0000218,2113.0,
8497,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL628422,,BAO_0000218,2113.0,
8498,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL628423,,BAO_0000218,2113.0,
8499,,Rattus norvegicus,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,N,A,1,Intermediate,1,,CHEMBL628424,,BAO_0000218,,
8500,,Rattus norvegicus,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,N,A,1,Intermediate,1,,CHEMBL628425,,BAO_0000218,,
8501,,Rattus norvegicus,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,N,A,1,Intermediate,1,,CHEMBL628426,,BAO_0000218,,
8502,,Rattus norvegicus,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,A,1,Intermediate,1,,CHEMBL628427,,BAO_0000218,,
8503,,Rattus norvegicus,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,A,1,Intermediate,1,,CHEMBL626938,,BAO_0000218,,
8504,,Rattus norvegicus,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL626939,,BAO_0000218,,
8505,,Rattus norvegicus,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626940,,BAO_0000218,,
8506,,Rattus norvegicus,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626941,,BAO_0000218,,
8507,,Rattus norvegicus,Plasma clearance was reported in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626942,,BAO_0000218,,
8508,,Rattus norvegicus,Plasma clearance after intravenous administration (1 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL876812,,BAO_0000218,,
8509,,Rattus norvegicus,Plasma clearance of compound in rats was evaluated,N,A,1,Intermediate,1,,CHEMBL626943,,BAO_0000218,,
8510,,Rattus norvegicus,Plasma clearance of compound in rats was evaluated; ND indicates not determined,N,A,1,Intermediate,1,,CHEMBL626944,,BAO_0000218,,
8511,,Rattus norvegicus,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,N,A,1,Intermediate,1,,CHEMBL626945,,BAO_0000218,,
8512,,Rattus norvegicus,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,A,1,Intermediate,1,,CHEMBL626946,,BAO_0000218,,
8513,,Rattus norvegicus,Plasma clearance rate in Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL626856,,BAO_0000218,,
8514,,Rattus norvegicus,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),N,A,1,Intermediate,1,,CHEMBL626857,,BAO_0000218,,
8515,,Rattus norvegicus,The compound was evaluated for plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL626858,,BAO_0000218,1969.0,
8516,,Rattus norvegicus,Total plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL627018,,BAO_0000218,1969.0,
8517,,Rattus norvegicus,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,N,A,1,Intermediate,1,,CHEMBL625331,,BAO_0000218,178.0,
8518,,Rattus norvegicus,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,N,A,1,Intermediate,1,,CHEMBL625332,,BAO_0000218,178.0,
8519,,Rattus norvegicus,C max was determined at 10 mg/kg po dose in rats,N,A,1,Intermediate,1,,CHEMBL877590,,BAO_0000218,,
8520,,Rattus norvegicus,C max was determined at 3 mg/kg po dose in rats,N,A,1,Intermediate,1,,CHEMBL625333,,BAO_0000218,,
8521,,Rattus norvegicus,Cmax after repeated oral dose of compound at 1 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL625334,,BAO_0000218,,
8522,,Rattus norvegicus,Cmax after single intravenous bolus of 1 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL625335,,BAO_0000218,,
8523,,Rattus norvegicus,Cmax of compound at 5 mg/kg after po administration was determined in rat,N,A,1,Intermediate,1,,CHEMBL625336,,BAO_0000218,,
8524,,Rattus norvegicus,Cmax 24 hr after 10 mg/kg oral administration in rats,N,A,1,Intermediate,1,,CHEMBL625337,,BAO_0000218,,
8525,,Rattus norvegicus,Cmax 24 hr after 2 mg/kg oral administration in rats,N,A,1,Intermediate,1,,CHEMBL625338,,BAO_0000218,,
8526,,Rattus norvegicus,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,N,A,1,Intermediate,1,,CHEMBL625339,,BAO_0000218,1969.0,
8527,,Rattus norvegicus,Cmax in rat after administration of 2 mg/kg iv,N,A,1,Intermediate,1,,CHEMBL625340,,BAO_0000218,,
8528,,Rattus norvegicus,Cmax in rat after administration of 2 mg/kg iv,N,A,1,Intermediate,1,,CHEMBL625341,,BAO_0000218,,
8529,,Rattus norvegicus,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL622687,,BAO_0000218,,
8530,,Rattus norvegicus,Cmax wa determined in rat plasma at 30 mg/kg after po administration,N,A,1,Intermediate,1,,CHEMBL622688,,BAO_0000218,1969.0,
8531,,Rattus norvegicus,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,N,A,1,Intermediate,1,,CHEMBL622689,,BAO_0000218,178.0,
8532,,Rattus norvegicus,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,N,A,1,Intermediate,1,,CHEMBL620295,,BAO_0000218,178.0,
8533,,Rattus norvegicus,Cmax after 10 mg/kg oral administration in rat,N,A,1,Intermediate,1,,CHEMBL620296,,BAO_0000218,,
8534,,Rattus norvegicus,Cmax after IV dosing at 0.5 mg/kg in rat; no data,N,A,1,Intermediate,1,,CHEMBL620297,,BAO_0000218,,
8535,,Rattus norvegicus,Cmax after IV dosing at 1 mg/kg in rat; no data,N,A,1,Intermediate,1,,CHEMBL620298,,BAO_0000218,,
8536,,Rattus norvegicus,Cmax after oral administration at 20 mpk in rats,N,A,1,Intermediate,1,,CHEMBL620299,,BAO_0000218,,
8537,,Rattus norvegicus,Cmax after oral administration at 20 mpk in rats; Not performed.,N,A,1,Intermediate,1,,CHEMBL620300,,BAO_0000218,,
8538,,Rattus norvegicus,Cmax after oral administration at 20 mpk in rats d; Not performed.,N,A,1,Intermediate,1,,CHEMBL620301,,BAO_0000218,,
8539,,Rattus norvegicus,Cmax after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL620302,,BAO_0000218,,
8540,,Rattus norvegicus,Cmax after oral administration at a dose of 2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL620303,,BAO_0000218,,
8541,,Rattus norvegicus,Cmax after oral administration at a dose of 4 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL620304,,BAO_0000218,,
8542,,Rattus norvegicus,Cmax in rats after 20 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL620305,,BAO_0000218,,
8543,,Rattus norvegicus,Cmax after peroral administration in rats at 2.4 uM/kg,N,A,1,Intermediate,1,,CHEMBL620306,,BAO_0000218,,
8544,,Rattus norvegicus,Cmax at the dose of 2 mg/Kg administered perorally in rats,N,A,1,Intermediate,1,,CHEMBL620307,,BAO_0000218,,
8545,,Rattus norvegicus,Cmax at the dose of 5 mg/Kg administered perorally in rats,N,A,1,Intermediate,1,,CHEMBL620308,,BAO_0000218,,
8546,,Rattus norvegicus,Cmax by administering at 20 mg/kg p.o. in rats,N,A,1,Intermediate,1,,CHEMBL620309,,BAO_0000218,,
8547,,Rattus norvegicus,Cmax in male rat,N,A,1,Intermediate,1,,CHEMBL620310,,BAO_0000218,,
8548,,Rattus norvegicus,Cmax in rat,N,A,1,Intermediate,1,,CHEMBL620311,,BAO_0000218,,
8549,,Rattus norvegicus,Cmax in rat,N,A,1,Intermediate,1,,CHEMBL620312,,BAO_0000218,,
8550,,Rattus norvegicus,Cmax in rat,N,A,1,Intermediate,1,,CHEMBL620313,,BAO_0000218,,
8551,,Rattus norvegicus,Cmax in rat at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL620314,,BAO_0000218,,
8552,,Rattus norvegicus,Cmax in rat at the dose of 1 mg/kg i.v.,N,A,1,Intermediate,1,,CHEMBL620315,,BAO_0000218,,
8553,,Rattus norvegicus,Cmax in rat by po administration at a dose of 40 mg/kg,N,A,1,Intermediate,1,,CHEMBL620316,,BAO_0000218,,
8554,,Rattus norvegicus,Cmax in rat p.o. at 20 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL620317,,BAO_0000218,,
8555,,Rattus norvegicus,Cmax in rats,N,A,1,Intermediate,1,,CHEMBL620318,,BAO_0000218,,
8556,,Rattus norvegicus,Cmax in rats,N,A,1,Intermediate,1,,CHEMBL620319,,BAO_0000218,,
8557,,Rattus norvegicus,Cmax was evaluated after 20 uM/kg of peroral administration,N,A,1,Intermediate,1,,CHEMBL620320,,BAO_0000218,,
8558,,Rattus norvegicus,Cmax was measured in rats after peroral administration at 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL620321,,BAO_0000218,,
8559,,Rattus norvegicus,Cmax value after oral dose at a dose of 10 mg/kg in rats.,N,A,1,Intermediate,1,,CHEMBL620322,,BAO_0000218,,
8560,,Rattus norvegicus,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620323,,BAO_0000218,,
8561,,Rattus norvegicus,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620324,,BAO_0000218,1870.0,
8562,,Rattus norvegicus,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620325,,BAO_0000218,1870.0,
8563,,Rattus norvegicus,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620326,,BAO_0000218,10000000.0,
8564,,Rattus norvegicus,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620327,,BAO_0000218,10000000.0,
8565,,Rattus norvegicus,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620328,,BAO_0000218,,
8566,,Rattus norvegicus,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620329,,BAO_0000218,,
8567,,Rattus norvegicus,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620330,,BAO_0000218,1891.0,
8568,,Rattus norvegicus,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL875286,,BAO_0000218,1891.0,
8569,,Rattus norvegicus,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620331,,BAO_0000218,,
8570,,Rattus norvegicus,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620332,,BAO_0000218,,
8571,,Rattus norvegicus,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620333,,BAO_0000218,2435.0,
8572,,Rattus norvegicus,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,A,1,Intermediate,1,,CHEMBL620334,,BAO_0000218,2435.0,
8573,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL621015,,BAO_0000218,178.0,
8574,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL621016,,BAO_0000218,178.0,
8575,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL621191,,BAO_0000218,178.0,
8576,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL621192,,BAO_0000218,178.0,
8577,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL621193,,BAO_0000218,178.0,
8578,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL621194,,BAO_0000218,178.0,
8579,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL624204,,BAO_0000218,178.0,
8580,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL624205,,BAO_0000218,178.0,
8581,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL624206,,BAO_0000218,178.0,
8582,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL624207,,BAO_0000218,178.0,
8583,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL624208,,BAO_0000218,178.0,
8584,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL624209,,BAO_0000218,178.0,
8585,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL624210,,BAO_0000218,178.0,
8586,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL624211,,BAO_0000218,178.0,
8587,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL624212,,BAO_0000218,178.0,
8588,,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL624213,,BAO_0000218,178.0,
8589,,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL876611,,BAO_0000218,178.0,
8590,,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL624214,,BAO_0000218,178.0,
8591,,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL624215,,BAO_0000218,178.0,
8592,,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL624216,,BAO_0000218,178.0,
8593,,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL624217,,BAO_0000218,178.0,
8594,,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL624218,,BAO_0000218,178.0,
8595,,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL624219,,BAO_0000218,178.0,
8596,,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL624220,,BAO_0000218,178.0,
8597,,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL624221,,BAO_0000218,178.0,
8598,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL624222,,BAO_0000218,,
8599,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL624223,,BAO_0000218,,
8600,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL624224,,BAO_0000218,,
8601,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL624225,,BAO_0000218,,
8602,,Rattus norvegicus,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,N,A,1,Intermediate,1,,CHEMBL622420,,BAO_0000218,,
8603,,Rattus norvegicus,Volume of steady state distribution after i.v. administration in rats,N,A,1,Intermediate,1,,CHEMBL622421,,BAO_0000218,,
8604,,Rattus norvegicus,Vss after intravenous administration (5.0 mg/kg) was determined in rat,N,A,1,Intermediate,1,,CHEMBL622422,,BAO_0000218,,
8605,,Rattus norvegicus,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,A,1,Intermediate,1,,CHEMBL622423,,BAO_0000218,,
8606,,Rattus norvegicus,Vss was determined,N,A,1,Intermediate,1,,CHEMBL622424,,BAO_0000218,,
8607,,Rattus norvegicus,Vss in rat,N,A,1,Intermediate,1,,CHEMBL622425,,BAO_0000218,,
8608,,Rattus norvegicus,Vss was evaluated after 10 uM/kg of intra arterial administration,N,A,1,Intermediate,1,,CHEMBL876612,,BAO_0000218,,
8609,,Rattus norvegicus,volume of distribution at steady state was observed after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL622426,,BAO_0000218,,
8610,,Rattus norvegicus,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL622427,,BAO_0000218,,
8611,,Rattus norvegicus,Pharmacokinetic (PK) parameter Vz in rat,N,A,1,Intermediate,1,,CHEMBL622428,,BAO_0000218,,
8612,,Rattus norvegicus,Volume distribution in rats,N,A,1,Intermediate,1,,CHEMBL622429,,BAO_0000218,,
8613,,Rattus norvegicus,Volume of distribution in rat; No data,N,A,1,Intermediate,1,,CHEMBL622430,,BAO_0000218,,
8614,,Rattus norvegicus,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL622431,,BAO_0000218,,
8615,,Rattus norvegicus,% absorption predicted from in vitro rat ileum transport studies,N,A,1,Intermediate,1,,CHEMBL622432,,BAO_0000218,2116.0,
8616,,Rattus norvegicus,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,A,1,Intermediate,1,,CHEMBL622433,,BAO_0000218,,
8617,,Rattus norvegicus,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,A,1,Intermediate,1,,CHEMBL622434,,BAO_0000218,,
8618,,Rattus norvegicus,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,N,A,1,Intermediate,1,,CHEMBL622435,,BAO_0000218,,
8619,,Rattus norvegicus,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL618748,,BAO_0000218,,
8620,,Rattus norvegicus,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,A,1,Intermediate,1,,CHEMBL618749,,BAO_0000218,,
8621,,Rattus norvegicus,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,A,1,Intermediate,1,,CHEMBL618750,,BAO_0000218,,
8622,,Rattus norvegicus,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,A,1,Intermediate,1,,CHEMBL618751,,BAO_0000218,,
8623,,Rattus norvegicus,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,A,1,Intermediate,1,,CHEMBL618752,,BAO_0000218,,
8624,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL618753,,BAO_0000218,,
8625,,Rattus norvegicus,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,N,A,1,Intermediate,1,,CHEMBL618754,,BAO_0000218,1969.0,
8626,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL618755,,BAO_0000218,,
8627,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL618756,,BAO_0000218,,
8628,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL618757,,BAO_0000218,,
8629,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL618758,,BAO_0000218,,
8630,,Rattus norvegicus,Oral bioavailability in rat (dose 30 mg/kg),N,A,1,Intermediate,1,,CHEMBL621088,,BAO_0000218,,
8631,,Rattus norvegicus,Pharmacokinetic property (cLogP) in rat,N,A,1,Intermediate,1,,CHEMBL621089,,BAO_0000218,,
8632,,Rattus norvegicus,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,N,F,1,Intermediate,1,,CHEMBL621090,,BAO_0000218,178.0,
8633,,Rattus norvegicus,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,N,F,1,Intermediate,1,,CHEMBL621091,,BAO_0000218,178.0,
8634,,Rattus norvegicus,Clearance in rat.,N,A,1,Intermediate,1,,CHEMBL876731,,BAO_0000218,,
8635,,Rattus norvegicus,Compound was evaluated for its clearance when administered intravenously in rat,N,A,1,Intermediate,1,,CHEMBL621092,,BAO_0000218,,
8636,,Rattus norvegicus,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL621093,,BAO_0000218,,
8637,,Rattus norvegicus,Blood: Brain distribution ratio is determined in rat,N,A,1,Intermediate,1,,CHEMBL621094,,BAO_0000218,,
8638,,Rattus norvegicus,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,N,A,1,Intermediate,1,,CHEMBL621095,,BAO_0000218,,
8639,,Rattus norvegicus,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,N,A,1,Intermediate,1,,CHEMBL621096,,BAO_0000218,,
8640,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL621097,,BAO_0000218,2113.0,
8641,,Rattus norvegicus,Percent dose excreted in 0-48 hours administered ip to male rat,N,F,1,Intermediate,1,,CHEMBL621098,,BAO_0000218,,
8642,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621099,,BAO_0000218,2037.0,
8643,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621100,,BAO_0000218,2037.0,
8644,,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL621101,,BAO_0000218,2037.0,
8645,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621102,,BAO_0000218,2037.0,
8646,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL876732,,BAO_0000218,2037.0,
8647,,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621103,,BAO_0000218,,
8648,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621104,,BAO_0000218,,
8649,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL621105,,BAO_0000218,,
8650,,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621106,,BAO_0000218,,
8651,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621107,,BAO_0000218,,
8652,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621108,,BAO_0000218,,
8653,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621109,,BAO_0000218,,
8654,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL621110,,BAO_0000218,2113.0,
8655,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL621111,,BAO_0000218,2113.0,
8656,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL622541,,BAO_0000218,2107.0,
8657,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL622542,,BAO_0000218,2107.0,
8658,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL622543,,BAO_0000218,2107.0,
8659,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624412,,BAO_0000218,2107.0,
8660,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624413,,BAO_0000218,2107.0,
8661,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624414,,BAO_0000218,2107.0,
8662,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624415,,BAO_0000218,2048.0,
8663,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624416,,BAO_0000218,2048.0,
8664,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624417,,BAO_0000218,2048.0,
8665,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624418,,BAO_0000218,2048.0,
8666,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624419,,BAO_0000218,2048.0,
8667,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624420,,BAO_0000218,2048.0,
8668,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624421,,BAO_0000218,2385.0,
8669,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624422,,BAO_0000218,2385.0,
8670,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL624423,,BAO_0000218,2385.0,
8671,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL625123,,BAO_0000218,2385.0,
8672,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL625124,,BAO_0000218,2385.0,
8673,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL625125,,BAO_0000218,2385.0,
8674,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL625126,,BAO_0000218,14.0,
8675,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626947,,BAO_0000218,14.0,
8676,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626948,,BAO_0000218,14.0,
8677,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626949,,BAO_0000218,14.0,
8678,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626950,,BAO_0000218,14.0,
8679,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626951,,BAO_0000218,14.0,
8680,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626952,,BAO_0000218,2106.0,
8681,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626953,,BAO_0000218,2106.0,
8682,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626954,,BAO_0000218,2106.0,
8683,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626955,,BAO_0000218,2106.0,
8684,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626956,,BAO_0000218,2106.0,
8685,,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626957,,BAO_0000218,2106.0,
8686,,Mus musculus,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626958,,BAO_0000218,178.0,
8687,,Mus musculus,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626959,,BAO_0000218,178.0,
8688,,Mus musculus,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626960,,BAO_0000218,178.0,
8689,,Mus musculus,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL626961,,BAO_0000218,178.0,
8690,,Mus musculus,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627589,,BAO_0000218,178.0,
8691,,Mus musculus,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),N,A,1,Intermediate,1,,CHEMBL627590,,BAO_0000218,178.0,
8692,,Mus musculus,Time taken for EC90 was determined when tested in mouse,N,A,1,Intermediate,1,,CHEMBL627591,,BAO_0000218,,
8693,,Mus musculus,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL627592,,BAO_0000218,,
8694,,Mus musculus,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),N,A,1,Intermediate,1,,CHEMBL627593,,BAO_0000218,,
8695,,Mus musculus,Half life in mice,N,A,1,Intermediate,1,,CHEMBL627594,,BAO_0000218,,
8696,,Mus musculus,Half life period in mouse after 10 mg/Kg dose,N,A,1,Intermediate,1,,CHEMBL876813,,BAO_0000218,,
8697,,Mus musculus,Half life period in mouse after 10 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL627595,,BAO_0000218,,
8698,,Mus musculus,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,N,A,1,Intermediate,1,,CHEMBL627596,,BAO_0000218,,
8699,,Rattus norvegicus,Cmax value at 5 mg/kg po was determined in rat,N,A,1,Intermediate,1,,CHEMBL627597,,BAO_0000218,,
8700,,Rattus norvegicus,Cmax value evaluated in rat,N,A,1,Intermediate,1,,CHEMBL627598,,BAO_0000218,,
8701,,Rattus norvegicus,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,N,A,1,Intermediate,1,,CHEMBL627599,,BAO_0000218,955.0,
8702,,Rattus norvegicus,Cmax value after administration of 20 mg/Kg oral dose in rat,N,A,1,Intermediate,1,,CHEMBL627600,,BAO_0000218,,
8703,,Rattus norvegicus,Cmax value at 1 mg/kg po in rat,N,A,1,Intermediate,1,,CHEMBL627601,,BAO_0000218,,
8704,,Rattus norvegicus,Cmax value at 5 mg/kg po in rat,N,A,1,Intermediate,1,,CHEMBL627776,,BAO_0000218,,
8705,,Rattus norvegicus,Cmax value at a dose of 10 mg/kg in male SD rats,N,A,1,Intermediate,1,,CHEMBL627777,,BAO_0000218,,
8706,,Rattus norvegicus,Cmax value at a dose of 100 mg/kg in male SD rats,N,A,1,Intermediate,1,,CHEMBL627778,,BAO_0000218,,
8707,,Rattus norvegicus,Cmax value at a dose of 50 mg/kg in male SD rats,N,A,1,Intermediate,1,,CHEMBL627779,,BAO_0000218,,
8708,,Rattus norvegicus,Cmax value in rats at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL876814,,BAO_0000218,,
8709,,Rattus norvegicus,Cmax value was evaluated in rats at a dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL627780,,BAO_0000218,,
8710,,Rattus norvegicus,Cmax value was determined after peroral administration of 20 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627781,,BAO_0000218,,
8711,,Rattus norvegicus,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,A,1,Intermediate,1,,CHEMBL627782,,BAO_0000218,,
8712,,Rattus norvegicus,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,N,A,1,Intermediate,1,,CHEMBL627783,,BAO_0000218,1969.0,
8713,,Rattus norvegicus,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,N,A,1,Intermediate,1,,CHEMBL627784,,BAO_0000218,1969.0,
8714,,Rattus norvegicus,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,N,A,1,Intermediate,1,,CHEMBL627785,,BAO_0000218,,
8715,,Rattus norvegicus,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,N,A,1,Intermediate,1,,CHEMBL627786,,BAO_0000218,,
8716,,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,N,A,1,Intermediate,1,,CHEMBL627787,,BAO_0000218,1969.0,
8717,,Rattus norvegicus,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,N,A,1,Intermediate,1,,CHEMBL627788,,BAO_0000218,1969.0,
8718,,Rattus norvegicus,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,N,A,1,Intermediate,1,,CHEMBL626579,,BAO_0000218,1969.0,
8719,,Rattus norvegicus,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,N,A,1,Intermediate,1,,CHEMBL626580,,BAO_0000218,1969.0,
8720,,Rattus norvegicus,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL876815,,BAO_0000218,,
8721,,Rattus norvegicus,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,N,A,1,Intermediate,1,,CHEMBL626581,,BAO_0000218,1969.0,
8722,,Rattus norvegicus,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,N,A,1,Intermediate,1,,CHEMBL626582,,BAO_0000218,1969.0,
8723,,Rattus norvegicus,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL626583,,BAO_0000218,,
8724,,Rattus norvegicus,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626205,,BAO_0000218,,
8725,,Rattus norvegicus,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626206,,BAO_0000218,,
8726,,Rattus norvegicus,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626207,,BAO_0000218,,
8727,,Rattus norvegicus,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623882,,BAO_0000218,,
8728,,Rattus norvegicus,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,N,A,1,Intermediate,1,,CHEMBL623883,,BAO_0000218,,
8729,,Rattus norvegicus,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL623884,,BAO_0000218,,
8730,,Rattus norvegicus,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,A,1,Intermediate,1,,CHEMBL623885,,BAO_0000218,1969.0,
8731,,Rattus norvegicus,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL623886,,BAO_0000218,1969.0,
8732,,Rattus norvegicus,Maximal concentration in rat was determined,N,A,1,Intermediate,1,,CHEMBL623887,,BAO_0000218,,
8733,,Rattus norvegicus,Maximal concentration after i.v. administration,N,A,1,Intermediate,1,,CHEMBL623888,,BAO_0000218,,
8734,,Rattus norvegicus,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL623889,,BAO_0000218,1969.0,
8735,,Rattus norvegicus,Maximal plasma concentration in rat after oral administration at 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL623890,,BAO_0000218,1969.0,
8736,,Rattus norvegicus,Cmax in rat plasma after oral dose (50 mg/Kg),N,A,1,Intermediate,1,,CHEMBL623891,,BAO_0000218,1969.0,
8737,,Rattus norvegicus,Maximal plasma concentration was determined.,N,A,1,Intermediate,1,,CHEMBL623892,,BAO_0000218,1969.0,
8738,,Rattus norvegicus,Maximal plasma drug concentration was determined,N,A,1,Intermediate,1,,CHEMBL623893,,BAO_0000218,1969.0,
8739,,Rattus norvegicus,Maximal concentration in rats after peroral administration,N,A,1,Intermediate,1,,CHEMBL877616,,BAO_0000218,,
8740,,Rattus norvegicus,Maximum concentration in rat after 2 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL623894,,BAO_0000218,,
8741,,Rattus norvegicus,Maximum concentration in rat plasma after 5 mg/kg oral gavage,N,A,1,Intermediate,1,,CHEMBL623895,,BAO_0000218,1969.0,
8742,,Rattus norvegicus,Maximum concentration of compound in rat was evaluated.,N,A,1,Intermediate,1,,CHEMBL623896,,BAO_0000218,,
8743,,Rattus norvegicus,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL623897,,BAO_0000218,,
8744,,Rattus norvegicus,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL623898,,BAO_0000218,,
8745,,Rattus norvegicus,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,N,A,1,Intermediate,1,,CHEMBL623899,,BAO_0000218,,
8746,,Rattus norvegicus,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL623900,,BAO_0000218,,
8747,,Rattus norvegicus,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,N,A,1,Intermediate,1,,CHEMBL623901,,BAO_0000218,,
8748,,Rattus norvegicus,Maximum concentration was evaluated in rats,N,A,1,Intermediate,1,,CHEMBL623902,,BAO_0000218,,
8749,,Rattus norvegicus,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,N,A,1,Intermediate,1,,CHEMBL623903,,BAO_0000218,1359.0,
8750,,Rattus norvegicus,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,N,A,1,Intermediate,1,,CHEMBL623904,,BAO_0000218,1969.0,
8751,,Rattus norvegicus,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,A,1,Intermediate,1,,CHEMBL877617,,BAO_0000218,1969.0,
8752,,Rattus norvegicus,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL623905,,BAO_0000218,,
8753,,Rattus norvegicus,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL623906,,BAO_0000218,,
8754,,Rattus norvegicus,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,A,1,Intermediate,1,,CHEMBL623907,,BAO_0000218,1969.0,
8755,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL623908,,BAO_0000218,,
8756,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL623909,,BAO_0000218,,
8757,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL623910,,BAO_0000218,,
8758,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL623911,,BAO_0000218,,
8759,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL623912,,BAO_0000218,,
8760,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL624616,,BAO_0000218,,
8761,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL624617,,BAO_0000218,,
8762,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL624618,,BAO_0000218,,
8763,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL624619,,BAO_0000218,,
8764,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL624794,,BAO_0000218,,
8765,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL624795,,BAO_0000218,,
8766,,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL623921,,BAO_0000218,,
8767,,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL623922,,BAO_0000218,,
8768,,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL623923,,BAO_0000218,,
8769,,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL623924,,BAO_0000218,,
8770,,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL623925,,BAO_0000218,,
8771,,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL623926,,BAO_0000218,,
8772,,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL623927,,BAO_0000218,,
8773,,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL623928,,BAO_0000218,,
8774,,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL623929,,BAO_0000218,,
8775,,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL623930,,BAO_0000218,,
8776,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL623931,,BAO_0000218,955.0,
8777,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL622165,,BAO_0000218,955.0,
8778,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL621249,,BAO_0000218,955.0,
8779,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL621250,,BAO_0000218,955.0,
8780,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL621448,,BAO_0000218,955.0,
8781,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL621449,,BAO_0000218,955.0,
8782,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL621450,,BAO_0000218,955.0,
8783,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL621451,,BAO_0000218,955.0,
8784,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL621452,,BAO_0000218,955.0,
8785,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL621453,,BAO_0000218,955.0,
8786,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL621454,,BAO_0000218,955.0,
8787,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL621455,,BAO_0000218,955.0,
8788,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL621456,,BAO_0000218,955.0,
8789,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL625145,,BAO_0000218,955.0,
8790,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL875847,,BAO_0000218,955.0,
8791,,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL625146,,BAO_0000218,955.0,
8792,,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL625147,,BAO_0000218,955.0,
8793,,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL625148,,BAO_0000218,955.0,
8794,,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL625149,,BAO_0000218,955.0,
8795,,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL625150,,BAO_0000218,955.0,
8796,,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL625151,,BAO_0000218,955.0,
8797,,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL625152,,BAO_0000218,955.0,
8798,,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL625153,,BAO_0000218,955.0,
8799,,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL625154,,BAO_0000218,955.0,
8800,,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL625155,,BAO_0000218,955.0,
8801,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL625156,,BAO_0000218,,
8802,,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624354,,BAO_0000218,,
8803,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624355,,BAO_0000218,10000000.0,
8804,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624356,,BAO_0000218,10000000.0,
8805,,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624357,,BAO_0000218,10000000.0,
8806,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624358,,BAO_0000218,10000000.0,
8807,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624359,,BAO_0000218,2435.0,
8808,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624360,,BAO_0000218,2435.0,
8809,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL624361,,BAO_0000218,2435.0,
8810,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624362,,BAO_0000218,2435.0,
8811,,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624363,,BAO_0000218,2435.0,
8812,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624364,,BAO_0000218,178.0,
8813,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624365,,BAO_0000218,178.0,
8814,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624366,,BAO_0000218,178.0,
8815,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624367,,BAO_0000218,178.0,
8816,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624368,,BAO_0000218,955.0,
8817,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL624369,,BAO_0000218,955.0,
8818,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL624370,,BAO_0000218,955.0,
8819,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL625069,,BAO_0000218,955.0,
8820,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL625070,,BAO_0000218,955.0,
8821,,Rattus norvegicus,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL626051,,BAO_0000218,948.0,
8822,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL626052,,BAO_0000218,948.0,
8823,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL626053,,BAO_0000218,948.0,
8824,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL626054,,BAO_0000218,948.0,
8825,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL626055,,BAO_0000218,948.0,
8826,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL626056,,BAO_0000218,2113.0,
8827,,Rattus norvegicus,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL626057,,BAO_0000218,2113.0,
8828,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL625193,,BAO_0000218,2113.0,
8829,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL625194,,BAO_0000218,2113.0,
8830,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL625195,,BAO_0000218,2107.0,
8831,,Rattus norvegicus,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL625196,,BAO_0000218,2107.0,
8832,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL625197,,BAO_0000218,2107.0,
8833,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL625198,,BAO_0000218,2107.0,
8834,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL627929,,BAO_0000218,2107.0,
8835,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL627074,,BAO_0000218,2048.0,
8836,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL627075,,BAO_0000218,2048.0,
8837,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL627076,,BAO_0000218,2048.0,
8838,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL627077,,BAO_0000218,2048.0,
8839,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL627078,,BAO_0000218,2048.0,
8840,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL627079,,BAO_0000218,2385.0,
8841,,Mus musculus,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,N,A,1,Intermediate,1,,CHEMBL873824,,BAO_0000218,,
8842,,Mus musculus,Half life in mouse plasma was determined at dose 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL627080,,BAO_0000218,1969.0,
8843,,Mus musculus,Half life was determined,N,A,1,Intermediate,1,,CHEMBL627081,,BAO_0000218,,
8844,,Mus musculus,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,A,1,Intermediate,1,,CHEMBL627082,,BAO_0000218,,
8845,,Mus musculus,Half-life in male mice after 1 mg/kg intravenous dose,N,A,1,Intermediate,1,,CHEMBL627083,,BAO_0000218,,
8847,,Mus musculus,Half life in mice plasma,N,A,1,Intermediate,1,,CHEMBL627085,,BAO_0000218,1969.0,
8848,,Mus musculus,Half life in mouse,N,A,1,Intermediate,1,,CHEMBL627086,,BAO_0000218,,
8849,,Mus musculus,Half life in mouse plasma at dose 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL627087,,BAO_0000218,1969.0,
8850,,Mus musculus,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,N,A,1,Intermediate,1,,CHEMBL627088,,BAO_0000218,,
8851,,Mus musculus,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,N,A,1,Intermediate,1,,CHEMBL627089,,BAO_0000218,,
8852,,Mus musculus,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,N,A,1,Intermediate,1,,CHEMBL627090,,BAO_0000218,,
8853,,Mus musculus,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),N,A,1,Intermediate,1,,CHEMBL627091,,BAO_0000218,,
8854,,Mus musculus,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",N,A,1,Intermediate,1,,CHEMBL627092,,BAO_0000218,,
8855,,Mus musculus,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",N,A,1,Intermediate,1,,CHEMBL876785,,BAO_0000218,,
8856,,Mus musculus,Half-life by iv administration in mouse,N,A,1,Intermediate,1,,CHEMBL627093,,BAO_0000218,,
8857,,Mus musculus,Half-life by oral administration in mouse,N,A,1,Intermediate,1,,CHEMBL627094,,BAO_0000218,,
8858,,Mus musculus,Half-life in mice,N,A,1,Intermediate,1,,CHEMBL627095,,BAO_0000218,,
8859,,Mus musculus,Half-life using mouse brain homogenate,N,A,1,Intermediate,1,,CHEMBL627096,,BAO_0000218,955.0,
8860,,Mus musculus,Half-life was measured in mice,N,A,1,Intermediate,1,,CHEMBL627097,,BAO_0000218,,
8861,,Mus musculus,Half-life was measured in mouse after an iv dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL627098,,BAO_0000218,,
8862,,Mus musculus,Half-life period was determined in mouse blood,N,A,1,Intermediate,1,,CHEMBL627099,,BAO_0000218,178.0,
8863,,Mus musculus,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",N,A,1,Intermediate,1,,CHEMBL627100,,BAO_0000218,955.0,
8864,,Mus musculus,Plasma half life in mouse,N,A,1,Intermediate,1,,CHEMBL627101,,BAO_0000218,1969.0,
8865,,Mus musculus,Stability of the peptide in the presence of mouse serum,N,A,1,Intermediate,1,,CHEMBL627102,,BAO_0000218,,
8866,,Mus musculus,Terminal half life of compound was determined in mouse,N,A,1,Intermediate,1,,CHEMBL627103,,BAO_0000218,,
8867,,Mus musculus,Terminal half life was evaluated in mice after intravenous administration,N,A,1,Intermediate,1,,CHEMBL627104,,BAO_0000218,,
8868,,Mus musculus,Terminal half life was evaluated in mice after oral administration,N,A,1,Intermediate,1,,CHEMBL627105,,BAO_0000218,,
8869,,Mus musculus,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,N,A,1,Intermediate,1,,CHEMBL876786,,BAO_0000218,,
8870,,Mus musculus,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,N,A,1,Intermediate,1,,CHEMBL873825,,BAO_0000218,,
8871,,Mus musculus,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,N,A,1,Intermediate,1,,CHEMBL627106,,BAO_0000218,,
8872,,Mus musculus,half life period is evaluated by administering intravenously at 25 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL626336,,BAO_0000218,,
8873,,Mus musculus,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",N,A,1,Intermediate,1,,CHEMBL877462,,BAO_0000218,,
8874,,Mus musculus,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",N,A,1,Intermediate,1,,CHEMBL626337,,BAO_0000218,,
8875,,Mus musculus,Half life after intraperitoneal administration of 100 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL626338,,BAO_0000218,,
8876,,Mus musculus,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,N,A,1,Intermediate,1,,CHEMBL626339,,BAO_0000218,,
8877,,Mus musculus,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,A,1,Intermediate,1,,CHEMBL626340,,BAO_0000218,,
8878,,Mus musculus,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,N,A,1,Intermediate,1,,CHEMBL625377,,BAO_0000218,,
8879,,Mus musculus,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,N,A,1,Intermediate,1,,CHEMBL625378,,BAO_0000218,,
8880,,Mus musculus,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,N,A,1,Intermediate,1,,CHEMBL625379,,BAO_0000218,,
8881,Microsomes,Sus scrofa,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),U,A,0,Autocuration,1,,CHEMBL625380,,BAO_0000251,,
8882,Microsomes,Sus scrofa,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),U,A,0,Autocuration,1,,CHEMBL625381,,BAO_0000251,,
8883,,Sus scrofa,Stability to porcine renal DHP-I,U,A,0,Autocuration,1,,CHEMBL625382,,BAO_0000019,,
8884,,Sus scrofa,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,U,A,0,Autocuration,1,,CHEMBL873828,,BAO_0000218,,
8885,,Sus scrofa,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,U,A,0,Autocuration,1,,CHEMBL625383,,BAO_0000218,,
8886,,Sus scrofa,Half-life of the parent prodrug in porcine esterase solution,U,A,0,Autocuration,1,,CHEMBL625384,,BAO_0000019,,
8887,,Sus scrofa,"First order rate constant, k was determined in in pig liver Esterase",U,A,0,Autocuration,1,,CHEMBL625385,,BAO_0000019,,
8888,,Sus scrofa,Half life of the in pig liver Esterase,U,A,0,Autocuration,1,,CHEMBL625386,,BAO_0000221,2107.0,
8889,,Sus scrofa,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,U,A,0,Autocuration,1,,CHEMBL623571,,BAO_0000221,2107.0,
8890,,Sus scrofa,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,U,A,0,Autocuration,1,,CHEMBL623572,,BAO_0000221,2107.0,
8891,,Sus scrofa,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,U,A,0,Autocuration,1,,CHEMBL623573,,BAO_0000221,2107.0,
8892,,Sus scrofa,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,U,A,0,Autocuration,1,,CHEMBL623574,,BAO_0000221,2107.0,
8893,,Sus scrofa,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,U,A,0,Autocuration,1,,CHEMBL623575,,BAO_0000221,2107.0,
8894,,Sus scrofa,Half-life in the presence of pig liver esterase(PLE) was evaluated.,U,A,0,Autocuration,1,,CHEMBL623749,,BAO_0000221,2107.0,
8895,,Sus scrofa,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,U,A,0,Autocuration,1,,CHEMBL623750,,BAO_0000221,2107.0,
8896,,Sus scrofa,Half-life in vitro in pig liver,U,A,0,Autocuration,1,,CHEMBL623751,,BAO_0000221,2107.0,
8897,,Sus scrofa,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,U,A,0,Autocuration,1,,CHEMBL623752,,BAO_0000221,2107.0,
8898,,Rattus norvegicus,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,N,A,1,Intermediate,1,,CHEMBL623753,,BAO_0000218,1969.0,
8899,,Rattus norvegicus,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,A,1,Intermediate,1,,CHEMBL623754,,BAO_0000218,1969.0,
8900,,Rattus norvegicus,Maximum concentration in rat plasma was determined,N,A,1,Intermediate,1,,CHEMBL623755,,BAO_0000218,1969.0,
8901,,Rattus norvegicus,Maximum concentration in rats,N,A,1,Intermediate,1,,CHEMBL623756,,BAO_0000218,,
8902,,Rattus norvegicus,Maximum concentration in rats at 1-2 hours,N,A,1,Intermediate,1,,CHEMBL623757,,BAO_0000218,,
8903,,Rattus norvegicus,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,N,A,1,Intermediate,1,,CHEMBL623758,,BAO_0000218,,
8904,,Rattus norvegicus,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,N,A,1,Intermediate,1,,CHEMBL623759,,BAO_0000218,955.0,
8905,,Rattus norvegicus,Maximum concentration at the dose of 2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL623760,,BAO_0000218,,
8906,,Rattus norvegicus,Maximum concentration was evaluated in rats,N,A,1,Intermediate,1,,CHEMBL623761,,BAO_0000218,,
8907,,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,N,A,1,Intermediate,1,,CHEMBL623762,,BAO_0000218,1969.0,
8908,,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,N,A,1,Intermediate,1,,CHEMBL877594,,BAO_0000218,1969.0,
8909,,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL623763,,BAO_0000218,1969.0,
8910,,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL623764,,BAO_0000218,1969.0,
8911,,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,N,A,1,Intermediate,1,,CHEMBL623765,,BAO_0000218,1969.0,
8912,,Rattus norvegicus,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,N,A,1,Intermediate,1,,CHEMBL623766,,BAO_0000218,178.0,
8913,,Rattus norvegicus,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,N,A,1,Intermediate,1,,CHEMBL623767,,BAO_0000218,178.0,
8914,,Rattus norvegicus,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,N,A,1,Intermediate,1,,CHEMBL623768,,BAO_0000218,178.0,
8915,,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623769,,BAO_0000218,1969.0,
8916,,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623770,,BAO_0000218,1969.0,
8917,,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623771,,BAO_0000218,1969.0,
8918,,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623772,,BAO_0000218,1969.0,
8919,,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623773,,BAO_0000218,1969.0,
8920,,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623774,,BAO_0000218,1969.0,
8921,,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL623775,,BAO_0000218,1969.0,
8922,,Rattus norvegicus,Cmax in rat (PO dose),N,A,1,Intermediate,1,,CHEMBL623776,,BAO_0000218,,
8923,,Rattus norvegicus,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL622191,,BAO_0000218,1969.0,
8924,,Rattus norvegicus,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL622192,,BAO_0000218,1969.0,
8925,,Rattus norvegicus,Maximum plasma concentration determined in rat,N,A,1,Intermediate,1,,CHEMBL622193,,BAO_0000218,1969.0,
8926,,Rattus norvegicus,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL622194,,BAO_0000218,1969.0,
8927,,Rattus norvegicus,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL622195,,BAO_0000218,1969.0,
8928,,Rattus norvegicus,Maximum plasma concentration in rat,N,A,1,Intermediate,1,,CHEMBL622196,,BAO_0000218,1969.0,
8929,,Rattus norvegicus,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,A,1,Intermediate,1,,CHEMBL622197,,BAO_0000218,1969.0,
8930,,Rattus norvegicus,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,N,A,1,Intermediate,1,,CHEMBL622198,,BAO_0000218,1969.0,
8931,,Rattus norvegicus,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,N,A,1,Intermediate,1,,CHEMBL622199,,BAO_0000218,1969.0,
8932,,Rattus norvegicus,Maximum plasma concentration of compound was measured in rat,N,A,1,Intermediate,1,,CHEMBL622200,,BAO_0000218,1969.0,
8933,,Rattus norvegicus,Maximum plasma concentration after 20 mg/kg oral administration in rat,N,A,1,Intermediate,1,,CHEMBL622201,,BAO_0000218,1969.0,
8934,,Rattus norvegicus,Maximum plasma concentration after oral administration to rats,N,A,1,Intermediate,1,,CHEMBL623990,,BAO_0000218,1969.0,
8935,,Rattus norvegicus,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,A,1,Intermediate,1,,CHEMBL623991,,BAO_0000218,1969.0,
8936,,Rattus norvegicus,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",N,A,1,Intermediate,1,,CHEMBL623992,,BAO_0000218,1969.0,
8937,,Rattus norvegicus,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,A,1,Intermediate,1,,CHEMBL623993,,BAO_0000218,1969.0,
8938,,Rattus norvegicus,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,N,A,1,Intermediate,1,,CHEMBL623994,,BAO_0000218,1969.0,
8939,,Rattus norvegicus,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,N,F,1,Intermediate,1,,CHEMBL623995,,BAO_0000218,1969.0,
8940,,Rattus norvegicus,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,N,F,1,Intermediate,1,,CHEMBL623996,,BAO_0000218,1969.0,
8941,,Rattus norvegicus,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,N,F,1,Intermediate,1,,CHEMBL623997,,BAO_0000218,1969.0,
8942,,Rattus norvegicus,Maximum plasma concentration dosed orally in rats,N,A,1,Intermediate,1,,CHEMBL623998,,BAO_0000218,1969.0,
8943,,Rattus norvegicus,Maximum plasma concentration dosed orally in rats after 6 hours,N,A,1,Intermediate,1,,CHEMBL623999,,BAO_0000218,1969.0,
8944,,Rattus norvegicus,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,N,A,1,Intermediate,1,,CHEMBL624000,,BAO_0000218,1969.0,
8945,,Rattus norvegicus,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL624001,,BAO_0000218,1969.0,
8946,,Rattus norvegicus,Maximum plasma concentration in rat after po administration,N,A,1,Intermediate,1,,CHEMBL624002,,BAO_0000218,1969.0,
8947,,Rattus norvegicus,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL624003,,BAO_0000218,1969.0,
8948,,Rattus norvegicus,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",N,A,1,Intermediate,1,,CHEMBL624004,,BAO_0000218,1969.0,
8949,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL624005,,BAO_0000218,948.0,
8950,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL624006,,BAO_0000218,948.0,
8951,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL624007,,BAO_0000218,948.0,
8952,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL624008,,BAO_0000218,948.0,
8953,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL624009,,BAO_0000218,948.0,
8954,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL874387,,BAO_0000218,948.0,
8955,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL624010,,BAO_0000218,948.0,
8956,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL624011,,BAO_0000218,948.0,
8957,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL624012,,BAO_0000218,948.0,
8958,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL624013,,BAO_0000218,948.0,
8959,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL624736,,BAO_0000218,948.0,
8960,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL624737,,BAO_0000218,948.0,
8961,,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL624738,,BAO_0000218,948.0,
8962,,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL624739,,BAO_0000218,948.0,
8963,,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL624740,,BAO_0000218,948.0,
8964,,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL624896,,BAO_0000218,948.0,
8965,,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL624897,,BAO_0000218,948.0,
8966,,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL624108,,BAO_0000218,948.0,
8967,,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL624109,,BAO_0000218,948.0,
8968,,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL624110,,BAO_0000218,948.0,
8969,,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL624111,,BAO_0000218,948.0,
8970,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL624112,,BAO_0000218,948.0,
8971,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL624113,,BAO_0000218,948.0,
8972,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL619709,,BAO_0000218,948.0,
8973,,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL619710,,BAO_0000218,948.0,
8974,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL619711,,BAO_0000218,2113.0,
8975,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL619712,,BAO_0000218,2113.0,
8976,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL619713,,BAO_0000218,2113.0,
8977,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL619714,,BAO_0000218,2113.0,
8978,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL619715,,BAO_0000218,2113.0,
8979,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL619716,,BAO_0000218,2113.0,
8980,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL619717,,BAO_0000218,2113.0,
8981,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL619718,,BAO_0000218,2113.0,
8982,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL619719,,BAO_0000218,2113.0,
8983,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL875329,,BAO_0000218,2113.0,
8984,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL619720,,BAO_0000218,2113.0,
8985,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL619721,,BAO_0000218,2113.0,
8986,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL619722,,BAO_0000218,2113.0,
8987,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL619723,,BAO_0000218,2113.0,
8988,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL619724,,BAO_0000218,2113.0,
8989,,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL619725,,BAO_0000218,2113.0,
8990,,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL619726,,BAO_0000218,2113.0,
8991,,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL619727,,BAO_0000218,2113.0,
8992,,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL619728,,BAO_0000218,2113.0,
8993,,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL619729,,BAO_0000218,2113.0,
8994,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL619730,,BAO_0000218,2385.0,
8995,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL619731,,BAO_0000218,2385.0,
8996,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL619732,,BAO_0000218,2385.0,
8997,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL619733,,BAO_0000218,2385.0,
8998,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL619734,,BAO_0000218,2385.0,
8999,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL619735,,BAO_0000218,14.0,
9000,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL875330,,BAO_0000218,14.0,
9001,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL628465,,BAO_0000218,14.0,
9002,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL628466,,BAO_0000218,14.0,
9003,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL628467,,BAO_0000218,14.0,
9004,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL628468,,BAO_0000218,2106.0,
9005,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL628469,,BAO_0000218,2106.0,
9006,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL628470,,BAO_0000218,2106.0,
9007,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL628471,,BAO_0000218,2106.0,
9008,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL628472,,BAO_0000218,2106.0,
9009,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL625191,,BAO_0000218,2046.0,
9010,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL625192,,BAO_0000218,2046.0,
9011,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,A,1,Intermediate,1,,CHEMBL875337,,BAO_0000218,2046.0,
9012,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL626341,,BAO_0000218,2046.0,
9013,,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL626342,,BAO_0000218,2046.0,
9014,,Rattus norvegicus,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,A,1,Intermediate,1,,CHEMBL621943,,BAO_0000218,2107.0,
9015,,Rattus norvegicus,Half life in rats,N,A,1,Intermediate,1,,CHEMBL621944,,BAO_0000218,,
9016,,Rattus norvegicus,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,N,A,1,Intermediate,1,,CHEMBL621945,,BAO_0000218,,
9017,,Rattus norvegicus,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),N,A,1,Intermediate,1,,CHEMBL621946,,BAO_0000218,,
9018,,Rattus norvegicus,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,A,1,Intermediate,1,,CHEMBL621947,,BAO_0000218,,
9019,,Rattus norvegicus,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),N,A,1,Intermediate,1,,CHEMBL621948,,BAO_0000218,,
9020,,Rattus norvegicus,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,A,1,Intermediate,1,,CHEMBL621949,,BAO_0000218,,
9021,,Rattus norvegicus,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),N,A,1,Intermediate,1,,CHEMBL621950,,BAO_0000218,,
9022,,Rattus norvegicus,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,N,A,1,Intermediate,1,,CHEMBL621951,,BAO_0000218,,
9023,,Rattus norvegicus,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,N,A,1,Intermediate,1,,CHEMBL621952,,BAO_0000218,178.0,
9024,,Rattus norvegicus,Stability (%) in rat liver microsomes,N,A,1,Intermediate,1,,CHEMBL621953,,BAO_0000218,2107.0,
9025,,Rattus norvegicus,Area under curve was calculated after intravenous administration,N,A,1,Intermediate,1,,CHEMBL621954,,BAO_0000218,,
9026,,Rattus norvegicus,Area under the curve was calculated after iv administration in rat,N,A,1,Intermediate,1,,CHEMBL621955,,BAO_0000218,,
9027,,Rattus norvegicus,Area under the curve was calculated in rat after peroral administration,N,A,1,Intermediate,1,,CHEMBL621956,,BAO_0000218,,
9028,,Rattus norvegicus,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL621957,,BAO_0000218,,
9029,,Rattus norvegicus,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,N,A,1,Intermediate,1,,CHEMBL621958,,BAO_0000218,,
9030,,Rattus norvegicus,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,N,A,1,Intermediate,1,,CHEMBL621959,,BAO_0000218,,
9031,,Rattus norvegicus,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,N,A,1,Intermediate,1,,CHEMBL621960,,BAO_0000218,,
9032,,Rattus norvegicus,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,N,A,1,Intermediate,1,,CHEMBL621961,,BAO_0000218,,
9033,,Rattus norvegicus,p value of the compound,N,A,1,Intermediate,1,,CHEMBL621962,,BAO_0000218,,
9034,,Rattus norvegicus,p value of the compound,N,F,1,Intermediate,1,,CHEMBL876787,,BAO_0000218,,
9035,,Rattus norvegicus,p value of the compound,N,A,1,Intermediate,1,,CHEMBL621963,,BAO_0000218,,
9036,,Rattus norvegicus,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,A,1,Intermediate,1,,CHEMBL622637,,BAO_0000218,945.0,
9037,,Rattus norvegicus,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,A,1,Intermediate,1,,CHEMBL622638,,BAO_0000218,945.0,
9038,,Rattus norvegicus,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,A,1,Intermediate,1,,CHEMBL626561,,BAO_0000218,945.0,
9039,,Oryctolagus cuniculus,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),U,F,0,Autocuration,1,,CHEMBL626562,,BAO_0000019,,
9040,,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),U,A,0,Autocuration,1,,CHEMBL626563,,BAO_0000218,,
9041,,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),U,A,0,Autocuration,1,,CHEMBL626564,,BAO_0000218,,
9042,,Oryctolagus cuniculus,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,A,0,Autocuration,1,,CHEMBL626565,,BAO_0000218,,
9043,,Oryctolagus cuniculus,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,A,0,Autocuration,1,,CHEMBL626566,,BAO_0000218,,
9044,,Oryctolagus cuniculus,Clearance rate in rabbits,U,A,0,Autocuration,1,,CHEMBL626567,,BAO_0000218,,
9045,,Oryctolagus cuniculus,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,A,0,Autocuration,1,,CHEMBL626568,,BAO_0000218,,
9046,,Oryctolagus cuniculus,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,A,0,Autocuration,1,,CHEMBL626569,,BAO_0000218,,
9047,,Oryctolagus cuniculus,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,A,0,Autocuration,1,,CHEMBL626570,,BAO_0000218,,
9048,,Oryctolagus cuniculus,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,A,0,Autocuration,1,,CHEMBL626571,,BAO_0000218,,
9049,,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,U,A,0,Autocuration,1,,CHEMBL626572,,BAO_0000218,,
9050,,Oryctolagus cuniculus,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,A,0,Autocuration,1,,CHEMBL626573,,BAO_0000218,1969.0,
9051,Microsomes,Oryctolagus cuniculus,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,U,A,0,Autocuration,1,,CHEMBL626574,,BAO_0000251,2107.0,
9052,Microsomes,Oryctolagus cuniculus,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,U,A,0,Autocuration,1,,CHEMBL626575,,BAO_0000251,2107.0,
9053,,Oryctolagus cuniculus,Dose at which bioavailability of intravenously administered compound was tested in rabbit,U,A,0,Autocuration,1,,CHEMBL626576,,BAO_0000218,,
9054,,Oryctolagus cuniculus,Dose at which bioavailability of perorally administered compound was tested in rabbit,U,A,0,Autocuration,1,,CHEMBL626577,,BAO_0000218,,
9055,,Oryctolagus cuniculus,The compound was tested for its bioavailability in rabbit (by oral dosage).,U,A,0,Autocuration,1,,CHEMBL626578,,BAO_0000218,,
9056,,Oryctolagus cuniculus,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,A,0,Autocuration,1,,CHEMBL625263,,BAO_0000218,,
9057,,Oryctolagus cuniculus,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,A,0,Autocuration,1,,CHEMBL625264,,BAO_0000218,,
9058,,Oryctolagus cuniculus,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,A,0,Autocuration,1,,CHEMBL625265,,BAO_0000218,,
9059,Microsomes,Oryctolagus cuniculus,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),U,A,0,Autocuration,1,,CHEMBL625266,,BAO_0000251,,
9060,Microsomes,Oryctolagus cuniculus,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),U,A,0,Autocuration,1,,CHEMBL876796,,BAO_0000251,,
9061,,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,U,A,0,Autocuration,1,,CHEMBL625267,,BAO_0000218,,
9062,,Oryctolagus cuniculus,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,A,0,Autocuration,1,,CHEMBL625268,,BAO_0000218,1969.0,
9063,,Oryctolagus cuniculus,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,A,0,Autocuration,1,,CHEMBL625269,,BAO_0000218,1969.0,
9064,,Oryctolagus cuniculus,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,A,0,Autocuration,1,,CHEMBL624689,,BAO_0000218,1969.0,
9065,,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,U,A,0,Autocuration,1,,CHEMBL624690,,BAO_0000218,,
9066,,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),U,A,0,Autocuration,1,,CHEMBL624691,,BAO_0000218,1088.0,
9067,,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),U,A,0,Autocuration,1,,CHEMBL624692,,BAO_0000218,1088.0,
9068,,Oryctolagus cuniculus,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,U,A,0,Autocuration,1,,CHEMBL624693,,BAO_0000218,,
9069,,Oryctolagus cuniculus,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,U,A,0,Autocuration,1,,CHEMBL624694,,BAO_0000218,,
9070,,Oryctolagus cuniculus,In vitro Biological half-life in crude homogenate of rabbit renal cortex,U,A,0,Autocuration,1,,CHEMBL877596,,BAO_0000221,,
9071,,Oryctolagus cuniculus,Time within which only 10% of the drug was degraded,U,A,0,Autocuration,1,,CHEMBL624695,,BAO_0000019,,
9072,,Oryctolagus cuniculus,Half life period in rabbit liver homogenate,U,A,0,Autocuration,1,,CHEMBL624696,,BAO_0000221,2107.0,
9073,,Oryctolagus cuniculus,Half life value in rabbits,U,A,0,Autocuration,1,,CHEMBL624697,,BAO_0000019,,
9074,,Oryctolagus cuniculus,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,A,0,Autocuration,1,,CHEMBL624698,,BAO_0000218,178.0,
9075,,Oryctolagus cuniculus,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,A,0,Autocuration,1,,CHEMBL624699,,BAO_0000218,178.0,
9076,,Oryctolagus cuniculus,Half-life period in rabbits following intravenous administration at 2 mg/kg,U,A,0,Autocuration,1,,CHEMBL624700,,BAO_0000218,,
9077,,Rattus norvegicus,AUC 0-8 hr value in rats at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL622903,,BAO_0000218,1969.0,
9078,,Rattus norvegicus,AUC after administration at 2000 mg/kg/day in rats,N,A,1,Intermediate,1,,CHEMBL622904,,BAO_0000218,1969.0,
9079,,Rattus norvegicus,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,N,A,1,Intermediate,1,,CHEMBL622905,,BAO_0000218,1969.0,
9080,,Rattus norvegicus,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL622906,,BAO_0000218,1969.0,
9081,,Rattus norvegicus,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL622907,,BAO_0000218,1969.0,
9082,,Rattus norvegicus,AUC in rat after oral administration at 10.5 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL622908,,BAO_0000218,1969.0,
9083,,Rattus norvegicus,AUC in rat after oral administration at 11.2 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL622909,,BAO_0000218,1969.0,
9084,,Rattus norvegicus,AUC in rat after oral administration at 9.7 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL622910,,BAO_0000218,1969.0,
9085,,Rattus norvegicus,AUC in rat brain after oral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL622911,,BAO_0000218,955.0,
9086,,Rattus norvegicus,AUC in rat p.o.,N,A,1,Intermediate,1,,CHEMBL622912,,BAO_0000218,1969.0,
9087,,Rattus norvegicus,AUC in rat p.o. at 20 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL622913,,BAO_0000218,1969.0,
9088,,Rattus norvegicus,AUC in rat plasma after oral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL622914,,BAO_0000218,1969.0,
9089,,Rattus norvegicus,AUC in rats,N,A,1,Intermediate,1,,CHEMBL622915,,BAO_0000218,1969.0,
9090,,Rattus norvegicus,AUC value after IV dose at a dose of 5 mg/kg in rats.,N,A,1,Intermediate,1,,CHEMBL622916,,BAO_0000218,1969.0,
9091,,Rattus norvegicus,AUC value after oral dose at a dose of 10 mg/kg in rats.,N,A,1,Intermediate,1,,CHEMBL622917,,BAO_0000218,1969.0,
9092,,Rattus norvegicus,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,A,1,Intermediate,1,,CHEMBL622918,,BAO_0000218,1969.0,
9093,,Rattus norvegicus,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,N,A,1,Intermediate,1,,CHEMBL622919,,BAO_0000218,1969.0,
9094,,Rattus norvegicus,Maximum plasma concentration was evaluated in rat,N,A,1,Intermediate,1,,CHEMBL622920,,BAO_0000218,1969.0,
9095,,Rattus norvegicus,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,A,1,Intermediate,1,,CHEMBL622921,,BAO_0000218,1969.0,
9096,,Rattus norvegicus,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,N,A,1,Intermediate,1,,CHEMBL622922,,BAO_0000218,1969.0,
9097,,Rattus norvegicus,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL622923,,BAO_0000218,1969.0,
9098,,Rattus norvegicus,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL877604,,BAO_0000218,1969.0,
9099,,Rattus norvegicus,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL622924,,BAO_0000218,1969.0,
9100,,Rattus norvegicus,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL622925,,BAO_0000218,1969.0,
9101,,Rattus norvegicus,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,N,A,1,Intermediate,1,,CHEMBL622926,,BAO_0000218,1969.0,
9102,,Rattus norvegicus,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL623625,,BAO_0000218,1969.0,
9103,,Rattus norvegicus,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,N,A,1,Expert,1,,CHEMBL623626,,BAO_0000218,1969.0,
9104,,Rattus norvegicus,Maximum plasma drug concentration was determined,N,A,1,Intermediate,1,,CHEMBL623627,,BAO_0000218,1969.0,
9105,,Rattus norvegicus,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL623628,,BAO_0000218,,
9106,,Rattus norvegicus,Mean peak plasma concentration was observed after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL623629,,BAO_0000218,1969.0,
9107,,Rattus norvegicus,Mean peak plasma concentration was observed after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL623630,,BAO_0000218,1969.0,
9108,,Rattus norvegicus,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL623804,,BAO_0000218,,
9109,,Rattus norvegicus,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL623805,,BAO_0000218,,
9110,,Rattus norvegicus,Peak oral plasma concentration was determined in rats by oral administration,N,A,1,Intermediate,1,,CHEMBL623806,,BAO_0000218,1969.0,
9111,,Rattus norvegicus,Peak plasma concentration (Cmax) was determined,N,A,1,Intermediate,1,,CHEMBL623807,,BAO_0000218,1969.0,
9112,,Rattus norvegicus,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL623808,,BAO_0000218,1969.0,
9113,,Rattus norvegicus,Peak plasma concentration (Cmax) in rats,N,A,1,Intermediate,1,,CHEMBL623809,,BAO_0000218,1969.0,
9114,,Rattus norvegicus,Peak plasma concentration at 1 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL623810,,BAO_0000218,1969.0,
9115,,Rattus norvegicus,Peak plasma concentration in rat,N,A,1,Intermediate,1,,CHEMBL623811,,BAO_0000218,1969.0,
9116,,Rattus norvegicus,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",N,A,1,Intermediate,1,,CHEMBL623812,,BAO_0000218,1969.0,
9117,,Rattus norvegicus,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL877605,,BAO_0000218,,
9118,,Rattus norvegicus,Pharmacokinetic property (Cmax) in rat,N,A,1,Intermediate,1,,CHEMBL623813,,BAO_0000218,,
9119,,Rattus norvegicus,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,A,1,Intermediate,1,,CHEMBL623814,,BAO_0000218,,
9120,,Rattus norvegicus,Cmax in rat after 3mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL623815,,BAO_0000218,,
9121,,Rattus norvegicus,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL623816,,BAO_0000218,,
9122,,Rattus norvegicus,Cmax in rats after 20 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL623145,,BAO_0000218,,
9123,,Rattus norvegicus,Cmax in rat plasma after 30mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL623146,,BAO_0000218,1969.0,
9124,,Rattus norvegicus,Plasma concentration after oral administration of 100 mg/kg to rats,N,A,1,Intermediate,1,,CHEMBL623147,,BAO_0000218,1969.0,
9125,,Rattus norvegicus,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL623042,,BAO_0000218,955.0,
9126,,Rattus norvegicus,Tested for the Cmax in rat at 10 mg/kg per orally,N,A,1,Intermediate,1,,CHEMBL623043,,BAO_0000218,,
9127,,Rattus norvegicus,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL623044,,BAO_0000218,,
9128,,Rattus norvegicus,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL623045,,BAO_0000218,,
9129,,Rattus norvegicus,Bioavailability as oral Cmax in rats at 30 mins,N,A,1,Intermediate,1,,CHEMBL623046,,BAO_0000218,,
9130,,Rattus norvegicus,Bioavailability as oral Cmax in rats at 6hr,N,A,1,Intermediate,1,,CHEMBL623226,,BAO_0000218,,
9131,,Rattus norvegicus,The maximum concentration of compound was measured at the dose of 100 umol/kg,N,A,1,Intermediate,1,,CHEMBL623227,,BAO_0000218,,
9132,,Rattus norvegicus,The maximum concentration of compound was measured at the dose of 300 umol/kg,N,A,1,Intermediate,1,,CHEMBL623228,,BAO_0000218,,
9133,,Rattus norvegicus,The maximum concentration of compound was measured at the dose of 30 umol/kg,N,A,1,Intermediate,1,,CHEMBL623229,,BAO_0000218,,
9134,,Rattus norvegicus,The maximum plasma levels for the compounds were determined by LC-MS.,N,A,1,Intermediate,1,,CHEMBL623230,,BAO_0000218,1969.0,
9135,,Rattus norvegicus,mean peak plasma concentration was observed after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL623231,,BAO_0000218,1969.0,
9136,,Rattus norvegicus,mean peak plasma concentration was observed after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL623232,,BAO_0000218,1969.0,
9137,,Rattus norvegicus,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL623233,,BAO_0000218,,
9138,,Rattus norvegicus,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,N,A,1,Intermediate,1,,CHEMBL623234,,BAO_0000218,,
9139,,Rattus norvegicus,Concentration in plasma (portal) following oral dose in rats at 1 hr,N,A,1,Intermediate,1,,CHEMBL623235,,BAO_0000218,,
9140,,Rattus norvegicus,Concentration in plasma (portal) following oral dose in rats at 2 hr,N,A,1,Intermediate,1,,CHEMBL623236,,BAO_0000218,,
9141,,Rattus norvegicus,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,N,A,1,Intermediate,1,,CHEMBL623237,,BAO_0000218,,
9142,,Rattus norvegicus,Concentration in plasma (systemic) following oral dose in rats at 1 hr,N,A,1,Intermediate,1,,CHEMBL623238,,BAO_0000218,,
9143,,Rattus norvegicus,Concentration in plasma (systemic) following oral dose in rats at 2 hr,N,A,1,Intermediate,1,,CHEMBL623239,,BAO_0000218,,
9144,,Rattus norvegicus,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,U,A,0,Intermediate,1,,CHEMBL623240,,BAO_0000218,1969.0,
9145,,Rattus norvegicus,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",N,A,1,Intermediate,1,,CHEMBL623241,,BAO_0000218,1898.0,
9146,,Rattus norvegicus,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",N,A,1,Intermediate,1,,CHEMBL623242,,BAO_0000218,1898.0,
9147,,Rattus norvegicus,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",N,A,1,Intermediate,1,,CHEMBL874394,,BAO_0000218,,
9148,,Rattus norvegicus,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",N,A,1,Intermediate,1,,CHEMBL623243,,BAO_0000218,,
9149,,Rattus norvegicus,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL623244,,BAO_0000218,,
9150,,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL623245,,BAO_0000218,2113.0,
9151,,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL623246,,BAO_0000218,2113.0,
9152,,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL623247,,BAO_0000218,2113.0,
9153,,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL623248,,BAO_0000218,2113.0,
9154,,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL623249,,BAO_0000218,2113.0,
9155,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL625072,,BAO_0000218,2107.0,
9156,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL625073,,BAO_0000218,2107.0,
9157,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL625074,,BAO_0000218,2107.0,
9158,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL625075,,BAO_0000218,2107.0,
9159,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL625076,,BAO_0000218,2107.0,
9160,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL625077,,BAO_0000218,2107.0,
9161,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL625078,,BAO_0000218,2107.0,
9162,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL874395,,BAO_0000218,2107.0,
9163,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL625079,,BAO_0000218,2107.0,
9164,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL625080,,BAO_0000218,2107.0,
9165,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL625081,,BAO_0000218,2107.0,
9166,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL625082,,BAO_0000218,2107.0,
9167,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL625083,,BAO_0000218,2107.0,
9168,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL625084,,BAO_0000218,2107.0,
9169,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL625085,,BAO_0000218,2107.0,
9170,,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL625086,,BAO_0000218,2107.0,
9171,,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL625087,,BAO_0000218,2107.0,
9172,,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL625088,,BAO_0000218,2107.0,
9173,,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL622205,,BAO_0000218,2107.0,
9174,,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL622206,,BAO_0000218,2107.0,
9175,,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL622207,,BAO_0000218,2107.0,
9176,,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL622366,,BAO_0000218,2107.0,
9177,,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL622367,,BAO_0000218,2107.0,
9178,,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL875331,,BAO_0000218,2107.0,
9179,,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL622368,,BAO_0000218,2107.0,
9180,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL622369,,BAO_0000218,2048.0,
9181,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL622370,,BAO_0000218,2048.0,
9182,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL622371,,BAO_0000218,2048.0,
9183,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL622372,,BAO_0000218,2048.0,
9184,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL622373,,BAO_0000218,2048.0,
9185,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL622374,,BAO_0000218,2048.0,
9186,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL622375,,BAO_0000218,2048.0,
9187,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL622376,,BAO_0000218,2048.0,
9188,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL622377,,BAO_0000218,2048.0,
9189,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL622378,,BAO_0000218,2048.0,
9190,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL622379,,BAO_0000218,2048.0,
9191,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL622380,,BAO_0000218,2048.0,
9192,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL622381,,BAO_0000218,2048.0,
9193,,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL622382,,BAO_0000218,2048.0,
9194,,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL622383,,BAO_0000218,2048.0,
9195,,Rattus norvegicus,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,A,1,Intermediate,1,,CHEMBL875332,,BAO_0000218,945.0,
9196,,Rattus norvegicus,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,A,1,Intermediate,1,,CHEMBL622384,,BAO_0000218,945.0,
9197,,Rattus norvegicus,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,A,1,Intermediate,1,,CHEMBL622385,,BAO_0000218,945.0,
9198,,Rattus norvegicus,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,A,1,Intermediate,1,,CHEMBL622386,,BAO_0000218,945.0,
9199,,Rattus norvegicus,The compound was tested for the plasma binding in rat,N,A,1,Intermediate,1,,CHEMBL622387,,BAO_0000218,,
9200,,Rattus norvegicus,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",N,A,1,Intermediate,1,,CHEMBL622388,,BAO_0000218,,
9201,,Rattus norvegicus,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",N,A,1,Intermediate,1,,CHEMBL622389,,BAO_0000218,,
9202,,Rattus norvegicus,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",N,A,1,Intermediate,1,,CHEMBL622390,,BAO_0000218,,
9203,,Rattus norvegicus,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),N,A,1,Intermediate,1,,CHEMBL622391,,BAO_0000218,,
9204,,Rattus norvegicus,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),N,A,1,Intermediate,1,,CHEMBL622392,,BAO_0000218,,
9205,,Rattus norvegicus,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),N,A,1,Intermediate,1,,CHEMBL622393,,BAO_0000218,,
9206,,Rattus norvegicus,Plasma level at 2 hr after administration of the compound,N,A,1,Intermediate,1,,CHEMBL622394,,BAO_0000218,,
9207,,Rattus norvegicus,plasma level at 2 hr after administration of the compound,N,A,1,Intermediate,1,,CHEMBL622395,,BAO_0000218,,
9208,,Rattus norvegicus,Stability in rat serum measured as % recovery at 1 min,N,A,1,Intermediate,1,,CHEMBL622396,,BAO_0000218,1977.0,
9209,,Rattus norvegicus,Stability in rat serum measured as % recovery at 10 min,N,A,1,Intermediate,1,,CHEMBL624894,,BAO_0000218,1977.0,
9210,,Rattus norvegicus,Stability in rat serum measured as % recovery at 10 mins,N,A,1,Intermediate,1,,CHEMBL624895,,BAO_0000218,1977.0,
9211,,Rattus norvegicus,Stability in rat serum measured as % recovery at 2 hr,N,A,1,Intermediate,1,,CHEMBL624058,,BAO_0000218,1977.0,
9212,,Rattus norvegicus,Stability in rat serum measured as % recovery at 3 min,N,A,1,Intermediate,1,,CHEMBL624059,,BAO_0000218,1977.0,
9213,,Rattus norvegicus,Stability in rat serum measured as % recovery at 3 mins,N,A,1,Intermediate,1,,CHEMBL624060,,BAO_0000218,1977.0,
9214,,Rattus norvegicus,Stability in rat serum measured as % recovery at 5 min,N,A,1,Intermediate,1,,CHEMBL624061,,BAO_0000218,1977.0,
9215,,Rattus norvegicus,Stability in rat serum measured as % recovery at 5 mins,N,A,1,Intermediate,1,,CHEMBL624062,,BAO_0000218,1977.0,
9216,,Rattus norvegicus,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL624063,,BAO_0000218,,
9217,,Rattus norvegicus,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL624064,,BAO_0000218,,
9218,,Rattus norvegicus,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,N,A,1,Intermediate,1,,CHEMBL624065,,BAO_0000218,1969.0,
9219,,Rattus norvegicus,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,N,A,1,Intermediate,1,,CHEMBL624066,,BAO_0000218,1969.0,
9220,,Rattus norvegicus,Half life tested in mature male rat at a dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL877490,,BAO_0000218,,
9221,,Rattus norvegicus,Half life after intravenous administration of 1 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL874442,,BAO_0000218,,
9222,,Rattus norvegicus,Half life period after administration (30 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL626890,,BAO_0000218,,
9223,,Rattus norvegicus,Half life period in rat after 5 mg/Kg dose,N,A,1,Intermediate,1,,CHEMBL626891,,BAO_0000218,,
9224,,Rattus norvegicus,Half life period in rat after 5 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL626892,,BAO_0000218,,
9225,,Rattus norvegicus,Half life period was determined,N,A,1,Intermediate,1,,CHEMBL626893,,BAO_0000218,,
9226,,Rattus norvegicus,Half life period was evaluated in rat,N,A,1,Intermediate,1,,CHEMBL626894,,BAO_0000218,,
9227,,Rattus norvegicus,Half life period was evaluated in rat; 0.5-1.0,N,A,1,Intermediate,1,,CHEMBL626895,,BAO_0000218,,
9228,,Rattus norvegicus,Half life period was evaluated in rat; 5.9-7.5,N,A,1,Intermediate,1,,CHEMBL626896,,BAO_0000218,,
9229,,Rattus norvegicus,Half-life in rat plasma,N,A,1,Intermediate,1,,CHEMBL626897,,BAO_0000218,1969.0,
9230,,Rattus norvegicus,Half-life time in rat was determined,N,A,1,Intermediate,1,,CHEMBL626898,,BAO_0000218,,
9231,,Rattus norvegicus,Terminal half-life after iv administration to rats,N,A,1,Intermediate,1,,CHEMBL626899,,BAO_0000218,,
9232,,Rattus norvegicus,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,N,A,1,Intermediate,1,,CHEMBL626900,,BAO_0000218,,
9233,,Rattus norvegicus,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,N,A,1,Intermediate,1,,CHEMBL626901,,BAO_0000218,,
9234,,Rattus norvegicus,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),N,A,1,Intermediate,1,,CHEMBL626902,,BAO_0000218,,
9235,,Rattus norvegicus,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),N,A,1,Intermediate,1,,CHEMBL626903,,BAO_0000218,,
9236,,Rattus norvegicus,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL874443,,BAO_0000218,,
9237,,Rattus norvegicus,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626904,,BAO_0000218,,
9238,,Rattus norvegicus,Half life in rats,N,A,1,Intermediate,1,,CHEMBL626905,,BAO_0000218,,
9239,,Rattus norvegicus,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,A,1,Intermediate,1,,CHEMBL873830,,BAO_0000218,1969.0,
9240,,Rattus norvegicus,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626906,,BAO_0000218,,
9241,,Rattus norvegicus,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,A,1,Intermediate,1,,CHEMBL631076,,BAO_0000218,1969.0,
9242,,Rattus norvegicus,Biological half-life was measured in plasma of rats,N,A,1,Intermediate,1,,CHEMBL631077,,BAO_0000218,1969.0,
9243,,Rattus norvegicus,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,A,1,Intermediate,1,,CHEMBL631078,,BAO_0000218,,
9244,,Rattus norvegicus,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,N,A,1,Intermediate,1,,CHEMBL631079,,BAO_0000218,,
9245,,Rattus norvegicus,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,N,A,1,Intermediate,1,,CHEMBL631080,,BAO_0000218,,
9246,,Rattus norvegicus,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,N,A,1,Intermediate,1,,CHEMBL631081,,BAO_0000218,,
9247,,Rattus norvegicus,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,N,A,1,Intermediate,1,,CHEMBL631239,,BAO_0000218,,
9248,,Rattus norvegicus,Compound was evaluated for plasma half life in rat,N,A,1,Intermediate,1,,CHEMBL631240,,BAO_0000218,1969.0,
9249,,Rattus norvegicus,AUC value at a dose of 5 mg/kg (p.o.) in rats,N,A,1,Intermediate,1,,CHEMBL631241,,BAO_0000218,1969.0,
9250,,Rattus norvegicus,AUC value after administration of 20 mg/Kg oral dose in rat,N,A,1,Intermediate,1,,CHEMBL631242,,BAO_0000218,1969.0,
9251,,Rattus norvegicus,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL631243,,BAO_0000218,1969.0,
9252,,Rattus norvegicus,AUC0-96 after administration at 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL874444,,BAO_0000218,1969.0,
9253,,Rattus norvegicus,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL631244,,BAO_0000218,1969.0,
9254,,Rattus norvegicus,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",N,A,1,Intermediate,1,,CHEMBL631245,,BAO_0000218,,
9255,,Rattus norvegicus,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,N,A,1,Intermediate,1,,CHEMBL627162,,BAO_0000218,,
9256,,Rattus norvegicus,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,N,A,1,Intermediate,1,,CHEMBL627163,,BAO_0000218,,
9257,,Rattus norvegicus,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,N,A,1,Intermediate,1,,CHEMBL627164,,BAO_0000218,,
9258,,Rattus norvegicus,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,N,A,1,Intermediate,1,,CHEMBL627165,,BAO_0000218,2113.0,
9259,,Rattus norvegicus,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,N,A,1,Intermediate,1,,CHEMBL627166,,BAO_0000218,,
9260,,Rattus norvegicus,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,N,A,1,Intermediate,1,,CHEMBL627167,,BAO_0000218,,
9261,,Rattus norvegicus,Area under curve (AUC) at a dose of 30 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL627822,,BAO_0000218,,
9262,,Rattus norvegicus,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL627823,,BAO_0000218,,
9263,,Rattus norvegicus,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL627824,,BAO_0000218,,
9264,,Rattus norvegicus,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL627825,,BAO_0000218,,
9265,,Rattus norvegicus,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL627826,,BAO_0000218,,
9266,,Rattus norvegicus,Area under curve (Pharmacokinetic property) was determined,N,A,1,Intermediate,1,,CHEMBL627827,,BAO_0000218,,
9267,,Rattus norvegicus,Area under curve (Pharmacokinetic property) of the compound; Not determined,N,A,1,Intermediate,1,,CHEMBL627828,,BAO_0000218,,
9268,,Rattus norvegicus,Area under curve after intravenous administration (1 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL627829,,BAO_0000218,,
9269,,Rattus norvegicus,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,N,A,1,Intermediate,1,,CHEMBL627830,,BAO_0000218,,
9270,,Rattus norvegicus,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,N,A,1,Intermediate,1,,CHEMBL627831,,BAO_0000218,,
9271,,Rattus norvegicus,Area under curve in male SD rats was observed after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL627832,,BAO_0000218,,
9272,,Rattus norvegicus,Area under curve of compound after iv administration of 20 mg/kg dose in rat,N,A,1,Intermediate,1,,CHEMBL627833,,BAO_0000218,,
9273,,Rattus norvegicus,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,N,A,1,Expert,1,,CHEMBL627834,,BAO_0000218,,
9274,,Rattus norvegicus,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,N,A,1,Expert,1,,CHEMBL628004,,BAO_0000218,,
9275,,Rattus norvegicus,Area under curve at 5 mg/kg po was determined in rat,N,A,1,Intermediate,1,,CHEMBL628005,,BAO_0000218,,
9276,,Rattus norvegicus,Area under curve in Rat at a oral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL628006,,BAO_0000218,,
9277,,Rattus norvegicus,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,A,1,Intermediate,1,,CHEMBL628007,,BAO_0000218,,
9278,,Rattus norvegicus,Area under curve was determined,N,A,1,Intermediate,1,,CHEMBL625676,,BAO_0000218,,
9279,,Rattus norvegicus,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,N,A,1,Intermediate,1,,CHEMBL631309,,BAO_0000218,,
9280,,Rattus norvegicus,Area under curve after intravenous administration at 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL631310,,BAO_0000218,,
9281,,Rattus norvegicus,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,N,A,1,Intermediate,1,,CHEMBL631311,,BAO_0000218,,
9282,,Rattus norvegicus,Area under curve at 4 hr in rat,N,A,1,Intermediate,1,,CHEMBL631312,,BAO_0000218,,
9283,,Rattus norvegicus,Area under curve at a dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL631313,,BAO_0000218,,
9284,,Rattus norvegicus,Area under curve at the dose of 2 mg/Kg administered perorally in rats,N,A,1,Intermediate,1,,CHEMBL631314,,BAO_0000218,,
9285,,Rattus norvegicus,Area under curve at the dose of 5 mg/Kg administered perorally in rats,N,A,1,Intermediate,1,,CHEMBL631315,,BAO_0000218,,
9286,,Rattus norvegicus,Area under curve for a 2-mpk po dose in SD rats,N,A,1,Intermediate,1,,CHEMBL631316,,BAO_0000218,,
9287,,Rattus norvegicus,Area under curve in SD rats,N,A,1,Intermediate,1,,CHEMBL631317,,BAO_0000218,,
9288,,Rattus norvegicus,Area under curve in rat after oral administration at 13 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL874471,,BAO_0000218,,
9289,,Rattus norvegicus,Area under curve in rat by po administration at 0-24 hr,N,A,1,Intermediate,1,,CHEMBL631318,,BAO_0000218,,
9290,,Rattus norvegicus,Area under curve in rat plasma,N,A,1,Intermediate,1,,CHEMBL631319,,BAO_0000218,1969.0,
9291,,Rattus norvegicus,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL631320,,BAO_0000218,,
9292,,Rattus norvegicus,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL631321,,BAO_0000218,,
9293,,Rattus norvegicus,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,N,A,1,Intermediate,1,,CHEMBL631322,,BAO_0000218,,
9294,,Rattus norvegicus,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,N,A,1,Intermediate,1,,CHEMBL631323,,BAO_0000218,,
9295,,Rattus norvegicus,Area under curve value in rat at a dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL631324,,BAO_0000218,,
9296,,Rattus norvegicus,Area under curve was determined after oral administration in rats,N,A,1,Intermediate,1,,CHEMBL631325,,BAO_0000218,,
9297,,Rattus norvegicus,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL631326,,BAO_0000218,,
9298,,Rattus norvegicus,Area under curve was determined after peroral administration in rat,N,A,1,Intermediate,1,,CHEMBL631327,,BAO_0000218,,
9299,,Rattus norvegicus,Area under curve was determined at a dose 30 mpk administered orally.,N,A,1,Intermediate,1,,CHEMBL631328,,BAO_0000218,,
9300,,Rattus norvegicus,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,N,A,1,Intermediate,1,,CHEMBL631329,,BAO_0000218,,
9301,,Rattus norvegicus,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627217,,BAO_0000218,,
9302,,Rattus norvegicus,Area under curve was determined in male rat,N,A,1,Intermediate,1,,CHEMBL626352,,BAO_0000218,,
9303,,Rattus norvegicus,Area under curve was determined in rat after PO administration,N,A,1,Intermediate,1,,CHEMBL626353,,BAO_0000218,,
9304,,Rattus norvegicus,Area under curve was determined in rat after a 3 mg/kg of oral dose,N,A,1,Intermediate,1,,CHEMBL626354,,BAO_0000218,,
9305,,Rattus norvegicus,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL626355,,BAO_0000218,,
9306,,Rattus norvegicus,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL626356,,BAO_0000218,,
9307,,Rattus norvegicus,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,N,A,1,Intermediate,1,,CHEMBL626357,,BAO_0000218,,
9308,,Rattus norvegicus,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL626358,,BAO_0000218,,
9309,,Rattus norvegicus,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL626359,,BAO_0000218,,
9310,,Rattus norvegicus,Peak plasma concentration in rat at a dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL626360,,BAO_0000218,1969.0,
9311,,Rattus norvegicus,Plasma concentration at 2 hr in rats was evaluated.,N,A,1,Intermediate,1,,CHEMBL626361,,BAO_0000218,,
9312,,Rattus norvegicus,Plasma concentration at 2 hr in rats was evaluated; Not available,N,A,1,Intermediate,1,,CHEMBL626362,,BAO_0000218,,
9313,,Rattus norvegicus,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL626363,,BAO_0000218,,
9314,,Rattus norvegicus,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL626970,,BAO_0000218,,
9315,,Rattus norvegicus,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL626971,,BAO_0000218,,
9316,,Rattus norvegicus,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL626972,,BAO_0000218,1969.0,
9317,,Rattus norvegicus,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL626973,,BAO_0000218,1969.0,
9318,,Rattus norvegicus,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL626974,,BAO_0000218,1969.0,
9319,,Rattus norvegicus,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL874592,,BAO_0000218,1969.0,
9320,,Rattus norvegicus,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,N,A,1,Intermediate,1,,CHEMBL626975,,BAO_0000218,,
9321,,Rattus norvegicus,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,N,A,1,Intermediate,1,,CHEMBL626976,,BAO_0000218,,
9322,,Rattus norvegicus,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,N,A,1,Intermediate,1,,CHEMBL626977,,BAO_0000218,,
9323,,Rattus norvegicus,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,N,A,1,Intermediate,1,,CHEMBL626978,,BAO_0000218,,
9324,,Rattus norvegicus,PK study was carried to determine the relative absorption ranking in rat.,N,A,1,Intermediate,1,,CHEMBL626979,,BAO_0000218,,
9325,,Rattus norvegicus,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL626980,,BAO_0000218,1969.0,
9326,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",N,A,1,Intermediate,1,,CHEMBL626981,,BAO_0000218,178.0,
9327,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",N,A,1,Intermediate,1,,CHEMBL626982,,BAO_0000218,178.0,
9328,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",N,A,1,Intermediate,1,,CHEMBL626983,,BAO_0000218,178.0,
9329,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",N,A,1,Intermediate,1,,CHEMBL622522,,BAO_0000218,178.0,
9330,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",N,A,1,Intermediate,1,,CHEMBL622523,,BAO_0000218,178.0,
9331,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",N,A,1,Intermediate,1,,CHEMBL622524,,BAO_0000218,178.0,
9332,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",N,A,1,Intermediate,1,,CHEMBL622525,,BAO_0000218,955.0,
9333,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",N,A,1,Intermediate,1,,CHEMBL622526,,BAO_0000218,955.0,
9334,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",N,A,1,Intermediate,1,,CHEMBL619849,,BAO_0000218,955.0,
9335,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",N,A,1,Intermediate,1,,CHEMBL619850,,BAO_0000218,955.0,
9336,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",N,A,1,Intermediate,1,,CHEMBL623864,,BAO_0000218,955.0,
9337,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",N,A,1,Intermediate,1,,CHEMBL623865,,BAO_0000218,955.0,
9338,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",N,A,1,Intermediate,1,,CHEMBL623866,,BAO_0000218,948.0,
9339,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",N,A,1,Intermediate,1,,CHEMBL623867,,BAO_0000218,948.0,
9340,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",N,A,1,Intermediate,1,,CHEMBL877615,,BAO_0000218,948.0,
9341,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",N,A,1,Intermediate,1,,CHEMBL623868,,BAO_0000218,948.0,
9342,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",N,A,1,Intermediate,1,,CHEMBL623869,,BAO_0000218,948.0,
9343,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",N,A,1,Intermediate,1,,CHEMBL623870,,BAO_0000218,948.0,
9344,,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL623871,,BAO_0000218,2048.0,
9345,,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL623872,,BAO_0000218,2048.0,
9346,,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL622129,,BAO_0000218,2048.0,
9347,,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL622130,,BAO_0000218,2048.0,
9348,,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL622131,,BAO_0000218,2048.0,
9349,,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL622132,,BAO_0000218,2048.0,
9350,,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL622133,,BAO_0000218,2048.0,
9351,,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL622134,,BAO_0000218,2048.0,
9352,,Rattus norvegicus,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL622135,,BAO_0000218,2048.0,
9353,,Rattus norvegicus,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL622136,,BAO_0000218,2048.0,
9354,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL622137,,BAO_0000218,2385.0,
9355,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL622138,,BAO_0000218,2385.0,
9356,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL623017,,BAO_0000218,2385.0,
9357,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL623018,,BAO_0000218,2385.0,
9358,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL623019,,BAO_0000218,2385.0,
9359,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL623020,,BAO_0000218,2385.0,
9360,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL623021,,BAO_0000218,2385.0,
9361,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL623022,,BAO_0000218,2385.0,
9362,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL623023,,BAO_0000218,2385.0,
9363,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL623024,,BAO_0000218,2385.0,
9364,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL623025,,BAO_0000218,2385.0,
9365,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL620545,,BAO_0000218,2385.0,
9366,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL620546,,BAO_0000218,2385.0,
9367,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL620547,,BAO_0000218,2385.0,
9368,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL620548,,BAO_0000218,2385.0,
9369,,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL620549,,BAO_0000218,2385.0,
9370,,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL620550,,BAO_0000218,2385.0,
9371,,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL620551,,BAO_0000218,2385.0,
9372,,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL620552,,BAO_0000218,2385.0,
9373,,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL620553,,BAO_0000218,2385.0,
9374,,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL620554,,BAO_0000218,2385.0,
9375,,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL875845,,BAO_0000218,2385.0,
9376,,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL620555,,BAO_0000218,2385.0,
9377,,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL620556,,BAO_0000218,2385.0,
9378,,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL620557,,BAO_0000218,2385.0,
9379,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL620558,,BAO_0000218,,
9380,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL620559,,BAO_0000218,,
9381,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL622939,,BAO_0000218,,
9382,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL622940,,BAO_0000218,,
9383,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL622941,,BAO_0000218,,
9384,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL622942,,BAO_0000218,,
9385,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL622943,,BAO_0000218,,
9386,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL622944,,BAO_0000218,,
9387,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL622945,,BAO_0000218,,
9388,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL622946,,BAO_0000218,,
9389,,Rattus norvegicus,Compound was evaluated for terminal half life in rat,N,A,1,Intermediate,1,,CHEMBL622947,,BAO_0000218,,
9390,,Rattus norvegicus,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,N,A,1,Intermediate,1,,CHEMBL622948,,BAO_0000218,1969.0,
9391,,Rattus norvegicus,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,N,A,1,Intermediate,1,,CHEMBL622949,,BAO_0000218,1969.0,
9392,,Rattus norvegicus,Compound was tested for its half life in rat,N,A,1,Intermediate,1,,CHEMBL622950,,BAO_0000218,,
9393,,Macaca mulatta,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,U,A,0,Intermediate,1,,CHEMBL622951,,BAO_0000218,1969.0,
9394,,Rattus norvegicus,Compound was tested for its plasma half life in Sprague Dawley rats,U,A,0,Intermediate,1,,CHEMBL622952,,BAO_0000366,1969.0,
9395,,Rattus norvegicus,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,U,A,0,Intermediate,1,,CHEMBL622953,,BAO_0000366,1969.0,
9396,,Rattus norvegicus,Compound was tested for plasma half-life period in rat,N,A,1,Intermediate,1,,CHEMBL873818,,BAO_0000218,1969.0,
9397,,Rattus norvegicus,Elimination half life after i.v. administration of compound in rats,N,A,1,Intermediate,1,,CHEMBL622954,,BAO_0000218,,
9398,,Rattus norvegicus,Elimination half-life after IV dosing at 0.5 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL622955,,BAO_0000218,,
9399,,Rattus norvegicus,Elimination half-life after IV dosing at 1 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL875229,,BAO_0000218,,
9400,,Rattus norvegicus,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL622956,,BAO_0000218,,
9401,,Rattus norvegicus,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL622957,,BAO_0000218,,
9402,,Rattus norvegicus,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,A,1,Intermediate,1,,CHEMBL622958,,BAO_0000218,955.0,
9403,,Rattus norvegicus,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,A,1,Intermediate,1,,CHEMBL622959,,BAO_0000218,1969.0,
9404,,Rattus norvegicus,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,A,1,Intermediate,1,,CHEMBL622960,,BAO_0000218,955.0,
9405,,Rattus norvegicus,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,A,1,Intermediate,1,,CHEMBL622961,,BAO_0000218,1969.0,
9406,,Rattus norvegicus,Evaluated for the half life in rat (in vivo),N,A,1,Intermediate,1,,CHEMBL622962,,BAO_0000218,,
9407,,Rattus norvegicus,Hafl life in rat,N,A,1,Intermediate,1,,CHEMBL622963,,BAO_0000218,,
9408,,Rattus norvegicus,Hafl life rat,N,A,1,Intermediate,1,,CHEMBL622964,,BAO_0000218,,
9409,,Rattus norvegicus,Hafl life rat,N,A,1,Intermediate,1,,CHEMBL622965,,BAO_0000218,,
9410,,Rattus norvegicus,Hafl life rat; Not determined,N,A,1,Intermediate,1,,CHEMBL622966,,BAO_0000218,,
9411,,Rattus norvegicus,Hafl life rat; Not determined,N,A,1,Intermediate,1,,CHEMBL622967,,BAO_0000218,,
9412,,Rattus norvegicus,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL622968,,BAO_0000218,2113.0,
9413,,Rattus norvegicus,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL622969,,BAO_0000218,2107.0,
9414,,Rattus norvegicus,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL875327,,BAO_0000218,2048.0,
9415,,Rattus norvegicus,Half life in rat after 1 mg/kg i.v. administration,N,A,1,Intermediate,1,,CHEMBL628638,,BAO_0000218,,
9416,,Rattus norvegicus,Half life in rat after 2 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL628639,,BAO_0000218,,
9417,,Rattus norvegicus,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL625840,,BAO_0000218,,
9418,,Rattus norvegicus,Half life of 10 mg/kg oral dose determined in rats,N,A,1,Intermediate,1,,CHEMBL625841,,BAO_0000218,,
9419,,Rattus norvegicus,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625842,,BAO_0000218,,
9420,,Rattus norvegicus,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625843,,BAO_0000218,,
9421,,Rattus norvegicus,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625844,,BAO_0000218,,
9422,,Rattus norvegicus,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL873822,,BAO_0000218,,
9423,,Rattus norvegicus,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625845,,BAO_0000218,,
9424,,Rattus norvegicus,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL627059,,BAO_0000218,,
9425,,Rattus norvegicus,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL627060,,BAO_0000218,,
9426,,Rattus norvegicus,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL627061,,BAO_0000218,,
9427,,Rattus norvegicus,Half life of compound at 5 mg/kg after po administration was determined in rat,N,A,1,Intermediate,1,,CHEMBL627709,,BAO_0000218,,
9428,,Rattus norvegicus,Half life of compound determined after intravenous administration to rat,N,A,1,Intermediate,1,,CHEMBL627710,,BAO_0000218,,
9429,,Rattus norvegicus,Half life of compound was determined in rat,N,A,1,Intermediate,1,,CHEMBL627711,,BAO_0000218,,
9430,,Rattus norvegicus,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,N,A,1,Intermediate,1,,CHEMBL627712,,BAO_0000218,1969.0,
9431,,Rattus norvegicus,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL627713,,BAO_0000218,,
9432,,Rattus norvegicus,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL627714,,BAO_0000218,,
9433,,Macaca fascicularis,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,U,A,0,Intermediate,1,,CHEMBL627889,,BAO_0000218,,
9434,,Rattus norvegicus,Half life determined in rat by intravenous administration,U,A,0,Intermediate,1,,CHEMBL627890,,BAO_0000218,,
9435,,Rattus norvegicus,Half life determined in rats after iv administration,N,A,1,Intermediate,1,,CHEMBL627891,,BAO_0000218,,
9436,,Rattus norvegicus,Half life in rat plasma after administration of 2 mg/kg iv,N,A,1,Intermediate,1,,CHEMBL627892,,BAO_0000218,1969.0,
9437,,Rattus norvegicus,Half life in rat plasma after administration of 2 mg/kg iv,N,A,1,Intermediate,1,,CHEMBL627893,,BAO_0000218,1969.0,
9438,,Rattus norvegicus,Half life in rat plasma was determined,N,A,1,Intermediate,1,,CHEMBL627894,,BAO_0000218,1969.0,
9439,,Rattus norvegicus,Half life in rat plasma was determined; NA means not applicable,N,A,1,Intermediate,1,,CHEMBL627895,,BAO_0000218,1969.0,
9440,,Rattus norvegicus,Half life in rat was tested,N,A,1,Intermediate,1,,CHEMBL627896,,BAO_0000218,,
9441,,Rattus norvegicus,Half life measured in rat plasma,N,A,1,Intermediate,1,,CHEMBL627897,,BAO_0000218,1969.0,
9442,,Rattus norvegicus,Half life recorded in rats,N,A,1,Intermediate,1,,CHEMBL627898,,BAO_0000218,,
9443,,Rattus norvegicus,Half life was calculated,N,A,1,Intermediate,1,,CHEMBL627899,,BAO_0000218,,
9444,,Rattus norvegicus,Half life was calculated in rat,N,A,1,Intermediate,1,,CHEMBL873823,,BAO_0000218,,
9445,,Rattus norvegicus,Half life was determined,N,A,1,Intermediate,1,,CHEMBL627900,,BAO_0000218,,
9446,,Rattus norvegicus,Half life after 10 mg/kg oral administration in rat,N,A,1,Intermediate,1,,CHEMBL627901,,BAO_0000218,,
9447,,Rattus norvegicus,Half life after administering orally a dose of 10 mg/kg to a fasting rat,N,A,1,Intermediate,1,,CHEMBL627902,,BAO_0000218,,
9448,,Rattus norvegicus,Half life after administering orally a dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL627903,,BAO_0000218,,
9449,,Rattus norvegicus,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,N,A,1,Intermediate,1,,CHEMBL627904,,BAO_0000218,,
9450,,Rattus norvegicus,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,N,A,1,Intermediate,1,,CHEMBL627905,,BAO_0000218,,
9451,,Rattus norvegicus,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627906,,BAO_0000218,,
9452,,Rattus norvegicus,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627907,,BAO_0000218,,
9453,,Rattus norvegicus,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL876783,,BAO_0000218,,
9454,,Rattus norvegicus,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,N,A,1,Intermediate,1,,CHEMBL627908,,BAO_0000218,,
9455,,Rattus norvegicus,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,A,1,Intermediate,1,,CHEMBL627909,,BAO_0000218,,
9456,,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,N,A,1,Intermediate,1,,CHEMBL627910,,BAO_0000218,,
9457,,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),N,A,1,Intermediate,1,,CHEMBL627911,,BAO_0000218,,
9458,,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),N,A,1,Intermediate,1,,CHEMBL627912,,BAO_0000218,,
9459,,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),N,A,1,Intermediate,1,,CHEMBL627913,,BAO_0000218,,
9460,,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),N,A,1,Intermediate,1,,CHEMBL627914,,BAO_0000218,,
9461,,Rattus norvegicus,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,N,A,1,Intermediate,1,,CHEMBL627915,,BAO_0000218,,
9462,,Rattus norvegicus,Area under the curve was evaluated after 20 uM/kg of peroral administration,N,A,1,Intermediate,1,,CHEMBL627916,,BAO_0000218,,
9463,,Rattus norvegicus,Area under the curve was measured in rat after an iv dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL627917,,BAO_0000218,,
9464,,Rattus norvegicus,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627918,,BAO_0000218,,
9465,,Rattus norvegicus,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,N,A,1,Intermediate,1,,CHEMBL627919,,BAO_0000218,,
9466,,Rattus norvegicus,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL627920,,BAO_0000218,,
9467,,Rattus norvegicus,Area under the curve was evaluated at an oral dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL627921,,BAO_0000218,,
9468,,Rattus norvegicus,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL627922,,BAO_0000218,,
9469,,Rattus norvegicus,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL876784,,BAO_0000218,,
9470,,Rattus norvegicus,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL627923,,BAO_0000218,,
9471,,Rattus norvegicus,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL626208,,BAO_0000218,,
9472,,Rattus norvegicus,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL626209,,BAO_0000218,,
9473,,Rattus norvegicus,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL626210,,BAO_0000218,,
9474,,Rattus norvegicus,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,A,1,Intermediate,1,,CHEMBL627994,,BAO_0000218,1969.0,
9475,,Rattus norvegicus,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627995,,BAO_0000218,,
9476,,Rattus norvegicus,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,N,A,1,Intermediate,1,,CHEMBL627996,,BAO_0000218,,
9477,,Rattus norvegicus,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,N,A,1,Intermediate,1,,CHEMBL627997,,BAO_0000218,,
9478,,Rattus norvegicus,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,N,A,1,Intermediate,1,,CHEMBL627998,,BAO_0000218,,
9479,,Rattus norvegicus,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,N,A,1,Intermediate,1,,CHEMBL628640,,BAO_0000218,,
9480,,Rattus norvegicus,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,N,A,1,Intermediate,1,,CHEMBL628641,,BAO_0000218,,
9481,,Rattus norvegicus,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,N,A,1,Intermediate,1,,CHEMBL628642,,BAO_0000218,,
9482,,Rattus norvegicus,Compound was evaluated for area under the curve expressed as (h*ug/ml),N,A,1,Intermediate,1,,CHEMBL628643,,BAO_0000218,,
9483,,Rattus norvegicus,Compound was tested for area under curve in rat,N,A,1,Intermediate,1,,CHEMBL628644,,BAO_0000218,,
9484,,Rattus norvegicus,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,N,A,1,Intermediate,1,,CHEMBL628645,,BAO_0000218,,
9485,,Rattus norvegicus,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL628646,,BAO_0000218,,
9486,,Rattus norvegicus,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),N,A,1,Intermediate,1,,CHEMBL628647,,BAO_0000218,,
9487,,Rattus norvegicus,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,A,1,Intermediate,1,,CHEMBL628648,,BAO_0000218,,
9488,,Rattus norvegicus,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,A,1,Intermediate,1,,CHEMBL625358,,BAO_0000218,,
9489,,Rattus norvegicus,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,A,1,Intermediate,1,,CHEMBL625359,,BAO_0000218,,
9490,,Rattus norvegicus,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,A,1,Intermediate,1,,CHEMBL625360,,BAO_0000218,,
9491,,Rattus norvegicus,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),N,A,1,Intermediate,1,,CHEMBL625361,,BAO_0000218,,
9492,,Rattus norvegicus,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),N,A,1,Intermediate,1,,CHEMBL625362,,BAO_0000218,,
9493,,Rattus norvegicus,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),N,A,1,Intermediate,1,,CHEMBL625363,,BAO_0000218,,
9494,,Rattus norvegicus,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,A,1,Intermediate,1,,CHEMBL625364,,BAO_0000218,,
9495,,Rattus norvegicus,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625365,,BAO_0000218,,
9496,,Rattus norvegicus,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625366,,BAO_0000218,,
9497,,Rattus norvegicus,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625367,,BAO_0000218,,
9498,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",N,A,1,Intermediate,1,,CHEMBL625368,,BAO_0000218,2113.0,
9499,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",N,A,1,Intermediate,1,,CHEMBL625369,,BAO_0000218,2113.0,
9500,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",N,A,1,Intermediate,1,,CHEMBL625370,,BAO_0000218,2113.0,
9501,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",N,A,1,Intermediate,1,,CHEMBL625371,,BAO_0000218,2113.0,
9502,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",N,A,1,Intermediate,1,,CHEMBL625372,,BAO_0000218,2113.0,
9503,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",N,A,1,Intermediate,1,,CHEMBL625373,,BAO_0000218,2113.0,
9504,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",N,A,1,Intermediate,1,,CHEMBL625374,,BAO_0000218,2107.0,
9505,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",N,A,1,Intermediate,1,,CHEMBL877593,,BAO_0000218,2107.0,
9506,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",N,A,1,Intermediate,1,,CHEMBL625375,,BAO_0000218,2107.0,
9507,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",N,A,1,Intermediate,1,,CHEMBL625376,,BAO_0000218,2107.0,
9508,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",N,A,1,Intermediate,1,,CHEMBL621973,,BAO_0000218,2107.0,
9509,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",N,A,1,Intermediate,1,,CHEMBL621974,,BAO_0000218,2107.0,
9510,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",N,A,1,Intermediate,1,,CHEMBL621975,,BAO_0000218,2048.0,
9511,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",N,A,1,Intermediate,1,,CHEMBL622166,,BAO_0000218,2048.0,
9512,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",N,A,1,Intermediate,1,,CHEMBL622167,,BAO_0000218,2048.0,
9513,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",N,A,1,Intermediate,1,,CHEMBL622168,,BAO_0000218,2048.0,
9514,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",N,A,1,Intermediate,1,,CHEMBL622169,,BAO_0000218,2048.0,
9515,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",N,A,1,Intermediate,1,,CHEMBL622170,,BAO_0000218,2048.0,
9516,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",N,A,1,Intermediate,1,,CHEMBL622171,,BAO_0000218,2046.0,
9517,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",N,A,1,Intermediate,1,,CHEMBL622172,,BAO_0000218,2046.0,
9518,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",N,A,1,Intermediate,1,,CHEMBL622173,,BAO_0000218,2046.0,
9519,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",N,A,1,Intermediate,1,,CHEMBL622174,,BAO_0000218,2046.0,
9520,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",N,A,1,Intermediate,1,,CHEMBL622175,,BAO_0000218,2046.0,
9521,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",N,A,1,Intermediate,1,,CHEMBL622176,,BAO_0000218,2046.0,
9522,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",N,A,1,Intermediate,1,,CHEMBL622177,,BAO_0000218,2046.0,
9523,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",N,A,1,Intermediate,1,,CHEMBL622178,,BAO_0000218,2046.0,
9524,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",N,A,1,Intermediate,1,,CHEMBL622179,,BAO_0000218,2046.0,
9525,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",N,A,1,Intermediate,1,,CHEMBL622180,,BAO_0000218,2046.0,
9526,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL622181,,BAO_0000218,,
9527,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL622182,,BAO_0000218,,
9528,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL622183,,BAO_0000218,,
9529,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL622184,,BAO_0000218,,
9530,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL622185,,BAO_0000218,,
9531,,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL622186,,BAO_0000218,,
9532,,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL622187,,BAO_0000218,,
9533,,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL625002,,BAO_0000218,,
9534,,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL622090,,BAO_0000218,,
9535,,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL622091,,BAO_0000218,,
9536,,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL622092,,BAO_0000218,,
9537,,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL622093,,BAO_0000218,,
9538,,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL622094,,BAO_0000218,,
9539,,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL622095,,BAO_0000218,,
9540,,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL622264,,BAO_0000218,,
9541,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL622265,,BAO_0000218,2106.0,
9542,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL622266,,BAO_0000218,2106.0,
9543,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL622267,,BAO_0000218,2106.0,
9544,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL622268,,BAO_0000218,2106.0,
9545,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL622269,,BAO_0000218,2106.0,
9546,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL625071,,BAO_0000218,2106.0,
9547,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL621621,,BAO_0000218,2106.0,
9548,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL621622,,BAO_0000218,2106.0,
9549,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL621623,,BAO_0000218,2106.0,
9550,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL621624,,BAO_0000218,2106.0,
9551,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL621625,,BAO_0000218,2106.0,
9552,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL621626,,BAO_0000218,2106.0,
9553,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL621627,,BAO_0000218,2106.0,
9554,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL621628,,BAO_0000218,2106.0,
9555,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL875328,,BAO_0000218,2106.0,
9556,,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL621629,,BAO_0000218,2106.0,
9557,,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL621630,,BAO_0000218,2106.0,
9558,,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL621631,,BAO_0000218,2106.0,
9559,,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL621632,,BAO_0000218,2106.0,
9560,,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL621633,,BAO_0000218,2106.0,
9561,,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL621634,,BAO_0000218,2106.0,
9562,,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL621635,,BAO_0000218,2106.0,
9563,,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL621636,,BAO_0000218,2106.0,
9564,,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL621637,,BAO_0000218,2106.0,
9565,,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL621638,,BAO_0000218,2106.0,
9566,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL618883,,BAO_0000218,,
9567,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL618884,,BAO_0000218,,
9568,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL628627,,BAO_0000218,,
9569,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL628628,,BAO_0000218,,
9570,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL628629,,BAO_0000218,,
9571,,Rattus norvegicus,Half life after administering orally a dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL628630,,BAO_0000218,,
9572,,Rattus norvegicus,Half life after administering orally a dose of 3 mg/kg to a fasting rat,N,A,1,Intermediate,1,,CHEMBL628631,,BAO_0000218,,
9573,,Rattus norvegicus,Half life after administering intravenously a dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL628632,,BAO_0000218,,
9574,,Rattus norvegicus,Half life after oral dosing in rats,N,A,1,Intermediate,1,,CHEMBL628633,,BAO_0000218,,
9575,,Rattus norvegicus,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,N,A,1,Intermediate,1,,CHEMBL628634,,BAO_0000218,,
9576,,Rattus norvegicus,Half life by intravenous administration of 3.4 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627789,,BAO_0000218,,
9577,,Rattus norvegicus,Half life in rat,N,A,1,Intermediate,1,,CHEMBL627790,,BAO_0000218,,
9578,,Rattus norvegicus,Half life in rat,N,A,1,Intermediate,1,,CHEMBL627791,,BAO_0000218,,
9579,,Rattus norvegicus,Half life in rat,N,A,1,Intermediate,1,,CHEMBL627792,,BAO_0000218,,
9580,,Rattus norvegicus,Half life in rat after intravenous administration of the compound,N,A,1,Intermediate,1,,CHEMBL627793,,BAO_0000218,,
9581,,Rattus norvegicus,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,N,A,1,Intermediate,1,,CHEMBL627794,,BAO_0000218,1969.0,
9582,,Rattus norvegicus,Half life in rat after po administration of the compound,N,A,1,Intermediate,1,,CHEMBL627795,,BAO_0000218,,
9583,,Rattus norvegicus,Half life in rat after po administration of the compound; ND means Not determined,N,A,1,Intermediate,1,,CHEMBL627796,,BAO_0000218,,
9584,,Rattus norvegicus,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,N,A,1,Intermediate,1,,CHEMBL875335,,BAO_0000218,1969.0,
9585,,Rattus norvegicus,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,N,A,1,Intermediate,1,,CHEMBL627797,,BAO_0000218,1969.0,
9586,,Rattus norvegicus,Half life in rat i.v.,N,A,1,Intermediate,1,,CHEMBL627798,,BAO_0000218,,
9587,,Rattus norvegicus,Half life in rat i.v. at 2 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL627799,,BAO_0000218,,
9588,,Rattus norvegicus,Half life in rats,N,A,1,Intermediate,1,,CHEMBL627800,,BAO_0000218,,
9589,,Rattus norvegicus,Half life in rats after intravenous administration,N,A,1,Intermediate,1,,CHEMBL627801,,BAO_0000218,,
9590,,Rattus norvegicus,Half life in rats at the dose of 1.0 mpk by i.v. administration,N,A,1,Intermediate,1,,CHEMBL627802,,BAO_0000218,,
9591,,Rattus norvegicus,Half life in rat,N,A,1,Expert,1,,CHEMBL627803,,BAO_0000218,,
9592,,Rattus norvegicus,Half life was evaluated after intravenous administration to rats,N,A,1,Intermediate,1,,CHEMBL873820,,BAO_0000218,,
9593,,Rattus norvegicus,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),N,A,1,Intermediate,1,,CHEMBL627804,,BAO_0000218,,
9594,,Rattus norvegicus,Half life was evaluated in rat,N,A,1,Intermediate,1,,CHEMBL627805,,BAO_0000218,,
9595,,Rattus norvegicus,Half life was evaluated in rat,N,A,1,Intermediate,1,,CHEMBL627806,,BAO_0000218,,
9596,,Rattus norvegicus,Half life was evaluated in rat; Not tested,N,A,1,Intermediate,1,,CHEMBL627107,,BAO_0000218,,
9597,,Rattus norvegicus,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,N,A,1,Intermediate,1,,CHEMBL627108,,BAO_0000218,,
9598,,Rattus norvegicus,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,N,A,1,Intermediate,1,,CHEMBL627109,,BAO_0000218,,
9599,,Rattus norvegicus,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,N,A,1,Intermediate,1,,CHEMBL627110,,BAO_0000218,178.0,
9600,,Primates,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,A,0,Intermediate,1,,CHEMBL627111,,BAO_0000218,,
9601,,Primates,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,A,0,Intermediate,1,,CHEMBL627112,,BAO_0000218,,
9602,,Rattus norvegicus,Half life was measured in rat at dose of 30 mg/kg by iv administration,U,A,0,Intermediate,1,,CHEMBL627113,,BAO_0000218,,
9603,,Rattus norvegicus,Half life was measured in rat at dose of 30 mg/kg by po administration,U,A,0,Intermediate,1,,CHEMBL627114,,BAO_0000218,,
9604,,Rattus norvegicus,Half life (t1/2) was determined,N,A,1,Intermediate,1,,CHEMBL627115,,BAO_0000218,,
9605,,Rattus norvegicus,Half life period at a dose of 10 uM/kg in rat was determined,N,A,1,Intermediate,1,,CHEMBL627116,,BAO_0000218,,
9606,,Rattus norvegicus,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,N,A,1,Intermediate,1,,CHEMBL627117,,BAO_0000218,,
9607,,Rattus norvegicus,Half life period was determined,N,A,1,Intermediate,1,,CHEMBL627118,,BAO_0000218,,
9608,,Rattus norvegicus,Half life period after intravenous administration at 20 mpk in rats,N,A,1,Intermediate,1,,CHEMBL627119,,BAO_0000218,,
9609,,Rattus norvegicus,Half life period after intravenous administration at 20 mpk in rats; Not performed.,N,A,1,Intermediate,1,,CHEMBL627120,,BAO_0000218,,
9610,,Rattus norvegicus,Half life period after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL626922,,BAO_0000218,,
9611,,Rattus norvegicus,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL626923,,BAO_0000218,,
9612,,Rattus norvegicus,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL626924,,BAO_0000218,,
9613,,Rattus norvegicus,Half life period in 80% rat plasma at 37 degree Centigrade,N,A,1,Intermediate,1,,CHEMBL626925,,BAO_0000218,1969.0,
9614,,Rattus norvegicus,Half life period in SD rats,N,A,1,Intermediate,1,,CHEMBL626926,,BAO_0000218,,
9615,,Rattus norvegicus,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),N,A,1,Intermediate,1,,CHEMBL626927,,BAO_0000218,1969.0,
9616,,Rattus norvegicus,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),N,A,1,Intermediate,1,,CHEMBL626928,,BAO_0000218,1969.0,
9617,,Rattus norvegicus,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,A,1,Intermediate,1,,CHEMBL626929,,BAO_0000218,1969.0,
9618,,Rattus norvegicus,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,A,1,Intermediate,1,,CHEMBL626930,,BAO_0000218,1969.0,
9619,,Rattus norvegicus,Half life period in rat,N,A,1,Intermediate,1,,CHEMBL626931,,BAO_0000218,,
9620,,Rattus norvegicus,Half life period in rat,N,A,1,Intermediate,1,,CHEMBL626932,,BAO_0000218,,
9621,,Rattus norvegicus,Half life period in rat,N,A,1,Intermediate,1,,CHEMBL626933,,BAO_0000218,,
9622,,Rattus norvegicus,Half life period in rat after oral administration at 10.5 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL873826,,BAO_0000218,,
9623,,Rattus norvegicus,Half life period in rat after oral administration at 11.2 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL626934,,BAO_0000218,,
9624,,Rattus norvegicus,Half life period in rat after oral administration at 13 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL626935,,BAO_0000218,,
9625,,Rattus norvegicus,Half life period in rat after oral administration at 9.7 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL626936,,BAO_0000218,,
9626,,Rattus norvegicus,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626937,,BAO_0000218,,
9627,,Rattus norvegicus,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL625906,,BAO_0000218,,
9628,,Rattus norvegicus,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL625907,,BAO_0000218,,
9629,,Rattus norvegicus,PK study was carried to determine AUC (area under curve) value in rat,N,A,1,Intermediate,1,,CHEMBL625908,,BAO_0000218,,
9630,,Rattus norvegicus,Pharmacokinetic parameter AUC after intravenous administration to rats,N,A,1,Intermediate,1,,CHEMBL625909,,BAO_0000218,,
9631,,Rattus norvegicus,Pharmacokinetic parameter AUC after oral administration to rats,N,A,1,Intermediate,1,,CHEMBL625910,,BAO_0000218,,
9632,,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL625911,,BAO_0000218,,
9633,,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,N,A,1,Intermediate,1,,CHEMBL625912,,BAO_0000218,,
9634,,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,N,A,1,Intermediate,1,,CHEMBL626538,,BAO_0000218,,
9635,,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,N,A,1,Intermediate,1,,CHEMBL876794,,BAO_0000218,,
9636,,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,N,A,1,Intermediate,1,,CHEMBL626539,,BAO_0000218,,
9637,,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,N,A,1,Intermediate,1,,CHEMBL626540,,BAO_0000218,,
9638,,Rattus norvegicus,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL626541,,BAO_0000218,,
9639,,Rattus norvegicus,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL626542,,BAO_0000218,,
9640,,Rattus norvegicus,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,N,A,1,Intermediate,1,,CHEMBL626543,,BAO_0000218,,
9641,,Rattus norvegicus,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,N,A,1,Intermediate,1,,CHEMBL626544,,BAO_0000218,,
9642,,Rattus norvegicus,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,N,A,1,Intermediate,1,,CHEMBL626545,,BAO_0000218,,
9643,,Rattus norvegicus,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,N,A,1,Intermediate,1,,CHEMBL626546,,BAO_0000218,,
9644,,Rattus norvegicus,Pharmacokinetic parameter area under curve was reported,N,A,1,Intermediate,1,,CHEMBL626547,,BAO_0000218,,
9645,,Rattus norvegicus,Pharmacokinetic property (AUC) in rat,N,A,1,Intermediate,1,,CHEMBL626548,,BAO_0000218,,
9646,,Rattus norvegicus,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,N,A,1,Intermediate,1,,CHEMBL626549,,BAO_0000218,,
9647,,Rattus norvegicus,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,N,A,1,Intermediate,1,,CHEMBL626550,,BAO_0000218,,
9648,,Rattus norvegicus,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,N,A,1,Intermediate,1,,CHEMBL626551,,BAO_0000218,,
9649,,Rattus norvegicus,Pharmacokinetic property was determined,N,A,1,Intermediate,1,,CHEMBL623777,,BAO_0000218,,
9650,,Rattus norvegicus,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,N,A,1,Intermediate,1,,CHEMBL623778,,BAO_0000218,,
9651,,Rattus norvegicus,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,N,A,1,Intermediate,1,,CHEMBL623779,,BAO_0000218,,
9652,,Rattus norvegicus,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,A,1,Intermediate,1,,CHEMBL623780,,BAO_0000218,1969.0,
9653,,Rattus norvegicus,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,N,A,1,Intermediate,1,,CHEMBL622015,,BAO_0000218,1969.0,
9654,,Rattus norvegicus,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,N,A,1,Intermediate,1,,CHEMBL622016,,BAO_0000218,1969.0,
9655,,Rattus norvegicus,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",N,A,1,Intermediate,1,,CHEMBL622017,,BAO_0000218,,
9656,,Rattus norvegicus,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",N,A,1,Intermediate,1,,CHEMBL622018,,BAO_0000218,,
9657,,Rattus norvegicus,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",N,A,1,Intermediate,1,,CHEMBL622019,,BAO_0000218,,
9658,,Rattus norvegicus,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",N,A,1,Intermediate,1,,CHEMBL622020,,BAO_0000218,,
9659,,Rattus norvegicus,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,N,A,1,Intermediate,1,,CHEMBL622021,,BAO_0000218,,
9660,,Rattus norvegicus,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,N,A,1,Intermediate,1,,CHEMBL622022,,BAO_0000218,,
9661,,Rattus norvegicus,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,N,A,1,Intermediate,1,,CHEMBL622023,,BAO_0000218,,
9662,,Rattus norvegicus,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL622024,,BAO_0000218,,
9663,,Rattus norvegicus,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),N,A,1,Intermediate,1,,CHEMBL622693,,BAO_0000218,,
9664,,Rattus norvegicus,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),N,A,1,Intermediate,1,,CHEMBL622694,,BAO_0000218,,
9665,,Rattus norvegicus,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL622695,,BAO_0000218,,
9666,,Rattus norvegicus,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,A,1,Intermediate,1,,CHEMBL622696,,BAO_0000218,,
9667,,Rattus norvegicus,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",N,A,1,Intermediate,1,,CHEMBL622697,,BAO_0000218,,
9668,,Rattus norvegicus,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",N,A,1,Intermediate,1,,CHEMBL622874,,BAO_0000218,,
9669,,Rattus norvegicus,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",N,A,1,Intermediate,1,,CHEMBL622875,,BAO_0000218,,
9670,,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,A,1,Intermediate,1,,CHEMBL622876,,BAO_0000218,,
9671,,Rattus norvegicus,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,A,1,Intermediate,1,,CHEMBL622877,,BAO_0000218,,
9672,,Rattus norvegicus,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL622878,,BAO_0000218,,
9673,,Rattus norvegicus,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL622879,,BAO_0000218,1969.0,
9674,,Rattus norvegicus,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,N,A,1,Intermediate,1,,CHEMBL877602,,BAO_0000218,,
9675,,Rattus norvegicus,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL622880,,BAO_0000218,,
9676,,Rattus norvegicus,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL622881,,BAO_0000218,,
9677,,Rattus norvegicus,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL622882,,BAO_0000218,,
9678,,Rattus norvegicus,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL622883,,BAO_0000218,,
9679,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",N,A,1,Intermediate,1,,CHEMBL622884,,BAO_0000218,2046.0,
9680,,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",N,A,1,Intermediate,1,,CHEMBL622885,,BAO_0000218,2046.0,
9681,,Rattus norvegicus,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,A,1,Intermediate,1,,CHEMBL622886,,BAO_0000218,,
9682,,Rattus norvegicus,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,A,1,Intermediate,1,,CHEMBL622887,,BAO_0000218,,
9683,,Rattus norvegicus,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,A,1,Intermediate,1,,CHEMBL622888,,BAO_0000218,1088.0,
9684,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622889,,BAO_0000218,178.0,
9685,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622890,,BAO_0000218,178.0,
9686,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622891,,BAO_0000218,178.0,
9687,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL877603,,BAO_0000218,178.0,
9688,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622892,,BAO_0000218,955.0,
9689,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622893,,BAO_0000218,955.0,
9690,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622894,,BAO_0000218,955.0,
9691,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622895,,BAO_0000218,955.0,
9692,,Rattus norvegicus,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,N,A,1,Intermediate,1,,CHEMBL622896,,BAO_0000218,955.0,
9693,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622897,,BAO_0000218,948.0,
9694,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622898,,BAO_0000218,948.0,
9695,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622899,,BAO_0000218,948.0,
9696,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622900,,BAO_0000218,2113.0,
9697,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624114,,BAO_0000218,2113.0,
9698,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624115,,BAO_0000218,2113.0,
9699,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624116,,BAO_0000218,2113.0,
9700,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624117,,BAO_0000218,2107.0,
9701,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624118,,BAO_0000218,2107.0,
9702,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624119,,BAO_0000218,2107.0,
9703,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624120,,BAO_0000218,2107.0,
9704,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624121,,BAO_0000218,2048.0,
9705,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624122,,BAO_0000218,2048.0,
9706,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624123,,BAO_0000218,2048.0,
9707,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624124,,BAO_0000218,2048.0,
9708,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624125,,BAO_0000218,2385.0,
9709,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624126,,BAO_0000218,2385.0,
9710,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624127,,BAO_0000218,2385.0,
9711,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624128,,BAO_0000218,2385.0,
9712,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624129,,BAO_0000218,14.0,
9713,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL624130,,BAO_0000218,14.0,
9714,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622340,,BAO_0000218,14.0,
9715,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622341,,BAO_0000218,14.0,
9716,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622342,,BAO_0000218,160.0,
9717,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622343,,BAO_0000218,160.0,
9718,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622344,,BAO_0000218,160.0,
9719,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622345,,BAO_0000218,160.0,
9720,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622346,,BAO_0000218,2106.0,
9721,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622347,,BAO_0000218,2106.0,
9722,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622348,,BAO_0000218,2106.0,
9723,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622349,,BAO_0000218,2106.0,
9724,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,A,1,Intermediate,1,,CHEMBL622350,,BAO_0000218,,
9725,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL622351,,BAO_0000218,,
9726,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL622352,,BAO_0000218,,
9727,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL622353,,BAO_0000218,,
9728,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL622354,,BAO_0000218,,
9729,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL622355,,BAO_0000218,,
9730,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL622356,,BAO_0000218,,
9731,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,A,1,Intermediate,1,,CHEMBL622357,,BAO_0000218,,
9732,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,A,1,Intermediate,1,,CHEMBL622358,,BAO_0000218,,
9733,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,A,1,Intermediate,1,,CHEMBL622359,,BAO_0000218,,
9734,,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,A,1,Intermediate,1,,CHEMBL874393,,BAO_0000218,,
9735,,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL622872,,BAO_0000218,,
9736,,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL622873,,BAO_0000218,,
9737,,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL623047,,BAO_0000218,,
9738,,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL623048,,BAO_0000218,,
9739,,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL623049,,BAO_0000218,,
9740,,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL623050,,BAO_0000218,,
9741,,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,A,1,Intermediate,1,,CHEMBL623051,,BAO_0000218,,
9742,,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL623052,,BAO_0000218,,
9743,,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL626343,,BAO_0000218,,
9744,,Rattus norvegicus,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,A,1,Intermediate,1,,CHEMBL626344,,BAO_0000218,,
9745,,Rattus norvegicus,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,A,1,Intermediate,1,,CHEMBL626345,,BAO_0000218,,
9746,,Rattus norvegicus,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,A,1,Intermediate,1,,CHEMBL626346,,BAO_0000218,,
9747,,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,A,1,Intermediate,1,,CHEMBL626347,,BAO_0000218,,
9748,,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,A,1,Intermediate,1,,CHEMBL626348,,BAO_0000218,,
9749,,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,A,1,Intermediate,1,,CHEMBL626349,,BAO_0000218,,
9750,,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,F,1,Intermediate,1,,CHEMBL626350,,BAO_0000218,,
9751,,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL626351,,BAO_0000218,,
9752,,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL627650,,BAO_0000218,,
9753,,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,F,1,Intermediate,1,,CHEMBL627651,,BAO_0000218,,
9754,,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,A,1,Intermediate,1,,CHEMBL627652,,BAO_0000218,,
9755,,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,A,1,Intermediate,1,,CHEMBL627653,,BAO_0000218,,
9756,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL627654,,BAO_0000218,,
9757,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL627835,,BAO_0000218,,
9758,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL627836,,BAO_0000218,,
9759,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL627837,,BAO_0000218,,
9760,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL627838,,BAO_0000218,,
9761,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL875338,,BAO_0000218,,
9762,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL627839,,BAO_0000218,,
9763,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL627840,,BAO_0000218,,
9764,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL627841,,BAO_0000218,,
9765,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL627842,,BAO_0000218,,
9766,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL627843,,BAO_0000218,,
9767,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL627844,,BAO_0000218,,
9768,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL627845,,BAO_0000218,,
9769,,Rattus norvegicus,Half life period in rat by iv administration at a dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL627846,,BAO_0000218,,
9770,,Rattus norvegicus,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),N,A,1,Intermediate,1,,CHEMBL627847,,BAO_0000218,1969.0,
9771,,Rattus norvegicus,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),N,A,1,Intermediate,1,,CHEMBL873821,,BAO_0000218,1969.0,
9772,,Rattus norvegicus,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,A,1,Intermediate,1,,CHEMBL626079,,BAO_0000218,1969.0,
9773,,Rattus norvegicus,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,A,1,Intermediate,1,,CHEMBL626080,,BAO_0000218,1969.0,
9774,,Rattus norvegicus,Half life period was evaluated in rat plasma,N,A,1,Intermediate,1,,CHEMBL626081,,BAO_0000218,1969.0,
9775,,Rattus norvegicus,Half life period was evaluated in rat plasma; Not tested,N,A,1,Intermediate,1,,CHEMBL875344,,BAO_0000218,1969.0,
9776,,Rattus norvegicus,Half life period was evaluated in rats,N,A,1,Intermediate,1,,CHEMBL626082,,BAO_0000218,,
9777,,Rattus norvegicus,"Half life period was evaluated in rats, iv",N,A,1,Intermediate,1,,CHEMBL626250,,BAO_0000218,,
9778,,Rattus norvegicus,Half life period after intravenous administration at 5 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL626251,,BAO_0000218,,
9779,,Rattus norvegicus,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,A,1,Intermediate,1,,CHEMBL626252,,BAO_0000218,,
9780,,Rattus norvegicus,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL626253,,BAO_0000218,,
9781,,Rattus norvegicus,Half life stability of compound was evaluated in rat plasma,N,A,1,Intermediate,1,,CHEMBL626254,,BAO_0000218,1969.0,
9782,,Rattus norvegicus,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,N,A,1,Intermediate,1,,CHEMBL626255,,BAO_0000218,,
9783,,Rattus norvegicus,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL626256,,BAO_0000218,,
9784,,Rattus norvegicus,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,A,1,Intermediate,1,,CHEMBL626257,,BAO_0000218,,
9785,,Rattus norvegicus,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,N,A,1,Intermediate,1,,CHEMBL626258,,BAO_0000218,,
9786,,Rattus norvegicus,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,N,A,1,Intermediate,1,,CHEMBL626259,,BAO_0000218,,
9787,,Rattus norvegicus,Half in rat i.v.,N,A,1,Intermediate,1,,CHEMBL626260,,BAO_0000218,,
9788,,Rattus norvegicus,Half period in rat after intravenous administration,N,A,1,Intermediate,1,,CHEMBL875345,,BAO_0000218,,
9789,,Rattus norvegicus,Half-life after repeated oral dose of compound at 1 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626261,,BAO_0000218,,
9790,,Rattus norvegicus,Half-life measured in in vitro Cathepsin B assay in rat liver,N,A,1,Intermediate,1,,CHEMBL626262,,BAO_0000218,2107.0,
9791,,Rattus norvegicus,Half-life of compound was determined in rats,N,A,1,Intermediate,1,,CHEMBL626263,,BAO_0000218,,
9792,,Rattus norvegicus,Half-life at 10 mg/kg in rat upon intravenous administration,N,A,1,Intermediate,1,,CHEMBL625270,,BAO_0000218,,
9793,,Rattus norvegicus,Half-life determined in rat,N,A,1,Intermediate,1,,CHEMBL625271,,BAO_0000218,,
9794,,Rattus norvegicus,Half-life determined in rat,N,A,1,Intermediate,1,,CHEMBL625272,,BAO_0000218,,
9795,,Rattus norvegicus,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL625273,,BAO_0000218,955.0,
9796,,Rattus norvegicus,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",N,A,1,Intermediate,1,,CHEMBL625274,,BAO_0000218,1969.0,
9797,,Rattus norvegicus,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,A,1,Intermediate,1,,CHEMBL625275,,BAO_0000218,,
9798,,Rattus norvegicus,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL625276,,BAO_0000218,1969.0,
9799,,Rattus norvegicus,Half-life in rat plasma,N,A,1,Intermediate,1,,CHEMBL625277,,BAO_0000218,1969.0,
9800,,Rattus norvegicus,Half-life in rat plasma was determined,N,A,1,Intermediate,1,,CHEMBL625278,,BAO_0000218,1969.0,
9801,,Rattus norvegicus,Half-life in rat plasma; Not tested,N,A,1,Intermediate,1,,CHEMBL625279,,BAO_0000218,1969.0,
9802,,Rattus norvegicus,Half-life in rat serum,N,A,1,Intermediate,1,,CHEMBL625280,,BAO_0000218,1977.0,
9803,,Rattus norvegicus,Half-life in rat serum; na is not available,N,A,1,Intermediate,1,,CHEMBL876797,,BAO_0000218,1977.0,
9804,,Rattus norvegicus,Half-life was calculated in rat,N,A,1,Intermediate,1,,CHEMBL625281,,BAO_0000218,,
9805,,Rattus norvegicus,Half-life was calculated in rat plasma,N,A,1,Intermediate,1,,CHEMBL873827,,BAO_0000218,1969.0,
9806,,Rattus norvegicus,Half-life was determined,N,A,1,Intermediate,1,,CHEMBL625282,,BAO_0000218,,
9807,,Rattus norvegicus,Half-life was determined,N,A,1,Intermediate,1,,CHEMBL625283,,BAO_0000218,,
9808,,Rattus norvegicus,Half-life after administration of 20 mg/Kg oral dose in rat,N,A,1,Intermediate,1,,CHEMBL625284,,BAO_0000218,,
9809,,Rattus norvegicus,Half-life after administration of 3.2 mg/kg intravenously in male rat,N,A,1,Intermediate,1,,CHEMBL625285,,BAO_0000218,,
9810,,Rattus norvegicus,Half-life after intravenous administration in female rat,N,A,1,Intermediate,1,,CHEMBL625286,,BAO_0000218,,
9811,,Rattus norvegicus,Half-life after intravenous administration in male rat,N,A,1,Intermediate,1,,CHEMBL625287,,BAO_0000218,,
9812,,Rattus norvegicus,Half-life after intravenous dose in rat,N,A,1,Intermediate,1,,CHEMBL625288,,BAO_0000218,,
9813,,Rattus norvegicus,Half-life in a rat liver homogenate preparation,N,A,1,Intermediate,1,,CHEMBL625289,,BAO_0000218,2107.0,
9814,,Rattus norvegicus,Half-life in plasma of rat,N,A,1,Intermediate,1,,CHEMBL625290,,BAO_0000218,1969.0,
9815,,Rattus norvegicus,Half-life in plasma of rat at dose of 3-10 mgkg,N,A,1,Intermediate,1,,CHEMBL876798,,BAO_0000218,1969.0,
9816,,Rattus norvegicus,Half-life in rat,N,A,1,Intermediate,1,,CHEMBL625291,,BAO_0000218,,
9817,,Rattus norvegicus,Half-life in rat,N,A,1,Intermediate,1,,CHEMBL625292,,BAO_0000218,,
9818,,Rattus norvegicus,Half-life in rat,N,A,1,Intermediate,1,,CHEMBL625293,,BAO_0000218,,
9819,,Rattus norvegicus,Half-life in rat,N,A,1,Intermediate,1,,CHEMBL622832,,BAO_0000218,,
9820,,Rattus norvegicus,Half-life in rat,N,A,1,Intermediate,1,,CHEMBL622833,,BAO_0000218,,
9821,,Rattus norvegicus,Half-life in rat,N,A,1,Intermediate,1,,CHEMBL622834,,BAO_0000218,,
9822,,Rattus norvegicus,Half-life in rat after oral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL622835,,BAO_0000218,,
9823,,Rattus norvegicus,Half-life in rat after po administration at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL622836,,BAO_0000218,,
9824,,Rattus norvegicus,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,A,1,Intermediate,1,,CHEMBL622837,,BAO_0000218,,
9825,,Rattus norvegicus,Half-life in rat at 3 mg/kg dose administered intravenously,N,A,1,Intermediate,1,,CHEMBL622838,,BAO_0000218,,
9826,,Rattus norvegicus,Half-life in rat brain homogenate,N,A,1,Intermediate,1,,CHEMBL622839,,BAO_0000218,955.0,
9827,,Rattus norvegicus,Half-life in rat plasma,N,A,1,Intermediate,1,,CHEMBL622840,,BAO_0000218,1969.0,
9828,,Rattus norvegicus,Half-life in rats,N,A,1,Intermediate,1,,CHEMBL622841,,BAO_0000218,,
9829,,Rattus norvegicus,Half-life in Dawley rats,N,A,1,Intermediate,1,,CHEMBL622842,,BAO_0000218,,
9830,,Rattus norvegicus,Half-life in vitro in rat plasma,N,A,1,Intermediate,1,,CHEMBL622843,,BAO_0000218,1969.0,
9831,,Rattus norvegicus,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,N,A,1,Intermediate,1,,CHEMBL622844,,BAO_0000218,1969.0,
9832,,Rattus norvegicus,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",N,A,1,Intermediate,1,,CHEMBL622845,,BAO_0000218,,
9833,,Rattus norvegicus,The area under the curve of compound was measured at the dose of 100 umol/kg,N,A,1,Intermediate,1,,CHEMBL622846,,BAO_0000218,,
9834,,Rattus norvegicus,The area under the curve of compound was measured at the dose of 300 umol/kg,N,A,1,Intermediate,1,,CHEMBL622847,,BAO_0000218,,
9835,,Rattus norvegicus,The area under the curve of compound was measured at the dose of 30 umol/kg,N,A,1,Intermediate,1,,CHEMBL622848,,BAO_0000218,,
9836,,Rattus norvegicus,Bioavailability as oral AUC in rats,N,A,1,Intermediate,1,,CHEMBL622849,,BAO_0000218,,
9837,,Rattus norvegicus,The plasma concentration versus time curve (AUC) was determined,N,A,1,Intermediate,1,,CHEMBL622850,,BAO_0000218,1969.0,
9838,,Rattus norvegicus,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL876807,,BAO_0000218,,
9839,,Rattus norvegicus,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL622851,,BAO_0000218,,
9840,,Rattus norvegicus,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL622852,,BAO_0000218,,
9841,,Rattus norvegicus,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,N,A,1,Intermediate,1,,CHEMBL622853,,BAO_0000218,,
9842,,Rattus norvegicus,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,N,A,1,Intermediate,1,,CHEMBL622854,,BAO_0000218,,
9843,,Rattus norvegicus,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL622855,,BAO_0000218,,
9844,,Rattus norvegicus,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",N,A,1,Intermediate,1,,CHEMBL622856,,BAO_0000218,1969.0,
9845,,Rattus norvegicus,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",N,A,1,Intermediate,1,,CHEMBL622857,,BAO_0000218,1969.0,
9846,,Rattus norvegicus,AUC in rat after po administration at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL622858,,BAO_0000218,1969.0,
9847,,Rattus norvegicus,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL622859,,BAO_0000218,1969.0,
9848,,Rattus norvegicus,Area under curve value 24 hr after 10 mg/kg iv administration in rats,N,A,1,Intermediate,1,,CHEMBL622860,,BAO_0000218,,
9849,,Rattus norvegicus,Area under curve value 24 hr after 10 mg/kg oral administration in rats,N,A,1,Intermediate,1,,CHEMBL622861,,BAO_0000218,,
9850,,Rattus norvegicus,Area under curve value 24 hr after 2 mg/kg iv administration in rats,N,A,1,Intermediate,1,,CHEMBL622862,,BAO_0000218,,
9851,,Rattus norvegicus,Area under curve value 24 hr after 2 mg/kg oral administration in rats,N,A,1,Intermediate,1,,CHEMBL622863,,BAO_0000218,,
9852,,Rattus norvegicus,Area under curve value 6 hr after po administration in rat,N,A,1,Intermediate,1,,CHEMBL623817,,BAO_0000218,,
9853,,Rattus norvegicus,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,A,1,Intermediate,1,,CHEMBL623818,,BAO_0000218,,
9854,,Rattus norvegicus,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",N,A,1,Intermediate,1,,CHEMBL623819,,BAO_0000218,,
9855,,Rattus norvegicus,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,A,1,Intermediate,1,,CHEMBL623820,,BAO_0000218,,
9856,,Rattus norvegicus,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,N,A,1,Intermediate,1,,CHEMBL623821,,BAO_0000218,,
9857,,Rattus norvegicus,AUC normalized for dose (AUCN) in rat,N,A,1,Intermediate,1,,CHEMBL623822,,BAO_0000218,1969.0,
9858,,Rattus norvegicus,Area under curve in rat after p.o. administration,N,A,1,Intermediate,1,,CHEMBL623823,,BAO_0000218,,
9859,,Rattus norvegicus,Area under curve in rat after p.o. administration,N,A,1,Intermediate,1,,CHEMBL623824,,BAO_0000218,,
9860,,Rattus norvegicus,Area under curve in rat after p.o. administration; Not determined,N,A,1,Intermediate,1,,CHEMBL623825,,BAO_0000218,,
9861,,Rattus norvegicus,Area under curve in rat after peroral administration,N,A,1,Intermediate,1,,CHEMBL622070,,BAO_0000218,,
9862,,Rattus norvegicus,Area under curve (carotid artery) value of the compound,N,A,1,Intermediate,1,,CHEMBL622071,,BAO_0000218,,
9863,,Rattus norvegicus,Bioavailability expressed as the area under curve of rat carotid artery,N,A,1,Intermediate,1,,CHEMBL622072,,BAO_0000218,,
9864,,Rattus norvegicus,Area under curve in male SD rats was observed after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL622073,,BAO_0000218,,
9865,,Rattus norvegicus,Area under curve of the compound was determined,N,A,1,Intermediate,1,,CHEMBL622074,,BAO_0000218,,
9866,,Rattus norvegicus,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,N,A,1,Intermediate,1,,CHEMBL622075,,BAO_0000218,,
9867,,Rattus norvegicus,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL622076,,BAO_0000218,1969.0,
9868,,Rattus norvegicus,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL622077,,BAO_0000218,1969.0,
9869,,Rattus norvegicus,Area under curve (portal vein) value of the compound,N,A,1,Intermediate,1,,CHEMBL622078,,BAO_0000218,,
9870,,Rattus norvegicus,Bioavailability expressed as the area under curve of rat portal vein,N,A,1,Intermediate,1,,CHEMBL622079,,BAO_0000218,,
9871,,Rattus norvegicus,Area Under plasma concentration time curve in rat upon peroral administration,N,A,1,Intermediate,1,,CHEMBL622080,,BAO_0000218,1969.0,
9872,,Rattus norvegicus,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL877612,,BAO_0000218,,
9873,,Rattus norvegicus,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL622081,,BAO_0000218,,
9874,,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats,N,A,1,Intermediate,1,,CHEMBL622082,,BAO_0000218,,
9875,,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats after iv administration,N,A,1,Intermediate,1,,CHEMBL622083,,BAO_0000218,,
9876,,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; 30-80,N,A,1,Intermediate,1,,CHEMBL622084,,BAO_0000218,,
9877,,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; 50-60,N,A,1,Intermediate,1,,CHEMBL622085,,BAO_0000218,,
9878,,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; no data,N,A,1,Intermediate,1,,CHEMBL622086,,BAO_0000218,,
9879,,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; peptide,N,A,1,Intermediate,1,,CHEMBL622087,,BAO_0000218,,
9880,,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",N,A,1,Intermediate,1,,CHEMBL622088,,BAO_0000218,178.0,
9881,,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",N,A,1,Intermediate,1,,CHEMBL622089,,BAO_0000218,178.0,
9882,,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",N,A,1,Intermediate,1,,CHEMBL623685,,BAO_0000218,178.0,
9883,,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",N,A,1,Intermediate,1,,CHEMBL623686,,BAO_0000218,178.0,
9884,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL623687,,BAO_0000218,945.0,
9885,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL623688,,BAO_0000218,945.0,
9886,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL623689,,BAO_0000218,945.0,
9887,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622485,,BAO_0000218,945.0,
9888,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622486,,BAO_0000218,2046.0,
9889,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL877613,,BAO_0000218,2046.0,
9890,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622487,,BAO_0000218,2046.0,
9891,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622488,,BAO_0000218,2046.0,
9892,,Rattus norvegicus,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622489,,BAO_0000218,948.0,
9893,,Rattus norvegicus,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,A,1,Intermediate,1,,CHEMBL622490,,BAO_0000218,1088.0,
9894,,Rattus norvegicus,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,A,1,Intermediate,1,,CHEMBL622491,,BAO_0000218,1088.0,
9895,,Rattus norvegicus,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,N,A,1,Intermediate,1,,CHEMBL622492,,BAO_0000218,2107.0,
9896,,Rattus norvegicus,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,A,1,Intermediate,1,,CHEMBL622493,,BAO_0000218,1088.0,
9897,,Rattus norvegicus,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,A,1,Intermediate,1,,CHEMBL622494,,BAO_0000218,1088.0,
9898,,Rattus norvegicus,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,A,1,Intermediate,1,,CHEMBL622495,,BAO_0000218,2385.0,
9899,,Rattus norvegicus,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,N,A,1,Intermediate,1,,CHEMBL622496,,BAO_0000218,,
9900,,Rattus norvegicus,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,A,1,Intermediate,1,,CHEMBL622497,,BAO_0000218,1088.0,
9901,,Rattus norvegicus,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,N,A,1,Intermediate,1,,CHEMBL622498,,BAO_0000218,,
9902,,Rattus norvegicus,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,N,A,1,Intermediate,1,,CHEMBL624918,,BAO_0000218,1088.0,
9903,,Rattus norvegicus,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,N,A,1,Intermediate,1,,CHEMBL624919,,BAO_0000218,1088.0,
9904,,Rattus norvegicus,Biodistribution of compound in rat blood after 5 min of administration,N,A,1,Intermediate,1,,CHEMBL624920,,BAO_0000218,178.0,
9905,,Rattus norvegicus,Biodistribution of compound in rat blood after 5 min of administration.,N,A,1,Intermediate,1,,CHEMBL624921,,BAO_0000218,178.0,
9906,,Rattus norvegicus,Biodistribution of compound in rat brain after 5 min of administration,N,A,1,Intermediate,1,,CHEMBL624922,,BAO_0000218,955.0,
9907,,Rattus norvegicus,Biodistribution of compound in rat heart after 5 min of administration,N,A,1,Intermediate,1,,CHEMBL624923,,BAO_0000218,948.0,
9908,,Rattus norvegicus,Biodistribution of compound in rat heart after 5 min of administration.,N,A,1,Intermediate,1,,CHEMBL624924,,BAO_0000218,948.0,
9909,,Rattus norvegicus,Biodistribution of compound in rat kidney after 5 min of administration,N,A,1,Intermediate,1,,CHEMBL624925,,BAO_0000218,2113.0,
9910,,Rattus norvegicus,Biodistribution of compound in rat kidney after 5 min of administration.,N,A,1,Intermediate,1,,CHEMBL624926,,BAO_0000218,2113.0,
9911,,Rattus norvegicus,Biodistribution of compound in rat liver after 5 min of administration,N,A,1,Intermediate,1,,CHEMBL624927,,BAO_0000218,2107.0,
9912,,Rattus norvegicus,Biodistribution of compound in rat liver after 5 min of administration.,N,A,1,Intermediate,1,,CHEMBL874402,,BAO_0000218,2107.0,
9913,,Rattus norvegicus,Biodistribution of compound in rat lung after 5 min of administration,N,A,1,Intermediate,1,,CHEMBL624928,,BAO_0000218,2048.0,
9914,,Rattus norvegicus,Biodistribution of compound in rat lung after 5 min of administration.,N,A,1,Intermediate,1,,CHEMBL624929,,BAO_0000218,2048.0,
9915,,Rattus norvegicus,Biodistribution of compound in rat muscle after 5 min of administration,N,A,1,Intermediate,1,,CHEMBL624930,,BAO_0000218,2385.0,
9916,,Rattus norvegicus,Biodistribution of compound in rat muscle after 5 min of administration.,N,A,1,Intermediate,1,,CHEMBL624931,,BAO_0000218,2385.0,
9917,,Rattus norvegicus,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL624932,,BAO_0000218,948.0,
9918,,Rattus norvegicus,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL624933,,BAO_0000218,948.0,
9919,,Rattus norvegicus,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL624934,,BAO_0000218,2107.0,
9920,,Rattus norvegicus,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL624935,,BAO_0000218,2107.0,
9921,,Rattus norvegicus,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL624936,,BAO_0000218,,
9922,,Rattus norvegicus,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL624937,,BAO_0000218,,
9923,,Rattus norvegicus,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL624938,,BAO_0000218,2106.0,
9924,,Rattus norvegicus,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL624939,,BAO_0000218,2106.0,
9925,,Rattus norvegicus,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL624940,,BAO_0000218,,
9926,,Rattus norvegicus,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,A,1,Intermediate,1,,CHEMBL874403,,BAO_0000218,,
9927,,Rattus norvegicus,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,N,A,1,Intermediate,1,,CHEMBL624941,,BAO_0000218,,
9928,,Rattus norvegicus,Dose required to lower urine osmolality to 300 mOsm/kg in rat,N,A,1,Intermediate,1,,CHEMBL624942,,BAO_0000218,1088.0,
9929,,Rattus norvegicus,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,N,A,1,Intermediate,1,,CHEMBL624943,,BAO_0000218,1088.0,
9930,,Rattus norvegicus,% Bioavailability after 1 day of the drug administration in rats,N,A,1,Intermediate,1,,CHEMBL624944,,BAO_0000218,,
9931,,Rattus norvegicus,% Bioavailability after 4 day of the drug administration in rats,N,A,1,Intermediate,1,,CHEMBL624945,,BAO_0000218,,
9932,,Rattus norvegicus,Absolute bioavailability was evaluated in rat,N,A,1,Intermediate,1,,CHEMBL624946,,BAO_0000218,,
9933,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL624947,,BAO_0000218,,
9934,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL624948,,BAO_0000218,,
9935,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL624949,,BAO_0000218,,
9936,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL622025,,BAO_0000218,2113.0,
9937,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL622026,,BAO_0000218,2113.0,
9938,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL622027,,BAO_0000218,2113.0,
9939,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL622028,,BAO_0000218,2113.0,
9940,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL622029,,BAO_0000218,2107.0,
9941,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL622208,,BAO_0000218,2107.0,
9942,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL622209,,BAO_0000218,2107.0,
9943,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL622210,,BAO_0000218,2107.0,
9944,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL622211,,BAO_0000218,,
9945,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL622212,,BAO_0000218,,
9946,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL622213,,BAO_0000218,,
9947,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL874404,,BAO_0000218,,
9948,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL620452,,BAO_0000218,2385.0,
9949,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL620453,,BAO_0000218,2385.0,
9950,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL620454,,BAO_0000218,2385.0,
9951,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL624067,,BAO_0000218,2385.0,
9952,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL624068,,BAO_0000218,,
9953,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL624069,,BAO_0000218,992.0,
9954,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL624070,,BAO_0000218,992.0,
9955,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL624071,,BAO_0000218,992.0,
9956,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL624072,,BAO_0000218,995.0,
9957,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL624073,,BAO_0000218,995.0,
9958,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL624788,,BAO_0000218,995.0,
9959,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL624789,,BAO_0000218,995.0,
9960,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL624790,,BAO_0000218,,
9961,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL624791,,BAO_0000218,,
9962,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL624792,,BAO_0000218,,
9963,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL624793,,BAO_0000218,,
9964,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,N,A,1,Intermediate,1,,CHEMBL877491,,BAO_0000218,2385.0,
9965,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,N,A,1,Intermediate,1,,CHEMBL624957,,BAO_0000218,2385.0,
9966,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,N,A,1,Intermediate,1,,CHEMBL624958,,BAO_0000218,2385.0,
9967,,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,N,A,1,Intermediate,1,,CHEMBL624959,,BAO_0000218,2385.0,
9968,,Rattus norvegicus,Dissociation constant was determined,N,A,1,Intermediate,1,,CHEMBL624960,,BAO_0000218,,
9969,,Rattus norvegicus,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",N,A,1,Intermediate,1,,CHEMBL624961,,BAO_0000218,,
9970,,Rattus norvegicus,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL624962,,BAO_0000218,,
9971,,Rattus norvegicus,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL624963,,BAO_0000218,,
9972,,Rattus norvegicus,Observed rate constant in 80% rat plasma at 37 degree Centigrade,N,A,1,Intermediate,1,,CHEMBL624964,,BAO_0000218,,
9973,,Rattus norvegicus,LogP value was evaluated in the in situ rat gut perfusion assay,N,A,1,Intermediate,1,,CHEMBL624965,,BAO_0000218,,
9974,,Rattus norvegicus,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,A,1,Intermediate,1,,CHEMBL624966,,BAO_0000218,,
9975,,Rattus norvegicus,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,N,A,1,Intermediate,1,,CHEMBL624967,,BAO_0000218,,
9976,,Rattus norvegicus,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,N,A,1,Intermediate,1,,CHEMBL624968,,BAO_0000218,,
9977,,Rattus norvegicus,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,N,A,1,Intermediate,1,,CHEMBL624969,,BAO_0000218,,
9978,,Rattus norvegicus,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,N,F,1,Expert,1,,CHEMBL624970,,BAO_0000218,,
9979,,Rattus norvegicus,Half-life was evaluated after 10 uM/kg of intra arterial administration,N,A,1,Intermediate,1,,CHEMBL624971,,BAO_0000218,,
9980,,Rattus norvegicus,Half-life was evaluated after 20 uM/kg of peroral administration,N,A,1,Intermediate,1,,CHEMBL624972,,BAO_0000218,,
9981,,Rattus norvegicus,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL624973,,BAO_0000218,,
9982,,Rattus norvegicus,Half-life was evaluated in plasma of rat,N,A,1,Intermediate,1,,CHEMBL624974,,BAO_0000218,1969.0,
9983,,Rattus norvegicus,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL624975,,BAO_0000218,,
9984,,Rattus norvegicus,Half-life was evaluated in rats at an oral dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL877492,,BAO_0000218,,
9985,,Rattus norvegicus,Half-life was measured in rat after an iv dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL624976,,BAO_0000218,,
9986,,Rattus norvegicus,Half-life period of compound in rats after peroral administration,N,A,1,Intermediate,1,,CHEMBL624977,,BAO_0000218,,
9987,,Rattus norvegicus,Half-life period of compound was measured in rat plasma.,N,A,1,Intermediate,1,,CHEMBL626848,,BAO_0000218,1969.0,
9988,,Rattus norvegicus,Half-life period of compound was measured in rat plasma; ND is not determined,N,A,1,Intermediate,1,,CHEMBL626849,,BAO_0000218,1969.0,
9989,,Rattus norvegicus,Half-life period of compound was measured in rat plasma; not determined,N,A,1,Intermediate,1,,CHEMBL626850,,BAO_0000218,1969.0,
9990,,Rattus norvegicus,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,A,1,Intermediate,1,,CHEMBL626851,,BAO_0000218,,
9991,,Rattus norvegicus,Half-life period in rat by iv administration,N,A,1,Intermediate,1,,CHEMBL626852,,BAO_0000218,,
9992,,Rattus norvegicus,Half-life period in rats following intravenous administration at 2 mg/kg,N,A,1,Intermediate,1,,CHEMBL626853,,BAO_0000218,,
9993,,Rattus norvegicus,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,A,1,Intermediate,1,,CHEMBL626854,,BAO_0000218,,
9994,,Rattus norvegicus,Half-life period was determined for the compound in rat,N,A,1,Intermediate,1,,CHEMBL627486,,BAO_0000218,,
9995,,Rattus norvegicus,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",N,A,1,Intermediate,1,,CHEMBL627487,,BAO_0000218,,
9996,,Rattus norvegicus,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",N,A,1,Intermediate,1,,CHEMBL627488,,BAO_0000218,,
9997,,Rattus norvegicus,Half-life value after IV dose at a dose of 5 mg/kg in rats.,N,A,1,Intermediate,1,,CHEMBL627489,,BAO_0000218,,
9998,,Rattus norvegicus,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL627490,,BAO_0000218,,
9999,,Rattus norvegicus,Half-life was determined in rat after intravenous administration (0.5 mg/kg),N,A,1,Intermediate,1,,CHEMBL873829,,BAO_0000218,,
10000,,Rattus norvegicus,Half-life was determined in rat at a dose of 1 mpk i.v.,N,A,1,Intermediate,1,,CHEMBL627655,,BAO_0000218,,
10001,,Rattus norvegicus,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,A,1,Intermediate,1,,CHEMBL625994,,BAO_0000218,,
10002,,Rattus norvegicus,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,A,1,Intermediate,1,,CHEMBL625995,,BAO_0000218,,
10003,,Rattus norvegicus,Half-life in rat,N,A,1,Intermediate,1,,CHEMBL625996,,BAO_0000218,,
10004,,Rattus norvegicus,In vitro half life in rat plasma,N,A,1,Intermediate,1,,CHEMBL625850,,BAO_0000218,1969.0,
10005,,Rattus norvegicus,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",N,A,1,Intermediate,1,,CHEMBL625851,,BAO_0000218,1969.0,
10006,,Rattus norvegicus,In vitro half life in rat,N,A,1,Intermediate,1,,CHEMBL625852,,BAO_0000218,,
10007,,Rattus norvegicus,In vivo half life period after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL625853,,BAO_0000218,,
10008,,Rattus norvegicus,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,A,1,Intermediate,1,,CHEMBL625854,,BAO_0000218,,
10009,,Rattus norvegicus,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,A,1,Intermediate,1,,CHEMBL874450,,BAO_0000218,,
10010,,Rattus norvegicus,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625855,,BAO_0000218,,
10011,,Rattus norvegicus,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625856,,BAO_0000218,,
10012,,Rattus norvegicus,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625857,,BAO_0000218,,
10013,,Rattus norvegicus,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL873831,,BAO_0000218,,
10014,,Rattus norvegicus,Longer half-life in rat (i.v.) at 0.5 mpk,N,A,1,Intermediate,1,,CHEMBL625858,,BAO_0000218,,
10015,,Rattus norvegicus,Longer half-life in rat (p.o.) at 2.0 mpk,N,A,1,Intermediate,1,,CHEMBL625859,,BAO_0000218,,
10016,,Rattus norvegicus,Pharmacokinetic property (half life) in rat,N,A,1,Intermediate,1,,CHEMBL625860,,BAO_0000218,,
10017,,Rattus norvegicus,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,N,A,1,Intermediate,1,,CHEMBL625861,,BAO_0000218,,
10018,,Rattus norvegicus,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,N,A,1,Intermediate,1,,CHEMBL625862,,BAO_0000218,,
10019,,Rattus norvegicus,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,N,A,1,Intermediate,1,,CHEMBL625863,,BAO_0000218,,
10020,,Rattus norvegicus,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,N,A,1,Intermediate,1,,CHEMBL625864,,BAO_0000218,,
10021,,Rattus norvegicus,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,N,A,1,Intermediate,1,,CHEMBL625865,,BAO_0000218,,
10022,,Rattus norvegicus,Pharmacokinetic half time was determined intravenously in rats.,N,A,1,Intermediate,1,,CHEMBL625866,,BAO_0000218,,
10023,,Rattus norvegicus,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,N,A,1,Intermediate,1,,CHEMBL625867,,BAO_0000218,1969.0,
10024,,Rattus norvegicus,Plasma half life of hydrolysis of the compound,N,A,1,Intermediate,1,,CHEMBL625868,,BAO_0000218,1969.0,
10025,,Rattus norvegicus,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,N,A,1,Intermediate,1,,CHEMBL625869,,BAO_0000218,1969.0,
10026,,Rattus norvegicus,Plasma half life period was calculated in rat,N,A,1,Intermediate,1,,CHEMBL874451,,BAO_0000218,1969.0,
10027,,Rattus norvegicus,Plasma half-life in Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL625870,,BAO_0000218,1969.0,
10028,,Rattus norvegicus,Plasma half-life in Sprague-Dawley rats; Not determined,N,A,1,Intermediate,1,,CHEMBL625871,,BAO_0000218,1969.0,
10029,,Rattus norvegicus,Plasma half-life in rats,N,A,1,Intermediate,1,,CHEMBL625872,,BAO_0000218,1969.0,
10030,,Rattus norvegicus,Plasma half-life in rats; <MQL,N,A,1,Intermediate,1,,CHEMBL625873,,BAO_0000218,1969.0,
10031,,Rattus norvegicus,Plasma half-life period (0-8 h) was determined,N,A,1,Intermediate,1,,CHEMBL625874,,BAO_0000218,1969.0,
10032,,Rattus norvegicus,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625875,,BAO_0000218,1969.0,
10033,,Rattus norvegicus,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL625876,,BAO_0000218,1969.0,
10034,,Rattus norvegicus,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL631258,,BAO_0000218,1969.0,
10035,,Rattus norvegicus,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,N,A,1,Intermediate,1,,CHEMBL631259,,BAO_0000218,1969.0,
10036,,Rattus norvegicus,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,N,A,1,Intermediate,1,,CHEMBL631260,,BAO_0000218,1969.0,
10037,,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",N,A,1,Intermediate,1,,CHEMBL631261,,BAO_0000218,178.0,
10038,,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",N,A,1,Intermediate,1,,CHEMBL631262,,BAO_0000218,178.0,
10039,,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",N,A,1,Intermediate,1,,CHEMBL631263,,BAO_0000218,178.0,
10040,,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",N,A,1,Intermediate,1,,CHEMBL631264,,BAO_0000218,,
10041,,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",N,A,1,Intermediate,1,,CHEMBL631265,,BAO_0000218,,
10042,,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",N,A,1,Intermediate,1,,CHEMBL631266,,BAO_0000218,,
10043,,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",N,A,1,Intermediate,1,,CHEMBL631267,,BAO_0000218,,
10044,,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",N,A,1,Intermediate,1,,CHEMBL631268,,BAO_0000218,,
10045,,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",N,A,1,Intermediate,1,,CHEMBL631269,,BAO_0000218,,
10046,,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",N,A,1,Intermediate,1,,CHEMBL631270,,BAO_0000218,,
10047,,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,A,1,Intermediate,1,,CHEMBL631271,,BAO_0000218,948.0,
10048,,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",N,A,1,Intermediate,1,,CHEMBL631272,,BAO_0000218,948.0,
10049,,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",N,A,1,Intermediate,1,,CHEMBL631273,,BAO_0000218,948.0,
10050,,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",N,A,1,Intermediate,1,,CHEMBL631274,,BAO_0000218,948.0,
10051,,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",N,A,1,Intermediate,1,,CHEMBL631275,,BAO_0000218,948.0,
10052,,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",N,A,1,Intermediate,1,,CHEMBL626984,,BAO_0000218,948.0,
10053,,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",N,A,1,Intermediate,1,,CHEMBL626985,,BAO_0000218,948.0,
10054,,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,A,1,Intermediate,1,,CHEMBL626986,,BAO_0000218,2107.0,
10055,,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",N,A,1,Intermediate,1,,CHEMBL626987,,BAO_0000218,2107.0,
10056,,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",N,A,1,Intermediate,1,,CHEMBL626988,,BAO_0000218,2107.0,
10057,,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",N,A,1,Intermediate,1,,CHEMBL626989,,BAO_0000218,2107.0,
10058,,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",N,A,1,Intermediate,1,,CHEMBL626990,,BAO_0000218,2107.0,
10059,,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",N,A,1,Intermediate,1,,CHEMBL626991,,BAO_0000218,2107.0,
10060,,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",N,A,1,Intermediate,1,,CHEMBL626992,,BAO_0000218,2107.0,
10061,,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",N,A,1,Intermediate,1,,CHEMBL626993,,BAO_0000218,2048.0,
10062,,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",N,A,1,Intermediate,1,,CHEMBL874593,,BAO_0000218,2048.0,
10063,,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",N,A,1,Intermediate,1,,CHEMBL626994,,BAO_0000218,2048.0,
10064,,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",N,A,1,Intermediate,1,,CHEMBL626995,,BAO_0000218,2048.0,
10065,,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",N,A,1,Intermediate,1,,CHEMBL626190,,BAO_0000218,2048.0,
10066,,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",N,A,1,Intermediate,1,,CHEMBL626191,,BAO_0000218,2048.0,
10067,,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",N,A,1,Intermediate,1,,CHEMBL626364,,BAO_0000218,2048.0,
10068,,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",N,A,1,Intermediate,1,,CHEMBL626365,,BAO_0000218,2046.0,
10069,,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",N,A,1,Intermediate,1,,CHEMBL626366,,BAO_0000218,2046.0,
10070,,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",N,A,1,Intermediate,1,,CHEMBL626367,,BAO_0000218,2046.0,
10071,,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",N,A,1,Intermediate,1,,CHEMBL626368,,BAO_0000218,2046.0,
10072,,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",N,A,1,Intermediate,1,,CHEMBL626369,,BAO_0000218,2046.0,
10073,,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",N,A,1,Intermediate,1,,CHEMBL626370,,BAO_0000218,2046.0,
10074,,Rattus norvegicus,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",N,A,1,Intermediate,1,,CHEMBL626371,,BAO_0000218,,
10075,,Rattus norvegicus,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",N,A,1,Intermediate,1,,CHEMBL626372,,BAO_0000218,,
10076,,Rattus norvegicus,Bioavailability after a dose of 10 mg/kg p.o.,N,A,1,Intermediate,1,,CHEMBL626373,,BAO_0000218,,
10077,,Rattus norvegicus,Bioavailability after peroral administration (10 mg/kg) was determined in rat,N,A,1,Intermediate,1,,CHEMBL626374,,BAO_0000218,,
10078,,Rattus norvegicus,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,N,A,1,Intermediate,1,,CHEMBL626375,,BAO_0000218,,
10079,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),N,A,1,Intermediate,1,,CHEMBL626376,,BAO_0000218,,
10080,,Rattus norvegicus,Bioavailability in rat po was determined,N,A,1,Intermediate,1,,CHEMBL626377,,BAO_0000218,,
10081,,Rattus norvegicus,Bioavailability of compound at 10 mg/kg in rat after oral administration,N,A,1,Intermediate,1,,CHEMBL626378,,BAO_0000218,,
10082,,Rattus norvegicus,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,N,A,1,Intermediate,1,,CHEMBL626379,,BAO_0000218,,
10083,,Rattus norvegicus,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL626380,,BAO_0000218,,
10084,,Rattus norvegicus,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL626381,,BAO_0000218,,
10085,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL626382,,BAO_0000218,,
10086,,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (female),N,A,1,Intermediate,1,,CHEMBL626383,,BAO_0000218,,
10087,,Rattus norvegicus,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,A,1,Intermediate,1,,CHEMBL874652,,BAO_0000218,,
10088,,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),N,A,1,Intermediate,1,,CHEMBL626384,,BAO_0000218,,
10089,,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,N,A,1,Intermediate,1,,CHEMBL626385,,BAO_0000218,,
10090,,Rattus norvegicus,Bioavailability in rat at an oral dose of 2 mg/kg,N,A,1,Intermediate,1,,CHEMBL626386,,BAO_0000218,,
10091,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL626387,,BAO_0000218,,
10092,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL626388,,BAO_0000218,,
10093,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL626389,,BAO_0000218,,
10094,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL626390,,BAO_0000218,,
10095,,Rattus norvegicus,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,N,A,1,Intermediate,1,,CHEMBL626391,,BAO_0000218,,
10096,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL626392,,BAO_0000218,,
10097,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL626393,,BAO_0000218,,
10098,,Rattus norvegicus,Bioavailability was determined in rat,N,A,1,Intermediate,1,,CHEMBL623026,,BAO_0000218,,
10099,,Rattus norvegicus,Bioavailability,N,A,1,Intermediate,1,,CHEMBL623027,,BAO_0000218,,
10100,,Rattus norvegicus,Bioavailability,N,A,1,Intermediate,1,,CHEMBL623028,,BAO_0000218,,
10101,,Rattus norvegicus,Bioavailability in rat after 1 day dosing,N,A,1,Intermediate,1,,CHEMBL623029,,BAO_0000218,,
10102,,Rattus norvegicus,Bioavailability in rat after 4 day dosing,N,A,1,Intermediate,1,,CHEMBL623030,,BAO_0000218,,
10103,,Rattus norvegicus,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,N,A,1,Intermediate,1,,CHEMBL623031,,BAO_0000218,,
10104,,Rattus norvegicus,Bioavailability after IV dosing at 1 mg/kg in rat; no data,N,A,1,Intermediate,1,,CHEMBL623032,,BAO_0000218,,
10105,,Rattus norvegicus,Bioavailability after oral administration at a dose of 2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL623033,,BAO_0000218,,
10106,,Rattus norvegicus,Bioavailability after oral administration at a dose of 4 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL623034,,BAO_0000218,,
10107,,Rattus norvegicus,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,N,A,1,Intermediate,1,,CHEMBL623035,,BAO_0000218,,
10108,,Rattus norvegicus,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,A,1,Intermediate,1,,CHEMBL623036,,BAO_0000218,,
10109,,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL623037,,BAO_0000218,,
10110,,Rattus norvegicus,Bioavailability by intravenous administration of 3.4 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL623038,,BAO_0000218,,
10111,,Rattus norvegicus,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL874385,,BAO_0000218,1969.0,
10112,,Rattus norvegicus,Bioavailability in rat (Fisher) (fasted),N,A,1,Intermediate,1,,CHEMBL623039,,BAO_0000218,,
10113,,Primates,Bioavailability in monkey after po administration of 10 mg/kg dose,U,A,0,Intermediate,1,,CHEMBL623040,,BAO_0000218,,
10114,,Primates,Oral bioavailability in monkey (dose 10 mg/kg),U,A,0,Intermediate,1,,CHEMBL623041,,BAO_0000218,,
10115,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623741,,BAO_0000218,,
10116,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623742,,BAO_0000218,,
10117,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623743,,BAO_0000218,,
10118,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623744,,BAO_0000218,,
10119,,Rattus norvegicus,Bioavailability in rat (dose 2.0 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL623745,,BAO_0000218,,
10120,,Rattus norvegicus,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL623746,,BAO_0000218,,
10121,,Rattus norvegicus,Oral bioavailability in rat (dose 5 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL623747,,BAO_0000218,,
10122,,Rattus norvegicus,Bioavailability in rat after po administration of 30 mg/kg dose,U,A,0,Intermediate,1,,CHEMBL623748,,BAO_0000218,,
10123,,Rattus norvegicus,Bioavailability in rat after po administration of 30 mg/kg dose,U,A,0,Intermediate,1,,CHEMBL623916,,BAO_0000218,,
10124,,Rattus norvegicus,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,A,1,Intermediate,1,,CHEMBL623917,,BAO_0000218,,
10125,,Rattus norvegicus,Bioavailability in rat (dose 2 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL623918,,BAO_0000218,,
10126,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL874386,,BAO_0000218,,
10127,,Rattus norvegicus,Bioavailability in rat; Only traces detected in rat plasma,N,A,1,Intermediate,1,,CHEMBL623919,,BAO_0000218,1969.0,
10128,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623920,,BAO_0000218,,
10129,,Rattus norvegicus,Bioavailability upon oral administration of compound,N,A,1,Intermediate,1,,CHEMBL623148,,BAO_0000218,,
10130,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),N,A,1,Intermediate,1,,CHEMBL623149,,BAO_0000218,,
10131,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623150,,BAO_0000218,,
10132,,Rattus norvegicus,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",N,A,1,Intermediate,1,,CHEMBL623151,,BAO_0000218,,
10133,,Rattus norvegicus,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",N,A,1,Intermediate,1,,CHEMBL623152,,BAO_0000218,,
10134,,Rattus norvegicus,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,N,F,1,Expert,1,,CHEMBL623153,,BAO_0000218,,
10135,,Rattus norvegicus,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,N,F,1,Expert,1,,CHEMBL623154,,BAO_0000218,,
10136,,Rattus norvegicus,In vitro and metabolic stability was determined,N,A,1,Intermediate,1,,CHEMBL623155,,BAO_0000218,,
10137,,Rattus norvegicus,In vitro metabolic stability in rat hepatocytes,N,A,1,Intermediate,1,,CHEMBL623156,,BAO_0000218,,
10138,,Rattus norvegicus,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,N,A,1,Intermediate,1,,CHEMBL623157,,BAO_0000218,,
10139,,Rattus norvegicus,Metabolic rate for compound was observed in rat hepatocytes,N,A,1,Intermediate,1,,CHEMBL623158,401.0,BAO_0000218,2107.0,
10140,,Rattus norvegicus,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,N,A,1,Intermediate,1,,CHEMBL623159,,BAO_0000218,,
10141,,Rattus norvegicus,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),N,A,1,Intermediate,1,,CHEMBL874390,,BAO_0000218,,
10142,,Rattus norvegicus,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),N,A,1,Intermediate,1,,CHEMBL623160,,BAO_0000218,,
10143,,Rattus norvegicus,Metabolism of compound in rat S9 microsomes; Trace,N,A,1,Intermediate,1,,CHEMBL623161,,BAO_0000218,,
10144,,Rattus norvegicus,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,N,A,1,Intermediate,1,,CHEMBL623162,,BAO_0000218,,
10145,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,N,A,1,Intermediate,1,,CHEMBL623163,,BAO_0000218,,
10146,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,N,A,1,Intermediate,1,,CHEMBL623164,,BAO_0000218,,
10147,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,N,A,1,Intermediate,1,,CHEMBL623165,,BAO_0000218,,
10148,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,N,A,1,Intermediate,1,,CHEMBL623166,,BAO_0000218,,
10149,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,N,A,1,Intermediate,1,,CHEMBL624983,,BAO_0000218,,
10150,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,N,A,1,Intermediate,1,,CHEMBL624984,,BAO_0000218,,
10151,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,N,A,1,Intermediate,1,,CHEMBL624985,,BAO_0000218,,
10152,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,N,A,1,Intermediate,1,,CHEMBL622970,,BAO_0000218,,
10153,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,N,A,1,Intermediate,1,,CHEMBL622971,,BAO_0000218,,
10154,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,N,A,1,Intermediate,1,,CHEMBL622972,,BAO_0000218,,
10155,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,N,A,1,Intermediate,1,,CHEMBL622973,,BAO_0000218,,
10156,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,N,A,1,Intermediate,1,,CHEMBL622974,,BAO_0000218,,
10157,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,N,A,1,Intermediate,1,,CHEMBL622975,,BAO_0000218,,
10158,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,N,A,1,Intermediate,1,,CHEMBL622976,,BAO_0000218,,
10159,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,N,A,1,Intermediate,1,,CHEMBL622977,,BAO_0000218,,
10160,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,A,1,Intermediate,1,,CHEMBL624351,,BAO_0000218,,
10161,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,N,A,1,Intermediate,1,,CHEMBL624352,,BAO_0000218,,
10162,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,A,1,Intermediate,1,,CHEMBL624353,,BAO_0000218,,
10163,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,N,A,1,Intermediate,1,,CHEMBL622397,,BAO_0000218,,
10164,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,N,A,1,Intermediate,1,,CHEMBL622398,,BAO_0000218,,
10165,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,N,A,1,Intermediate,1,,CHEMBL622399,,BAO_0000218,,
10166,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,A,1,Intermediate,1,,CHEMBL622400,,BAO_0000218,,
10167,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,A,1,Intermediate,1,,CHEMBL628428,,BAO_0000218,,
10168,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,N,A,1,Intermediate,1,,CHEMBL628590,,BAO_0000218,,
10169,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,A,1,Intermediate,1,,CHEMBL628591,,BAO_0000218,,
10170,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,N,A,1,Intermediate,1,,CHEMBL628592,,BAO_0000218,,
10171,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,A,1,Intermediate,1,,CHEMBL628593,,BAO_0000218,,
10172,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,N,A,1,Intermediate,1,,CHEMBL875333,,BAO_0000218,,
10173,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,A,1,Intermediate,1,,CHEMBL628594,,BAO_0000218,,
10174,,Rattus norvegicus,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,N,A,1,Intermediate,1,,CHEMBL628595,,BAO_0000218,1969.0,
10175,,Rattus norvegicus,Stability in rat plasma was determined,N,A,1,Intermediate,1,,CHEMBL628596,,BAO_0000218,1969.0,
10176,,Rattus norvegicus,Stability in rat plasma was determined; ND= no data,N,A,1,Intermediate,1,,CHEMBL628597,,BAO_0000218,1969.0,
10177,,Rattus norvegicus,Tested for plasma half life period in rat (0-8 hr),N,A,1,Intermediate,1,,CHEMBL628598,,BAO_0000218,1969.0,
10178,,Rattus norvegicus,Tested for plasma half life period in rat (0-8 hr); Not determined,N,A,1,Intermediate,1,,CHEMBL628599,,BAO_0000218,1969.0,
10179,,Rattus norvegicus,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,N,A,1,Intermediate,1,,CHEMBL628600,,BAO_0000218,,
10180,,Rattus norvegicus,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,N,A,1,Intermediate,1,,CHEMBL628601,,BAO_0000218,,
10181,,Rattus norvegicus,Tested for the half life in rat,N,A,1,Intermediate,1,,CHEMBL628602,,BAO_0000218,,
10182,,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,N,A,1,Intermediate,1,,CHEMBL628603,,BAO_0000218,,
10183,,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,N,A,1,Intermediate,1,,CHEMBL628604,,BAO_0000218,,
10184,,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,N,A,1,Intermediate,1,,CHEMBL628605,,BAO_0000218,,
10185,,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,N,A,1,Intermediate,1,,CHEMBL628606,,BAO_0000218,,
10186,,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,N,A,1,Intermediate,1,,CHEMBL628607,,BAO_0000218,,
10187,,Rattus norvegicus,The biological half life the compound was measured at the dose of 100 umol/kg,N,A,1,Intermediate,1,,CHEMBL628608,,BAO_0000218,,
10188,,Rattus norvegicus,The biological half life the compound was measured at the dose of 30 umol/kg,N,A,1,Intermediate,1,,CHEMBL628609,,BAO_0000218,,
10189,,Rattus norvegicus,The compound was evaluated for plasma half life period in rat,N,A,1,Intermediate,1,,CHEMBL628610,,BAO_0000218,1969.0,
10190,,Rattus norvegicus,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL873819,,BAO_0000218,,
10191,,Rattus norvegicus,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL628611,,BAO_0000218,,
10192,,Rattus norvegicus,The pharmacokinetic parameter half-life period in vivo in rats,N,A,1,Intermediate,1,,CHEMBL628612,,BAO_0000218,,
10193,,Rattus norvegicus,"The pharmacokinetic property, Half-life was determined",N,A,1,Intermediate,1,,CHEMBL628613,,BAO_0000218,,
10194,,Rattus norvegicus,"The pharmacokinetic property, Half-life in rat in vivo",N,A,1,Intermediate,1,,CHEMBL628614,,BAO_0000218,,
10195,,Rattus norvegicus,"The pharmacokinetic property, Half-life was determined; ND denotes no data",N,A,1,Intermediate,1,,CHEMBL628615,,BAO_0000218,,
10196,,Rattus norvegicus,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",N,A,1,Intermediate,1,,CHEMBL628616,,BAO_0000218,,
10197,,Rattus norvegicus,The plasma half life period in rats,N,A,1,Intermediate,1,,CHEMBL627924,,BAO_0000218,1969.0,
10198,,Rattus norvegicus,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,N,A,1,Intermediate,1,,CHEMBL627925,,BAO_0000218,2107.0,
10199,,Rattus norvegicus,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,A,1,Intermediate,1,,CHEMBL627926,,BAO_0000218,,
10200,,Rattus norvegicus,t1/2 (apparent elimination)of the compound was determined,N,A,1,Intermediate,1,,CHEMBL627927,,BAO_0000218,,
10201,,Rattus norvegicus,t1/2 value in rat,N,A,1,Intermediate,1,,CHEMBL627928,,BAO_0000218,,
10202,,Rattus norvegicus,Half life in rat,N,A,1,Intermediate,1,,CHEMBL627539,,BAO_0000218,,
10203,,Rattus norvegicus,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,A,1,Intermediate,1,,CHEMBL876790,,BAO_0000218,1969.0,
10204,,Rattus norvegicus,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,N,A,1,Intermediate,1,,CHEMBL858186,,BAO_0000218,,
10205,,Rattus norvegicus,Half-life period in fasted rats,N,A,1,Intermediate,1,,CHEMBL627540,,BAO_0000218,,
10206,,Rattus norvegicus,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,N,A,1,Intermediate,1,,CHEMBL627541,,BAO_0000218,,
10207,,Rattus norvegicus,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,N,A,1,Intermediate,1,,CHEMBL627715,,BAO_0000218,,
10208,,Rattus norvegicus,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL627716,,BAO_0000218,,
10209,,Rattus norvegicus,Maximum time required to achieve Cmax was determined in rat,N,A,1,Intermediate,1,,CHEMBL627717,,BAO_0000218,,
10210,,Rattus norvegicus,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,A,1,Intermediate,1,,CHEMBL627718,,BAO_0000218,,
10211,,Rattus norvegicus,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,A,1,Intermediate,1,,CHEMBL627719,,BAO_0000218,,
10212,,Rattus norvegicus,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,N,A,1,Intermediate,1,,CHEMBL627720,,BAO_0000218,,
10213,,Rattus norvegicus,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL627721,,BAO_0000218,,
10214,,Rattus norvegicus,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,N,A,1,Intermediate,1,,CHEMBL627722,,BAO_0000218,,
10215,,Rattus norvegicus,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL627723,,BAO_0000218,,
10216,,Rattus norvegicus,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626058,,BAO_0000218,,
10217,,Rattus norvegicus,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626059,,BAO_0000218,,
10218,,Rattus norvegicus,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL626060,,BAO_0000218,,
10219,,Rattus norvegicus,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,N,A,1,Intermediate,1,,CHEMBL626061,,BAO_0000218,1969.0,
10220,,Rattus norvegicus,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL876791,,BAO_0000218,,
10221,,Rattus norvegicus,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,A,1,Intermediate,1,,CHEMBL626062,,BAO_0000218,,
10222,,Rattus norvegicus,Tmax at the dose of 2 mg/Kg administered perorally in rats,N,A,1,Intermediate,1,,CHEMBL626063,,BAO_0000218,,
10223,,Rattus norvegicus,Tmax at the dose of 5 mg/Kg administered perorally in rats,N,A,1,Intermediate,1,,CHEMBL626064,,BAO_0000218,,
10224,,Rattus norvegicus,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,N,A,1,Intermediate,1,,CHEMBL626065,,BAO_0000218,1969.0,
10225,,Rattus norvegicus,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,N,A,1,Intermediate,1,,CHEMBL626066,,BAO_0000218,1969.0,
10226,,Rattus norvegicus,tmax upon peroral administration of 10.0 mg/Kg dose in rat,N,A,1,Intermediate,1,,CHEMBL626067,,BAO_0000218,,
10227,,Rattus norvegicus,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,N,F,1,Intermediate,1,,CHEMBL626068,,BAO_0000218,,
10228,,Rattus norvegicus,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,N,F,1,Intermediate,1,,CHEMBL626069,,BAO_0000218,,
10229,,Rattus norvegicus,Percent total excretion of 3-methoxyacetaminophen glucuronide,N,F,1,Intermediate,1,,CHEMBL626070,,BAO_0000218,,
10230,,Rattus norvegicus,Percent total excretion of N-methoxyacetaminophen glucuronide,N,F,1,Intermediate,1,,CHEMBL626071,,BAO_0000218,,
10231,,Rattus norvegicus,Percent total excretion of N-methoxyacetaminophen sulfate,N,F,1,Intermediate,1,,CHEMBL626072,,BAO_0000218,,
10232,,Rattus norvegicus,Percent total excretion of acetaminophen,N,F,1,Intermediate,1,,CHEMBL626073,,BAO_0000218,,
10233,,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",N,A,1,Intermediate,1,,CHEMBL626741,,BAO_0000218,2046.0,
10234,,Rattus norvegicus,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",N,A,1,Intermediate,1,,CHEMBL626742,,BAO_0000218,,
10235,,Rattus norvegicus,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,N,A,1,Intermediate,1,,CHEMBL626743,,BAO_0000218,,
10236,,Rattus norvegicus,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,N,A,1,Intermediate,1,,CHEMBL876792,,BAO_0000218,,
10237,,Rattus norvegicus,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,A,1,Intermediate,1,,CHEMBL626744,,BAO_0000218,,
10238,,Rattus norvegicus,Compound was tested for antidiuretic activity in rats,N,A,1,Intermediate,1,,CHEMBL626745,,BAO_0000218,,
10239,,Rattus norvegicus,AUC in rat after 3mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL626746,,BAO_0000218,1969.0,
10240,,Rattus norvegicus,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL626747,,BAO_0000218,,
10241,,Rattus norvegicus,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL626748,,BAO_0000218,,
10242,,Rattus norvegicus,Bioavailability administered orally at a dose of 10 mg/kg to rats,N,A,1,Intermediate,1,,CHEMBL626749,,BAO_0000218,,
10243,,Rattus norvegicus,Oral Bioavailability was determined,N,A,1,Intermediate,1,,CHEMBL626750,,BAO_0000218,,
10244,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL626751,,BAO_0000218,,
10245,,Rattus norvegicus,Oral bioavailability in rat; Not performed.,N,A,1,Intermediate,1,,CHEMBL626913,,BAO_0000218,,
10246,,Rattus norvegicus,Bioavailability,N,A,1,Intermediate,1,,CHEMBL626914,,BAO_0000218,,
10247,,Rattus norvegicus,Bioavailability was determined; ND denotes no data,N,A,1,Intermediate,1,,CHEMBL626915,,BAO_0000218,,
10248,,Rattus norvegicus,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626916,,BAO_0000218,,
10249,,Rattus norvegicus,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626917,,BAO_0000218,,
10250,,Rattus norvegicus,Binding towards rat plasma protein at 10 uM,N,A,1,Intermediate,1,,CHEMBL626918,,BAO_0000218,,
10251,,Rattus norvegicus,Binding towards rat plasma protein at 100 uM,N,A,1,Intermediate,1,,CHEMBL626919,,BAO_0000218,,
10252,,Rattus norvegicus,Bioavailability in rat (dose 20 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL626920,,BAO_0000218,,
10253,,Rattus norvegicus,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,A,1,Intermediate,1,,CHEMBL621976,,BAO_0000218,,
10254,,Rattus norvegicus,Bioavailability in rat after 5 mg/kg oral gavage,N,A,1,Intermediate,1,,CHEMBL877599,,BAO_0000218,,
10255,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL621977,,BAO_0000218,,
10256,,Rattus norvegicus,Bioavailability in rat (dose 1 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL621978,,BAO_0000218,,
10257,,Rattus norvegicus,Bioavailability in rat (dose 3 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL621979,,BAO_0000218,,
10258,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL621980,,BAO_0000218,,
10259,,Rattus norvegicus,Bioavailability of the compound in rats after administration of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL621981,,BAO_0000218,,
10260,,Rattus norvegicus,Bioavailability after administration of 10 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL621982,,BAO_0000218,,
10261,,Rattus norvegicus,Bioavailability after administration of 2 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL882953,,BAO_0000218,,
10262,,Rattus norvegicus,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,N,A,1,Intermediate,1,,CHEMBL621983,,BAO_0000218,,
10263,,Rattus norvegicus,Bioavailability in dogs was determined; high,N,A,1,Intermediate,1,,CHEMBL621984,,BAO_0000218,,
10264,,Rattus norvegicus,Bioavailability in monkey after intravenous administration at 1 mpk,N,A,1,Intermediate,1,,CHEMBL621985,,BAO_0000218,,
10265,,Rattus norvegicus,Bioavailability in monkey after peroral administration at 10 mpk,N,A,1,Intermediate,1,,CHEMBL621986,,BAO_0000218,,
10266,,Rattus norvegicus,Bioavailability in rat after intravenous administration at 1 mpk,N,A,1,Intermediate,1,,CHEMBL621987,,BAO_0000218,,
10267,,Rattus norvegicus,Bioavailability in rat after intravenous administration at 2 mpk,N,F,1,Intermediate,1,,CHEMBL877600,,BAO_0000218,,
10268,,Rattus norvegicus,Bioavailability in rat after peroral administration at 30 mpk,N,A,1,Intermediate,1,,CHEMBL621988,,BAO_0000218,,
10269,,Rattus norvegicus,Bioavailability in rat after peroral administration at at 100 mpk,N,F,1,Intermediate,1,,CHEMBL621989,,BAO_0000218,,
10270,,Rattus norvegicus,Bioavailability in rats was evaluated,N,A,1,Intermediate,1,,CHEMBL621990,,BAO_0000218,,
10271,,Rattus norvegicus,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,N,A,1,Intermediate,1,,CHEMBL621991,,BAO_0000218,,
10272,,Rattus norvegicus,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,N,A,1,Intermediate,1,,CHEMBL621992,,BAO_0000218,,
10273,,Rattus norvegicus,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,N,A,1,Intermediate,1,,CHEMBL621993,,BAO_0000218,,
10274,,Rattus norvegicus,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,N,A,1,Intermediate,1,,CHEMBL621994,,BAO_0000218,,
10275,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL621995,,BAO_0000218,,
10276,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL621996,,BAO_0000218,,
10277,,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg),N,A,1,Intermediate,1,,CHEMBL621997,,BAO_0000218,,
10278,,Rattus norvegicus,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,A,1,Intermediate,1,,CHEMBL621998,,BAO_0000218,,
10279,,Rattus norvegicus,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,N,A,1,Intermediate,1,,CHEMBL621999,,BAO_0000218,,
10280,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622000,,BAO_0000218,,
10281,,Rattus norvegicus,Bioavailability was measured in rat after oral administration; 2-4,N,A,1,Intermediate,1,,CHEMBL622001,,BAO_0000218,,
10282,,Rattus norvegicus,Bioavailability was measured in rat after oral administration; 3-7,N,A,1,Intermediate,1,,CHEMBL622002,,BAO_0000218,,
10283,,Rattus norvegicus,Bioavailability in rat (intraduodenal administration),N,A,1,Intermediate,1,,CHEMBL622003,,BAO_0000218,,
10284,,Rattus norvegicus,Bioavailability in rat (intraduodenal administration),N,A,1,Intermediate,1,,CHEMBL877601,,BAO_0000218,,
10285,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL624871,,BAO_0000218,,
10286,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622004,,BAO_0000218,,
10287,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL882954,,BAO_0000218,,
10288,,Rattus norvegicus,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,N,A,1,Intermediate,1,,CHEMBL622005,,BAO_0000218,,
10289,,Rattus norvegicus,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,N,A,1,Intermediate,1,,CHEMBL622006,,BAO_0000218,,
10290,,Rattus norvegicus,Bioavailability was measured in rat,N,A,1,Intermediate,1,,CHEMBL622007,,BAO_0000218,,
10291,,Rattus norvegicus,Bioavailability was reported,N,A,1,Intermediate,1,,CHEMBL622008,,BAO_0000218,,
10292,,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL622009,,BAO_0000218,,
10293,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,A,1,Intermediate,1,,CHEMBL622010,,BAO_0000218,,
10294,,Rattus norvegicus,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,A,1,Intermediate,1,,CHEMBL622011,,BAO_0000218,,
10295,,Rattus norvegicus,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),N,A,1,Intermediate,1,,CHEMBL622012,,BAO_0000218,,
10296,,Rattus norvegicus,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),N,A,1,Intermediate,1,,CHEMBL622013,,BAO_0000218,,
10297,,Rattus norvegicus,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL622014,,BAO_0000218,,
10298,,Rattus norvegicus,Bioavailability was determined at 3 mg/kg po dose in rats,N,A,1,Intermediate,1,,CHEMBL624749,,BAO_0000218,,
10299,,Rattus norvegicus,Oral bioavailability in rat (dose 2 mg/kg),N,A,1,Intermediate,1,,CHEMBL624750,,BAO_0000218,,
10300,,Rattus norvegicus,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL624751,,BAO_0000218,,
10301,,Rattus norvegicus,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,A,1,Intermediate,1,,CHEMBL624752,,BAO_0000218,,
10302,,Rattus norvegicus,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,A,1,Intermediate,1,,CHEMBL624753,,BAO_0000218,,
10303,,Rattus norvegicus,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL624754,,BAO_0000218,,
10304,,Rattus norvegicus,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,A,1,Intermediate,1,,CHEMBL624755,,BAO_0000218,,
10305,,Rattus norvegicus,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL624756,,BAO_0000218,,
10306,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL624757,,BAO_0000218,,
10307,,Rattus norvegicus,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,A,1,Intermediate,1,,CHEMBL624758,,BAO_0000218,,
10308,,Rattus norvegicus,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL622270,,BAO_0000218,,
10309,,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley),N,A,1,Intermediate,1,,CHEMBL622271,,BAO_0000218,,
10310,,Rattus norvegicus,Bioavailability in rat at the dose of 2 mg/kg,N,A,1,Intermediate,1,,CHEMBL622272,,BAO_0000218,,
10311,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622273,,BAO_0000218,,
10312,,Rattus norvegicus,Bioavailability in rat (cannulated) (dose 2 mg/kg),N,A,1,Intermediate,1,,CHEMBL622274,,BAO_0000218,,
10313,,Rattus norvegicus,Bioavailability value of compound in rats was determined after peroral administration,N,A,1,Intermediate,1,,CHEMBL622275,,BAO_0000218,,
10314,,Rattus norvegicus,Oral bioavailability in rat (dose 20 mg/kg),N,A,1,Intermediate,1,,CHEMBL622276,,BAO_0000218,,
10315,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622277,,BAO_0000218,,
10316,,Rattus norvegicus,Oral bioavailability in rat (dose 5 mg/kg),N,A,1,Intermediate,1,,CHEMBL622278,,BAO_0000218,,
10317,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622279,,BAO_0000218,,
10318,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622280,,BAO_0000218,,
10319,,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; 15-27 %,N,A,1,Intermediate,1,,CHEMBL624083,,BAO_0000218,,
10320,,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,N,A,1,Intermediate,1,,CHEMBL624084,,BAO_0000218,,
10321,,Rattus norvegicus,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),N,A,1,Intermediate,1,,CHEMBL624085,,BAO_0000218,,
10322,,Rattus norvegicus,Compound was tested for bioavailability in rats,N,A,1,Intermediate,1,,CHEMBL624086,,BAO_0000218,,
10323,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL624087,,BAO_0000218,,
10324,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL624088,,BAO_0000218,,
10325,,Macaca mulatta,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,U,A,0,Intermediate,1,,CHEMBL624089,,BAO_0000218,,
10326,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),U,A,0,Intermediate,1,,CHEMBL624090,,BAO_0000218,,
10327,,Rattus norvegicus,Evaluated for the bioavailability in rat (in vivo),N,A,1,Intermediate,1,,CHEMBL624091,,BAO_0000218,,
10328,,Rattus norvegicus,F value of compound in rats was determined after peroral administration,N,A,1,Intermediate,1,,CHEMBL624092,,BAO_0000218,,
10329,,Rattus norvegicus,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624093,,BAO_0000218,,
10330,,Rattus norvegicus,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624094,,BAO_0000218,,
10331,,Rattus norvegicus,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624095,,BAO_0000218,,
10332,,Rattus norvegicus,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL624096,,BAO_0000218,,
10333,,Rattus norvegicus,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",N,A,1,Intermediate,1,,CHEMBL624097,,BAO_0000218,,
10334,,Rattus norvegicus,Maximum fall in carotid flow in rat,N,A,1,Intermediate,1,,CHEMBL624098,,BAO_0000218,,
10335,,Rattus norvegicus,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL874392,,BAO_0000218,,
10336,,Rattus norvegicus,Oral bioavailability in rat (dose 5 mg/kg),N,A,1,Intermediate,1,,CHEMBL624099,,BAO_0000218,,
10337,,Rattus norvegicus,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL624100,,BAO_0000218,,
10338,,Rattus norvegicus,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,A,1,Intermediate,1,,CHEMBL624101,,BAO_0000218,,
10339,,Rattus norvegicus,Oral bioavailability in rat (male Wistar),N,A,1,Intermediate,1,,CHEMBL624102,,BAO_0000218,,
10340,,Rattus norvegicus,Oral bioavailability after administration (30 mg/kg) in rat; good,N,A,1,Intermediate,1,,CHEMBL624103,,BAO_0000218,,
10341,,Rattus norvegicus,Oral bioavailability at the dose of 2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL624104,,BAO_0000218,,
10342,,Rattus norvegicus,Oral bioavailability determined in rats,N,A,1,Intermediate,1,,CHEMBL624105,,BAO_0000218,,
10343,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL624106,,BAO_0000218,,
10344,,Rattus norvegicus,Oral bioavailability in rat (dose single 10 mg/kg),N,A,1,Intermediate,1,,CHEMBL624107,,BAO_0000218,,
10345,,Rattus norvegicus,Oral bioavailability in rat (dose single 10 mg/kg),N,A,1,Intermediate,1,,CHEMBL623943,,BAO_0000218,,
10346,,Rattus norvegicus,Oral bioavailability in rat (dose 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL623944,,BAO_0000218,,
10347,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,N,A,1,Intermediate,1,,CHEMBL623945,,BAO_0000218,,
10348,,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,N,A,1,Intermediate,1,,CHEMBL623946,,BAO_0000218,,
10349,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,N,A,1,Intermediate,1,,CHEMBL623947,,BAO_0000218,,
10350,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,N,A,1,Intermediate,1,,CHEMBL623948,,BAO_0000218,,
10351,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,N,A,1,Intermediate,1,,CHEMBL623949,,BAO_0000218,,
10352,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,N,A,1,Intermediate,1,,CHEMBL623950,,BAO_0000218,,
10353,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,N,A,1,Intermediate,1,,CHEMBL874398,,BAO_0000218,,
10354,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,N,A,1,Intermediate,1,,CHEMBL623951,,BAO_0000218,,
10355,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,N,A,1,Intermediate,1,,CHEMBL623952,,BAO_0000218,,
10356,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,N,A,1,Intermediate,1,,CHEMBL623953,,BAO_0000218,,
10357,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,N,A,1,Intermediate,1,,CHEMBL623954,,BAO_0000218,,
10358,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,N,A,1,Intermediate,1,,CHEMBL623955,,BAO_0000218,,
10359,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,N,A,1,Intermediate,1,,CHEMBL623956,,BAO_0000218,,
10360,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,N,A,1,Intermediate,1,,CHEMBL627807,,BAO_0000218,,
10361,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,N,A,1,Intermediate,1,,CHEMBL627808,,BAO_0000218,,
10362,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,N,A,1,Intermediate,1,,CHEMBL627809,,BAO_0000218,,
10363,,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,N,A,1,Intermediate,1,,CHEMBL627810,,BAO_0000218,,
10364,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",N,A,1,Intermediate,1,,CHEMBL627811,,BAO_0000218,,
10365,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",N,A,1,Intermediate,1,,CHEMBL627812,,BAO_0000218,,
10366,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",N,A,1,Intermediate,1,,CHEMBL627813,,BAO_0000218,,
10367,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",N,A,1,Intermediate,1,,CHEMBL627814,,BAO_0000218,,
10368,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",N,A,1,Intermediate,1,,CHEMBL875336,,BAO_0000218,,
10369,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",N,A,1,Intermediate,1,,CHEMBL627815,,BAO_0000218,,
10370,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",N,A,1,Intermediate,1,,CHEMBL627816,,BAO_0000218,,
10371,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",N,A,1,Intermediate,1,,CHEMBL627817,,BAO_0000218,,
10372,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",N,A,1,Intermediate,1,,CHEMBL627818,,BAO_0000218,,
10373,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",N,A,1,Intermediate,1,,CHEMBL627819,,BAO_0000218,,
10374,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",N,A,1,Intermediate,1,,CHEMBL627820,,BAO_0000218,,
10375,,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",N,A,1,Intermediate,1,,CHEMBL627821,,BAO_0000218,,
10376,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,A,1,Intermediate,1,,CHEMBL628464,,BAO_0000218,,
10377,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,N,A,1,Intermediate,1,,CHEMBL626239,,BAO_0000218,,
10378,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,N,A,1,Intermediate,1,,CHEMBL626240,,BAO_0000218,,
10379,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,N,A,1,Intermediate,1,,CHEMBL626241,,BAO_0000218,,
10380,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,N,A,1,Intermediate,1,,CHEMBL626242,,BAO_0000218,,
10381,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,N,A,1,Intermediate,1,,CHEMBL626243,,BAO_0000218,,
10382,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,A,1,Intermediate,1,,CHEMBL626244,,BAO_0000218,,
10383,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,N,A,1,Intermediate,1,,CHEMBL626907,,BAO_0000218,,
10384,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,A,1,Intermediate,1,,CHEMBL626908,,BAO_0000218,,
10385,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,A,1,Intermediate,1,,CHEMBL626909,,BAO_0000218,,
10386,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,A,1,Intermediate,1,,CHEMBL626910,,BAO_0000218,,
10387,,Rattus norvegicus,Percent total excretion of acetaminophen cysteine conjugate,N,F,1,Intermediate,1,,CHEMBL875342,,BAO_0000218,,
10388,,Rattus norvegicus,Percent total excretion of acetaminophen glucuronide,N,F,1,Intermediate,1,,CHEMBL626911,,BAO_0000218,,
10389,,Rattus norvegicus,Percent total excretion of acetaminophen sulfate,N,F,1,Intermediate,1,,CHEMBL626912,,BAO_0000218,,
10390,,Rattus norvegicus,Percent total excretion of acetaminophen-mercapturic acid,N,F,1,Intermediate,1,,CHEMBL627065,,BAO_0000218,,
10391,,Rattus norvegicus,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,N,A,1,Intermediate,1,,CHEMBL627066,,BAO_0000218,1088.0,
10392,,Rattus norvegicus,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL627067,,BAO_0000218,,
10393,,ratrat,Biodistribution of compound in rat muscle after 5 min of administration,U,A,0,Autocuration,1,,CHEMBL627068,,BAO_0000218,2385.0,
10394,,ratrat,Biodistribution of compound in rat muscle after 5 min of administration.,U,A,0,Autocuration,1,,CHEMBL627069,,BAO_0000218,2385.0,
10395,,Ovis aries,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,A,0,Autocuration,1,,CHEMBL627070,,BAO_0000218,,
10396,,Ovis aries,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,A,0,Autocuration,1,,CHEMBL627071,,BAO_0000218,,
10397,,Ovis aries,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,A,0,Autocuration,1,,CHEMBL627072,,BAO_0000218,,
10398,,Ovis aries,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,A,0,Autocuration,1,,CHEMBL627073,,BAO_0000218,,
10399,,Ovis aries,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,A,0,Autocuration,1,,CHEMBL625387,,BAO_0000218,,
10400,,Ovis aries,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,A,0,Autocuration,1,,CHEMBL625388,,BAO_0000218,,
10401,,Ovis aries,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,A,0,Autocuration,1,,CHEMBL625389,,BAO_0000218,1969.0,
10402,,Ovis aries,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,A,0,Autocuration,1,,CHEMBL875343,,BAO_0000218,1969.0,
10403,,Serpentes,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),N,A,1,Intermediate,1,,CHEMBL876795,,BAO_0000218,,
10404,,Serpentes,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,N,A,1,Intermediate,1,,CHEMBL626552,,BAO_0000218,,
10405,,Serpentes,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,N,A,1,Intermediate,1,,CHEMBL626553,,BAO_0000218,,
10406,,Homo sapiens,The human biological plasma half life of the compound,U,A,0,Autocuration,1,,CHEMBL626554,,BAO_0000366,1969.0,
10407,,Rattus norvegicus,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,A,1,Intermediate,1,,CHEMBL626555,,BAO_0000218,1088.0,
10408,,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,N,A,1,Intermediate,1,,CHEMBL626556,,BAO_0000218,,
10409,,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL626557,,BAO_0000218,,
10410,,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,N,A,1,Intermediate,1,,CHEMBL626558,,BAO_0000218,,
10411,,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL626559,,BAO_0000218,,
10412,,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL626560,,BAO_0000218,,
10413,,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL876803,,BAO_0000218,,
10414,,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,N,A,1,Intermediate,1,,CHEMBL627964,,BAO_0000218,,
10415,,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL627965,,BAO_0000218,,
10416,,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,N,A,1,Intermediate,1,,CHEMBL627966,,BAO_0000218,,
10417,,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL627967,,BAO_0000218,,
10418,,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL627968,,BAO_0000218,,
10419,,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL627969,,BAO_0000218,,
10420,,Rattus norvegicus,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL627970,,BAO_0000218,,
10421,,Rattus norvegicus,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL627971,,BAO_0000218,178.0,
10422,,Rattus norvegicus,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,N,A,1,Intermediate,1,,CHEMBL627972,,BAO_0000218,178.0,
10423,,Homo sapiens,Dissociation constant against binding to human cyclophilin A,D,B,9,Expert,1,,CHEMBL856029,,BAO_0000357,,
10424,,Bos taurus,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,H,B,8,Expert,1,,CHEMBL627973,,BAO_0000019,,
10425,,,-Log C was determined by performing the electroshock minimum test,U,A,0,Autocuration,1,,CHEMBL627974,,BAO_0000019,,
10426,,,-Log C was determined by performing the foot shock test,U,A,0,Autocuration,1,,CHEMBL627975,,BAO_0000019,,
10427,,,-Log C was determined by performing the incl screen test,U,A,0,Autocuration,1,,CHEMBL627976,,BAO_0000019,,
10428,,,-Log C was determined by performing the maximum electroshock test,U,A,0,Autocuration,1,,CHEMBL627977,,BAO_0000019,,
10429,,,-Log C was determined by performing the pentylenetetrazole test,U,A,0,Autocuration,1,,CHEMBL627978,,BAO_0000019,,
10430,,,Tested for experimental arotinoid inhibitory dose,U,A,0,Autocuration,1,,CHEMBL627979,,BAO_0000019,,
10431,,,Negative log transformed activity,U,A,0,Autocuration,1,,CHEMBL876804,,BAO_0000019,,
10432,,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",U,A,0,Autocuration,1,,CHEMBL627980,,BAO_0000019,,
10433,,Cavia porcellus,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,N,A,1,Intermediate,1,,CHEMBL627981,,BAO_0000218,,
10434,,Cavia porcellus,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,N,A,1,Intermediate,1,,CHEMBL627982,,BAO_0000218,,
10435,,Cavia porcellus,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,N,A,1,Intermediate,1,,CHEMBL627983,,BAO_0000218,,
10436,,Cavia porcellus,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,N,A,1,Intermediate,1,,CHEMBL627984,,BAO_0000218,2116.0,
10437,,,Solubility in water was determined; values expressed as -log,U,P,0,Autocuration,1,,CHEMBL627985,,BAO_0000100,,
10438,,,Ratio of Kcat to that of Km was determined,U,A,0,Autocuration,1,,CHEMBL627986,,BAO_0000019,,
10439,,,Observed first order rate constant,U,A,0,Autocuration,1,,CHEMBL627987,,BAO_0000019,,
10440,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,U,A,0,Autocuration,1,,CHEMBL627988,,BAO_0000019,,
10441,,Rattus norvegicus,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,N,A,1,Intermediate,1,,CHEMBL627989,,BAO_0000218,,
10442,,Rattus norvegicus,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,N,A,1,Intermediate,1,,CHEMBL627990,,BAO_0000218,,
10443,,Rattus norvegicus,Oral Bioavailability after administration of 10 mg/kg in male rat,N,A,1,Intermediate,1,,CHEMBL876805,,BAO_0000218,,
10444,,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL627991,,BAO_0000218,,
10445,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL627992,,BAO_0000218,,
10446,,Rattus norvegicus,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,A,1,Intermediate,1,,CHEMBL627993,,BAO_0000218,,
10447,,Rattus norvegicus,Oral bioavailability at 1 mg/kg was determined in rat,N,A,1,Intermediate,1,,CHEMBL622817,,BAO_0000218,,
10448,,Rattus norvegicus,Oral bioavailability at 10 mg/kg was determined in rat,N,A,1,Intermediate,1,,CHEMBL622818,,BAO_0000218,,
10449,,Rattus norvegicus,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",N,A,1,Intermediate,1,,CHEMBL622819,,BAO_0000218,,
10450,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL872267,,BAO_0000218,,
10451,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622820,,BAO_0000218,,
10452,,Rattus norvegicus,Oral bioavailability after intravenous administration in rats at 24 uM/kg,N,A,1,Intermediate,1,,CHEMBL622821,,BAO_0000218,,
10453,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622822,,BAO_0000218,,
10454,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622823,,BAO_0000218,,
10455,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622824,,BAO_0000218,,
10456,,Rattus norvegicus,Oral bioavailability in rat at a dose of 3 mg/kg,N,A,1,Intermediate,1,,CHEMBL622825,,BAO_0000218,,
10457,,Rattus norvegicus,Oral bioavailability in rat after oral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL622901,,BAO_0000218,,
10458,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622902,,BAO_0000218,,
10459,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL621844,,BAO_0000218,,
10460,,Rattus norvegicus,Oral bioavailability in Dawley rats,N,A,1,Intermediate,1,,CHEMBL621845,,BAO_0000218,,
10461,,Rattus norvegicus,Oral bioavailability,N,A,1,Intermediate,1,,CHEMBL621846,,BAO_0000218,,
10462,,Rattus norvegicus,Oral bioavailability in rat (dose 30 mg/kg),N,A,1,Intermediate,1,,CHEMBL621847,,BAO_0000218,,
10463,,Rattus norvegicus,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,A,1,Intermediate,1,,CHEMBL877609,,BAO_0000218,,
10464,,Rattus norvegicus,Bioavailability in rat (dose 3 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL621848,,BAO_0000218,,
10465,,Rattus norvegicus,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,A,1,Intermediate,1,,CHEMBL621849,,BAO_0000218,,
10466,,Rattus norvegicus,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL622030,,BAO_0000218,,
10467,,Rattus norvegicus,Percent oral bioavailability determined in rats,N,A,1,Intermediate,1,,CHEMBL622031,,BAO_0000218,,
10468,,Rattus norvegicus,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,A,1,Intermediate,1,,CHEMBL622032,,BAO_0000218,,
10469,,Rattus norvegicus,The compound was evaluated for bioavailability in rats; 32-51,N,A,1,Intermediate,1,,CHEMBL622033,,BAO_0000218,,
10470,,Rattus norvegicus,Bioavailability in rat (dose 20 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL622034,,BAO_0000218,,
10471,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622035,,BAO_0000218,,
10472,,Rattus norvegicus,Bioavailability percent in rat at the dose of 2 mg/kg,N,A,1,Intermediate,1,,CHEMBL882966,,BAO_0000218,,
10473,,Rattus norvegicus,Bioavailability was evaluated after 20 uM/kg of peroral administration,N,A,1,Intermediate,1,,CHEMBL622036,,BAO_0000218,,
10474,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622037,,BAO_0000218,,
10475,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622038,,BAO_0000218,,
10476,,Rattus norvegicus,Bioavailability in rats,N,A,1,Intermediate,1,,CHEMBL622039,,BAO_0000218,,
10477,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622040,,BAO_0000218,178.0,
10478,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622041,,BAO_0000218,178.0,
10479,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622042,,BAO_0000218,178.0,
10480,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622043,,BAO_0000218,178.0,
10481,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622044,,BAO_0000218,178.0,
10482,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622045,,BAO_0000218,10000001.0,
10483,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622046,,BAO_0000218,10000001.0,
10484,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622047,,BAO_0000218,10000001.0,
10485,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL877610,,BAO_0000218,10000001.0,
10486,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622048,,BAO_0000218,955.0,
10487,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622049,,BAO_0000218,955.0,
10488,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622050,,BAO_0000218,955.0,
10489,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622051,,BAO_0000218,955.0,
10490,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622052,,BAO_0000218,,
10491,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622053,,BAO_0000218,,
10492,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622054,,BAO_0000218,,
10493,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622055,,BAO_0000218,,
10494,,Rattus norvegicus,Oral bioavailability in rats was determined; High,N,A,1,Intermediate,1,,CHEMBL622056,,BAO_0000218,,
10495,,Rattus norvegicus,Oral bioavailability in the rat was determined,N,A,1,Intermediate,1,,CHEMBL622057,,BAO_0000218,,
10496,,Rattus norvegicus,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,N,A,1,Intermediate,1,,CHEMBL628008,,BAO_0000218,,
10497,,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL622058,,BAO_0000218,,
10498,,Rattus norvegicus,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL622059,,BAO_0000218,,
10499,,Rattus norvegicus,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL622060,,BAO_0000218,,
10500,,Rattus norvegicus,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL622061,,BAO_0000218,,
10501,,Rattus norvegicus,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,A,1,Intermediate,1,,CHEMBL622062,,BAO_0000218,,
10502,,Rattus norvegicus,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,N,A,1,Intermediate,1,,CHEMBL622063,,BAO_0000218,,
10503,,Rattus norvegicus,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,N,A,1,Expert,1,,CHEMBL877611,,BAO_0000218,,
10504,,Rattus norvegicus,Oral bioavailability of compound in Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL622064,,BAO_0000218,,
10505,,Rattus norvegicus,Oral bioavailability of compound in rat,N,A,1,Intermediate,1,,CHEMBL622065,,BAO_0000218,,
10506,,Rattus norvegicus,Oral bioavailability in rat (dose 2 mg/kg),N,A,1,Intermediate,1,,CHEMBL622066,,BAO_0000218,,
10507,,Rattus norvegicus,Oral bioavailability of compound in rat was determined,N,A,1,Intermediate,1,,CHEMBL622067,,BAO_0000218,,
10508,,Rattus norvegicus,Oral bioavailability of compound in rats,N,A,1,Intermediate,1,,CHEMBL622068,,BAO_0000218,,
10509,,Rattus norvegicus,Oral bioavailability of compound was determined in rats,N,A,1,Intermediate,1,,CHEMBL622069,,BAO_0000218,,
10510,,Rattus norvegicus,Oral bioavailability at a dose of 30 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL624796,,BAO_0000218,,
10511,,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg),N,A,1,Intermediate,1,,CHEMBL624797,,BAO_0000218,,
10512,,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg),N,A,1,Intermediate,1,,CHEMBL623053,,BAO_0000218,,
10513,,Rattus norvegicus,Oral bioavailability evaluated in rat,N,A,1,Intermediate,1,,CHEMBL623054,,BAO_0000218,,
10514,,Rattus norvegicus,Oral bioavailability in fasted rat,N,A,1,Intermediate,1,,CHEMBL623055,,BAO_0000218,,
10515,,Rattus norvegicus,Oral bioavailability in fed rat,N,A,1,Intermediate,1,,CHEMBL623056,,BAO_0000218,,
10516,,Rattus norvegicus,Oral bioavailability in rat (mature male) (dose 30 mg/kg),N,A,1,Intermediate,1,,CHEMBL623057,,BAO_0000218,,
10517,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623058,,BAO_0000218,,
10518,,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL623059,,BAO_0000218,,
10519,,Rattus norvegicus,Oral bioavailability in rat after administration of 10 mg/kg po,N,A,1,Intermediate,1,,CHEMBL623060,,BAO_0000218,,
10520,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623061,,BAO_0000218,,
10521,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623062,,BAO_0000218,,
10522,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623063,,BAO_0000218,,
10523,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623064,,BAO_0000218,,
10524,,Rattus norvegicus,Oral bioavailability in ratrs,N,A,1,Intermediate,1,,CHEMBL623065,,BAO_0000218,,
10525,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623066,,BAO_0000218,,
10526,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623067,,BAO_0000218,,
10527,,Rattus norvegicus,Oral bioavailability in rats was determined; High,N,A,1,Intermediate,1,,CHEMBL623068,,BAO_0000218,,
10528,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623069,,BAO_0000218,,
10529,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623070,,BAO_0000218,,
10530,,Rattus norvegicus,Oral bioavailability was calculated in rat,N,A,1,Intermediate,1,,CHEMBL623071,,BAO_0000218,,
10531,,Rattus norvegicus,Oral bioavailability,N,A,1,Intermediate,1,,CHEMBL623072,,BAO_0000218,,
10532,,Rattus norvegicus,Oral bioavailability,N,A,1,Intermediate,1,,CHEMBL623073,,BAO_0000218,,
10533,,Rattus norvegicus,Oral bioavailability,N,A,1,Intermediate,1,,CHEMBL623074,,BAO_0000218,,
10534,,Rattus norvegicus,Oral bioavailability,N,A,1,Intermediate,1,,CHEMBL623075,,BAO_0000218,,
10535,,Rattus norvegicus,Oral bioavailability after i.v. administration,N,A,1,Intermediate,1,,CHEMBL623076,,BAO_0000218,,
10536,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL623077,,BAO_0000218,,
10537,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley),N,A,1,Intermediate,1,,CHEMBL623078,,BAO_0000218,,
10538,,Rattus norvegicus,Oral bioavailability in Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL623079,,BAO_0000218,,
10539,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL623080,,BAO_0000218,,
10540,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,A,1,Intermediate,1,,CHEMBL623081,,BAO_0000218,,
10541,,Rattus norvegicus,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,N,A,1,Intermediate,1,,CHEMBL623082,,BAO_0000218,,
10542,,Rattus norvegicus,Oral bioavailability in fasted rat,N,A,1,Intermediate,1,,CHEMBL874400,,BAO_0000218,,
10543,,Rattus norvegicus,Oral bioavailability in fed rat,N,A,1,Intermediate,1,,CHEMBL623083,,BAO_0000218,,
10544,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623084,,BAO_0000218,,
10545,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623085,,BAO_0000218,,
10546,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623086,,BAO_0000218,,
10547,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623087,,BAO_0000218,,
10548,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623088,,BAO_0000218,,
10549,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623089,,BAO_0000218,,
10550,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623090,,BAO_0000218,,
10551,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623091,,BAO_0000218,,
10552,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623092,,BAO_0000218,,
10553,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623093,,BAO_0000218,,
10554,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL874401,,BAO_0000218,,
10555,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623094,,BAO_0000218,,
10556,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL623095,,BAO_0000218,,
10557,,Rattus norvegicus,Oral bioavailability in rat after peroral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL623096,,BAO_0000218,,
10558,,Rattus norvegicus,Oral bioavailability in rat after peroral administration at 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL624913,,BAO_0000218,,
10559,,Rattus norvegicus,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL624914,,BAO_0000218,,
10560,,Rattus norvegicus,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,N,A,1,Intermediate,1,,CHEMBL624915,,BAO_0000218,,
10561,,Rattus norvegicus,Oral bioavailability in rat; Not measured,N,A,1,Intermediate,1,,CHEMBL624916,,BAO_0000218,,
10562,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL624917,,BAO_0000218,,
10563,,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,N,A,1,Intermediate,1,,CHEMBL625157,,BAO_0000218,,
10564,,Rattus norvegicus,In vitro metabolic potential in rat liver microsomes,N,A,1,Intermediate,1,,CHEMBL625158,,BAO_0000218,2107.0,
10565,,Rattus norvegicus,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",N,A,1,Intermediate,1,,CHEMBL625159,,BAO_0000218,,
10566,,Rattus norvegicus,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",N,A,1,Intermediate,1,,CHEMBL625160,,BAO_0000218,,
10567,,Rattus norvegicus,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,N,A,1,Intermediate,1,,CHEMBL625161,,BAO_0000218,,
10568,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL625162,,BAO_0000218,,
10569,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL625163,,BAO_0000218,,
10570,,Rattus norvegicus,Oral bioavailability in rats at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL625164,,BAO_0000218,,
10571,,Rattus norvegicus,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,A,1,Intermediate,1,,CHEMBL625165,,BAO_0000218,,
10572,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL625166,,BAO_0000218,,
10573,,Rattus norvegicus,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,N,A,1,Intermediate,1,,CHEMBL625167,,BAO_0000218,,
10574,,Rattus norvegicus,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,N,A,1,Intermediate,1,,CHEMBL625168,,BAO_0000218,,
10575,,Rattus norvegicus,Plasma clearance of the compound,N,A,1,Intermediate,1,,CHEMBL625169,,BAO_0000218,,
10576,,Rattus norvegicus,Plasma clearance at 10 mg/kg in rat upon intravenous administration,N,A,1,Intermediate,1,,CHEMBL626264,,BAO_0000218,,
10577,,Rattus norvegicus,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,N,A,1,Intermediate,1,,CHEMBL626265,,BAO_0000218,,
10578,,Rattus norvegicus,The compound was tested for plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL626266,,BAO_0000218,1969.0,
10579,,Rattus norvegicus,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,N,A,1,Intermediate,1,,CHEMBL626267,,BAO_0000218,1969.0,
10580,,Rattus norvegicus,Plasma concentration upon oral administration of 1 mg/Kg in rats,N,A,1,Intermediate,1,,CHEMBL626268,,BAO_0000218,,
10581,,Rattus norvegicus,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,N,A,1,Intermediate,1,,CHEMBL626269,,BAO_0000218,,
10582,,Rattus norvegicus,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,N,A,1,Intermediate,1,,CHEMBL626270,,BAO_0000218,,
10583,,Rattus norvegicus,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL626271,,BAO_0000218,,
10584,,Rattus norvegicus,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",N,A,1,Intermediate,1,,CHEMBL626272,,BAO_0000218,,
10585,,Rattus norvegicus,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,A,1,Intermediate,1,,CHEMBL626273,,BAO_0000218,,
10586,,Rattus norvegicus,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,A,1,Intermediate,1,,CHEMBL875346,,BAO_0000218,,
10587,,Rattus norvegicus,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",N,A,1,Intermediate,1,,CHEMBL626274,,BAO_0000218,,
10588,,Rattus norvegicus,Compound was tested for protein binding in rat plasma,N,A,1,Intermediate,1,,CHEMBL626275,,BAO_0000218,,
10589,,Rattus norvegicus,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,N,A,1,Intermediate,1,,CHEMBL624646,,BAO_0000218,,
10590,,Rattus norvegicus,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,N,A,1,Intermediate,1,,CHEMBL624647,,BAO_0000218,,
10591,,Rattus norvegicus,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,N,A,1,Intermediate,1,,CHEMBL624648,,BAO_0000218,2107.0,
10592,,Rattus norvegicus,Area under curve ratio was determined (po/iv) in rat,N,A,1,Intermediate,1,,CHEMBL624649,,BAO_0000218,,
10593,,Rattus norvegicus,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL624650,,BAO_0000218,,
10594,,Rattus norvegicus,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL624651,,BAO_0000218,,
10595,,Rattus norvegicus,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL624652,,BAO_0000218,,
10596,,Rattus norvegicus,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL624653,,BAO_0000218,,
10597,,Rattus norvegicus,Ratio of AUCbrain to AUCplasma,N,A,1,Intermediate,1,,CHEMBL624654,,BAO_0000218,,
10598,,Rattus norvegicus,Ratio of brain to plasma,N,A,1,Intermediate,1,,CHEMBL624655,,BAO_0000218,,
10599,,Rattus norvegicus,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,N,A,1,Intermediate,1,,CHEMBL624656,,BAO_0000218,,
10600,,Rattus norvegicus,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,A,1,Intermediate,1,,CHEMBL624657,,BAO_0000218,,
10601,,Rattus norvegicus,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,A,1,Intermediate,1,,CHEMBL624658,,BAO_0000218,,
10602,,Rattus norvegicus,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,N,A,1,Intermediate,1,,CHEMBL624659,,BAO_0000218,,
10603,,Rattus norvegicus,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,N,A,1,Intermediate,1,,CHEMBL624660,,BAO_0000218,,
10604,,Rattus norvegicus,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,N,A,1,Intermediate,1,,CHEMBL624661,,BAO_0000218,,
10605,,Rattus norvegicus,Steady state brain :blood ratio was determined,N,A,1,Intermediate,1,,CHEMBL624662,,BAO_0000218,,
10606,,Rattus norvegicus,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL625199,,BAO_0000218,,
10607,,Rattus norvegicus,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,A,1,Intermediate,1,,CHEMBL625200,,BAO_0000218,,
10608,,Rattus norvegicus,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,A,1,Intermediate,1,,CHEMBL625201,,BAO_0000218,,
10609,,Rattus norvegicus,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,A,1,Intermediate,1,,CHEMBL625202,,BAO_0000218,,
10610,,Rattus norvegicus,Percentage recovery after 3h incubation with rat hapatocytes was determined,N,A,1,Intermediate,1,,CHEMBL625203,,BAO_0000218,,
10611,,Rattus norvegicus,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,N,A,1,Intermediate,1,,CHEMBL625204,,BAO_0000218,,
10612,,Rattus norvegicus,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,N,A,1,Intermediate,1,,CHEMBL625205,,BAO_0000218,,
10613,,Rattus norvegicus,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL625206,,BAO_0000218,,
10614,,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",U,A,0,Autocuration,1,,CHEMBL625207,,BAO_0000019,,
10615,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,U,A,0,Autocuration,1,,CHEMBL625208,,BAO_0000019,,
10616,,Homo sapiens,In vivo absorption in Caco-2 cell line monolayers was determined,N,A,1,Intermediate,1,,CHEMBL625209,495.0,BAO_0000218,,
10617,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625210,,BAO_0000100,,
10618,,Rattus norvegicus,Area under curve was determine after peroral administration at 10 mpk in Rat,N,A,1,Intermediate,1,,CHEMBL625211,,BAO_0000218,,
10619,,Macaca mulatta,Area under curve was determine after peroral administration at 10 mpk in Rhesus,N,A,1,Intermediate,1,,CHEMBL625212,,BAO_0000218,,
10620,,Rattus norvegicus,Area under curve was determine after peroral administration at 160 mpk in Rat,N,A,1,Intermediate,1,,CHEMBL625213,,BAO_0000218,,
10621,,Rattus norvegicus,Area under curve was determine after peroral administration at 20 mpk in Rat,N,A,1,Intermediate,1,,CHEMBL625214,,BAO_0000218,,
10622,,Rattus norvegicus,Area under curve was determine after peroral administration at 50 mpk in Rat,N,A,1,Intermediate,1,,CHEMBL874542,,BAO_0000218,,
10623,,,Calculated partition coefficient (clogP) (AlogP),U,P,0,Autocuration,1,,CHEMBL625215,,BAO_0000100,,
10624,,,Activated partial thromboplastin time measured,U,A,0,Autocuration,1,,CHEMBL625216,,BAO_0000019,,
10625,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),U,P,0,Autocuration,1,,CHEMBL625217,,BAO_0000100,,
10626,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),U,P,0,Autocuration,1,,CHEMBL625218,,BAO_0000100,,
10627,,Canis lupus familiaris,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,N,A,1,Intermediate,1,,CHEMBL622864,,BAO_0000218,1969.0,
10628,,Rattus norvegicus,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,N,A,1,Intermediate,1,,CHEMBL622865,,BAO_0000218,1969.0,
10629,,Rattus norvegicus,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,N,A,1,Intermediate,1,,CHEMBL622866,,BAO_0000218,1969.0,
10630,,Canis lupus familiaris,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,N,A,1,Intermediate,1,,CHEMBL622867,,BAO_0000218,1969.0,
10631,,Cavia porcellus,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,N,A,1,Intermediate,1,,CHEMBL876808,,BAO_0000218,1969.0,
10632,,,AUC in brain,U,A,0,Autocuration,1,,CHEMBL627725,,BAO_0000019,955.0,
10633,,,AUC in serum,U,A,0,Autocuration,1,,CHEMBL627726,,BAO_0000019,1977.0,
10634,,,AUC was determined,U,A,0,Autocuration,1,,CHEMBL627727,,BAO_0000019,1969.0,
10635,,,AUC of the compound.,U,A,0,Autocuration,1,,CHEMBL627728,,BAO_0000019,1969.0,
10636,,,AUC value (0-4 hr),U,A,0,Autocuration,1,,CHEMBL627729,,BAO_0000019,1969.0,
10637,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",U,A,0,Autocuration,1,,CHEMBL627730,,BAO_0000019,1969.0,
10638,,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,U,A,0,Autocuration,1,,CHEMBL627731,,BAO_0000019,1969.0,
10639,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",U,A,0,Autocuration,1,,CHEMBL627732,,BAO_0000019,1969.0,
10640,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",U,A,0,Autocuration,1,,CHEMBL627733,,BAO_0000019,1969.0,
10641,,Rattus norvegicus,AUC(area under curve) was determined after intravenous administration in rats,N,A,1,Intermediate,1,,CHEMBL627734,,BAO_0000218,1969.0,
10642,,Rattus norvegicus,AUC(area under curve) was determined after oral administration in rats,N,A,1,Intermediate,1,,CHEMBL627735,,BAO_0000218,1969.0,
10643,,Cavia porcellus,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,N,A,1,Intermediate,1,,CHEMBL627736,,BAO_0000218,1969.0,
10644,,Rattus norvegicus,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,N,A,1,Intermediate,1,,CHEMBL876809,,BAO_0000218,1969.0,
10645,,,Area Under Curve after oral dosing of 100 uM/Kg,U,A,0,Autocuration,1,,CHEMBL627737,,BAO_0000019,,
10646,,,Area Under Curve after oral dosing of 30 uM/Kg,U,A,0,Autocuration,1,,CHEMBL627738,,BAO_0000019,,
10647,,,Area Under Curve was measured by ploting the graph between concentration verses time,U,A,0,Autocuration,1,,CHEMBL627739,,BAO_0000019,,
10648,,Canis lupus familiaris,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,N,A,1,Intermediate,1,,CHEMBL626143,,BAO_0000218,,
10649,,Simiiformes,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL626144,,BAO_0000218,,
10650,,Oryctolagus cuniculus,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,N,A,1,Intermediate,1,,CHEMBL626145,,BAO_0000218,,
10651,,Rattus norvegicus,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,N,A,1,Intermediate,1,,CHEMBL626146,,BAO_0000218,,
10652,,Rattus norvegicus,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,N,A,1,Intermediate,1,,CHEMBL626147,,BAO_0000218,178.0,
10653,,,Area under curve (AUC) was determined,U,A,0,Autocuration,1,,CHEMBL626148,,BAO_0000019,,
10654,,,Area under curve (AUC) following ip administration at 1 mg/kg,U,A,0,Autocuration,1,,CHEMBL626149,,BAO_0000218,,
10655,,,Area under curve (AUC) was determined; ND is Not determined,U,A,0,Autocuration,1,,CHEMBL626150,,BAO_0000019,,
10656,,Canis lupus familiaris,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL626151,,BAO_0000218,,
10657,,Canis lupus familiaris,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL626152,,BAO_0000218,,
10658,,Canis lupus familiaris,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL626153,,BAO_0000218,,
10659,,,Area under curve (AUR) was determined,U,A,0,Autocuration,1,,CHEMBL626154,,BAO_0000019,,
10660,,,Area under curve at 1 uM/dg administered intravenously,U,A,0,Autocuration,1,,CHEMBL626155,,BAO_0000019,,
10661,,,Area under curve at 10 uM/dg administered perorally,U,A,0,Autocuration,1,,CHEMBL626156,,BAO_0000019,,
10662,,,Area under curve at 2 uM/dg administered intravenously,U,A,0,Autocuration,1,,CHEMBL626157,,BAO_0000019,,
10663,,,Area under curve at 20 uM/dg administered perorally,U,A,0,Autocuration,1,,CHEMBL626158,,BAO_0000019,,
10664,,Canis lupus familiaris,Area under curve at a peroral dose of 3 mg/kg in dog,N,A,1,Intermediate,1,,CHEMBL626159,,BAO_0000218,,
10665,,Rattus norvegicus,Area under curve at a peroral dose of 3 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL626160,,BAO_0000218,,
10666,,Canis lupus familiaris,Area under curve at an iv dose of 1 mg/kg in dog,N,A,1,Intermediate,1,,CHEMBL626161,,BAO_0000218,,
10667,,Rattus norvegicus,Area under curve at an iv dose of 1 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL626162,,BAO_0000218,,
10668,,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,U,A,0,Autocuration,1,,CHEMBL626163,,BAO_0000019,,
10669,,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,U,A,0,Autocuration,1,,CHEMBL626164,,BAO_0000019,,
10670,,Mus musculus,Area under curve measured as conc vs time after intravenous administration to mice.,N,A,1,Intermediate,1,,CHEMBL626165,,BAO_0000218,,
10671,,Mus musculus,Area under curve measured as conc vs time after peroral administration to mice.,N,A,1,Intermediate,1,,CHEMBL626166,,BAO_0000218,,
10672,,Canis lupus familiaris,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,A,1,Intermediate,1,,CHEMBL626167,,BAO_0000218,,
10673,,Canis lupus familiaris,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,N,A,1,Intermediate,1,,CHEMBL626168,,BAO_0000218,,
10674,,Canis lupus familiaris,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,N,A,1,Intermediate,1,,CHEMBL877463,,BAO_0000218,,
10675,,Canis lupus familiaris,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,N,A,1,Intermediate,1,,CHEMBL626169,,BAO_0000218,,
10676,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL626170,,BAO_0000218,948.0,
10677,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL626171,,BAO_0000218,948.0,
10678,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL626172,,BAO_0000218,948.0,
10679,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL626173,,BAO_0000218,948.0,
10680,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL626174,,BAO_0000218,2113.0,
10681,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL626175,,BAO_0000218,2113.0,
10682,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL626176,,BAO_0000218,2113.0,
10683,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL626177,,BAO_0000218,2113.0,
10684,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622499,,BAO_0000218,2113.0,
10685,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622500,,BAO_0000218,2107.0,
10686,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622501,,BAO_0000218,2107.0,
10687,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622502,,BAO_0000218,2107.0,
10688,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL622503,,BAO_0000218,2107.0,
10689,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL877614,,BAO_0000218,2107.0,
10690,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL624839,,BAO_0000218,2048.0,
10691,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL624840,,BAO_0000218,2048.0,
10692,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL624841,,BAO_0000218,2048.0,
10693,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL624842,,BAO_0000218,2048.0,
10694,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL624843,,BAO_0000218,2385.0,
10695,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL624844,,BAO_0000218,2385.0,
10696,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL624845,,BAO_0000218,2385.0,
10697,,Rattus norvegicus,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,N,A,1,Intermediate,1,,CHEMBL621904,,BAO_0000218,2385.0,
10698,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL621905,,BAO_0000218,178.0,
10699,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL874382,,BAO_0000218,178.0,
10700,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL621906,,BAO_0000218,178.0,
10701,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL621907,,BAO_0000218,955.0,
10702,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622096,,BAO_0000218,955.0,
10703,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622097,,BAO_0000218,955.0,
10704,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622098,,BAO_0000218,948.0,
10705,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622099,,BAO_0000218,948.0,
10706,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622100,,BAO_0000218,948.0,
10707,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622101,,BAO_0000218,2113.0,
10708,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622102,,BAO_0000218,2113.0,
10709,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622103,,BAO_0000218,2113.0,
10710,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622104,,BAO_0000218,2107.0,
10711,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622105,,BAO_0000218,2107.0,
10712,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622106,,BAO_0000218,2107.0,
10713,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622107,,BAO_0000218,2048.0,
10714,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622108,,BAO_0000218,2048.0,
10715,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622109,,BAO_0000218,2048.0,
10716,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622110,,BAO_0000218,2385.0,
10717,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622111,,BAO_0000218,2385.0,
10718,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL874383,,BAO_0000218,2385.0,
10719,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622112,,BAO_0000218,14.0,
10720,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622113,,BAO_0000218,14.0,
10721,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622114,,BAO_0000218,14.0,
10722,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622115,,BAO_0000218,2106.0,
10723,,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,N,A,1,Intermediate,1,,CHEMBL622116,,BAO_0000218,2106.0,
10724,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622117,,BAO_0000218,,
10725,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622118,,BAO_0000218,,
10726,,Rattus norvegicus,Oral bioavailability in rats at 6 mg/kg,N,A,1,Intermediate,1,,CHEMBL622119,,BAO_0000218,,
10727,,Rattus norvegicus,Oral bioavailability in rat (dose 6 mg/kg),N,A,1,Intermediate,1,,CHEMBL622120,,BAO_0000218,,
10728,,Rattus norvegicus,Oral bioavailability in rats at 6 mg/kg dose; Not tested,N,A,1,Intermediate,1,,CHEMBL622121,,BAO_0000218,,
10729,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622122,,BAO_0000218,,
10730,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622123,,BAO_0000218,,
10731,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622124,,BAO_0000218,,
10732,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL622125,,BAO_0000218,,
10733,,Rattus norvegicus,Oral bioavailability,N,A,1,Intermediate,1,,CHEMBL622126,,BAO_0000218,,
10734,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,A,1,Intermediate,1,,CHEMBL620455,,BAO_0000218,,
10735,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL620456,,BAO_0000218,,
10736,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL620457,,BAO_0000218,,
10737,,Rattus norvegicus,Oral bioavailability was evaluated; Not tested,N,A,1,Intermediate,1,,CHEMBL620458,,BAO_0000218,,
10738,,Rattus norvegicus,Oral bioavailability,N,A,1,Intermediate,1,,CHEMBL620459,,BAO_0000218,,
10739,,Rattus norvegicus,Oral bioavailability in rat by oral dosing,N,A,1,Intermediate,1,,CHEMBL620460,,BAO_0000218,,
10740,,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL620461,,BAO_0000218,,
10741,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley),N,A,1,Intermediate,1,,CHEMBL620462,,BAO_0000218,,
10742,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL620463,,BAO_0000218,,
10743,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL620464,,BAO_0000218,,
10744,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,A,1,Intermediate,1,,CHEMBL620465,,BAO_0000218,,
10745,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL620466,,BAO_0000218,,
10746,,Rattus norvegicus,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL620467,,BAO_0000218,,
10747,,Rattus norvegicus,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,N,A,1,Intermediate,1,,CHEMBL620468,,BAO_0000218,,
10748,,Rattus norvegicus,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,N,A,1,Intermediate,1,,CHEMBL620469,,BAO_0000218,,
10749,,Rattus norvegicus,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,N,A,1,Intermediate,1,,CHEMBL620470,,BAO_0000218,,
10750,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL620471,,BAO_0000218,,
10751,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL620472,,BAO_0000218,,
10752,,Rattus norvegicus,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,N,A,1,Intermediate,1,,CHEMBL620473,,BAO_0000218,,
10753,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL620474,,BAO_0000218,,
10754,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),N,A,1,Intermediate,1,,CHEMBL620475,,BAO_0000218,,
10755,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL620476,,BAO_0000218,,
10756,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL620477,,BAO_0000218,,
10757,,Rattus norvegicus,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL620478,,BAO_0000218,,
10758,,Rattus norvegicus,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL618768,,BAO_0000218,,
10759,,Rattus norvegicus,Oral bioavailability in rat after oral administration at 13 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL618769,,BAO_0000218,,
10760,,Rattus norvegicus,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL618770,,BAO_0000218,,
10761,,Rattus norvegicus,Oral bioavailability (dose 20 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL618771,,BAO_0000218,,
10762,,Rattus norvegicus,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL618772,,BAO_0000218,,
10763,,Rattus norvegicus,Oral bioavailability in rat at 10 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL618773,,BAO_0000218,,
10764,,Rattus norvegicus,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,A,1,Intermediate,1,,CHEMBL875842,,BAO_0000218,,
10765,,Rattus norvegicus,Bioavailability in rat (dose 3 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL618774,,BAO_0000218,,
10766,,Rattus norvegicus,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,A,1,Intermediate,1,,CHEMBL618775,,BAO_0000218,,
10767,,Rattus norvegicus,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL618776,,BAO_0000218,,
10768,,Rattus norvegicus,Percent bioavailability (F) in rats after iv administration,N,A,1,Intermediate,1,,CHEMBL618777,,BAO_0000218,,
10769,,Rattus norvegicus,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL618778,,BAO_0000218,,
10770,,Rattus norvegicus,Bioavailability in rat (dose 5 uM/kg p.o.),N,A,1,Intermediate,1,,CHEMBL618779,,BAO_0000218,,
10771,,Rattus norvegicus,Oral bioavailability,N,A,1,Intermediate,1,,CHEMBL618780,,BAO_0000218,,
10772,,Rattus norvegicus,Bioavailability in rat (dose 2 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL618781,,BAO_0000218,,
10773,,Rattus norvegicus,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,N,A,1,Intermediate,1,,CHEMBL618782,,BAO_0000218,,
10774,,Rattus norvegicus,Oral bioavailability in rat (dose 20 mg/kg),N,A,1,Intermediate,1,,CHEMBL618783,,BAO_0000218,,
10775,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL618784,,BAO_0000218,,
10776,,Rattus norvegicus,Percent oral bioavailability evaluated in rat,N,A,1,Intermediate,1,,CHEMBL618785,,BAO_0000218,,
10777,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL618786,,BAO_0000218,,
10778,,Rattus norvegicus,Percent oral bioavailability in rat; Not determined,N,A,1,Intermediate,1,,CHEMBL618787,,BAO_0000218,,
10779,,Rattus norvegicus,Oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL618788,,BAO_0000218,,
10780,,Rattus norvegicus,Bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL618789,,BAO_0000218,,
10781,,Rattus norvegicus,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),N,A,1,Intermediate,1,,CHEMBL618790,,BAO_0000218,,
10782,,Rattus norvegicus,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),N,A,1,Intermediate,1,,CHEMBL618791,,BAO_0000218,,
10783,,Rattus norvegicus,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,N,A,1,Intermediate,1,,CHEMBL875843,,BAO_0000218,,
10784,,Rattus norvegicus,Oral bioavailability in rat (dose 20 mg/kg p.o.),N,A,1,Intermediate,1,,CHEMBL618792,,BAO_0000218,,
10785,,Rattus norvegicus,Cmax at a dose of 30 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL623395,,BAO_0000218,,
10786,,Simiiformes,Cmax in monkeys at a dose of 1 mg/kg,U,A,0,Autocuration,1,,CHEMBL623396,,BAO_0000218,,
10787,,Rattus norvegicus,Cmax in rat,N,A,1,Intermediate,1,,CHEMBL623397,,BAO_0000218,,
10788,,Rattus norvegicus,Cmax in rats at a dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL623398,,BAO_0000218,,
10789,,Mus musculus,Cmax was measured in mice after an oral dose of 50 mg/kg.,N,A,1,Intermediate,1,,CHEMBL623399,,BAO_0000218,,
10790,,,"Cmax value at a dose of 12.7 uM/kg, po",U,A,0,Autocuration,1,,CHEMBL623400,,BAO_0000218,,
10791,,,"Cmax value at a dose of 6.3 uM/kg, iv",U,A,0,Autocuration,1,,CHEMBL623401,,BAO_0000218,,
10792,,,"Cmax value at a dose of 7.1 uM/kg, iv",U,A,0,Autocuration,1,,CHEMBL623402,,BAO_0000218,,
10793,,,Cmax value of compound was determined after 1 hr,U,A,0,Autocuration,1,,CHEMBL623403,,BAO_0000218,,
10794,,,Cmax value of the compound,U,A,0,Autocuration,1,,CHEMBL623404,,BAO_0000218,,
10795,,Rattus norvegicus,Cmax value administered intraintestinal in rats.,N,A,1,Intermediate,1,,CHEMBL625997,,BAO_0000218,,
10796,,Rattus norvegicus,Cmax value administered perorally was determined in rat; Not determined,N,A,1,Intermediate,1,,CHEMBL625998,,BAO_0000218,,
10797,,,Cmax value at the dose of 2.3 mg/kg,U,A,0,Autocuration,1,,CHEMBL625999,,BAO_0000218,,
10798,,,Cmax value at the dose of 5 mg/kg,U,A,0,Autocuration,1,,CHEMBL626000,,BAO_0000218,,
10799,,,Cmax value in the period of 8 hr after dosing. ,U,A,0,Autocuration,1,,CHEMBL626001,,BAO_0000218,,
10800,,,Cmax value at a oral dose of 20 mg/kg; Not tested,U,A,0,Autocuration,1,,CHEMBL626002,,BAO_0000218,,
10801,,,Cmax value at a oral dose of 20 mg/kg,U,A,0,Autocuration,1,,CHEMBL626003,,BAO_0000218,,
10802,,Rattus norvegicus,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,A,1,Intermediate,1,,CHEMBL626004,,BAO_0000218,,
10803,,Cavia porcellus,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,N,A,1,Intermediate,1,,CHEMBL626005,,BAO_0000218,,
10804,,Rattus norvegicus,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,N,A,1,Intermediate,1,,CHEMBL626006,,BAO_0000218,,
10805,,Rattus norvegicus,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,N,A,1,Intermediate,1,,CHEMBL626007,,BAO_0000218,1969.0,
10806,,Mus musculus,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL626008,,BAO_0000218,1969.0,
10807,,Canis lupus familiaris,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,N,A,1,Intermediate,1,,CHEMBL626009,,BAO_0000218,2107.0,
10808,,Canis lupus familiaris,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,N,A,1,Intermediate,1,,CHEMBL626010,,BAO_0000218,,
10809,,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL626011,,BAO_0000218,178.0,
10810,,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL626012,,BAO_0000218,178.0,
10811,,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL626013,,BAO_0000218,178.0,
10812,,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL626014,,BAO_0000218,178.0,
10813,,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,N,A,1,Intermediate,1,,CHEMBL877496,,BAO_0000218,178.0,
10814,,Canis lupus familiaris,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,N,F,1,Intermediate,1,,CHEMBL626015,,BAO_0000218,,
10815,,Canis lupus familiaris,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,N,F,1,Intermediate,1,,CHEMBL626016,,BAO_0000218,,
10816,,Canis lupus familiaris,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,N,F,1,Intermediate,1,,CHEMBL626017,,BAO_0000218,,
10817,,Canis lupus familiaris,Bioavailability as maximal plasma concentration in dogs,N,A,1,Intermediate,1,,CHEMBL626018,,BAO_0000218,1969.0,
10818,,Canis lupus familiaris,Bioavailability as maximal plasma concentration in dogs,N,A,1,Intermediate,1,,CHEMBL626692,,BAO_0000218,1969.0,
10819,,Rattus norvegicus,Bioavailability as maximal plasma concentration in rats,N,A,1,Intermediate,1,,CHEMBL626693,,BAO_0000218,1969.0,
10820,,Rattus norvegicus,Bioavailability as maximal plasma concentration in rats,U,A,0,Autocuration,1,,CHEMBL626694,,BAO_0000218,1969.0,
10821,,Canis lupus familiaris,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,A,1,Intermediate,1,,CHEMBL626695,,BAO_0000218,178.0,
10822,,Canis lupus familiaris,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,A,1,Intermediate,1,,CHEMBL626696,,BAO_0000218,178.0,
10823,,Canis lupus familiaris,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,A,1,Intermediate,1,,CHEMBL626697,,BAO_0000218,178.0,
10824,,Canis lupus familiaris,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,N,A,1,Intermediate,1,,CHEMBL626859,,BAO_0000218,178.0,
10825,,Canis lupus familiaris,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,A,1,Intermediate,1,,CHEMBL626860,,BAO_0000218,178.0,
10826,,Canis lupus familiaris,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,A,1,Intermediate,1,,CHEMBL626861,,BAO_0000218,178.0,
10827,,Rattus norvegicus,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,A,1,Intermediate,1,,CHEMBL626296,,BAO_0000218,,
10828,,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,U,A,0,Autocuration,1,,CHEMBL626297,,BAO_0000218,,
10829,,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,U,A,0,Autocuration,1,,CHEMBL626298,,BAO_0000218,1969.0,
10830,,Rattus norvegicus,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",N,A,1,Intermediate,1,,CHEMBL626299,,BAO_0000218,1969.0,
10831,,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,N,A,1,Intermediate,1,,CHEMBL626300,,BAO_0000218,1969.0,
10832,,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,N,A,1,Intermediate,1,,CHEMBL626301,,BAO_0000218,1969.0,
10833,,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,N,A,1,Intermediate,1,,CHEMBL626962,,BAO_0000218,1969.0,
10834,,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,N,A,1,Intermediate,1,,CHEMBL626963,,BAO_0000218,1969.0,
10835,,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,N,A,1,Intermediate,1,,CHEMBL626964,,BAO_0000218,1969.0,
10836,,Macaca fascicularis,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,N,A,1,Intermediate,1,,CHEMBL626965,,BAO_0000218,1969.0,
10837,,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL626966,,BAO_0000218,1969.0,
10838,,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL626967,,BAO_0000218,1969.0,
10839,,Macaca fascicularis,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,N,A,1,Intermediate,1,,CHEMBL626968,,BAO_0000218,1969.0,
10840,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,N,A,1,Intermediate,1,,CHEMBL626969,,BAO_0000218,948.0,
10841,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,N,A,1,Intermediate,1,,CHEMBL627126,,BAO_0000218,948.0,
10842,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,N,A,1,Intermediate,1,,CHEMBL631276,,BAO_0000218,948.0,
10843,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,N,A,1,Intermediate,1,,CHEMBL631277,,BAO_0000218,948.0,
10844,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,N,A,1,Intermediate,1,,CHEMBL631278,,BAO_0000218,948.0,
10845,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,N,A,1,Intermediate,1,,CHEMBL874457,,BAO_0000218,948.0,
10846,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,N,A,1,Intermediate,1,,CHEMBL631279,,BAO_0000218,948.0,
10847,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,N,A,1,Intermediate,1,,CHEMBL631280,,BAO_0000218,948.0,
10848,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,N,A,1,Intermediate,1,,CHEMBL631281,,BAO_0000218,948.0,
10849,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,N,A,1,Intermediate,1,,CHEMBL631968,,BAO_0000218,948.0,
10850,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,N,A,1,Intermediate,1,,CHEMBL631969,,BAO_0000218,948.0,
10851,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,N,A,1,Intermediate,1,,CHEMBL631970,,BAO_0000218,948.0,
10852,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,N,A,1,Intermediate,1,,CHEMBL631971,,BAO_0000218,948.0,
10853,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,N,A,1,Intermediate,1,,CHEMBL631972,,BAO_0000218,948.0,
10854,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,N,A,1,Intermediate,1,,CHEMBL630435,,BAO_0000218,948.0,
10855,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,N,A,1,Intermediate,1,,CHEMBL630436,,BAO_0000218,948.0,
10856,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,N,A,1,Intermediate,1,,CHEMBL630437,,BAO_0000218,948.0,
10857,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,N,A,1,Intermediate,1,,CHEMBL630438,,BAO_0000218,948.0,
10858,,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,N,A,1,Intermediate,1,,CHEMBL630439,,BAO_0000218,948.0,
10859,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,N,A,1,Intermediate,1,,CHEMBL630440,,BAO_0000218,2113.0,
10860,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,N,A,1,Intermediate,1,,CHEMBL630441,,BAO_0000218,2113.0,
10861,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,N,A,1,Intermediate,1,,CHEMBL630442,,BAO_0000218,2113.0,
10862,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,N,A,1,Intermediate,1,,CHEMBL625234,,BAO_0000218,2113.0,
10863,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,N,A,1,Intermediate,1,,CHEMBL625235,,BAO_0000218,2113.0,
10864,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,N,A,1,Intermediate,1,,CHEMBL625236,,BAO_0000218,2113.0,
10865,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,N,A,1,Intermediate,1,,CHEMBL625237,,BAO_0000218,2113.0,
10866,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,N,A,1,Intermediate,1,,CHEMBL626125,,BAO_0000218,2113.0,
10867,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,N,A,1,Intermediate,1,,CHEMBL626126,,BAO_0000218,2113.0,
10868,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,N,A,1,Intermediate,1,,CHEMBL626127,,BAO_0000218,2113.0,
10869,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,N,A,1,Intermediate,1,,CHEMBL626128,,BAO_0000218,2113.0,
10870,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,N,A,1,Intermediate,1,,CHEMBL626129,,BAO_0000218,2113.0,
10871,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,N,A,1,Intermediate,1,,CHEMBL626130,,BAO_0000218,2113.0,
10872,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,N,A,1,Intermediate,1,,CHEMBL626131,,BAO_0000218,2113.0,
10873,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,N,A,1,Intermediate,1,,CHEMBL626132,,BAO_0000218,2113.0,
10874,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,N,A,1,Intermediate,1,,CHEMBL626752,,BAO_0000218,2113.0,
10875,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,N,A,1,Intermediate,1,,CHEMBL626753,,BAO_0000218,2113.0,
10876,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,N,A,1,Intermediate,1,,CHEMBL626754,,BAO_0000218,2113.0,
10877,,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,N,A,1,Intermediate,1,,CHEMBL626755,,BAO_0000218,2113.0,
10878,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,N,A,1,Intermediate,1,,CHEMBL626756,,BAO_0000218,2107.0,
10879,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,N,A,1,Intermediate,1,,CHEMBL626757,,BAO_0000218,2107.0,
10880,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,N,A,1,Intermediate,1,,CHEMBL626758,,BAO_0000218,2107.0,
10881,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,N,A,1,Intermediate,1,,CHEMBL626759,,BAO_0000218,2107.0,
10882,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,N,A,1,Intermediate,1,,CHEMBL626760,,BAO_0000218,2107.0,
10883,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL626394,,BAO_0000218,,
10884,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL626395,,BAO_0000218,,
10885,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL626396,,BAO_0000218,,
10886,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,A,1,Intermediate,1,,CHEMBL626397,,BAO_0000218,,
10887,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,A,1,Intermediate,1,,CHEMBL626398,,BAO_0000218,,
10888,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL626399,,BAO_0000218,,
10889,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL874653,,BAO_0000218,,
10890,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL626400,,BAO_0000218,,
10891,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL626401,,BAO_0000218,,
10892,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL626402,,BAO_0000218,,
10893,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL626403,,BAO_0000218,,
10894,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL626404,,BAO_0000218,,
10895,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL626405,,BAO_0000218,,
10896,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL625529,,BAO_0000218,,
10897,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL625530,,BAO_0000218,,
10898,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL625531,,BAO_0000218,,
10899,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL625532,,BAO_0000218,,
10900,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL625533,,BAO_0000218,,
10901,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL875474,,BAO_0000218,,
10902,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL625534,,BAO_0000218,,
10903,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL625535,,BAO_0000218,,
10904,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL625536,,BAO_0000218,,
10905,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL625537,,BAO_0000218,,
10906,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL625538,,BAO_0000218,,
10907,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL625539,,BAO_0000218,,
10908,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL625540,,BAO_0000218,,
10909,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL625541,,BAO_0000218,,
10910,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL625542,,BAO_0000218,,
10911,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL625543,,BAO_0000218,,
10912,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL625544,,BAO_0000218,,
10913,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL625545,,BAO_0000218,,
10914,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL625546,,BAO_0000218,,
10915,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL625547,,BAO_0000218,,
10916,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL625548,,BAO_0000218,,
10917,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL625549,,BAO_0000218,,
10918,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL625550,,BAO_0000218,,
10919,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL625551,,BAO_0000218,,
10920,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL875475,,BAO_0000218,,
10921,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL625552,,BAO_0000218,,
10922,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL625553,,BAO_0000218,,
10923,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,A,1,Intermediate,1,,CHEMBL625554,,BAO_0000218,,
10924,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,A,1,Intermediate,1,,CHEMBL625555,,BAO_0000218,,
10925,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL625556,,BAO_0000218,,
10926,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL624986,,BAO_0000218,,
10927,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL624987,,BAO_0000218,,
10928,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,A,1,Intermediate,1,,CHEMBL624988,,BAO_0000218,,
10929,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,N,A,1,Intermediate,1,,CHEMBL624989,,BAO_0000218,1637.0,
10930,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,N,A,1,Intermediate,1,,CHEMBL624990,,BAO_0000218,1637.0,
10931,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,N,A,1,Intermediate,1,,CHEMBL874391,,BAO_0000218,1637.0,
10932,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,N,A,1,Intermediate,1,,CHEMBL624991,,BAO_0000218,1637.0,
10933,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,N,A,1,Intermediate,1,,CHEMBL624992,,BAO_0000218,1637.0,
10934,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,N,A,1,Intermediate,1,,CHEMBL624993,,BAO_0000218,1637.0,
10935,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,N,A,1,Intermediate,1,,CHEMBL624994,,BAO_0000218,1637.0,
10936,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,N,A,1,Intermediate,1,,CHEMBL624995,,BAO_0000218,1637.0,
10937,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,N,A,1,Intermediate,1,,CHEMBL624996,,BAO_0000218,1637.0,
10938,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,N,A,1,Intermediate,1,,CHEMBL624997,,BAO_0000218,1637.0,
10939,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,N,A,1,Intermediate,1,,CHEMBL624998,,BAO_0000218,1637.0,
10940,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,N,A,1,Intermediate,1,,CHEMBL624999,,BAO_0000218,1637.0,
10941,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,N,A,1,Intermediate,1,,CHEMBL882955,,BAO_0000218,1637.0,
10942,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,N,A,1,Intermediate,1,,CHEMBL625000,,BAO_0000218,1637.0,
10943,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,N,A,1,Intermediate,1,,CHEMBL625001,,BAO_0000218,1637.0,
10944,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,N,A,1,Intermediate,1,,CHEMBL625089,,BAO_0000218,1637.0,
10945,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,N,A,1,Intermediate,1,,CHEMBL625090,,BAO_0000218,1637.0,
10946,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,N,A,1,Intermediate,1,,CHEMBL625091,,BAO_0000218,1637.0,
10947,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,N,A,1,Intermediate,1,,CHEMBL625092,,BAO_0000218,1637.0,
10948,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,N,A,1,Intermediate,1,,CHEMBL625093,,BAO_0000218,1637.0,
10949,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,N,A,1,Intermediate,1,,CHEMBL625094,,BAO_0000218,1637.0,
10950,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,N,A,1,Intermediate,1,,CHEMBL625095,,BAO_0000218,1637.0,
10951,,Canis lupus familiaris,Compound was evaluated for its bioavailability in the dogs,N,A,1,Intermediate,1,,CHEMBL625096,,BAO_0000218,,
10952,,Rattus norvegicus,Compound was evaluated for its bioavailability in the rats,N,A,1,Intermediate,1,,CHEMBL625097,,BAO_0000218,,
10953,,,Compound was evaluated for oral bioavailability,U,A,0,Autocuration,1,,CHEMBL882956,,BAO_0000218,,
10954,,Rattus norvegicus,Compound was evaluated for percentage of Oral bioavailability in rats,N,A,1,Intermediate,1,,CHEMBL625098,,BAO_0000218,,
10955,,Cavia porcellus,Bioavailability in guinea pig,U,A,0,Autocuration,1,,CHEMBL625099,,BAO_0000218,,
10956,,Rattus norvegicus,Compound was evaluated for the oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL625100,,BAO_0000218,,
10957,,Canis lupus familiaris,Compound was evaluated for the oral bioavailability in dog,N,A,1,Intermediate,1,,CHEMBL625101,,BAO_0000218,,
10958,,Rattus norvegicus,Compound was evaluated for the oral bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL874396,,BAO_0000218,,
10959,,Canis lupus familiaris,Bioavailability in dog (dosed i.v.),U,F,0,Autocuration,1,,CHEMBL625102,,BAO_0000218,,
10960,,Canis lupus familiaris,Compound was tested for in vivo bioavailability in dog,N,A,1,Intermediate,1,,CHEMBL625103,,BAO_0000218,,
10961,,Cricetinae,Compound was tested for in vivo bioavailability in hamsters,N,A,1,Intermediate,1,,CHEMBL625104,,BAO_0000218,,
10962,,Simiiformes,Compound was tested for in vivo bioavailability in monkey,U,A,0,Autocuration,1,,CHEMBL625105,,BAO_0000218,,
10963,,Rattus norvegicus,Compound was tested for in vivo bioavailability in rat,N,A,1,Intermediate,1,,CHEMBL625106,,BAO_0000218,,
10964,,Mus musculus,Oral bioavailability in mouse,U,A,0,Autocuration,1,,CHEMBL625107,,BAO_0000218,,
10965,,Mus musculus,Compound was tested for percent of oral bioavailability in mice; 56-74,N,A,1,Intermediate,1,,CHEMBL625108,,BAO_0000218,,
10966,,Mus musculus,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),U,A,0,Autocuration,1,,CHEMBL625109,,BAO_0000218,,
10967,,Macaca fascicularis,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),U,A,0,Autocuration,1,,CHEMBL625110,,BAO_0000218,,
10968,,Macaca fascicularis,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),U,A,0,Autocuration,1,,CHEMBL625111,,BAO_0000218,,
10969,,Mus musculus,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),N,A,1,Intermediate,1,,CHEMBL625112,,BAO_0000218,,
10970,,Mus musculus,Oral bioavailability in nude mice,N,A,1,Intermediate,1,,CHEMBL875334,,BAO_0000218,,
10971,,Primates,Bioavailability in monkey (i.d. dosing),U,A,0,Autocuration,1,,CHEMBL628617,,BAO_0000218,,
10972,,Rattus norvegicus,Bioavailability in rat,U,A,0,Autocuration,1,,CHEMBL628618,,BAO_0000218,,
10973,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,U,A,0,Autocuration,1,,CHEMBL628619,,BAO_0000218,,
10974,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,U,A,0,Autocuration,1,,CHEMBL628620,,BAO_0000218,,
10975,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,A,1,Intermediate,1,,CHEMBL628621,,BAO_0000218,,
10976,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,A,1,Intermediate,1,,CHEMBL628622,,BAO_0000218,,
10977,,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,A,1,Intermediate,1,,CHEMBL628623,,BAO_0000218,,
10978,,Macaca fascicularis,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL628624,,BAO_0000218,1969.0,
10979,,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL628625,,BAO_0000218,1969.0,
10980,,Macaca fascicularis,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL628626,,BAO_0000218,1969.0,
10981,,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL627041,,BAO_0000218,1969.0,
10982,,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL627042,,BAO_0000218,1969.0,
10983,,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL627043,,BAO_0000218,1969.0,
10984,,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,U,A,0,Autocuration,1,,CHEMBL627044,,BAO_0000218,1969.0,
10985,,Mus musculus,Cmax in mouse plasma,N,A,1,Intermediate,1,,CHEMBL627045,,BAO_0000218,1969.0,
10986,,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,U,A,0,Autocuration,1,,CHEMBL627046,,BAO_0000218,1969.0,
10987,,Rattus norvegicus,Maximal plasma concentration in rat,N,A,1,Intermediate,1,,CHEMBL627047,,BAO_0000218,1969.0,
10988,,Rattus norvegicus,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,N,A,1,Intermediate,1,,CHEMBL627048,,BAO_0000218,1969.0,
10989,,Rattus norvegicus,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627049,,BAO_0000218,,
10990,,Rattus norvegicus,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627050,,BAO_0000218,,
10991,,Rattus norvegicus,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627051,,BAO_0000218,,
10992,,Rattus norvegicus,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627052,,BAO_0000218,,
10993,,Rattus norvegicus,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627053,,BAO_0000218,,
10994,,Rattus norvegicus,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627054,,BAO_0000218,,
10995,,Mus musculus,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL627055,,BAO_0000218,,
10996,,Mus musculus,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL627056,,BAO_0000218,,
10997,,Mus musculus,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,A,1,Intermediate,1,,CHEMBL627057,,BAO_0000218,,
10998,,Mus musculus,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL627058,,BAO_0000218,,
10999,,Mus musculus,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,A,1,Intermediate,1,,CHEMBL626211,,BAO_0000218,,
11000,,,Maximum Concentration of the compound.,U,A,0,Autocuration,1,,CHEMBL626212,,BAO_0000218,,
11001,,Canis lupus familiaris,Maximum Concentration was measured after iv administration into Beagle dog,N,A,1,Intermediate,1,,CHEMBL626213,,BAO_0000218,,
11002,,Canis lupus familiaris,Maximum Concentration was measured after iv administration into Beagle dog.,N,A,1,Intermediate,1,,CHEMBL626214,,BAO_0000218,,
11003,,Canis lupus familiaris,Maximum Concentration was measured after po administration into Beagle dog,N,A,1,Intermediate,1,,CHEMBL626215,,BAO_0000218,,
11004,,Canis lupus familiaris,Maximum Concentration was measured after po administration into Beagle dog.,N,A,1,Intermediate,1,,CHEMBL626216,,BAO_0000218,,
11005,,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,U,A,0,Autocuration,1,,CHEMBL626217,,BAO_0000218,178.0,
11006,,,Maximum blood level reached after an iv dose of 12.2 uM/kg,U,A,0,Autocuration,1,,CHEMBL626218,,BAO_0000218,178.0,
11007,,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,U,A,0,Autocuration,1,,CHEMBL626219,,BAO_0000218,178.0,
11008,,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,U,A,0,Autocuration,1,,CHEMBL626220,,BAO_0000218,178.0,
11009,,,Maximum blood level reached after an oral dose of 5.0 mg/kg,U,A,0,Autocuration,1,,CHEMBL626221,,BAO_0000218,178.0,
11010,,,Maximum blood level reached at dose of 10.6 uM/kg orally,U,A,0,Autocuration,1,,CHEMBL626222,,BAO_0000218,178.0,
11011,,Cavia porcellus,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,N,A,1,Intermediate,1,,CHEMBL626223,,BAO_0000218,,
11012,,Cavia porcellus,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,N,A,1,Intermediate,1,,CHEMBL626224,,BAO_0000218,,
11013,,Rattus norvegicus,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL626225,,BAO_0000218,955.0,
11014,,Rattus norvegicus,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL626226,,BAO_0000218,955.0,
11015,,Rattus norvegicus,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,N,A,1,Intermediate,1,,CHEMBL626227,,BAO_0000218,955.0,
11016,,Rattus norvegicus,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL626228,,BAO_0000218,955.0,
11017,,Rattus norvegicus,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL626229,,BAO_0000218,,
11018,,Rattus norvegicus,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL626921,,BAO_0000218,,
11019,,Rattus norvegicus,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,N,A,1,Intermediate,1,,CHEMBL876793,,BAO_0000218,,
11020,,Rattus norvegicus,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL625309,,BAO_0000218,,
11021,,Bacillus subtilis,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,A,1,Intermediate,1,,CHEMBL625310,,BAO_0000218,,
11022,,Simiiformes,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,U,A,0,Autocuration,1,,CHEMBL625311,,BAO_0000218,,
11023,,Rattus norvegicus,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL625312,,BAO_0000218,,
11024,,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,U,A,0,Autocuration,1,,CHEMBL625313,,BAO_0000218,,
11025,,Mus musculus,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL625314,,BAO_0000218,,
11026,,Rattus norvegicus,Maximum concentration in male rats after iv administration of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL625315,,BAO_0000218,,
11027,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,N,A,1,Intermediate,1,,CHEMBL625316,,BAO_0000218,2107.0,
11028,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,N,A,1,Intermediate,1,,CHEMBL625317,,BAO_0000218,2107.0,
11029,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,N,A,1,Intermediate,1,,CHEMBL625318,,BAO_0000218,2107.0,
11030,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,N,A,1,Intermediate,1,,CHEMBL625319,,BAO_0000218,2107.0,
11031,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,N,A,1,Intermediate,1,,CHEMBL625320,,BAO_0000218,2107.0,
11032,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,N,A,1,Intermediate,1,,CHEMBL625321,,BAO_0000218,2107.0,
11033,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,N,A,1,Intermediate,1,,CHEMBL625322,,BAO_0000218,2107.0,
11034,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,N,A,1,Intermediate,1,,CHEMBL876801,,BAO_0000218,2107.0,
11035,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,N,A,1,Intermediate,1,,CHEMBL625323,,BAO_0000218,2107.0,
11036,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,N,A,1,Intermediate,1,,CHEMBL625324,,BAO_0000218,2107.0,
11037,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,N,A,1,Intermediate,1,,CHEMBL625325,,BAO_0000218,2107.0,
11038,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,N,A,1,Intermediate,1,,CHEMBL625326,,BAO_0000218,2107.0,
11039,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,N,A,1,Intermediate,1,,CHEMBL625327,,BAO_0000218,2107.0,
11040,,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,N,A,1,Intermediate,1,,CHEMBL625328,,BAO_0000218,2107.0,
11041,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,N,A,1,Intermediate,1,,CHEMBL625329,,BAO_0000218,2048.0,
11042,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,N,A,1,Intermediate,1,,CHEMBL625330,,BAO_0000218,2048.0,
11043,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,N,A,1,Intermediate,1,,CHEMBL627774,,BAO_0000218,2048.0,
11044,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,N,A,1,Intermediate,1,,CHEMBL627775,,BAO_0000218,2048.0,
11045,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,N,A,1,Intermediate,1,,CHEMBL627949,,BAO_0000218,2048.0,
11046,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,N,A,1,Intermediate,1,,CHEMBL627950,,BAO_0000218,2048.0,
11047,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,N,A,1,Intermediate,1,,CHEMBL627951,,BAO_0000218,2048.0,
11048,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,N,A,1,Intermediate,1,,CHEMBL627952,,BAO_0000218,2048.0,
11049,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,N,A,1,Intermediate,1,,CHEMBL627953,,BAO_0000218,2048.0,
11050,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,N,A,1,Intermediate,1,,CHEMBL627954,,BAO_0000218,2048.0,
11051,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,N,A,1,Intermediate,1,,CHEMBL627955,,BAO_0000218,2048.0,
11052,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,N,A,1,Intermediate,1,,CHEMBL627956,,BAO_0000218,2048.0,
11053,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,N,A,1,Intermediate,1,,CHEMBL876802,,BAO_0000218,2048.0,
11054,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,N,A,1,Intermediate,1,,CHEMBL627957,,BAO_0000218,2048.0,
11055,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,N,A,1,Intermediate,1,,CHEMBL627958,,BAO_0000218,2048.0,
11056,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,N,A,1,Intermediate,1,,CHEMBL627959,,BAO_0000218,2048.0,
11057,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,N,A,1,Intermediate,1,,CHEMBL627960,,BAO_0000218,2048.0,
11058,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,N,A,1,Intermediate,1,,CHEMBL627961,,BAO_0000218,2048.0,
11059,,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,N,A,1,Intermediate,1,,CHEMBL627962,,BAO_0000218,2048.0,
11060,,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL627963,,BAO_0000218,,
11061,,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL624759,,BAO_0000218,,
11062,,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL624760,,BAO_0000218,,
11063,,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL624761,,BAO_0000218,,
11064,,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL877607,,BAO_0000218,,
11065,,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL624762,,BAO_0000218,2107.0,
11066,,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL624763,,BAO_0000218,2107.0,
11067,,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL624764,,BAO_0000218,2107.0,
11068,,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL624765,,BAO_0000218,2107.0,
11069,,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL624766,,BAO_0000218,2107.0,
11070,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL624767,,BAO_0000218,,
11071,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL624768,,BAO_0000218,,
11072,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL624769,,BAO_0000218,,
11073,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,A,1,Intermediate,1,,CHEMBL624770,,BAO_0000218,,
11074,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,A,1,Intermediate,1,,CHEMBL624771,,BAO_0000218,,
11075,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL624772,,BAO_0000218,,
11076,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL624773,,BAO_0000218,,
11077,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL624774,,BAO_0000218,,
11078,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL624775,,BAO_0000218,,
11079,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL624776,,BAO_0000218,,
11080,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL624777,,BAO_0000218,,
11081,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL624778,,BAO_0000218,,
11082,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL624779,,BAO_0000218,,
11083,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL624780,,BAO_0000218,,
11084,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL624781,,BAO_0000218,,
11085,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL877608,,BAO_0000218,,
11086,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL624782,,BAO_0000218,,
11087,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL624783,,BAO_0000218,,
11088,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL624784,,BAO_0000218,,
11089,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL624785,,BAO_0000218,,
11090,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL624786,,BAO_0000218,,
11091,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL624787,,BAO_0000218,,
11092,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL628676,,BAO_0000218,,
11093,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL621842,,BAO_0000218,,
11094,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL621843,,BAO_0000218,,
11095,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL623873,,BAO_0000218,,
11096,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL623874,,BAO_0000218,,
11097,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL623875,,BAO_0000218,,
11098,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL623876,,BAO_0000218,,
11099,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL623877,,BAO_0000218,,
11100,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL623878,,BAO_0000218,,
11101,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL623879,,BAO_0000218,,
11102,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL623880,,BAO_0000218,,
11103,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL623881,,BAO_0000218,,
11104,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL623957,,BAO_0000218,,
11105,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL623958,,BAO_0000218,,
11106,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL623959,,BAO_0000218,,
11107,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL623960,,BAO_0000218,,
11108,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL623961,,BAO_0000218,,
11109,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,A,1,Intermediate,1,,CHEMBL623962,,BAO_0000218,,
11110,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,A,1,Intermediate,1,,CHEMBL624676,,BAO_0000218,,
11111,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL624677,,BAO_0000218,,
11112,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL624678,,BAO_0000218,,
11113,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL624679,,BAO_0000218,,
11114,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,A,1,Intermediate,1,,CHEMBL624680,,BAO_0000218,,
11115,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,U,A,0,Autocuration,1,,CHEMBL624849,,BAO_0000218,,
11116,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,U,A,0,Autocuration,1,,CHEMBL624850,,BAO_0000218,,
11117,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,U,A,0,Autocuration,1,,CHEMBL874399,,BAO_0000218,,
11118,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,U,A,0,Autocuration,1,,CHEMBL624851,,BAO_0000218,,
11119,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,U,A,0,Autocuration,1,,CHEMBL624852,,BAO_0000218,,
11120,,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg),U,A,0,Autocuration,1,,CHEMBL624853,,BAO_0000218,,
11121,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley),U,A,0,Autocuration,1,,CHEMBL624854,,BAO_0000218,,
11122,,Rattus norvegicus,Oral bioavailability in rat,U,A,0,Autocuration,1,,CHEMBL624855,,BAO_0000218,,
11123,,Rattus norvegicus,Oral bioavailability in rats was determined in vivo,U,A,0,Autocuration,1,,CHEMBL624856,,BAO_0000218,,
11124,,Canis lupus familiaris,Oral bioavailability in dog,U,A,0,Autocuration,1,,CHEMBL882957,,BAO_0000218,,
11125,,Simiiformes,Oral bioavailability of compound in monkey,U,A,0,Autocuration,1,,CHEMBL624857,,BAO_0000218,,
11126,,Rattus norvegicus,Oral bioavailability of compound in rat,N,A,1,Intermediate,1,,CHEMBL622202,,BAO_0000218,,
11127,,Rattus norvegicus,Bioavailability in rat of PMEA prodrug,U,A,0,Autocuration,1,,CHEMBL622203,,BAO_0000218,,
11128,,Rattus norvegicus,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,N,A,1,Intermediate,1,,CHEMBL625522,,BAO_0000218,,
11129,,Macaca mulatta,Serum conc at 3 hours following 25 mg/kg dose,U,A,0,Autocuration,1,,CHEMBL622868,,BAO_0000218,,
11130,,Macaca mulatta,Urine conc 0-5 hours following 25 mg/kg dose,U,A,0,Autocuration,1,,CHEMBL622869,,BAO_0000218,1088.0,
11131,,Macaca mulatta,Urine conc 0-24 hours following 25 mg/kg dose,U,A,0,Autocuration,1,,CHEMBL622870,,BAO_0000218,1088.0,
11132,,Chlorocebus aethiops,Oral bioavailability in African green monkeys; 20-25,U,A,0,Autocuration,1,,CHEMBL622871,,BAO_0000218,,
11133,,Macaca fascicularis,Oral bioavailability in cynomolgus monkey.,N,A,1,Intermediate,1,,CHEMBL620560,,BAO_0000218,,
11134,,Canis lupus familiaris,Oral bioavailability in dog,U,A,0,Autocuration,1,,CHEMBL620561,,BAO_0000218,,
11135,,Canis lupus familiaris,Oral bioavailability in dog at 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL620562,,BAO_0000218,,
11136,,Cricetinae,Oral bioavailability in hamster at 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL620563,,BAO_0000218,,
11137,,Rattus norvegicus,Oral bioavailability in rat at 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL620564,,BAO_0000218,,
11138,,Rattus norvegicus,Oral bioavailability in rat,U,A,0,Autocuration,1,,CHEMBL872265,,BAO_0000218,,
11139,,Rattus norvegicus,Oral bioavailability in rat,U,A,0,Autocuration,1,,CHEMBL620565,,BAO_0000218,,
11140,,Eutheria,Oral bioavailability,U,A,0,Autocuration,1,,CHEMBL620566,,BAO_0000218,,
11141,,,Oral bioavailability was determined; range 49-102%,U,A,0,Autocuration,1,,CHEMBL620567,,BAO_0000218,,
11142,,Canis lupus familiaris,Oral bioavailability was determined in dogs,N,A,1,Intermediate,1,,CHEMBL620568,,BAO_0000218,,
11143,,Rattus norvegicus,Oral bioavailability in rat,U,A,0,Autocuration,1,,CHEMBL620569,,BAO_0000218,,
11144,,Eutheria,Oral bioavailability,U,A,0,Autocuration,1,,CHEMBL620570,,BAO_0000218,,
11145,,,Oral bioavailability was determined; Not orally available,U,A,0,Autocuration,1,,CHEMBL620571,,BAO_0000218,,
11146,,Mus musculus,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),N,A,1,Intermediate,1,,CHEMBL620572,,BAO_0000218,,
11147,,Mus musculus,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),U,A,0,Autocuration,1,,CHEMBL620573,,BAO_0000218,,
11148,,Mus musculus,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,U,A,0,Autocuration,1,,CHEMBL620574,,BAO_0000218,,
11149,,Macaca mulatta,Oral bioavailability in Rhesus monkey,U,A,0,Autocuration,1,,CHEMBL620575,,BAO_0000218,,
11150,,Canis lupus familiaris,Oral bioavailability in dog (female mongrel),U,A,0,Autocuration,1,,CHEMBL620576,,BAO_0000218,,
11151,,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,U,A,0,Autocuration,1,,CHEMBL875846,,BAO_0000218,,
11152,,Canis lupus familiaris,Oral bioavailability in dog,U,A,0,Autocuration,1,,CHEMBL620577,,BAO_0000218,,
11153,,,Percentage Bioavailability was evaluated.,U,A,0,Autocuration,1,,CHEMBL620578,,BAO_0000218,,
11154,,Rattus norvegicus,Bioavailability in rat administered i.d.,U,A,0,Autocuration,1,,CHEMBL620579,,BAO_0000218,,
11155,,Eutheria,Bioavailability,U,A,0,Autocuration,1,,CHEMBL621248,,BAO_0000218,,
11156,,Canis lupus familiaris,Bioavailability in dog (male Beagle) i.v. administration,U,A,0,Autocuration,1,,CHEMBL625390,,BAO_0000218,,
11157,,Rattus norvegicus,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",U,A,0,Autocuration,1,,CHEMBL625391,,BAO_0000218,,
11158,,Primates,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),U,A,0,Autocuration,1,,CHEMBL872266,,BAO_0000218,,
11159,,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (male),U,A,0,Autocuration,1,,CHEMBL625392,,BAO_0000218,,
11160,,Rattus norvegicus,The oral bioavailability was measured on rats after oral administration,N,A,1,Intermediate,1,,CHEMBL625393,,BAO_0000218,,
11161,,Rattus norvegicus,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL625394,,BAO_0000218,,
11162,,Macaca mulatta,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL625395,,BAO_0000218,,
11163,,Rattus norvegicus,Bioavailability in rat (dose 10 mg/kg i.d.),U,A,0,Autocuration,1,,CHEMBL625396,,BAO_0000218,,
11164,,Canis lupus familiaris,Bioavailability in dog (male Beagle) i.v. administration,U,A,0,Autocuration,1,,CHEMBL625397,,BAO_0000218,,
11165,,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL625398,,BAO_0000218,,
11166,,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL625399,,BAO_0000218,178.0,
11167,,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL626074,,BAO_0000218,2037.0,
11168,,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL626075,,BAO_0000218,,
11169,,Rattus norvegicus,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL626076,,BAO_0000218,1969.0,
11170,,Macaca mulatta,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL626077,,BAO_0000218,1969.0,
11171,,Rattus norvegicus,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),N,A,1,Intermediate,1,,CHEMBL626078,,BAO_0000218,178.0,
11172,,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),U,A,0,Autocuration,1,,CHEMBL625846,,BAO_0000218,178.0,
11173,,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),U,A,0,Autocuration,1,,CHEMBL625847,,BAO_0000218,178.0,
11174,,Rattus norvegicus,Maximum concentration observed in rats at an oral dose of 50 mg/kg,N,A,1,Expert,1,,CHEMBL625848,,BAO_0000218,,
11175,,Rattus norvegicus,Maximum concentration of compound in plasma administered orally to rats,N,A,1,Intermediate,1,,CHEMBL625849,,BAO_0000218,1969.0,
11176,,Canis lupus familiaris,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",N,A,1,Intermediate,1,,CHEMBL626023,,BAO_0000218,1969.0,
11177,,Canis lupus familiaris,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",N,A,1,Intermediate,1,,CHEMBL626024,,BAO_0000218,1969.0,
11178,,Canis lupus familiaris,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",N,A,1,Intermediate,1,,CHEMBL626025,,BAO_0000218,1969.0,
11179,,,Maximum concentration after 10 mg/kg by oral administration,U,A,0,Autocuration,1,,CHEMBL626026,,BAO_0000218,,
11180,,,Maximum concentration at a dose of 1.5 mg/kg,U,A,0,Autocuration,1,,CHEMBL626027,,BAO_0000218,,
11181,,,Maximum concentration at a dose of 2.0 mg/kg,U,A,0,Autocuration,1,,CHEMBL626028,,BAO_0000218,,
11182,,Canis lupus familiaris,Maximum concentration in dog plasma,N,A,1,Intermediate,1,,CHEMBL626029,,BAO_0000218,1969.0,
11183,,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,U,A,0,Autocuration,1,,CHEMBL626030,,BAO_0000218,1969.0,
11184,,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,U,A,0,Autocuration,1,,CHEMBL626031,,BAO_0000218,1969.0,
11185,,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,U,A,0,Autocuration,1,,CHEMBL626032,,BAO_0000218,1969.0,
11186,,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,U,A,0,Autocuration,1,,CHEMBL626033,,BAO_0000218,1969.0,
11187,,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,U,A,0,Autocuration,1,,CHEMBL626034,,BAO_0000218,1969.0,
11188,,Canis lupus familiaris,Maximum concentration in plasma after oral administration in dog (25 mg/kg),N,A,1,Intermediate,1,,CHEMBL626035,,BAO_0000218,1969.0,
11189,,,Maximum concentration in plasma at Tmax,U,A,0,Autocuration,1,,CHEMBL626036,,BAO_0000218,1969.0,
11190,,Canis lupus familiaris,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,N,A,1,Expert,1,,CHEMBL626037,,BAO_0000218,1969.0,
11191,,Cricetinae,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL626038,,BAO_0000218,1969.0,
11192,,Rattus norvegicus,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL626039,,BAO_0000218,1969.0,
11193,,Rattus norvegicus,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL626040,,BAO_0000218,1969.0,
11194,,Oryctolagus cuniculus,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL626041,,BAO_0000218,1969.0,
11195,,,Maximum concentration was calculated,U,A,0,Autocuration,1,,CHEMBL626042,,BAO_0000218,,
11196,,,Maximum concentration was calculated.,U,A,0,Autocuration,1,,CHEMBL626043,,BAO_0000218,,
11197,,,Maximum concentration at a peroral dose of 10 mg/kg,U,A,0,Autocuration,1,,CHEMBL626044,,BAO_0000218,,
11198,,,Maximum concentration of the drug at 10 uM/dg administered perorally,U,A,0,Autocuration,1,,CHEMBL626045,,BAO_0000218,,
11199,,,Maximum concentration of the drug at 2 uM/dg administered intravenously,U,A,0,Autocuration,1,,CHEMBL626046,,BAO_0000218,,
11200,,Canis lupus familiaris,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",N,A,1,Intermediate,1,,CHEMBL626047,,BAO_0000218,1969.0,
11201,,Cricetinae,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",N,A,1,Intermediate,1,,CHEMBL626048,,BAO_0000218,1969.0,
11202,,Rattus norvegicus,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",N,A,1,Intermediate,1,,CHEMBL626049,,BAO_0000218,1969.0,
11203,,Rattus norvegicus,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL626050,,BAO_0000218,1969.0,
11204,,Canis lupus familiaris,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL874541,,BAO_0000218,1969.0,
11205,,Cricetinae,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL622826,,BAO_0000218,1969.0,
11206,,Cricetinae,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL622827,,BAO_0000218,1969.0,
11207,,Rattus norvegicus,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL622828,,BAO_0000218,1969.0,
11208,,Rattus norvegicus,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,N,A,1,Intermediate,1,,CHEMBL622829,,BAO_0000218,1969.0,
11209,,Rattus norvegicus,Maximum concentration reached following intravenous administration in male rat,N,A,1,Intermediate,1,,CHEMBL876806,,BAO_0000218,,
11210,,Canis lupus familiaris,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,N,A,1,Intermediate,1,,CHEMBL622830,,BAO_0000218,,
11211,,Rattus norvegicus,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,N,A,1,Intermediate,1,,CHEMBL622831,,BAO_0000218,,
11212,,Canis lupus familiaris,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,N,A,1,Intermediate,1,,CHEMBL626794,,BAO_0000218,,
11213,,Rattus norvegicus,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL626795,,BAO_0000218,,
11214,,Rattus norvegicus,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL626796,,BAO_0000218,,
11215,,Rattus norvegicus,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL626797,,BAO_0000218,,
11216,,Rattus norvegicus,Maximum drug concentration is determined after oral dosing in rats.,N,A,1,Intermediate,1,,CHEMBL626798,,BAO_0000218,,
11217,,Canis lupus familiaris,Maximum observed concentration in oral (5 mg/kg) fasted dogs,N,A,1,Intermediate,1,,CHEMBL626799,,BAO_0000218,,
11218,,Canis lupus familiaris,Maximum observed concentration in oral (5 mg/kg) fed dogs,N,A,1,Intermediate,1,,CHEMBL626800,,BAO_0000218,,
11219,,,Maximum plasma concentration,U,A,0,Autocuration,1,,CHEMBL626801,,BAO_0000218,1969.0,
11220,,Rattus norvegicus,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,N,A,1,Intermediate,1,,CHEMBL876816,,BAO_0000218,1969.0,
11221,,Rattus norvegicus,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626802,,BAO_0000218,1969.0,
11222,,Canis lupus familiaris,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,N,A,1,Intermediate,1,,CHEMBL626803,,BAO_0000218,1969.0,
11223,,,Maximum plasma concentration following oral administration of 30 umol/kg,U,A,0,Autocuration,1,,CHEMBL626804,,BAO_0000218,1969.0,
11224,,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,N,A,1,Intermediate,1,,CHEMBL626805,,BAO_0000218,1969.0,
11225,,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL626309,,BAO_0000218,1969.0,
11226,,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL626310,,BAO_0000218,1969.0,
11227,,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL626311,,BAO_0000218,1969.0,
11228,,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL626312,,BAO_0000218,1969.0,
11229,,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL626313,,BAO_0000218,995.0,
11230,,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL626314,,BAO_0000218,995.0,
11231,,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL626315,,BAO_0000218,995.0,
11232,,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL626316,,BAO_0000218,995.0,
11233,,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,A,1,Intermediate,1,,CHEMBL626317,,BAO_0000218,995.0,
11234,,Rattus norvegicus,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),N,A,1,Intermediate,1,,CHEMBL626318,,BAO_0000218,,
11235,,Rattus norvegicus,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),N,A,1,Intermediate,1,,CHEMBL626319,,BAO_0000218,,
11236,,Rattus norvegicus,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),N,A,1,Intermediate,1,,CHEMBL626320,,BAO_0000218,,
11237,,Rattus norvegicus,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),N,A,1,Intermediate,1,,CHEMBL875053,,BAO_0000218,,
11238,,Rattus norvegicus,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),N,A,1,Intermediate,1,,CHEMBL626321,,BAO_0000218,,
11239,,Rattus norvegicus,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),N,A,1,Intermediate,1,,CHEMBL626322,,BAO_0000218,,
11240,,Rattus norvegicus,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),N,A,1,Intermediate,1,,CHEMBL626323,,BAO_0000218,,
11241,,Rattus norvegicus,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),N,A,1,Intermediate,1,,CHEMBL626324,,BAO_0000218,,
11242,,Rattus norvegicus,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),N,A,1,Intermediate,1,,CHEMBL626325,,BAO_0000218,,
11243,,Rattus norvegicus,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),N,A,1,Intermediate,1,,CHEMBL626326,,BAO_0000218,,
11244,,Rattus norvegicus,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),N,A,1,Intermediate,1,,CHEMBL626327,,BAO_0000218,,
11245,,Rattus norvegicus,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),N,A,1,Intermediate,1,,CHEMBL626328,,BAO_0000218,,
11246,,Rattus norvegicus,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL626329,,BAO_0000218,178.0,
11247,,Rattus norvegicus,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL626330,,BAO_0000218,178.0,
11248,,Rattus norvegicus,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL626331,,BAO_0000218,178.0,
11249,,Rattus norvegicus,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL626332,,BAO_0000218,178.0,
11250,,Rattus norvegicus,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL626333,,BAO_0000218,178.0,
11251,,Rattus norvegicus,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL626334,,BAO_0000218,178.0,
11252,,Rattus norvegicus,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL626335,,BAO_0000218,178.0,
11253,,Rattus norvegicus,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624798,,BAO_0000218,178.0,
11254,,Rattus norvegicus,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624799,,BAO_0000218,955.0,
11255,,Rattus norvegicus,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624800,,BAO_0000218,955.0,
11256,,Rattus norvegicus,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624801,,BAO_0000218,955.0,
11257,,Rattus norvegicus,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624802,,BAO_0000218,955.0,
11258,,Rattus norvegicus,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624803,,BAO_0000218,955.0,
11259,,Rattus norvegicus,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624804,,BAO_0000218,955.0,
11260,,Rattus norvegicus,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624805,,BAO_0000218,955.0,
11261,,Rattus norvegicus,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624806,,BAO_0000218,955.0,
11262,,Rattus norvegicus,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624807,,BAO_0000218,,
11263,,Rattus norvegicus,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624808,,BAO_0000218,,
11264,,Rattus norvegicus,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624809,,BAO_0000218,,
11265,,Rattus norvegicus,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624810,,BAO_0000218,,
11266,,Rattus norvegicus,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL877618,,BAO_0000218,,
11267,,Rattus norvegicus,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624811,,BAO_0000218,,
11268,,Rattus norvegicus,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624812,,BAO_0000218,,
11269,,Rattus norvegicus,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624813,,BAO_0000218,,
11270,,Rattus norvegicus,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624814,,BAO_0000218,,
11271,,Rattus norvegicus,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624815,,BAO_0000218,,
11272,,Rattus norvegicus,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624816,,BAO_0000218,,
11273,,Rattus norvegicus,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624817,,BAO_0000218,,
11274,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL624818,,BAO_0000218,,
11275,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL624819,,BAO_0000218,,
11276,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL624820,,BAO_0000218,,
11277,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,A,1,Intermediate,1,,CHEMBL624821,,BAO_0000218,,
11278,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,A,1,Intermediate,1,,CHEMBL624822,,BAO_0000218,,
11279,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL624823,,BAO_0000218,,
11280,,Escherichia coli,Observed diffusion coefficient in organic solvent for Escherichia coli,N,A,1,Intermediate,1,,CHEMBL624824,,BAO_0000218,,
11281,,Rattus norvegicus,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,A,1,Intermediate,1,,CHEMBL624825,,BAO_0000218,178.0,
11282,,Rattus norvegicus,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,A,1,Intermediate,1,,CHEMBL624826,,BAO_0000218,178.0,
11283,,Rattus norvegicus,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,A,1,Intermediate,1,,CHEMBL876817,,BAO_0000218,2081.0,
11284,,Rattus norvegicus,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,A,1,Intermediate,1,,CHEMBL624827,,BAO_0000218,2081.0,
11285,,Rattus norvegicus,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,A,1,Intermediate,1,,CHEMBL624828,,BAO_0000218,,
11286,,Rattus norvegicus,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,A,1,Intermediate,1,,CHEMBL624829,,BAO_0000218,,
11287,,Rattus norvegicus,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,A,1,Intermediate,1,,CHEMBL624830,,BAO_0000218,2107.0,
11288,,Rattus norvegicus,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,A,1,Intermediate,1,,CHEMBL624831,,BAO_0000218,2107.0,
11289,,Rattus norvegicus,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,A,1,Intermediate,1,,CHEMBL624832,,BAO_0000218,2081.0,
11290,,Rattus norvegicus,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,A,1,Intermediate,1,,CHEMBL624833,,BAO_0000218,2081.0,
11291,,Rattus norvegicus,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,A,1,Intermediate,1,,CHEMBL624834,,BAO_0000218,,
11292,,Rattus norvegicus,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,A,1,Intermediate,1,,CHEMBL624835,,BAO_0000218,,
11293,,Rattus norvegicus,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,A,1,Intermediate,1,,CHEMBL624836,,BAO_0000218,2106.0,
11294,,Rattus norvegicus,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,A,1,Intermediate,1,,CHEMBL624837,,BAO_0000218,2106.0,
11295,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL624838,,BAO_0000218,178.0,
11296,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL622188,,BAO_0000218,178.0,
11297,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL622189,,BAO_0000218,948.0,
11298,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,N,A,1,Intermediate,1,,CHEMBL622190,,BAO_0000218,948.0,
11299,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL625170,,BAO_0000218,948.0,
11300,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL625171,,BAO_0000218,2113.0,
11301,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL625172,,BAO_0000218,2113.0,
11302,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL625173,,BAO_0000218,2113.0,
11303,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL625174,,BAO_0000218,2107.0,
11304,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL625175,,BAO_0000218,2107.0,
11305,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,N,A,1,Intermediate,1,,CHEMBL625176,,BAO_0000218,2107.0,
11306,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL625177,,BAO_0000218,2048.0,
11307,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL625178,,BAO_0000218,2048.0,
11308,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,N,A,1,Intermediate,1,,CHEMBL625179,,BAO_0000218,2048.0,
11309,,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,A,1,Intermediate,1,,CHEMBL625180,,BAO_0000218,2048.0,
11310,,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",U,A,0,Autocuration,1,,CHEMBL625181,,BAO_0000218,,
11311,,Mus musculus,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,N,A,1,Intermediate,1,,CHEMBL625182,,BAO_0000218,1088.0,
11312,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL625183,,BAO_0000218,,
11313,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL875848,,BAO_0000218,,
11314,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL622260,,BAO_0000218,,
11315,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL622261,,BAO_0000218,,
11316,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL622262,,BAO_0000218,,
11317,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL622263,,BAO_0000218,2113.0,
11318,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL622418,,BAO_0000218,2113.0,
11319,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL622419,,BAO_0000218,2107.0,
11320,,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL623388,,BAO_0000218,,
11321,,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL623389,,BAO_0000218,2107.0,
11322,,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL623390,,BAO_0000218,,
11323,,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL623391,,BAO_0000218,,
11324,,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL623392,,BAO_0000218,178.0,
11325,,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL623393,,BAO_0000218,2037.0,
11326,,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL623394,,BAO_0000218,,
11327,,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL618885,,BAO_0000218,,
11328,,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL618886,,BAO_0000218,2107.0,
11329,,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL618887,,BAO_0000218,,
11330,,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL619535,,BAO_0000218,,
11331,,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL619536,,BAO_0000218,178.0,
11332,,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL619537,,BAO_0000218,2037.0,
11333,,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL619705,,BAO_0000218,,
11334,,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL619706,,BAO_0000218,,
11335,,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL619707,,BAO_0000218,2107.0,
11336,,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL619708,,BAO_0000218,,
11337,,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL625219,,BAO_0000218,,
11338,,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL625220,,BAO_0000218,178.0,
11339,,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL625221,,BAO_0000218,2037.0,
11340,,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL625222,,BAO_0000218,,
11341,,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL625223,,BAO_0000218,,
11342,,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL625224,,BAO_0000218,2107.0,
11343,,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,A,1,Intermediate,1,,CHEMBL625225,,BAO_0000218,,
11344,,Rattus norvegicus,Biodistribution in Rat blood after 24 hours of iv administration,N,A,1,Intermediate,1,,CHEMBL625226,,BAO_0000218,178.0,
11345,,Rattus norvegicus,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL625227,,BAO_0000218,178.0,
11346,,Rattus norvegicus,Biodistribution in Rat blood after 30 minutes of iv administration,N,A,1,Intermediate,1,,CHEMBL625228,,BAO_0000218,178.0,
11347,,Rattus norvegicus,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL875354,,BAO_0000218,178.0,
11348,,Rattus norvegicus,Biodistribution in Rat blood after 5 minutes of iv administration,N,A,1,Intermediate,1,,CHEMBL625229,,BAO_0000218,178.0,
11349,,Rattus norvegicus,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL625230,,BAO_0000218,178.0,
11350,,Rattus norvegicus,Biodistribution in Rat heart after 24 hours of iv administration,N,A,1,Intermediate,1,,CHEMBL625231,,BAO_0000218,948.0,
11351,,Rattus norvegicus,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL625900,,BAO_0000218,948.0,
11352,,Rattus norvegicus,Biodistribution in Rat heart after 30 minutes of iv administration,N,A,1,Intermediate,1,,CHEMBL625901,,BAO_0000218,948.0,
11353,,Rattus norvegicus,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL625902,,BAO_0000218,948.0,
11354,,Rattus norvegicus,Biodistribution in Rat heart after 5 minutes of iv administration,N,A,1,Intermediate,1,,CHEMBL625903,,BAO_0000218,948.0,
11355,,Rattus norvegicus,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL625904,,BAO_0000218,948.0,
11356,,Rattus norvegicus,Biodistribution in Rat liver after 24 hours of iv administration,N,A,1,Intermediate,1,,CHEMBL625905,,BAO_0000218,2107.0,
11357,,Rattus norvegicus,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL627861,,BAO_0000218,2107.0,
11358,,Rattus norvegicus,Biodistribution in Rat liver after 30 minutes of iv administration,N,A,1,Intermediate,1,,CHEMBL627862,,BAO_0000218,2107.0,
11359,,Rattus norvegicus,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL627863,,BAO_0000218,2107.0,
11360,,Rattus norvegicus,Biodistribution in Rat liver after 30 minutes of iv administration,N,A,1,Intermediate,1,,CHEMBL627769,,BAO_0000218,2107.0,
11361,,Canis lupus familiaris,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,A,1,Intermediate,1,,CHEMBL627770,,BAO_0000218,1969.0,
11362,,Macaca fascicularis,Cmax in cynomolgus monkey (PO dose),N,A,1,Intermediate,1,,CHEMBL627771,,BAO_0000218,,
11363,,Rattus norvegicus,Cmax in rat (PO dose),N,A,1,Intermediate,1,,CHEMBL627772,,BAO_0000218,,
11364,,Rattus norvegicus,Cmax in rat (PO dose),N,A,1,Intermediate,1,,CHEMBL627773,,BAO_0000218,,
11365,,Rattus norvegicus,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL621922,,BAO_0000218,1969.0,
11366,,Rattus norvegicus,Cmax in rat plasma after oral dose (10 mg/kg),N,A,1,Intermediate,1,,CHEMBL621923,,BAO_0000218,1969.0,
11367,,,Cmax in plasma after oral dose (10 mg/kg),U,A,0,Autocuration,1,,CHEMBL621924,,BAO_0000218,1969.0,
11368,,Canis lupus familiaris,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,N,A,1,Intermediate,1,,CHEMBL621925,,BAO_0000218,1969.0,
11369,,Simiiformes,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL621926,,BAO_0000218,1969.0,
11370,,Oryctolagus cuniculus,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,N,A,1,Intermediate,1,,CHEMBL621927,,BAO_0000218,1969.0,
11371,,Rattus norvegicus,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,N,A,1,Intermediate,1,,CHEMBL621928,,BAO_0000218,1969.0,
11372,,Rattus norvegicus,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,N,A,1,Intermediate,1,,CHEMBL621929,,BAO_0000218,1969.0,
11373,,Mus musculus,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,N,A,1,Intermediate,1,,CHEMBL621930,,BAO_0000218,1969.0,
11374,,Rattus norvegicus,Maximum plasma concentration after oral dosing in rat,N,A,1,Intermediate,1,,CHEMBL621931,,BAO_0000218,1969.0,
11375,,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL621932,,BAO_0000218,1969.0,
11376,,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL621933,,BAO_0000218,1969.0,
11377,,Canis lupus familiaris,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,N,A,1,Intermediate,1,,CHEMBL621934,,BAO_0000218,1969.0,
11378,,Canis lupus familiaris,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,N,A,1,Intermediate,1,,CHEMBL621935,,BAO_0000218,1969.0,
11379,,Rattus norvegicus,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,N,A,1,Intermediate,1,,CHEMBL621936,,BAO_0000218,1969.0,
11380,,,Maximum plasma concentration was determined,U,A,0,Autocuration,1,,CHEMBL621937,,BAO_0000218,1969.0,
11381,,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL621938,,BAO_0000218,1969.0,
11382,,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL621939,,BAO_0000218,1969.0,
11383,,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL621940,,BAO_0000218,1969.0,
11384,,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL621941,,BAO_0000218,1969.0,
11385,,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL621942,,BAO_0000218,1969.0,
11386,,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL626178,,BAO_0000218,1969.0,
11387,,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL626179,,BAO_0000218,1969.0,
11388,,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL626180,,BAO_0000218,1969.0,
11389,,Rattus norvegicus,Plasma Cmax in rat (PO dose),N,A,1,Intermediate,1,,CHEMBL626181,,BAO_0000218,1969.0,
11390,,Rattus norvegicus,Maximum serum concentration after po dose of 5.22 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626182,,BAO_0000218,,
11391,,Rattus norvegicus,Maximum serum concentration after po dose of 5.46 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626183,,BAO_0000218,,
11392,,Rattus norvegicus,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626184,,BAO_0000218,,
11393,,Rattus norvegicus,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL626185,,BAO_0000218,,
11394,,Canis lupus familiaris,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,N,A,1,Intermediate,1,,CHEMBL626186,,BAO_0000218,1969.0,
11395,,Canis lupus familiaris,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,N,A,1,Intermediate,1,,CHEMBL877589,,BAO_0000218,1969.0,
11396,,,Maximum concentration of the drug at 1 uM/dg administered intravenously,U,A,0,Autocuration,1,,CHEMBL626187,,BAO_0000218,,
11397,,,Maximum concentration of the drug at 20 uM/dg administered perorally,U,A,0,Autocuration,1,,CHEMBL626188,,BAO_0000218,,
11398,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,U,A,0,Autocuration,1,,CHEMBL626189,,BAO_0000218,,
11399,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,A,0,Autocuration,1,,CHEMBL626855,,BAO_0000218,178.0,
11400,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,A,0,Autocuration,1,,CHEMBL623781,,BAO_0000218,178.0,
11401,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,A,0,Autocuration,1,,CHEMBL623782,,BAO_0000218,178.0,
11402,,Rattus norvegicus,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL623783,,BAO_0000218,1969.0,
11403,,Canis lupus familiaris,Cmax in dog plasma after 1mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL623784,,BAO_0000218,1969.0,
11404,,Canis lupus familiaris,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL623785,,BAO_0000218,1969.0,
11405,,Rattus norvegicus,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL623786,,BAO_0000218,1969.0,
11406,,Rattus norvegicus,Oral maximum concentration in rat,N,A,1,Intermediate,1,,CHEMBL623787,,BAO_0000218,,
11407,,Rattus norvegicus,Oral maximum concentration in rat,N,A,1,Intermediate,1,,CHEMBL623788,,BAO_0000218,,
11408,,Mus musculus,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,N,A,1,Intermediate,1,,CHEMBL623789,,BAO_0000218,1969.0,
11409,,Mus musculus,Peak concentration in blood after intravenous administration to mice,N,A,1,Intermediate,1,,CHEMBL623790,,BAO_0000218,178.0,
11410,,Mus musculus,Peak concentration in blood after peroral administration to mice,N,A,1,Intermediate,1,,CHEMBL623791,,BAO_0000218,178.0,
11411,,Rattus norvegicus,Peak concentration in rat plasma was determined,N,A,1,Intermediate,1,,CHEMBL623792,,BAO_0000218,1969.0,
11412,,Simiiformes,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,U,A,0,Autocuration,1,,CHEMBL623793,,BAO_0000218,1969.0,
11413,,Mus musculus,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,N,A,1,Intermediate,1,,CHEMBL623794,,BAO_0000218,1969.0,
11414,,Rattus norvegicus,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,N,A,1,Intermediate,1,,CHEMBL623795,,BAO_0000218,1969.0,
11415,,Rattus norvegicus,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623796,,BAO_0000218,,
11416,,Rattus norvegicus,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623797,,BAO_0000218,,
11417,,Rattus norvegicus,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623798,,BAO_0000218,,
11418,,Rattus norvegicus,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623799,,BAO_0000218,,
11419,,Rattus norvegicus,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624490,,BAO_0000218,160.0,
11420,,Rattus norvegicus,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624491,,BAO_0000218,160.0,
11421,,Rattus norvegicus,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624492,,BAO_0000218,160.0,
11422,,Rattus norvegicus,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624493,,BAO_0000218,160.0,
11423,,Rattus norvegicus,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL877595,,BAO_0000218,160.0,
11424,,Rattus norvegicus,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624494,,BAO_0000218,160.0,
11425,,Rattus norvegicus,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624495,,BAO_0000218,160.0,
11426,,Rattus norvegicus,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624681,,BAO_0000218,160.0,
11427,,Rattus norvegicus,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624682,,BAO_0000218,,
11428,,Rattus norvegicus,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624683,,BAO_0000218,,
11429,,Rattus norvegicus,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624684,,BAO_0000218,,
11430,,Rattus norvegicus,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624685,,BAO_0000218,,
11431,,Rattus norvegicus,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624686,,BAO_0000218,,
11432,,Rattus norvegicus,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624687,,BAO_0000218,,
11433,,Rattus norvegicus,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624688,,BAO_0000218,,
11434,,Rattus norvegicus,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL627161,,BAO_0000218,,
11435,,Rattus norvegicus,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL622127,,BAO_0000218,,
11436,,Rattus norvegicus,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL622128,,BAO_0000218,,
11437,,Rattus norvegicus,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL874384,,BAO_0000218,,
11438,,Rattus norvegicus,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624898,,BAO_0000218,,
11439,,Rattus norvegicus,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624899,,BAO_0000218,,
11440,,Rattus norvegicus,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624900,,BAO_0000218,,
11441,,Rattus norvegicus,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624901,,BAO_0000218,,
11442,,Rattus norvegicus,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624902,,BAO_0000218,,
11443,,Rattus norvegicus,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624903,,BAO_0000218,,
11444,,Rattus norvegicus,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624904,,BAO_0000218,,
11445,,Rattus norvegicus,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624905,,BAO_0000218,,
11446,,Rattus norvegicus,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624906,,BAO_0000218,,
11447,,Rattus norvegicus,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624907,,BAO_0000218,,
11448,,Rattus norvegicus,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624908,,BAO_0000218,,
11449,,Rattus norvegicus,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624909,,BAO_0000218,,
11450,,Rattus norvegicus,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624910,,BAO_0000218,,
11451,,Rattus norvegicus,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624911,,BAO_0000218,2385.0,
11452,,Rattus norvegicus,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL874388,,BAO_0000218,2385.0,
11453,,Rattus norvegicus,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL624912,,BAO_0000218,2385.0,
11454,,Rattus norvegicus,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL622930,,BAO_0000218,2385.0,
11455,,Rattus norvegicus,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623121,,BAO_0000218,2385.0,
11456,,Rattus norvegicus,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623122,,BAO_0000218,2385.0,
11457,,Rattus norvegicus,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623123,,BAO_0000218,2385.0,
11458,,Rattus norvegicus,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623124,,BAO_0000218,2385.0,
11459,,Rattus norvegicus,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623125,,BAO_0000218,,
11460,,Rattus norvegicus,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623126,,BAO_0000218,,
11461,,Rattus norvegicus,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623127,,BAO_0000218,,
11462,,Rattus norvegicus,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623128,,BAO_0000218,,
11463,,Rattus norvegicus,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623129,,BAO_0000218,,
11464,,Rattus norvegicus,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623130,,BAO_0000218,,
11465,,Rattus norvegicus,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623131,,BAO_0000218,,
11466,,Rattus norvegicus,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL623132,,BAO_0000218,,
11467,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL623133,,BAO_0000218,2107.0,
11468,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL623134,,BAO_0000218,,
11469,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL874389,,BAO_0000218,,
11470,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL623135,,BAO_0000218,,
11471,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL623136,,BAO_0000218,,
11472,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL623137,,BAO_0000218,,
11473,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL623138,,BAO_0000218,,
11474,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL623139,,BAO_0000218,2113.0,
11475,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL623140,,BAO_0000218,2113.0,
11476,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL623141,,BAO_0000218,2107.0,
11477,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL623142,,BAO_0000218,2107.0,
11478,,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL623143,,BAO_0000218,,
11479,,Mus musculus,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,N,A,1,Intermediate,1,,CHEMBL623144,,BAO_0000218,1088.0,
11480,,Rattus norvegicus,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,N,A,1,Intermediate,1,,CHEMBL623405,,BAO_0000218,1088.0,
11481,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624074,,BAO_0000218,,
11482,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL624075,,BAO_0000218,,
11483,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624076,,BAO_0000218,,
11484,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL624077,,BAO_0000218,,
11485,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624078,,BAO_0000218,,
11486,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL624079,,BAO_0000218,2113.0,
11487,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624261,,BAO_0000218,2113.0,
11488,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL624262,,BAO_0000218,,
11489,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624263,,BAO_0000218,,
11490,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624264,,BAO_0000218,,
11491,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624265,,BAO_0000218,,
11492,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL624266,,BAO_0000218,,
11493,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624267,,BAO_0000218,,
11494,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL624268,,BAO_0000218,,
11495,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL875227,,BAO_0000218,,
11496,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL624269,,BAO_0000218,2113.0,
11497,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624270,,BAO_0000218,2113.0,
11498,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,A,1,Intermediate,1,,CHEMBL624271,,BAO_0000218,,
11499,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624272,,BAO_0000218,,
11500,,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,A,1,Intermediate,1,,CHEMBL624273,,BAO_0000218,,
11501,,Rattus norvegicus,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL624274,,BAO_0000218,1088.0,
11502,,Rattus norvegicus,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL624275,,BAO_0000218,1088.0,
11503,,Rattus norvegicus,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL624276,,BAO_0000218,1088.0,
11504,,Rattus norvegicus,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,N,A,1,Intermediate,1,,CHEMBL624277,,BAO_0000218,1088.0,
11505,,,% dose converted to 2-amino-5-chlorophenyl sulfate,U,A,0,Autocuration,1,,CHEMBL624278,,BAO_0000019,,
11506,,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),U,A,0,Autocuration,1,,CHEMBL624279,,BAO_0000019,,
11507,,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,A,1,Intermediate,1,,CHEMBL624280,,BAO_0000218,1988.0,
11508,,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,A,1,Intermediate,1,,CHEMBL624281,,BAO_0000218,1988.0,
11509,,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,A,1,Intermediate,1,,CHEMBL622933,,BAO_0000218,1988.0,
11510,,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,A,1,Intermediate,1,,CHEMBL622934,,BAO_0000218,1988.0,
11511,,Rattus norvegicus,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL622935,,BAO_0000218,2107.0,
11512,,Rattus norvegicus,Biodistribution in Rat liver after 5 minutes of iv administration,N,A,1,Intermediate,1,,CHEMBL622936,,BAO_0000218,2107.0,
11513,,Rattus norvegicus,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL875228,,BAO_0000218,2107.0,
11514,,Rattus norvegicus,Biodistribution in Rat lung after 24 hours of iv administration,N,A,1,Intermediate,1,,CHEMBL622937,,BAO_0000218,2048.0,
11515,,Rattus norvegicus,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL622938,,BAO_0000218,2048.0,
11516,,Rattus norvegicus,Biodistribution in Rat lung after 30 minutes of iv administration,N,A,1,Intermediate,1,,CHEMBL619736,,BAO_0000218,2048.0,
11517,,Rattus norvegicus,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL625117,,BAO_0000218,2048.0,
11518,,Rattus norvegicus,Biodistribution in Rat lung after 5 minutes of iv administration,N,A,1,Intermediate,1,,CHEMBL625118,,BAO_0000218,2048.0,
11519,,Rattus norvegicus,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,N,A,1,Intermediate,1,,CHEMBL625119,,BAO_0000218,2048.0,
11520,,Rattus norvegicus,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",N,A,1,Intermediate,1,,CHEMBL625120,,BAO_0000218,2037.0,
11521,,Rattus norvegicus,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",N,A,1,Intermediate,1,,CHEMBL625121,,BAO_0000218,,
11522,,Rattus norvegicus,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",N,A,1,Intermediate,1,,CHEMBL625122,,BAO_0000218,10000006.0,
11523,,Rattus norvegicus,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL622204,,BAO_0000218,178.0,
11524,,Rattus norvegicus,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL877503,,BAO_0000218,178.0,
11525,,Rattus norvegicus,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL627127,,BAO_0000218,178.0,
11526,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,U,A,0,Autocuration,1,,CHEMBL627128,,BAO_0000218,10000000.0,
11527,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,U,A,0,Autocuration,1,,CHEMBL627129,,BAO_0000218,10000000.0,
11528,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,U,A,0,Autocuration,1,,CHEMBL627130,,BAO_0000218,10000000.0,
11529,,Rattus norvegicus,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL627131,,BAO_0000218,955.0,
11530,,Rattus norvegicus,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL627132,,BAO_0000218,955.0,
11531,,Rattus norvegicus,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL627133,,BAO_0000218,955.0,
11532,,Rattus norvegicus,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL627134,,BAO_0000218,2037.0,
11533,,Rattus norvegicus,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL627135,,BAO_0000218,2037.0,
11534,,Rattus norvegicus,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL627136,,BAO_0000218,2037.0,
11535,,Rattus norvegicus,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL628435,,BAO_0000218,,
11536,,Rattus norvegicus,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL628436,,BAO_0000218,,
11537,,Rattus norvegicus,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL628437,,BAO_0000218,,
11538,,Rattus norvegicus,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL628438,,BAO_0000218,948.0,
11539,,Rattus norvegicus,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL628439,,BAO_0000218,948.0,
11540,,Rattus norvegicus,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL628440,,BAO_0000218,948.0,
11541,,Rattus norvegicus,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL628441,,BAO_0000218,10000000.0,
11542,,Rattus norvegicus,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL628442,,BAO_0000218,10000000.0,
11543,,Rattus norvegicus,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL628443,,BAO_0000218,10000000.0,
11544,,Rattus norvegicus,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL628444,,BAO_0000218,2113.0,
11545,,Rattus norvegicus,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL628445,,BAO_0000218,2113.0,
11546,,Rattus norvegicus,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL877504,,BAO_0000218,2113.0,
11547,,Rattus norvegicus,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL628446,,BAO_0000218,2107.0,
11548,,Rattus norvegicus,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL626874,,BAO_0000218,2107.0,
11549,,Rattus norvegicus,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL626875,,BAO_0000218,2107.0,
11550,,Rattus norvegicus,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL626876,,BAO_0000218,2048.0,
11551,,Rattus norvegicus,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL626877,,BAO_0000218,2048.0,
11552,,Rattus norvegicus,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL626878,,BAO_0000218,2048.0,
11553,,Rattus norvegicus,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL626879,,BAO_0000218,2385.0,
11554,,Simiiformes,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,U,A,0,Autocuration,1,,CHEMBL626880,,BAO_0000218,1969.0,
11555,,Mus musculus,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,N,A,1,Intermediate,1,,CHEMBL626881,,BAO_0000218,1969.0,
11556,,Rattus norvegicus,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,N,A,1,Intermediate,1,,CHEMBL626882,,BAO_0000218,1969.0,
11557,,Canis lupus familiaris,Peak plasma concentration was measured in dogs,N,A,1,Intermediate,1,,CHEMBL626883,,BAO_0000218,1969.0,
11558,,Rattus norvegicus,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,A,1,Intermediate,1,,CHEMBL626884,,BAO_0000218,,
11559,,Rattus norvegicus,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,A,1,Intermediate,1,,CHEMBL626885,,BAO_0000218,,
11560,,Rattus norvegicus,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL626886,,BAO_0000218,,
11561,,Rattus norvegicus,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,A,1,Intermediate,1,,CHEMBL626887,,BAO_0000218,,
11562,,Rattus norvegicus,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,A,1,Intermediate,1,,CHEMBL626888,,BAO_0000218,,
11563,,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,N,A,1,Intermediate,1,,CHEMBL626889,,BAO_0000218,,
11564,,Simiiformes,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,U,A,0,Autocuration,1,,CHEMBL626761,,BAO_0000218,,
11565,,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,N,A,1,Intermediate,1,,CHEMBL626762,,BAO_0000218,,
11566,,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,N,A,1,Intermediate,1,,CHEMBL626763,,BAO_0000218,,
11567,,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,N,A,1,Intermediate,1,,CHEMBL626764,,BAO_0000218,,
11568,,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,N,A,1,Intermediate,1,,CHEMBL626765,,BAO_0000218,,
11569,,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,N,A,1,Intermediate,1,,CHEMBL626766,,BAO_0000218,,
11570,,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,N,A,1,Intermediate,1,,CHEMBL626767,,BAO_0000218,,
11571,,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,N,A,1,Intermediate,1,,CHEMBL626768,,BAO_0000218,,
11572,,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,N,A,1,Intermediate,1,,CHEMBL626769,,BAO_0000218,,
11573,,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,N,A,1,Intermediate,1,,CHEMBL874463,,BAO_0000218,,
11574,,Simiiformes,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,U,A,0,Autocuration,1,,CHEMBL626770,,BAO_0000218,,
11575,,Simiiformes,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,U,A,0,Autocuration,1,,CHEMBL626771,,BAO_0000218,,
11576,,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,N,A,1,Intermediate,1,,CHEMBL626772,,BAO_0000218,,
11577,,Macaca fascicularis,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,A,1,Intermediate,1,,CHEMBL626773,,BAO_0000218,,
11578,,Mus musculus,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,N,A,1,Intermediate,1,,CHEMBL626774,,BAO_0000218,,
11579,,Canis lupus familiaris,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,A,1,Intermediate,1,,CHEMBL626775,,BAO_0000218,,
11580,,Canis lupus familiaris,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,A,1,Intermediate,1,,CHEMBL626776,,BAO_0000218,,
11581,,Rattus norvegicus,Maximum concentration (Cmax) in rat when administered orally,N,A,1,Intermediate,1,,CHEMBL626777,,BAO_0000218,,
11582,,Simiiformes,Maximal concentration in monkey plasma after 25 mg/kg oral dose,U,A,0,Autocuration,1,,CHEMBL626778,,BAO_0000218,1969.0,
11583,,Rattus norvegicus,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",U,A,0,Autocuration,1,,CHEMBL626779,,BAO_0000218,,
11584,,Rattus norvegicus,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",U,A,0,Autocuration,1,,CHEMBL626780,,BAO_0000218,,
11585,,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,U,A,0,Autocuration,1,,CHEMBL626781,,BAO_0000218,1969.0,
11586,,Rattus norvegicus,Pharmacokinetic profile Cmax was evaluated in rats,N,A,1,Intermediate,1,,CHEMBL632164,,BAO_0000218,,
11587,,Canis lupus familiaris,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),N,A,1,Intermediate,1,,CHEMBL632165,,BAO_0000218,,
11588,,Mus musculus,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),N,A,1,Intermediate,1,,CHEMBL632166,,BAO_0000218,,
11589,,Canis lupus familiaris,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),N,A,1,Intermediate,1,,CHEMBL632167,,BAO_0000218,,
11590,,Mus musculus,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),N,A,1,Intermediate,1,,CHEMBL632168,,BAO_0000218,,
11591,,Rattus norvegicus,Cmax in rat plasma,U,A,0,Autocuration,1,,CHEMBL632169,,BAO_0000218,1969.0,
11592,,Canis lupus familiaris,Cmax in dog plasma after 30mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL632170,,BAO_0000218,1969.0,
11593,,Rattus norvegicus,Cmax in rat plasma after 30mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL632171,,BAO_0000218,1969.0,
11594,,Rattus norvegicus,Plasma level in rats at 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL632172,,BAO_0000218,1969.0,
11595,,Mus musculus,Tested for maximum plasma concentration in mice,N,A,1,Intermediate,1,,CHEMBL632173,,BAO_0000218,1969.0,
11596,,Rattus norvegicus,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL632174,,BAO_0000218,,
11597,,Rattus norvegicus,The Cmax values in female wistar rats.,N,A,1,Intermediate,1,,CHEMBL632175,,BAO_0000218,,
11598,,Canis lupus familiaris,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL632176,,BAO_0000218,1969.0,
11599,,Rattus norvegicus,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL632177,,BAO_0000218,1969.0,
11600,,Rattus norvegicus,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,N,A,1,Intermediate,1,,CHEMBL632178,,BAO_0000218,1969.0,
11601,,Rattus norvegicus,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,N,A,1,Intermediate,1,,CHEMBL632179,,BAO_0000218,,
11602,,Rattus norvegicus,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,N,A,1,Intermediate,1,,CHEMBL632180,,BAO_0000218,178.0,
11603,,Rattus norvegicus,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,N,A,1,Intermediate,1,,CHEMBL632181,,BAO_0000218,178.0,
11604,,Rattus norvegicus,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,N,A,1,Intermediate,1,,CHEMBL632182,,BAO_0000218,178.0,
11605,,Mus musculus,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,U,A,0,Autocuration,1,,CHEMBL632183,,BAO_0000218,178.0,
11606,,Canis lupus familiaris,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,N,A,1,Intermediate,1,,CHEMBL632184,,BAO_0000218,,
11607,,Rattus norvegicus,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,N,A,1,Intermediate,1,,CHEMBL874470,,BAO_0000218,,
11608,,Rattus norvegicus,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL631302,,BAO_0000218,,
11609,,Rattus norvegicus,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL631303,,BAO_0000218,,
11610,,Rattus norvegicus,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL631304,,BAO_0000218,,
11611,,Rattus norvegicus,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL631305,,BAO_0000218,,
11612,,Rattus norvegicus,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL631306,,BAO_0000218,,
11613,,Rattus norvegicus,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL631307,,BAO_0000218,,
11614,,Rattus norvegicus,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL631308,,BAO_0000218,,
11615,,Rattus norvegicus,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625557,,BAO_0000218,,
11616,,Rattus norvegicus,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625558,,BAO_0000218,2106.0,
11617,,Rattus norvegicus,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625559,,BAO_0000218,2106.0,
11618,,Rattus norvegicus,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625560,,BAO_0000218,2106.0,
11619,,Rattus norvegicus,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625561,,BAO_0000218,2106.0,
11620,,Rattus norvegicus,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625562,,BAO_0000218,2106.0,
11621,,Rattus norvegicus,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL875320,,BAO_0000218,2106.0,
11622,,Rattus norvegicus,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625563,,BAO_0000218,2106.0,
11623,,Rattus norvegicus,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625564,,BAO_0000218,2106.0,
11624,,Rattus norvegicus,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625565,,BAO_0000218,995.0,
11625,,Rattus norvegicus,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625566,,BAO_0000218,995.0,
11626,,Rattus norvegicus,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625567,,BAO_0000218,995.0,
11627,,Rattus norvegicus,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL625568,,BAO_0000218,995.0,
11628,,Rattus norvegicus,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL628217,,BAO_0000218,995.0,
11629,,Rattus norvegicus,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL628218,,BAO_0000218,995.0,
11630,,Rattus norvegicus,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL628219,,BAO_0000218,995.0,
11631,,Rattus norvegicus,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",N,A,1,Intermediate,1,,CHEMBL628220,,BAO_0000218,995.0,
11632,,,Distribution in the blood after 120 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628221,,BAO_0000019,,
11633,,,Distribution in the blood after 15 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628222,,BAO_0000019,,
11634,,,Distribution in the blood after 30 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628223,,BAO_0000019,,
11635,,,Distribution in the blood after 5 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628224,,BAO_0000019,,
11636,,,Distribution in the blood after 60 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628225,,BAO_0000019,,
11637,,,Distribution in the blood after 90 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628226,,BAO_0000019,,
11638,,,Distribution in the bone after 120 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628227,,BAO_0000019,,
11639,,,Distribution in the bone after 15 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL875481,,BAO_0000019,,
11640,,,Distribution in the bone after 30 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628228,,BAO_0000019,,
11641,,,Distribution in the bone after 5 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628229,,BAO_0000019,,
11642,,,Distribution in the bone after 60 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628230,,BAO_0000019,,
11643,,,Distribution in the bone after 90 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628231,,BAO_0000019,,
11644,,,Distribution in the heart after 120 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628232,,BAO_0000019,,
11645,,,Distribution in the heart after 15 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628233,,BAO_0000019,,
11646,,,Distribution in the heart after 30 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628234,,BAO_0000019,,
11647,,,Distribution in the heart after 5 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628235,,BAO_0000019,,
11648,,,Distribution in the heart after 60 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628236,,BAO_0000019,,
11649,,,Distribution in the heart after 90 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628237,,BAO_0000019,,
11650,,,Distribution in the kidneys after 120 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628238,,BAO_0000019,,
11651,,,Distribution in the kidneys after 15 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628239,,BAO_0000019,,
11652,,,Distribution in the kidneys after 30 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628240,,BAO_0000019,,
11653,,,Distribution in the kidneys after 5 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628241,,BAO_0000019,,
11654,,,Distribution in the kidneys after 60 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628242,,BAO_0000019,,
11655,,,Distribution in the kidneys after 90 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL875482,,BAO_0000019,,
11656,,,Distribution in the liver after 120 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628243,,BAO_0000019,,
11657,,,Distribution in the liver after 15 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628244,,BAO_0000019,,
11658,,,Distribution in the liver after 30 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628245,,BAO_0000019,,
11659,,,Distribution in the liver after 5 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628246,,BAO_0000019,,
11660,,,Distribution in the liver after 60 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628247,,BAO_0000019,,
11661,,,Distribution in the liver after 90 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628248,,BAO_0000019,,
11662,,,Distribution in the lung after 120 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628249,,BAO_0000019,,
11663,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",N,A,1,Intermediate,1,,CHEMBL625452,,BAO_0000218,,
11664,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",N,A,1,Intermediate,1,,CHEMBL625453,,BAO_0000218,,
11665,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",N,A,1,Intermediate,1,,CHEMBL625454,,BAO_0000218,,
11666,,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",N,A,1,Intermediate,1,,CHEMBL623844,,BAO_0000218,,
11667,,Rattus norvegicus,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,N,A,1,Intermediate,1,,CHEMBL623845,,BAO_0000218,,
11668,,Rattus norvegicus,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,N,A,1,Intermediate,1,,CHEMBL623846,,BAO_0000218,,
11669,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,U,A,0,Autocuration,1,,CHEMBL623847,,BAO_0000218,,
11670,,Macaca fascicularis,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,A,1,Intermediate,1,,CHEMBL623848,,BAO_0000218,,
11671,,Macaca fascicularis,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,A,1,Intermediate,1,,CHEMBL623849,,BAO_0000218,,
11672,,Macaca fascicularis,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,A,1,Intermediate,1,,CHEMBL623850,,BAO_0000218,,
11673,,Macaca fascicularis,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,A,1,Intermediate,1,,CHEMBL623851,,BAO_0000218,,
11674,,Simiiformes,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,A,0,Autocuration,1,,CHEMBL623852,,BAO_0000218,,
11675,,Mustela putorius furo,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,A,1,Intermediate,1,,CHEMBL624551,,BAO_0000218,,
11676,,Mustela putorius furo,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,A,1,Intermediate,1,,CHEMBL624552,,BAO_0000218,,
11677,,Simiiformes,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,A,0,Autocuration,1,,CHEMBL624553,,BAO_0000218,,
11678,,Simiiformes,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,U,A,0,Autocuration,1,,CHEMBL624554,,BAO_0000218,,
11679,,Rattus norvegicus,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL624555,,BAO_0000218,,
11680,,Rattus norvegicus,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,A,1,Intermediate,1,,CHEMBL624741,,BAO_0000218,,
11681,,Canis lupus familiaris,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",N,A,1,Intermediate,1,,CHEMBL624742,,BAO_0000218,,
11682,,Cricetinae,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",N,A,1,Intermediate,1,,CHEMBL624743,,BAO_0000218,,
11683,,Rattus norvegicus,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",N,A,1,Intermediate,1,,CHEMBL877606,,BAO_0000218,,
11684,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,U,A,0,Autocuration,1,,CHEMBL624744,,BAO_0000218,,
11685,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,A,0,Autocuration,1,,CHEMBL624745,,BAO_0000218,178.0,
11686,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,A,0,Autocuration,1,,CHEMBL624746,,BAO_0000218,178.0,
11687,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,A,0,Autocuration,1,,CHEMBL624747,,BAO_0000218,178.0,
11688,,,Oral absorption expressed as Area under curve was determined,U,A,0,Autocuration,1,,CHEMBL624748,,BAO_0000019,,
11689,,Canis lupus familiaris,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,N,A,1,Intermediate,1,,CHEMBL622504,,BAO_0000218,,
11690,,Canis lupus familiaris,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",N,A,1,Intermediate,1,,CHEMBL622505,,BAO_0000218,,
11691,,Cricetinae,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,A,1,Intermediate,1,,CHEMBL622506,,BAO_0000218,,
11692,,Cricetinae,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,A,1,Intermediate,1,,CHEMBL622507,,BAO_0000218,,
11693,,Rattus norvegicus,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",N,A,1,Intermediate,1,,CHEMBL622508,,BAO_0000218,,
11694,,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,U,A,0,Autocuration,1,,CHEMBL622509,,BAO_0000019,,
11695,,Rattus norvegicus,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,A,1,Intermediate,1,,CHEMBL622510,,BAO_0000218,,
11696,,Rattus norvegicus,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),N,A,1,Intermediate,1,,CHEMBL622511,,BAO_0000218,,
11697,,Macaca fascicularis,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL622512,,BAO_0000218,,
11698,,Macaca fascicularis,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL622513,,BAO_0000218,,
11699,,Macaca fascicularis,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL622514,,BAO_0000218,,
11700,,Canis lupus familiaris,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL622515,,BAO_0000218,,
11701,,Canis lupus familiaris,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL622516,,BAO_0000218,,
11702,,Rattus norvegicus,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL622517,,BAO_0000218,,
11703,,Rattus norvegicus,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL622518,,BAO_0000218,,
11704,,Rattus norvegicus,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL622519,,BAO_0000218,,
11705,,Rattus norvegicus,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL622520,,BAO_0000218,2385.0,
11706,,Rattus norvegicus,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL622521,,BAO_0000218,2385.0,
11707,,Mus musculus,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL625113,,BAO_0000218,14.0,
11708,,Rattus norvegicus,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL625114,,BAO_0000218,14.0,
11709,,Rattus norvegicus,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL874397,,BAO_0000218,14.0,
11710,,Rattus norvegicus,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL625115,,BAO_0000218,2106.0,
11711,,Rattus norvegicus,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL625116,,BAO_0000218,2106.0,
11712,,Rattus norvegicus,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL623932,,BAO_0000218,2106.0,
11713,,Rattus norvegicus,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL623933,,BAO_0000218,2435.0,
11714,,Rattus norvegicus,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL623934,,BAO_0000218,2435.0,
11715,,Rattus norvegicus,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL623935,,BAO_0000218,2435.0,
11716,,Rattus norvegicus,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,A,1,Intermediate,1,,CHEMBL623936,,BAO_0000218,2046.0,
11717,,Rattus norvegicus,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,A,1,Intermediate,1,,CHEMBL623937,,BAO_0000218,2046.0,
11718,,Rattus norvegicus,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,A,1,Intermediate,1,,CHEMBL623938,,BAO_0000218,2046.0,
11719,,Mus musculus,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,A,1,Intermediate,1,,CHEMBL623939,,BAO_0000218,,
11720,,Mus musculus,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,A,1,Intermediate,1,,CHEMBL623940,,BAO_0000218,,
11721,,Mus musculus,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,A,1,Intermediate,1,,CHEMBL623941,,BAO_0000218,,
11722,,Mus musculus,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL627216,,BAO_0000218,,
11723,,Mus musculus,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL623942,,BAO_0000218,,
11724,,Mus musculus,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,A,1,Intermediate,1,,CHEMBL618793,,BAO_0000218,955.0,
11725,,Mus musculus,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL618794,,BAO_0000218,955.0,
11726,,Mus musculus,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL618795,,BAO_0000218,955.0,
11727,,Mus musculus,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL618796,,BAO_0000218,,
11728,,Mus musculus,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL618797,,BAO_0000218,,
11729,,Mus musculus,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,A,1,Intermediate,1,,CHEMBL618798,,BAO_0000218,2113.0,
11730,,Mus musculus,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,A,1,Intermediate,1,,CHEMBL618799,,BAO_0000218,2113.0,
11731,,Mus musculus,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,A,1,Intermediate,1,,CHEMBL618800,,BAO_0000218,2113.0,
11732,,Mus musculus,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,A,1,Intermediate,1,,CHEMBL618801,,BAO_0000218,2113.0,
11733,,Mus musculus,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL618802,,BAO_0000218,2113.0,
11734,,Mus musculus,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL618803,,BAO_0000218,2113.0,
11735,,Mus musculus,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,A,1,Intermediate,1,,CHEMBL618804,,BAO_0000218,2107.0,
11736,,Mus musculus,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,A,1,Intermediate,1,,CHEMBL618805,,BAO_0000218,2107.0,
11737,,Mus musculus,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,A,1,Intermediate,1,,CHEMBL618806,,BAO_0000218,2107.0,
11738,,Mus musculus,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,A,1,Intermediate,1,,CHEMBL618807,,BAO_0000218,2107.0,
11739,,Mus musculus,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL618808,,BAO_0000218,2107.0,
11740,,Mus musculus,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL618809,,BAO_0000218,2107.0,
11741,,Mus musculus,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,A,1,Intermediate,1,,CHEMBL618810,,BAO_0000218,2385.0,
11742,,Mus musculus,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,A,1,Intermediate,1,,CHEMBL618811,,BAO_0000218,2385.0,
11743,,Mus musculus,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,A,1,Intermediate,1,,CHEMBL875844,,BAO_0000218,2385.0,
11744,,Mus musculus,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL618812,,BAO_0000218,2385.0,
11745,,Mus musculus,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL618813,,BAO_0000218,2385.0,
11746,,Mus musculus,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,A,1,Intermediate,1,,CHEMBL618814,,BAO_0000218,,
11747,,Mus musculus,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL618815,,BAO_0000218,,
11748,,Mus musculus,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL618816,,BAO_0000218,,
11749,,Mus musculus,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL618817,,BAO_0000218,,
11750,,Mus musculus,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL620544,,BAO_0000218,,
11751,,Rattus norvegicus,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,N,A,1,Intermediate,1,,CHEMBL626230,,BAO_0000218,,
11752,,Rattus norvegicus,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,N,A,1,Intermediate,1,,CHEMBL626231,,BAO_0000218,,
11753,,Rattus norvegicus,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,N,A,1,Intermediate,1,,CHEMBL626232,,BAO_0000218,,
11754,,Canis lupus familiaris,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,N,A,1,Intermediate,1,,CHEMBL626233,,BAO_0000218,1969.0,
11755,,Rattus norvegicus,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,N,A,1,Intermediate,1,,CHEMBL626234,,BAO_0000218,1969.0,
11756,,Rattus norvegicus,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,N,A,1,Intermediate,1,,CHEMBL875341,,BAO_0000218,1969.0,
11757,,Homo sapiens,The maximum plasma concentration (100 mg/kg) administered orally in human,N,A,1,Intermediate,1,,CHEMBL626235,,BAO_0000218,1969.0,
11758,,Callithrix,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,U,A,0,Autocuration,1,,CHEMBL626236,,BAO_0000218,1969.0,
11759,,Simiiformes,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,U,A,0,Autocuration,1,,CHEMBL626237,,BAO_0000218,1969.0,
11760,,Canis lupus familiaris,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,N,A,1,Intermediate,1,,CHEMBL626238,,BAO_0000218,1969.0,
11761,,Homo sapiens,The maximum plasma concentration (200 mg/kg) administered orally in human,N,A,1,Intermediate,1,,CHEMBL622412,,BAO_0000218,1969.0,
11762,,Rattus norvegicus,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,N,A,1,Intermediate,1,,CHEMBL623114,,BAO_0000218,1969.0,
11763,,Callithrix,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,U,A,0,Autocuration,1,,CHEMBL623115,,BAO_0000218,1969.0,
11764,,Simiiformes,The maximum plasma concentration (25 mg/kg) administered orally in monkey,U,A,0,Autocuration,1,,CHEMBL623116,,BAO_0000218,1969.0,
11765,,Canis lupus familiaris,The maximum plasma concentration (30 mg/kg) administered orally in dog,U,A,0,Autocuration,1,,CHEMBL623117,,BAO_0000218,1969.0,
11766,,Homo sapiens,The maximum plasma concentration (400 mg/kg) administered orally in human,N,A,1,Intermediate,1,,CHEMBL623118,,BAO_0000218,1969.0,
11767,,Rattus norvegicus,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,N,A,1,Intermediate,1,,CHEMBL623119,,BAO_0000218,1969.0,
11768,,Rattus norvegicus,The maximum plasma concentration (50 mg/kg) administered orally in rat,N,A,1,Intermediate,1,,CHEMBL623120,,BAO_0000218,1969.0,
11769,,Homo sapiens,The maximum plasma concentration (800 mg/kg) administered orally in human,N,A,1,Intermediate,1,,CHEMBL623286,,BAO_0000218,1969.0,
11770,,Rattus norvegicus,The maximum plasma concentration was measured on rats,N,A,1,Intermediate,1,,CHEMBL623287,,BAO_0000218,1969.0,
11771,,Rattus norvegicus,The maximum plasma concentration was measured on rats after oral administration,N,A,1,Intermediate,1,,CHEMBL623288,,BAO_0000218,1969.0,
11772,,Rattus norvegicus,Plasma drug Cmax in rat (PO dose),N,A,1,Intermediate,1,,CHEMBL623289,,BAO_0000218,1969.0,
11773,,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,U,A,0,Autocuration,1,,CHEMBL623290,,BAO_0000218,,
11774,,Canis lupus familiaris,maximum Plasma concentration in Dog was determined after Peroral administration,N,A,1,Intermediate,1,,CHEMBL623291,,BAO_0000218,1969.0,
11775,,Rattus norvegicus,maximum Plasma concentration in Rats was determined after Peroral administration,N,A,1,Intermediate,1,,CHEMBL623292,,BAO_0000218,1969.0,
11776,,Canis lupus familiaris,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,A,1,Intermediate,1,,CHEMBL623293,,BAO_0000218,1969.0,
11777,,Simiiformes,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,A,0,Autocuration,1,,CHEMBL623294,,BAO_0000218,1969.0,
11778,,Rattus norvegicus,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL623295,,BAO_0000218,1969.0,
11779,,Mus musculus,maximum concentration was measured when administered through oral route in mice,N,A,1,Intermediate,1,,CHEMBL623296,,BAO_0000218,,
11780,,Mus musculus,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,N,A,1,Intermediate,1,,CHEMBL875349,,BAO_0000218,,
11781,,Simiiformes,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,U,A,0,Autocuration,1,,CHEMBL623297,,BAO_0000019,,
11782,,Simiiformes,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,U,A,0,Autocuration,1,,CHEMBL623298,,BAO_0000019,,
11783,,Simiiformes,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,U,A,0,Autocuration,1,,CHEMBL623299,,BAO_0000019,,
11784,,Rattus norvegicus,Pharmacokinetic parameter was evaluated in rats,N,A,1,Intermediate,1,,CHEMBL623300,,BAO_0000218,,
11785,,Mus musculus,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,A,1,Intermediate,1,,CHEMBL623301,,BAO_0000218,,
11786,,Mus musculus,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,N,A,1,Intermediate,1,,CHEMBL623302,,BAO_0000218,,
11787,,Mus musculus,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,A,1,Intermediate,1,,CHEMBL623303,,BAO_0000218,,
11788,,Mus musculus,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,N,A,1,Intermediate,1,,CHEMBL623304,,BAO_0000218,,
11789,,Mus musculus,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,N,A,1,Intermediate,1,,CHEMBL623305,,BAO_0000218,,
11790,,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,N,A,1,Intermediate,1,,CHEMBL623306,,BAO_0000218,1969.0,
11791,,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,N,A,1,Intermediate,1,,CHEMBL623307,,BAO_0000218,1969.0,
11792,,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,N,A,1,Intermediate,1,,CHEMBL623308,,BAO_0000218,1969.0,
11793,,Mus musculus,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,N,A,1,Intermediate,1,,CHEMBL623309,,BAO_0000218,1969.0,
11794,,Mus musculus,Plasma Concentration after 120 min of oral administration to mice,N,A,1,Intermediate,1,,CHEMBL623310,,BAO_0000218,,
11795,,Mus musculus,Plasma Concentration after 30 min of oral administration to mice,N,A,1,Intermediate,1,,CHEMBL623311,,BAO_0000218,,
11796,,Macaca fascicularis,Plasma Concentration after 60 min of oral administration to mice,N,A,1,Intermediate,1,,CHEMBL623312,,BAO_0000218,,
11797,,Mus musculus,Plasma Concentration after 60 min of oral administration to mice; Not determined,N,A,1,Intermediate,1,,CHEMBL875350,,BAO_0000218,,
11798,,Mus musculus,Plasma Concentration after 90 min of oral administration to mice,N,A,1,Intermediate,1,,CHEMBL628635,,BAO_0000218,,
11799,,Rattus norvegicus,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL628636,,BAO_0000218,,
11800,,Rattus norvegicus,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL628637,,BAO_0000218,,
11801,,Rattus norvegicus,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,N,A,1,Intermediate,1,,CHEMBL628058,,BAO_0000218,,
11802,,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,N,A,1,Intermediate,1,,CHEMBL628059,,BAO_0000218,,
11803,,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,N,A,1,Intermediate,1,,CHEMBL628060,,BAO_0000218,,
11804,,,Distribution in the lung after 15 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628061,,BAO_0000019,,
11805,,,Distribution in the lung after 30 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628062,,BAO_0000019,,
11806,,,Distribution in the lung after 5 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628063,,BAO_0000019,,
11807,,,Distribution in the lung after 60 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628064,,BAO_0000019,,
11808,,,Distribution in the lung after 90 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628065,,BAO_0000019,,
11809,,,Distribution in the muscle after 120 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628066,,BAO_0000019,2385.0,
11810,,,Distribution in the muscle after 15 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628067,,BAO_0000019,2385.0,
11811,,Mus musculus,Distribution in the muscle after 30 min of intravenous administration,N,A,1,Intermediate,1,,CHEMBL874646,,BAO_0000218,2385.0,
11812,,,Distribution in the muscle after 5 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628068,,BAO_0000019,2385.0,
11813,,,Distribution in the muscle after 60 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628069,,BAO_0000019,2385.0,
11814,,,Distribution in the muscle after 90 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628070,,BAO_0000019,2385.0,
11815,,,Distribution in the spleen after 120 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628071,,BAO_0000019,2106.0,
11816,,,Distribution in the spleen after 15 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628072,,BAO_0000019,2106.0,
11817,,,Distribution in the spleen after 30 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628073,,BAO_0000019,2106.0,
11818,,,Distribution in the spleen after 5 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628074,,BAO_0000019,2106.0,
11819,,,Distribution in the spleen after 60 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628075,,BAO_0000019,2106.0,
11820,,,Distribution in the spleen after 90 min of intravenous administration,U,A,0,Autocuration,1,,CHEMBL628076,,BAO_0000019,2106.0,
11821,,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL628077,,BAO_0000218,1235.0,
11822,,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL628078,,BAO_0000218,178.0,
11823,,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL628079,,BAO_0000218,2107.0,
11824,,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL628080,,BAO_0000218,992.0,
11825,,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL628081,,BAO_0000218,2046.0,
11826,,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL628082,,BAO_0000218,1235.0,
11827,,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL874647,,BAO_0000218,178.0,
11828,,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL626406,,BAO_0000218,2107.0,
11829,,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL626407,,BAO_0000218,992.0,
11830,,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,N,A,1,Intermediate,1,,CHEMBL626408,,BAO_0000218,2046.0,
11831,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",N,A,1,Intermediate,1,,CHEMBL626409,,BAO_0000218,178.0,
11832,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",N,A,1,Intermediate,1,,CHEMBL626410,,BAO_0000218,178.0,
11833,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",N,A,1,Intermediate,1,,CHEMBL626411,,BAO_0000218,178.0,
11834,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",N,A,1,Intermediate,1,,CHEMBL626412,,BAO_0000218,178.0,
11835,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",N,A,1,Intermediate,1,,CHEMBL626413,,BAO_0000218,178.0,
11836,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",N,A,1,Intermediate,1,,CHEMBL626414,,BAO_0000218,178.0,
11837,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",N,A,1,Intermediate,1,,CHEMBL626415,,BAO_0000218,178.0,
11838,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",N,A,1,Intermediate,1,,CHEMBL626416,,BAO_0000218,178.0,
11839,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",N,A,1,Intermediate,1,,CHEMBL627062,,BAO_0000218,178.0,
11840,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",N,A,1,Intermediate,1,,CHEMBL627063,,BAO_0000218,178.0,
11841,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",N,A,1,Intermediate,1,,CHEMBL627064,,BAO_0000218,178.0,
11842,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",N,A,1,Intermediate,1,,CHEMBL627227,,BAO_0000218,178.0,
11843,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",N,A,1,Intermediate,1,,CHEMBL627228,,BAO_0000218,178.0,
11844,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",N,A,1,Intermediate,1,,CHEMBL627229,,BAO_0000218,178.0,
11845,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",N,A,1,Intermediate,1,,CHEMBL625792,,BAO_0000218,178.0,
11846,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",N,A,1,Intermediate,1,,CHEMBL625793,,BAO_0000218,178.0,
11847,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",N,A,1,Intermediate,1,,CHEMBL625794,,BAO_0000218,178.0,
11848,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",N,A,1,Intermediate,1,,CHEMBL625795,,BAO_0000218,178.0,
11849,,Mus musculus,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,N,A,1,Intermediate,1,,CHEMBL625796,,BAO_0000218,,
11850,,Canis lupus familiaris,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,A,1,Intermediate,1,,CHEMBL625797,,BAO_0000218,,
11851,,Canis lupus familiaris,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,A,1,Intermediate,1,,CHEMBL625798,,BAO_0000218,,
11852,,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL875613,,BAO_0000218,,
11853,,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL625799,,BAO_0000218,,
11854,,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL625800,,BAO_0000218,,
11855,,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL625801,,BAO_0000218,,
11856,,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL625802,,BAO_0000218,,
11857,,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL625803,,BAO_0000218,,
11858,,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,U,A,0,Autocuration,1,,CHEMBL625804,,BAO_0000019,,
11859,,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL622530,,BAO_0000218,,
11860,,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,N,A,1,Intermediate,1,,CHEMBL622531,,BAO_0000218,,
11861,,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,A,1,Intermediate,1,,CHEMBL622532,,BAO_0000218,,
11862,,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL623176,,BAO_0000218,,
11863,,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,A,1,Intermediate,1,,CHEMBL623177,,BAO_0000218,,
11864,,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,A,1,Intermediate,1,,CHEMBL623178,,BAO_0000218,,
11865,,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,N,A,1,Intermediate,1,,CHEMBL623179,,BAO_0000218,,
11866,,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,A,1,Intermediate,1,,CHEMBL623180,,BAO_0000218,,
11867,,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL623181,,BAO_0000218,,
11868,,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL624131,,BAO_0000218,,
11869,,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),N,A,1,Intermediate,1,,CHEMBL624132,,BAO_0000218,,
11870,,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL624133,,BAO_0000218,,
11871,,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,N,A,1,Intermediate,1,,CHEMBL624846,,BAO_0000218,,
11872,,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL624847,,BAO_0000218,,
11873,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL624848,,BAO_0000218,,
11874,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,A,1,Intermediate,1,,CHEMBL625012,,BAO_0000218,,
11875,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL625013,,BAO_0000218,,
11876,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,N,A,1,Intermediate,1,,CHEMBL625014,,BAO_0000218,,
11877,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),N,A,1,Intermediate,1,,CHEMBL625015,,BAO_0000218,,
11878,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL625016,,BAO_0000218,,
11879,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,N,A,1,Intermediate,1,,CHEMBL625017,,BAO_0000218,,
11880,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL625018,,BAO_0000218,,
11881,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL625019,,BAO_0000218,,
11882,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL625020,,BAO_0000218,,
11883,,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,N,A,1,Intermediate,1,,CHEMBL625021,,BAO_0000218,,
11884,,Rattus norvegicus,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,A,1,Intermediate,1,,CHEMBL625022,,BAO_0000218,,
11885,,Mus musculus,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,N,A,1,Intermediate,1,,CHEMBL625023,,BAO_0000218,,
11886,,Macaca fascicularis,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,N,A,1,Intermediate,1,,CHEMBL625024,,BAO_0000218,,
11887,,Macaca fascicularis,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,A,1,Intermediate,1,,CHEMBL627626,,BAO_0000218,,
11888,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,A,0,Autocuration,1,,CHEMBL627627,,BAO_0000218,955.0,
11889,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,U,A,0,Autocuration,1,,CHEMBL627628,,BAO_0000218,1977.0,
11890,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,A,0,Autocuration,1,,CHEMBL627629,,BAO_0000218,955.0,
11891,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,U,A,0,Autocuration,1,,CHEMBL627630,,BAO_0000218,1977.0,
11892,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),U,A,0,Autocuration,1,,CHEMBL627631,,BAO_0000019,,
11893,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),U,A,0,Autocuration,1,,CHEMBL629515,,BAO_0000218,,
11894,,Mus musculus,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,A,1,Intermediate,1,,CHEMBL629516,,BAO_0000218,2106.0,
11895,,Mus musculus,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL629517,,BAO_0000218,2106.0,
11896,,Mus musculus,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL629518,,BAO_0000218,2106.0,
11897,,Mus musculus,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,A,1,Intermediate,1,,CHEMBL877499,,BAO_0000218,,
11898,,Mus musculus,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,A,1,Intermediate,1,,CHEMBL629519,,BAO_0000218,,
11899,,Mus musculus,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,A,1,Intermediate,1,,CHEMBL629520,,BAO_0000218,,
11900,,Mus musculus,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,A,1,Intermediate,1,,CHEMBL629521,,BAO_0000218,,
11901,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),N,A,1,Intermediate,1,,CHEMBL629522,,BAO_0000218,,
11902,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),N,A,1,Intermediate,1,,CHEMBL629523,,BAO_0000218,,
11903,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),N,A,1,Intermediate,1,,CHEMBL629524,,BAO_0000218,,
11904,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),N,A,1,Intermediate,1,,CHEMBL629525,,BAO_0000218,,
11905,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),N,A,1,Intermediate,1,,CHEMBL629526,,BAO_0000218,,
11906,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),N,A,1,Intermediate,1,,CHEMBL629527,,BAO_0000218,,
11907,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),N,A,1,Intermediate,1,,CHEMBL629528,,BAO_0000218,,
11908,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),N,A,1,Intermediate,1,,CHEMBL629529,,BAO_0000218,,
11909,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),N,A,1,Intermediate,1,,CHEMBL629530,,BAO_0000218,,
11910,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),N,A,1,Intermediate,1,,CHEMBL629531,,BAO_0000218,,
11911,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),N,A,1,Intermediate,1,,CHEMBL628656,,BAO_0000218,,
11912,,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),N,A,1,Intermediate,1,,CHEMBL628657,,BAO_0000218,,
11913,,Rattus norvegicus,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628658,,BAO_0000218,,
11914,,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628659,,BAO_0000218,,
11915,,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL877500,,BAO_0000218,,
11916,,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628660,,BAO_0000218,,
11917,,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628661,,BAO_0000218,,
11918,,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628662,,BAO_0000218,,
11919,,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628663,,BAO_0000218,,
11920,,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628664,,BAO_0000218,,
11921,,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628665,,BAO_0000218,178.0,
11922,,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628666,,BAO_0000218,178.0,
11923,,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628667,,BAO_0000218,178.0,
11924,,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628668,,BAO_0000218,178.0,
11925,,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628669,,BAO_0000218,178.0,
11926,,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628670,,BAO_0000218,178.0,
11927,,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628671,,BAO_0000218,178.0,
11928,,Rattus norvegicus,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL628672,,BAO_0000218,10000001.0,
11929,,Rattus norvegicus,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL630300,,BAO_0000218,10000001.0,
11930,,Rattus norvegicus,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629787,,BAO_0000218,10000001.0,
11931,,Rattus norvegicus,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629788,,BAO_0000218,10000001.0,
11932,,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629789,,BAO_0000218,955.0,
11933,,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629790,,BAO_0000218,955.0,
11934,,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629791,,BAO_0000218,955.0,
11935,,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629792,,BAO_0000218,955.0,
11936,,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629793,,BAO_0000218,955.0,
11937,,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629794,,BAO_0000218,955.0,
11938,,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,N,A,1,Intermediate,1,,CHEMBL874459,,BAO_0000218,,
11939,,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,N,A,1,Intermediate,1,,CHEMBL629795,,BAO_0000218,,
11940,,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,N,A,1,Intermediate,1,,CHEMBL629796,,BAO_0000218,,
11941,,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,N,A,1,Intermediate,1,,CHEMBL629797,,BAO_0000218,,
11942,,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,N,A,1,Intermediate,1,,CHEMBL629798,,BAO_0000218,,
11943,,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629799,,BAO_0000218,2369.0,
11944,,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629800,,BAO_0000218,2369.0,
11945,,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629801,,BAO_0000218,2369.0,
11946,,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,N,A,1,Intermediate,1,,CHEMBL629802,,BAO_0000218,2369.0,
11947,,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629803,,BAO_0000218,2369.0,
11948,,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629804,,BAO_0000218,178.0,
11949,,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629805,,BAO_0000218,178.0,
11950,,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629806,,BAO_0000218,178.0,
11951,,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629807,,BAO_0000218,178.0,
11952,,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629808,,BAO_0000218,178.0,
11953,,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629809,,BAO_0000218,955.0,
11954,,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629810,,BAO_0000218,955.0,
11955,,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629811,,BAO_0000218,955.0,
11956,,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629812,,BAO_0000218,955.0,
11957,,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629813,,BAO_0000218,955.0,
11958,,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL874460,,BAO_0000218,955.0,
11959,,Rattus norvegicus,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629814,,BAO_0000218,,
11960,,Rattus norvegicus,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629815,,BAO_0000218,,
11961,,Rattus norvegicus,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629816,,BAO_0000218,,
11962,,Rattus norvegicus,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL629817,,BAO_0000218,,
11963,,Rattus norvegicus,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL626643,,BAO_0000218,2113.0,
11964,,Rattus norvegicus,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL626644,,BAO_0000218,2113.0,
11965,,Rattus norvegicus,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL626806,,BAO_0000218,2113.0,
11966,,Rattus norvegicus,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL626807,,BAO_0000218,2113.0,
11967,,Rattus norvegicus,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627261,,BAO_0000218,2107.0,
11968,,Rattus norvegicus,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627262,,BAO_0000218,2107.0,
11969,,Rattus norvegicus,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627263,,BAO_0000218,2107.0,
11970,,Rattus norvegicus,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627264,,BAO_0000218,2107.0,
11971,,Rattus norvegicus,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627265,,BAO_0000218,2048.0,
11972,,Rattus norvegicus,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627266,,BAO_0000218,2048.0,
11973,,Rattus norvegicus,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627267,,BAO_0000218,2048.0,
11974,,Rattus norvegicus,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627268,,BAO_0000218,2048.0,
11975,,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627269,,BAO_0000218,2385.0,
11976,,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627270,,BAO_0000218,2385.0,
11977,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",N,A,1,Intermediate,1,,CHEMBL627271,,BAO_0000218,,
11978,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",N,A,1,Intermediate,1,,CHEMBL627946,,BAO_0000218,,
11979,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",N,A,1,Intermediate,1,,CHEMBL875472,,BAO_0000218,,
11980,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",N,A,1,Intermediate,1,,CHEMBL627947,,BAO_0000218,,
11981,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",N,A,1,Intermediate,1,,CHEMBL627948,,BAO_0000218,,
11982,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",N,A,1,Intermediate,1,,CHEMBL628113,,BAO_0000218,,
11983,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",N,A,1,Intermediate,1,,CHEMBL628114,,BAO_0000218,,
11984,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",N,A,1,Intermediate,1,,CHEMBL628115,,BAO_0000218,,
11985,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",N,A,1,Intermediate,1,,CHEMBL628116,,BAO_0000218,,
11986,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",N,A,1,Intermediate,1,,CHEMBL628117,,BAO_0000218,,
11987,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",N,A,1,Intermediate,1,,CHEMBL628118,,BAO_0000218,,
11988,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",N,A,1,Intermediate,1,,CHEMBL628119,,BAO_0000218,,
11989,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",N,A,1,Intermediate,1,,CHEMBL628120,,BAO_0000218,,
11990,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",N,A,1,Intermediate,1,,CHEMBL628121,,BAO_0000218,,
11991,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",N,A,1,Intermediate,1,,CHEMBL628122,,BAO_0000218,,
11992,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",N,A,1,Intermediate,1,,CHEMBL627297,,BAO_0000218,,
11993,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",N,A,1,Intermediate,1,,CHEMBL627298,,BAO_0000218,,
11994,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",N,A,1,Intermediate,1,,CHEMBL627299,,BAO_0000218,,
11995,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",N,A,1,Intermediate,1,,CHEMBL627300,,BAO_0000218,,
11996,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",N,A,1,Intermediate,1,,CHEMBL627301,,BAO_0000218,,
11997,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",N,A,1,Intermediate,1,,CHEMBL627302,,BAO_0000218,,
11998,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",N,A,1,Intermediate,1,,CHEMBL627303,,BAO_0000218,,
11999,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",N,A,1,Intermediate,1,,CHEMBL627304,,BAO_0000218,,
12000,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",N,A,1,Intermediate,1,,CHEMBL627305,,BAO_0000218,,
12001,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,A,1,Intermediate,1,,CHEMBL627306,,BAO_0000218,,
12002,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",N,A,1,Intermediate,1,,CHEMBL623982,,BAO_0000218,,
12003,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",N,A,1,Intermediate,1,,CHEMBL623983,,BAO_0000218,,
12004,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",N,A,1,Intermediate,1,,CHEMBL623984,,BAO_0000218,,
12005,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",N,A,1,Intermediate,1,,CHEMBL623985,,BAO_0000218,,
12006,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",N,A,1,Intermediate,1,,CHEMBL623986,,BAO_0000218,,
12007,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",N,A,1,Intermediate,1,,CHEMBL623987,,BAO_0000218,,
12008,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",N,A,1,Intermediate,1,,CHEMBL623988,,BAO_0000218,,
12009,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",N,A,1,Intermediate,1,,CHEMBL623989,,BAO_0000218,,
12010,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",N,A,1,Intermediate,1,,CHEMBL622215,,BAO_0000218,,
12011,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",N,A,1,Intermediate,1,,CHEMBL622216,,BAO_0000218,,
12012,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",N,A,1,Intermediate,1,,CHEMBL877481,,BAO_0000218,,
12013,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),U,A,0,Autocuration,1,,CHEMBL622217,,BAO_0000218,,
12014,,Mus musculus,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,A,1,Intermediate,1,,CHEMBL622218,,BAO_0000218,,
12015,,Rattus norvegicus,Pharmacokinetic profile AUC was evaluated in rats,N,A,1,Intermediate,1,,CHEMBL622219,,BAO_0000218,,
12016,,,Pharmacokinetic property (Area under curve),U,A,0,Autocuration,1,,CHEMBL622220,,BAO_0000019,,
12017,,Canis lupus familiaris,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",N,A,1,Intermediate,1,,CHEMBL622221,,BAO_0000218,,
12018,,Mus musculus,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",N,A,1,Intermediate,1,,CHEMBL622222,,BAO_0000218,,
12019,,Canis lupus familiaris,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",N,A,1,Intermediate,1,,CHEMBL622223,,BAO_0000218,,
12020,,Mus musculus,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",N,A,1,Intermediate,1,,CHEMBL622224,,BAO_0000218,,
12021,,,Plasma concentration (AUC) was determined,U,A,0,Autocuration,1,,CHEMBL622225,,BAO_0000019,,
12022,,,Plasma concentration (AUC) was determined; Not detectable,U,A,0,Autocuration,1,,CHEMBL622226,,BAO_0000019,,
12023,,Cavia porcellus,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),N,A,1,Intermediate,1,,CHEMBL624154,,BAO_0000218,,
12024,,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL624155,,BAO_0000218,,
12025,,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,A,1,Intermediate,1,,CHEMBL624156,,BAO_0000218,,
12026,,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,N,A,1,Intermediate,1,,CHEMBL624157,,BAO_0000218,,
12027,,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,N,A,1,Intermediate,1,,CHEMBL624158,,BAO_0000218,,
12028,,Rattus norvegicus,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,N,A,1,Intermediate,1,,CHEMBL624159,,BAO_0000218,,
12029,,Rattus norvegicus,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,N,A,1,Intermediate,1,,CHEMBL624160,,BAO_0000218,,
12030,,Rattus norvegicus,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,N,A,1,Intermediate,1,,CHEMBL624161,,BAO_0000218,,
12031,,Rattus norvegicus,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,N,A,1,Intermediate,1,,CHEMBL624162,,BAO_0000218,,
12032,,Canis lupus familiaris,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,N,A,1,Intermediate,1,,CHEMBL624163,,BAO_0000218,,
12033,,Rattus norvegicus,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL624164,,BAO_0000218,,
12034,,Rattus norvegicus,The AUC(0-infinity) values in female wistar rats.,N,A,1,Intermediate,1,,CHEMBL624165,,BAO_0000218,,
12035,,Rattus norvegicus,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL624166,,BAO_0000218,,
12036,,Rattus norvegicus,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",N,A,1,Intermediate,1,,CHEMBL624167,,BAO_0000218,,
12037,,Rattus norvegicus,The AUC(0-t)values in female wistar rats.,N,A,1,Intermediate,1,,CHEMBL624168,,BAO_0000218,,
12038,,Rattus norvegicus,The Area under the concentration time curve of compound was measured on rats,N,A,1,Intermediate,1,,CHEMBL624169,,BAO_0000218,,
12039,,Homo sapiens,The area under curve (100 mg/kg) administered orally in humans,N,A,1,Intermediate,1,,CHEMBL624170,,BAO_0000218,,
12040,,Callithrix,The area under curve (12.5 mg/kg) administered intravenously in marmoset,U,A,0,Autocuration,1,,CHEMBL624171,,BAO_0000218,,
12041,,Simiiformes,The area under curve (12.5 mg/kg) administered intravenously in monkey,U,A,0,Autocuration,1,,CHEMBL624172,,BAO_0000218,,
12042,,Canis lupus familiaris,The area under curve (15 mg/kg) administered intravenously in dog,N,A,1,Intermediate,1,,CHEMBL624173,,BAO_0000218,,
12043,,Homo sapiens,The area under curve (200 mg/kg) administered orally in humans,N,A,1,Intermediate,1,,CHEMBL877488,,BAO_0000218,,
12044,,Rattus norvegicus,The area under curve (25 mg/kg) administered intravenously in rat,N,A,1,Intermediate,1,,CHEMBL624174,,BAO_0000218,,
12045,,Callithrix,The area under curve (25 mg/kg) administered orally in marmoset,U,A,0,Autocuration,1,,CHEMBL624175,,BAO_0000218,,
12046,,Simiiformes,The area under curve (25 mg/kg) administered orally in monkey,U,A,0,Autocuration,1,,CHEMBL624176,,BAO_0000218,,
12047,,Canis lupus familiaris,The area under curve (30 mg/kg) administered orally in dog,N,A,1,Intermediate,1,,CHEMBL624177,,BAO_0000218,,
12048,,Homo sapiens,The area under curve (400 mg/kg) administered orally in humans,N,A,1,Intermediate,1,,CHEMBL624178,,BAO_0000218,,
12049,,Rattus norvegicus,The area under curve (50 mg/kg) administered orally in fasted rat,N,A,1,Intermediate,1,,CHEMBL624179,,BAO_0000218,,
12050,,Rattus norvegicus,The area under curve (50 mg/kg) administered orally in rat,N,A,1,Intermediate,1,,CHEMBL627689,,BAO_0000218,,
12051,,Homo sapiens,The area under curve (800 mg/kg) administered orally in humans,N,A,1,Intermediate,1,,CHEMBL627690,,BAO_0000218,,
12052,,,The compound was evaluated for area under the curve,U,A,0,Autocuration,1,,CHEMBL627691,,BAO_0000019,,
12053,,Callithrix,The compound was evaluated for area under the curve in marmosets,U,A,0,Autocuration,1,,CHEMBL627692,,BAO_0000019,,
12054,,Callithrix,The compound was evaluated for area under the curve in marmosets,U,A,0,Autocuration,1,,CHEMBL627693,,BAO_0000019,,
12055,,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,A,1,Intermediate,1,,CHEMBL627694,,BAO_0000218,,
12056,,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,N,A,1,Intermediate,1,,CHEMBL627695,,BAO_0000218,,
12057,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),U,A,0,Autocuration,1,,CHEMBL627696,,BAO_0000218,,
12058,,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,A,1,Intermediate,1,,CHEMBL627697,,BAO_0000218,,
12059,,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,A,1,Intermediate,1,,CHEMBL627698,,BAO_0000218,,
12060,,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,N,A,1,Intermediate,1,,CHEMBL627699,,BAO_0000218,,
12061,,Rattus norvegicus,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,N,A,1,Intermediate,1,,CHEMBL627700,,BAO_0000218,,
12062,,Rattus norvegicus,Total drug exposure is determined after oral dosing in rats.,N,A,1,Intermediate,1,,CHEMBL627701,,BAO_0000218,,
12063,,,Total drug exposure (5 mg/kg) when administered intravenously,U,A,0,Autocuration,1,,CHEMBL627702,,BAO_0000218,,
12064,,,Total drug exposure (5 mg/kg) when administered orally,U,A,0,Autocuration,1,,CHEMBL627703,,BAO_0000218,,
12065,,Simiiformes,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,A,0,Autocuration,1,,CHEMBL626873,,BAO_0000218,,
12066,,Rattus norvegicus,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL629583,,BAO_0000218,,
12067,,Canis lupus familiaris,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,A,1,Intermediate,1,,CHEMBL629584,,BAO_0000218,,
12068,,Canis lupus familiaris,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,A,1,Intermediate,1,,CHEMBL629585,,BAO_0000218,,
12069,,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629586,,BAO_0000218,955.0,
12070,,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629587,,BAO_0000218,955.0,
12071,,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629588,,BAO_0000218,,
12072,,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629589,,BAO_0000218,,
12073,,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629590,,BAO_0000218,,
12074,,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629591,,BAO_0000218,,
12075,,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629592,,BAO_0000218,,
12076,,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629593,,BAO_0000218,,
12077,,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629594,,BAO_0000218,,
12078,,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL629595,,BAO_0000218,948.0,
12079,,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL630290,,BAO_0000218,948.0,
12080,,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627137,,BAO_0000218,948.0,
12081,,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627138,,BAO_0000218,948.0,
12082,,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627139,,BAO_0000218,948.0,
12083,,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627140,,BAO_0000218,948.0,
12084,,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627141,,BAO_0000218,948.0,
12085,,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627142,,BAO_0000218,2113.0,
12086,,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627143,,BAO_0000218,2113.0,
12087,,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL874449,,BAO_0000218,2113.0,
12088,,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627144,,BAO_0000218,2113.0,
12089,,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627145,,BAO_0000218,2113.0,
12090,,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627146,,BAO_0000218,2113.0,
12091,,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627147,,BAO_0000218,2113.0,
12092,,Rattus norvegicus,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627148,,BAO_0000218,2107.0,
12093,,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627149,,BAO_0000218,2048.0,
12094,,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL632160,,BAO_0000218,2048.0,
12095,,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL632161,,BAO_0000218,2048.0,
12096,,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL632162,,BAO_0000218,2048.0,
12097,,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL632163,,BAO_0000218,2048.0,
12098,,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL874469,,BAO_0000218,2048.0,
12099,,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627182,,BAO_0000218,2048.0,
12100,,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627183,,BAO_0000218,2385.0,
12101,,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627184,,BAO_0000218,2385.0,
12102,,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627185,,BAO_0000218,2385.0,
12103,,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627186,,BAO_0000218,2385.0,
12104,,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627187,,BAO_0000218,2385.0,
12105,,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627188,,BAO_0000218,2385.0,
12106,,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627189,,BAO_0000218,2385.0,
12107,,Rattus norvegicus,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627190,,BAO_0000218,,
12108,,Rattus norvegicus,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627191,,BAO_0000218,2107.0,
12109,,Rattus norvegicus,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627192,,BAO_0000218,2107.0,
12110,,Rattus norvegicus,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL627193,,BAO_0000218,2107.0,
12111,,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL874590,,BAO_0000218,2385.0,
12112,,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627194,,BAO_0000218,2385.0,
12113,,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627195,,BAO_0000218,2385.0,
12114,,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627196,,BAO_0000218,992.0,
12115,,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627197,,BAO_0000218,992.0,
12116,,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627198,,BAO_0000218,992.0,
12117,,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,N,A,1,Intermediate,1,,CHEMBL627199,,BAO_0000218,992.0,
12118,,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627200,,BAO_0000218,992.0,
12119,,Rattus norvegicus,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627201,,BAO_0000218,1969.0,
12120,,Rattus norvegicus,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627202,,BAO_0000218,1969.0,
12121,,Rattus norvegicus,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627203,,BAO_0000218,1969.0,
12122,,Rattus norvegicus,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627204,,BAO_0000218,1969.0,
12123,,Rattus norvegicus,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627205,,BAO_0000218,2106.0,
12124,,Rattus norvegicus,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627206,,BAO_0000218,2106.0,
12125,,Rattus norvegicus,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627207,,BAO_0000218,2106.0,
12126,,Rattus norvegicus,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627208,,BAO_0000218,2106.0,
12127,,Rattus norvegicus,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627209,,BAO_0000218,2046.0,
12128,,Rattus norvegicus,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627210,,BAO_0000218,2046.0,
12129,,Rattus norvegicus,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627211,,BAO_0000218,2046.0,
12130,,Rattus norvegicus,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627212,,BAO_0000218,2046.0,
12131,,Rattus norvegicus,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL627213,,BAO_0000218,995.0,
12132,,Rattus norvegicus,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL626599,,BAO_0000218,995.0,
12133,,Rattus norvegicus,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL626600,,BAO_0000218,995.0,
12134,,Rattus norvegicus,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,A,1,Intermediate,1,,CHEMBL626601,,BAO_0000218,995.0,
12135,,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,U,A,0,Autocuration,1,,CHEMBL627484,,BAO_0000019,,
12136,,Macaca fascicularis,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),N,A,1,Intermediate,1,,CHEMBL627485,,BAO_0000218,1969.0,
12137,,Macaca fascicularis,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,N,A,1,Intermediate,1,,CHEMBL628147,,BAO_0000218,1969.0,
12138,,Macaca fascicularis,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,N,A,1,Intermediate,1,,CHEMBL628148,,BAO_0000218,1969.0,
12139,,Canis lupus familiaris,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),N,A,1,Intermediate,1,,CHEMBL628149,,BAO_0000218,1969.0,
12140,,Canis lupus familiaris,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,N,A,1,Intermediate,1,,CHEMBL628150,,BAO_0000218,1969.0,
12141,,Canis lupus familiaris,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,N,A,1,Intermediate,1,,CHEMBL628318,,BAO_0000218,1969.0,
12142,,Canis lupus familiaris,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,N,A,1,Intermediate,1,,CHEMBL628319,,BAO_0000218,1969.0,
12143,,Canis lupus familiaris,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,A,1,Intermediate,1,,CHEMBL875609,,BAO_0000218,,
12144,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,U,A,0,Autocuration,1,,CHEMBL628320,,BAO_0000019,,
12145,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,U,A,0,Autocuration,1,,CHEMBL628321,,BAO_0000019,,
12146,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,U,A,0,Autocuration,1,,CHEMBL628322,,BAO_0000019,,
12147,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,U,A,0,Autocuration,1,,CHEMBL628323,,BAO_0000019,,
12148,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,U,A,0,Autocuration,1,,CHEMBL628324,,BAO_0000019,,
12149,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,U,A,0,Autocuration,1,,CHEMBL628325,,BAO_0000019,,
12150,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,U,A,0,Autocuration,1,,CHEMBL628326,,BAO_0000019,,
12151,,Canis lupus familiaris,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL628327,,BAO_0000218,1236.0,
12152,,Canis lupus familiaris,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL628328,,BAO_0000218,1236.0,
12153,,Canis lupus familiaris,"Concentration of compound in blood of dog 1, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL628329,,BAO_0000218,178.0,
12154,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",N,A,1,Intermediate,1,,CHEMBL628330,,BAO_0000218,2107.0,
12155,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",N,A,1,Intermediate,1,,CHEMBL628331,,BAO_0000218,2107.0,
12156,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",N,A,1,Intermediate,1,,CHEMBL628332,,BAO_0000218,2107.0,
12157,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",N,A,1,Intermediate,1,,CHEMBL628333,,BAO_0000218,2107.0,
12158,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",N,A,1,Intermediate,1,,CHEMBL628334,,BAO_0000218,2107.0,
12159,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",N,A,1,Intermediate,1,,CHEMBL628335,,BAO_0000218,2107.0,
12160,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",N,A,1,Intermediate,1,,CHEMBL628336,,BAO_0000218,2107.0,
12161,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,A,1,Intermediate,1,,CHEMBL628337,,BAO_0000218,2107.0,
12162,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",N,A,1,Intermediate,1,,CHEMBL628338,,BAO_0000218,2107.0,
12163,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",N,A,1,Intermediate,1,,CHEMBL875610,,BAO_0000218,2107.0,
12164,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",N,A,1,Intermediate,1,,CHEMBL628339,,BAO_0000218,2107.0,
12165,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",N,A,1,Intermediate,1,,CHEMBL628340,,BAO_0000218,2107.0,
12166,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",N,A,1,Intermediate,1,,CHEMBL628341,,BAO_0000218,2107.0,
12167,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",N,A,1,Intermediate,1,,CHEMBL622214,,BAO_0000218,2107.0,
12168,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",N,A,1,Intermediate,1,,CHEMBL623167,,BAO_0000218,2107.0,
12169,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",N,A,1,Intermediate,1,,CHEMBL623168,,BAO_0000218,2107.0,
12170,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",N,A,1,Intermediate,1,,CHEMBL623169,,BAO_0000218,2107.0,
12171,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",N,A,1,Intermediate,1,,CHEMBL623170,,BAO_0000218,2107.0,
12172,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",N,A,1,Intermediate,1,,CHEMBL627224,,BAO_0000218,2048.0,
12173,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",N,A,1,Intermediate,1,,CHEMBL875634,,BAO_0000218,2048.0,
12174,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",N,A,1,Intermediate,1,,CHEMBL627225,,BAO_0000218,2048.0,
12175,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",N,A,1,Intermediate,1,,CHEMBL627226,,BAO_0000218,2048.0,
12176,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",N,A,1,Intermediate,1,,CHEMBL626083,,BAO_0000218,2048.0,
12177,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",N,A,1,Intermediate,1,,CHEMBL626084,,BAO_0000218,2048.0,
12178,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",N,A,1,Intermediate,1,,CHEMBL626085,,BAO_0000218,2048.0,
12179,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",N,A,1,Intermediate,1,,CHEMBL626086,,BAO_0000218,2048.0,
12180,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",N,A,1,Intermediate,1,,CHEMBL626087,,BAO_0000218,2048.0,
12181,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",N,A,1,Intermediate,1,,CHEMBL626088,,BAO_0000218,2048.0,
12182,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",N,A,1,Intermediate,1,,CHEMBL626089,,BAO_0000218,2048.0,
12183,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",N,A,1,Intermediate,1,,CHEMBL626090,,BAO_0000218,2048.0,
12184,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",N,A,1,Intermediate,1,,CHEMBL626091,,BAO_0000218,2048.0,
12185,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",N,A,1,Intermediate,1,,CHEMBL626092,,BAO_0000218,2048.0,
12186,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",N,A,1,Intermediate,1,,CHEMBL626093,,BAO_0000218,2048.0,
12187,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",N,A,1,Intermediate,1,,CHEMBL626094,,BAO_0000218,2048.0,
12188,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",N,A,1,Intermediate,1,,CHEMBL626095,,BAO_0000218,2048.0,
12189,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",N,A,1,Intermediate,1,,CHEMBL626096,,BAO_0000218,2048.0,
12190,,Simiiformes,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,A,0,Autocuration,1,,CHEMBL626097,,BAO_0000218,,
12191,,Rattus norvegicus,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL626098,,BAO_0000218,,
12192,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,U,A,0,Autocuration,1,,CHEMBL626099,,BAO_0000218,1969.0,
12193,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,U,A,0,Autocuration,1,,CHEMBL626100,,BAO_0000218,1969.0,
12194,,Canis lupus familiaris,AUC 0-inf in dog,N,A,1,Intermediate,1,,CHEMBL626101,,BAO_0000218,1969.0,
12195,,Cavia porcellus,AUC 0-inf in guinea pig,N,A,1,Intermediate,1,,CHEMBL626102,,BAO_0000218,1969.0,
12196,,Canis lupus familiaris,AUC 0-t in dog,N,A,1,Intermediate,1,,CHEMBL626103,,BAO_0000218,1969.0,
12197,,Cavia porcellus,AUC 0-t in guinea pig,N,A,1,Intermediate,1,,CHEMBL628391,,BAO_0000218,1969.0,
12198,,Rattus norvegicus,The compound was tested for brain to plasma partition in rat,N,A,1,Intermediate,1,,CHEMBL628392,,BAO_0000218,,
12199,,Rattus norvegicus,The compound was tested for brain to plasma partition in rat.,N,A,1,Intermediate,1,,CHEMBL628393,,BAO_0000218,,
12200,,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,U,A,0,Autocuration,1,,CHEMBL628394,,BAO_0000019,178.0,
12201,,Canis lupus familiaris,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,N,A,1,Intermediate,1,,CHEMBL628395,,BAO_0000218,,
12202,,Simiiformes,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,U,A,0,Autocuration,1,,CHEMBL628396,,BAO_0000218,,
12203,,Oryctolagus cuniculus,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,A,1,Intermediate,1,,CHEMBL628397,,BAO_0000218,,
12204,,Rattus norvegicus,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,N,A,1,Intermediate,1,,CHEMBL628398,,BAO_0000218,,
12205,,Macaca mulatta,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,N,A,1,Intermediate,1,,CHEMBL628399,,BAO_0000218,,
12206,,Canis lupus familiaris,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL628400,,BAO_0000218,,
12207,,Rattus norvegicus,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL874907,,BAO_0000218,,
12208,,,Area under curve of the compound was determined,U,A,0,Autocuration,1,,CHEMBL628401,,BAO_0000019,,
12209,,Simiiformes,AUC in monkeys at a dose of 1 mg/kg,U,A,0,Autocuration,1,,CHEMBL628402,,BAO_0000218,1969.0,
12210,,Rattus norvegicus,AUC in rats at a dose of 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL628403,,BAO_0000218,1969.0,
12211,,,Compound was evaluated for the overall absorbance loss at pH of 2,U,A,0,Autocuration,1,,CHEMBL628404,,BAO_0000019,,
12212,,,Compound was evaluated for the overall absorbance loss at pH of 4,U,A,0,Autocuration,1,,CHEMBL628405,,BAO_0000019,,
12213,,,Compound was evaluated for the overall absorbance loss at pH of 7,U,A,0,Autocuration,1,,CHEMBL628406,,BAO_0000019,,
12214,,Rattus norvegicus,Compound was evaluated for its absorption in the rats,N,A,1,Intermediate,1,,CHEMBL628407,,BAO_0000218,,
12215,,Rattus norvegicus,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,A,1,Intermediate,1,,CHEMBL628408,,BAO_0000218,1088.0,
12216,,Rattus norvegicus,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,N,A,1,Intermediate,1,,CHEMBL629171,,BAO_0000218,1088.0,
12217,,Rattus norvegicus,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,A,1,Intermediate,1,,CHEMBL629172,,BAO_0000218,1088.0,
12218,,Rattus norvegicus,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,N,A,1,Intermediate,1,,CHEMBL629173,,BAO_0000218,1088.0,
12219,,Rattus norvegicus,In vitro percent permeability into rat ileum,N,A,1,Intermediate,1,,CHEMBL629174,,BAO_0000218,,
12220,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 10-17,N,A,1,Intermediate,1,,CHEMBL629175,,BAO_0000218,,
12221,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 10-18,N,A,1,Intermediate,1,,CHEMBL629176,,BAO_0000218,,
12222,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 10-19,N,A,1,Intermediate,1,,CHEMBL629177,,BAO_0000218,,
12223,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 12-15,N,A,1,Intermediate,1,,CHEMBL629178,,BAO_0000218,,
12224,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 13-19,N,A,1,Intermediate,1,,CHEMBL631869,,BAO_0000218,,
12225,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 14-17,N,A,1,Intermediate,1,,CHEMBL631870,,BAO_0000218,,
12226,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 15-18,N,A,1,Intermediate,1,,CHEMBL631871,,BAO_0000218,,
12227,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 2-5,N,A,1,Intermediate,1,,CHEMBL631872,,BAO_0000218,,
12228,,,In vitro percent permeability into rat ileum; Range is 23-42,U,A,0,Autocuration,1,,CHEMBL875775,,BAO_0000221,2116.0,
12229,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 28-36,N,A,1,Intermediate,1,,CHEMBL631873,,BAO_0000218,,
12230,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 29-35,N,A,1,Intermediate,1,,CHEMBL631874,,BAO_0000218,,
12231,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 46-66,N,A,1,Intermediate,1,,CHEMBL631875,,BAO_0000218,,
12232,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 50-68,N,A,1,Intermediate,1,,CHEMBL631876,,BAO_0000218,,
12233,,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 78-81,N,A,1,Intermediate,1,,CHEMBL631877,,BAO_0000218,,
12234,,Rattus norvegicus,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,N,A,1,Intermediate,1,,CHEMBL631878,,BAO_0000218,,
12235,,Rattus norvegicus,In vitro percent permeability into rat ileum; nd indicates not detected,N,A,1,Intermediate,1,,CHEMBL631879,,BAO_0000218,,
12236,,Rattus norvegicus,In vitro percent permeability into rat ileum; nt indicates not detected,N,A,1,Intermediate,1,,CHEMBL631880,,BAO_0000218,,
12237,,Rattus norvegicus,In vitro percent permeability into rat ileum; nt indicates not tested,N,A,1,Intermediate,1,,CHEMBL631881,,BAO_0000218,,
12238,,Rattus norvegicus,Compound was tested for oral absorption in bile-duct cannulated rats,N,A,1,Intermediate,1,,CHEMBL631882,,BAO_0000218,,
12239,,Rattus norvegicus,Compound was tested for oral absorption in bile-duct cannulated rats.,N,A,1,Intermediate,1,,CHEMBL630749,,BAO_0000218,,
12240,,Homo sapiens,Oral absorption using Caco-2 cell monolayers.,N,A,1,Intermediate,1,,CHEMBL630750,,BAO_0000218,,
12241,,Homo sapiens,Percent of the drug absorbed after administration to humans was determined,N,A,1,Intermediate,1,,CHEMBL630253,,BAO_0000218,,
12242,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,A,1,Intermediate,1,,CHEMBL630254,,BAO_0000218,1969.0,
12243,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,A,1,Intermediate,1,,CHEMBL630255,,BAO_0000218,1969.0,
12244,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,A,1,Intermediate,1,,CHEMBL630256,,BAO_0000218,1969.0,
12245,,Rattus norvegicus,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL875781,,BAO_0000218,2107.0,
12246,,Rattus norvegicus,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL630257,,BAO_0000218,2107.0,
12247,,Rattus norvegicus,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,A,1,Intermediate,1,,CHEMBL630258,,BAO_0000218,2107.0,
12248,,Rattus norvegicus,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",N,A,1,Intermediate,1,,CHEMBL630259,,BAO_0000218,,
12249,,Rattus norvegicus,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",N,A,1,Intermediate,1,,CHEMBL630260,,BAO_0000218,2435.0,
12250,,Rattus norvegicus,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",N,A,1,Intermediate,1,,CHEMBL630261,,BAO_0000218,2435.0,
12251,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,N,A,1,Intermediate,1,,CHEMBL630262,,BAO_0000218,,
12252,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,N,A,1,Intermediate,1,,CHEMBL630263,,BAO_0000218,,
12253,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,N,A,1,Intermediate,1,,CHEMBL630264,,BAO_0000218,,
12254,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,N,A,1,Intermediate,1,,CHEMBL630265,,BAO_0000218,,
12255,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,N,A,1,Intermediate,1,,CHEMBL630266,,BAO_0000218,,
12256,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,N,A,1,Intermediate,1,,CHEMBL630267,,BAO_0000218,2113.0,
12257,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,N,A,1,Intermediate,1,,CHEMBL630268,,BAO_0000218,2113.0,
12258,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,N,A,1,Intermediate,1,,CHEMBL630269,,BAO_0000218,,
12259,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,N,A,1,Intermediate,1,,CHEMBL630270,,BAO_0000218,,
12260,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,N,A,1,Intermediate,1,,CHEMBL630141,,BAO_0000218,2048.0,
12261,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,N,A,1,Intermediate,1,,CHEMBL630142,,BAO_0000218,2048.0,
12262,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,N,A,1,Intermediate,1,,CHEMBL630143,,BAO_0000218,2385.0,
12263,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,N,A,1,Intermediate,1,,CHEMBL630144,,BAO_0000218,2385.0,
12264,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,N,A,1,Intermediate,1,,CHEMBL630145,,BAO_0000218,2367.0,
12265,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,N,A,1,Intermediate,1,,CHEMBL630146,,BAO_0000218,2367.0,
12266,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,N,A,1,Intermediate,1,,CHEMBL630147,,BAO_0000218,,
12267,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,N,A,1,Intermediate,1,,CHEMBL630148,,BAO_0000218,,
12268,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,N,A,1,Intermediate,1,,CHEMBL630149,,BAO_0000218,,
12269,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,N,A,1,Intermediate,1,,CHEMBL630150,,BAO_0000218,2106.0,
12270,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,N,A,1,Intermediate,1,,CHEMBL630151,,BAO_0000218,2106.0,
12271,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,N,A,1,Intermediate,1,,CHEMBL632031,,BAO_0000218,2046.0,
12272,,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,N,A,1,Intermediate,1,,CHEMBL632032,,BAO_0000218,2046.0,
12273,,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,N,A,1,Intermediate,1,,CHEMBL632033,,BAO_0000218,,
12274,,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,N,A,1,Intermediate,1,,CHEMBL632034,,BAO_0000218,,
12275,,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,N,A,1,Intermediate,1,,CHEMBL632035,,BAO_0000218,2385.0,
12276,,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,N,A,1,Intermediate,1,,CHEMBL632036,,BAO_0000218,,
12277,,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,N,A,1,Intermediate,1,,CHEMBL632037,,BAO_0000218,2046.0,
12278,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,A,1,Intermediate,1,,CHEMBL632038,,BAO_0000218,178.0,
12279,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,A,1,Intermediate,1,,CHEMBL632039,,BAO_0000218,178.0,
12280,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,A,1,Intermediate,1,,CHEMBL632040,,BAO_0000218,178.0,
12281,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,A,1,Intermediate,1,,CHEMBL632041,,BAO_0000218,178.0,
12282,,Canis lupus familiaris,"Concentration of compound in blood of dog 2, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632042,,BAO_0000218,178.0,
12283,,Canis lupus familiaris,"Concentration of compound in left ventricle of dog 1, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632043,,BAO_0000218,,
12284,,Canis lupus familiaris,"Concentration of compound in left ventricle of dog 2, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632044,,BAO_0000218,,
12285,,Canis lupus familiaris,"Concentration of compound in liver of dog 1, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632045,,BAO_0000218,2107.0,
12286,,Canis lupus familiaris,"Concentration of compound in liver of dog 2, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632046,,BAO_0000218,2107.0,
12287,,Canis lupus familiaris,"Concentration of compound in lung of dog 1, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632047,,BAO_0000218,2048.0,
12288,,Canis lupus familiaris,"Concentration of compound in lung of dog 2, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632048,,BAO_0000218,2048.0,
12289,,Canis lupus familiaris,"Concentration of compound in muscle of dog 1, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632049,,BAO_0000218,2385.0,
12290,,Canis lupus familiaris,"Concentration of compound in muscle of dog 2, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL876418,,BAO_0000218,2385.0,
12291,,Canis lupus familiaris,"Concentration of compound in spleen of dog 1,after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632050,,BAO_0000218,2106.0,
12292,,Canis lupus familiaris,"Concentration of compound in spleen of dog 2, after administering intravenously",N,A,1,Intermediate,1,,CHEMBL632051,,BAO_0000218,2106.0,
12293,,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,U,F,0,Autocuration,1,,CHEMBL632052,,BAO_0000218,,
12294,,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,U,F,0,Autocuration,1,,CHEMBL632053,,BAO_0000218,,
12295,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,A,0,Autocuration,1,,CHEMBL632054,,BAO_0000218,,
12296,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,F,0,Autocuration,1,,CHEMBL632055,,BAO_0000218,,
12297,,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,U,F,0,Autocuration,1,,CHEMBL631181,,BAO_0000218,,
12298,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,U,A,0,Autocuration,1,,CHEMBL631182,,BAO_0000218,,
12299,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,A,0,Autocuration,1,,CHEMBL631183,,BAO_0000218,,
12300,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,A,0,Autocuration,1,,CHEMBL631184,,BAO_0000218,,
12301,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,A,0,Autocuration,1,,CHEMBL629774,,BAO_0000218,,
12302,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,A,0,Autocuration,1,,CHEMBL629775,,BAO_0000218,,
12303,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,A,0,Autocuration,1,,CHEMBL876549,,BAO_0000218,,
12304,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,A,0,Autocuration,1,,CHEMBL628172,,BAO_0000218,,
12305,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,A,0,Autocuration,1,,CHEMBL628173,,BAO_0000218,,
12306,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,U,A,0,Autocuration,1,,CHEMBL628174,,BAO_0000218,,
12307,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,U,A,0,Autocuration,1,,CHEMBL628175,,BAO_0000218,,
12308,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,A,0,Autocuration,1,,CHEMBL628176,,BAO_0000218,,
12309,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,A,0,Autocuration,1,,CHEMBL628177,,BAO_0000218,,
12310,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,A,0,Autocuration,1,,CHEMBL628178,,BAO_0000218,,
12311,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,A,0,Autocuration,1,,CHEMBL628179,,BAO_0000218,,
12312,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,A,0,Autocuration,1,,CHEMBL628180,,BAO_0000218,,
12313,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,U,A,0,Autocuration,1,,CHEMBL628181,,BAO_0000218,,
12314,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,A,0,Autocuration,1,,CHEMBL628182,,BAO_0000218,,
12315,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,A,0,Autocuration,1,,CHEMBL628183,,BAO_0000218,,
12316,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,U,A,0,Autocuration,1,,CHEMBL628184,,BAO_0000218,,
12317,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,A,0,Autocuration,1,,CHEMBL628185,,BAO_0000218,,
12318,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,A,0,Autocuration,1,,CHEMBL875617,,BAO_0000218,,
12319,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,A,0,Autocuration,1,,CHEMBL628186,,BAO_0000218,,
12320,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,A,0,Autocuration,1,,CHEMBL628187,,BAO_0000218,,
12321,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,A,0,Autocuration,1,,CHEMBL628188,,BAO_0000218,,
12322,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,A,0,Autocuration,1,,CHEMBL628189,,BAO_0000218,,
12323,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,U,A,0,Autocuration,1,,CHEMBL628190,,BAO_0000218,,
12324,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,A,0,Autocuration,1,,CHEMBL628191,,BAO_0000218,,
12325,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,U,A,0,Autocuration,1,,CHEMBL626513,,BAO_0000218,,
12326,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",N,A,1,Intermediate,1,,CHEMBL626514,,BAO_0000218,2046.0,
12327,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",N,A,1,Intermediate,1,,CHEMBL626515,,BAO_0000218,2046.0,
12328,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",N,A,1,Intermediate,1,,CHEMBL626516,,BAO_0000218,2046.0,
12329,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",N,A,1,Intermediate,1,,CHEMBL626517,,BAO_0000218,2046.0,
12330,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",N,A,1,Intermediate,1,,CHEMBL626518,,BAO_0000218,2046.0,
12331,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",N,A,1,Intermediate,1,,CHEMBL626519,,BAO_0000218,2046.0,
12332,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",N,A,1,Intermediate,1,,CHEMBL626520,,BAO_0000218,2046.0,
12333,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",N,A,1,Intermediate,1,,CHEMBL626521,,BAO_0000218,2046.0,
12334,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",N,A,1,Intermediate,1,,CHEMBL626522,,BAO_0000218,2046.0,
12335,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",N,A,1,Intermediate,1,,CHEMBL626523,,BAO_0000218,2046.0,
12336,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",N,A,1,Intermediate,1,,CHEMBL626524,,BAO_0000218,2046.0,
12337,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",N,A,1,Intermediate,1,,CHEMBL626688,,BAO_0000218,2046.0,
12338,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",N,A,1,Intermediate,1,,CHEMBL626689,,BAO_0000218,2046.0,
12339,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",N,A,1,Intermediate,1,,CHEMBL626690,,BAO_0000218,2046.0,
12340,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",N,A,1,Intermediate,1,,CHEMBL626691,,BAO_0000218,2046.0,
12341,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",N,A,1,Intermediate,1,,CHEMBL627319,,BAO_0000218,2046.0,
12342,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",N,A,1,Intermediate,1,,CHEMBL624052,,BAO_0000218,2046.0,
12343,,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",N,A,1,Intermediate,1,,CHEMBL624053,,BAO_0000218,2046.0,
12344,,Rattus norvegicus,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL624054,,BAO_0000218,,
12345,,Rattus norvegicus,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL624055,,BAO_0000218,,
12346,,Rattus norvegicus,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL624056,,BAO_0000218,,
12347,,Rattus norvegicus,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL624057,,BAO_0000218,995.0,
12348,,Rattus norvegicus,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL622281,,BAO_0000218,995.0,
12349,,Rattus norvegicus,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL622282,,BAO_0000218,995.0,
12350,,Rattus norvegicus,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL622283,,BAO_0000218,995.0,
12351,,Rattus norvegicus,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL622284,,BAO_0000218,995.0,
12352,,Rattus norvegicus,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL622285,,BAO_0000218,995.0,
12353,,Rattus norvegicus,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,A,1,Intermediate,1,,CHEMBL622286,,BAO_0000218,995.0,
12354,,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,U,P,0,Autocuration,1,,CHEMBL622287,,BAO_0000100,,
12355,,Mus musculus,Partition coefficient (logD7.4),N,A,1,Intermediate,1,,CHEMBL622288,,BAO_0000218,,
12356,,Mus musculus,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,A,1,Intermediate,1,,CHEMBL622289,,BAO_0000218,,
12357,,Mus musculus,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,A,1,Intermediate,1,,CHEMBL622290,,BAO_0000218,955.0,
12358,,Mus musculus,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,A,1,Intermediate,1,,CHEMBL622291,,BAO_0000218,,
12359,,Mus musculus,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,A,1,Intermediate,1,,CHEMBL622292,,BAO_0000218,955.0,
12360,,Mus musculus,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,A,1,Intermediate,1,,CHEMBL622293,,BAO_0000218,,
12361,,Mus musculus,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,A,1,Intermediate,1,,CHEMBL622294,,BAO_0000218,955.0,
12362,,Mus musculus,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,A,1,Intermediate,1,,CHEMBL622295,,BAO_0000218,,
12363,,Rattus norvegicus,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,A,1,Intermediate,1,,CHEMBL622296,,BAO_0000218,955.0,
12364,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,N,A,1,Intermediate,1,,CHEMBL874409,,BAO_0000218,1969.0,
12365,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,A,1,Intermediate,1,,CHEMBL622297,,BAO_0000218,1969.0,
12366,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,A,1,Intermediate,1,,CHEMBL622298,,BAO_0000218,1969.0,
12367,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,A,1,Intermediate,1,,CHEMBL622299,,BAO_0000218,1969.0,
12368,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,A,1,Intermediate,1,,CHEMBL622300,,BAO_0000218,1969.0,
12369,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,A,1,Intermediate,1,,CHEMBL622301,,BAO_0000218,1969.0,
12370,,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,A,1,Intermediate,1,,CHEMBL622302,,BAO_0000218,1969.0,
12371,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,A,1,Intermediate,1,,CHEMBL622303,,BAO_0000218,1969.0,
12372,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,A,1,Intermediate,1,,CHEMBL622304,,BAO_0000218,1969.0,
12373,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,N,A,1,Intermediate,1,,CHEMBL622305,,BAO_0000218,1969.0,
12374,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,A,1,Intermediate,1,,CHEMBL622306,,BAO_0000218,1969.0,
12375,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,N,A,1,Intermediate,1,,CHEMBL626864,,BAO_0000218,1969.0,
12376,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,A,1,Intermediate,1,,CHEMBL626865,,BAO_0000218,1969.0,
12377,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,N,A,1,Intermediate,1,,CHEMBL626866,,BAO_0000218,1969.0,
12378,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,A,1,Intermediate,1,,CHEMBL626867,,BAO_0000218,1969.0,
12379,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,A,1,Intermediate,1,,CHEMBL626868,,BAO_0000218,1969.0,
12380,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,N,A,1,Intermediate,1,,CHEMBL626869,,BAO_0000218,1969.0,
12381,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,A,1,Intermediate,1,,CHEMBL626870,,BAO_0000218,1969.0,
12382,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,N,A,1,Intermediate,1,,CHEMBL626871,,BAO_0000218,1969.0,
12383,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,A,1,Intermediate,1,,CHEMBL626872,,BAO_0000218,1969.0,
12384,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,A,1,Intermediate,1,,CHEMBL632185,,BAO_0000218,1969.0,
12385,,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,N,A,1,Intermediate,1,,CHEMBL632186,,BAO_0000218,1969.0,
12386,,,Amount of acetic acid produced by the compound,U,A,0,Autocuration,1,,CHEMBL629310,,BAO_0000019,,
12387,,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,U,A,0,Autocuration,1,,CHEMBL629311,,BAO_0000019,,
12388,,Rattus norvegicus,Log of (Cbrain/Cblood) in rats,N,A,1,Intermediate,1,,CHEMBL629312,,BAO_0000218,,
12389,,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629313,,BAO_0000221,,
12390,,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629314,,BAO_0000221,,
12391,,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629315,,BAO_0000221,,
12392,,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),U,B,0,Autocuration,1,,CHEMBL629316,,BAO_0000219,,
12393,,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629317,,BAO_0000221,,
12394,,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629318,,BAO_0000019,,
12395,,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL877497,,BAO_0000019,,
12396,,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629319,,BAO_0000019,,
12397,,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629320,,BAO_0000019,,
12398,,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629496,,BAO_0000019,,
12399,,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629497,,BAO_0000019,,
12400,,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629498,,BAO_0000019,,
12401,,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629499,,BAO_0000019,,
12402,,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629500,,BAO_0000019,,
12403,,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629501,,BAO_0000019,,
12404,,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),U,A,0,Autocuration,1,,CHEMBL629502,,BAO_0000019,,
12405,,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,U,F,0,Autocuration,1,,CHEMBL629503,,BAO_0000218,,
12406,,Canis lupus familiaris,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,N,A,1,Intermediate,1,,CHEMBL629504,,BAO_0000218,,
12407,,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,U,A,0,Autocuration,1,,CHEMBL629505,,BAO_0000019,,
12408,,,Compound was evaluated for total body clearance,U,A,0,Autocuration,1,,CHEMBL629506,,BAO_0000019,,
12409,,,Compound was evaluated for volume of distribution at steady state,U,A,0,Autocuration,1,,CHEMBL629507,,BAO_0000019,,
12410,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,U,A,0,Autocuration,1,,CHEMBL877498,,BAO_0000019,,
12411,,,Percentage of the diamine which is monoprotonated at pH 7.4,U,A,0,Autocuration,1,,CHEMBL629508,,BAO_0000019,,
12412,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,U,A,0,Autocuration,1,,CHEMBL629509,,BAO_0000019,,
12413,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,A,1,Intermediate,1,,CHEMBL629510,,BAO_0000218,178.0,
12414,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,A,1,Intermediate,1,,CHEMBL629511,,BAO_0000218,178.0,
12415,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,A,1,Intermediate,1,,CHEMBL629512,,BAO_0000218,178.0,
12416,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,A,1,Intermediate,1,,CHEMBL629513,,BAO_0000218,178.0,
12417,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,A,1,Intermediate,1,,CHEMBL629514,,BAO_0000218,178.0,
12418,,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,A,1,Intermediate,1,,CHEMBL628447,,BAO_0000218,178.0,
12419,,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,A,1,Intermediate,1,,CHEMBL628448,,BAO_0000218,178.0,
12420,,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,A,1,Intermediate,1,,CHEMBL628449,,BAO_0000218,178.0,
12421,,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,A,1,Intermediate,1,,CHEMBL631119,,BAO_0000218,178.0,
12422,,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,A,1,Intermediate,1,,CHEMBL631120,,BAO_0000218,178.0,
12423,,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,A,1,Intermediate,1,,CHEMBL631121,,BAO_0000218,178.0,
12424,,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,N,A,1,Intermediate,1,,CHEMBL874458,,BAO_0000218,178.0,
12425,,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,A,1,Intermediate,1,,CHEMBL631122,,BAO_0000218,178.0,
12426,,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,A,1,Intermediate,1,,CHEMBL631123,,BAO_0000218,178.0,
12427,,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,A,1,Intermediate,1,,CHEMBL631124,,BAO_0000218,178.0,
12428,,Rattus norvegicus,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,A,1,Intermediate,1,,CHEMBL631125,,BAO_0000218,178.0,
12429,,Rattus norvegicus,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,A,1,Intermediate,1,,CHEMBL631290,,BAO_0000218,178.0,
12430,,Rattus norvegicus,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,A,1,Intermediate,1,,CHEMBL631291,,BAO_0000218,178.0,
12431,,Rattus norvegicus,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,A,1,Intermediate,1,,CHEMBL631292,,BAO_0000218,178.0,
12432,,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,A,1,Intermediate,1,,CHEMBL631293,,BAO_0000218,178.0,
12433,,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,A,1,Intermediate,1,,CHEMBL631294,,BAO_0000218,178.0,
12434,,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,A,1,Intermediate,1,,CHEMBL631295,,BAO_0000218,178.0,
12435,,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,A,1,Intermediate,1,,CHEMBL631296,,BAO_0000218,178.0,
12436,,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,A,1,Intermediate,1,,CHEMBL631297,,BAO_0000218,178.0,
12437,,,Maximum biodistribution (Bmax) was determined.,U,A,0,Autocuration,1,,CHEMBL631298,,BAO_0000218,,
12438,,Mus musculus,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,N,A,1,Intermediate,1,,CHEMBL631299,,BAO_0000218,,
12439,,Mus musculus,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,N,A,1,Intermediate,1,,CHEMBL631300,,BAO_0000218,,
12440,,Mus musculus,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,N,A,1,Intermediate,1,,CHEMBL631301,,BAO_0000218,,
12441,,Mus musculus,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,N,A,1,Intermediate,1,,CHEMBL630291,,BAO_0000218,,
12442,,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,U,A,0,Autocuration,1,,CHEMBL630292,,BAO_0000218,,
12443,,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,U,A,0,Autocuration,1,,CHEMBL630293,,BAO_0000218,,
12444,,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL630294,,BAO_0000218,,
12445,,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,U,A,0,Autocuration,1,,CHEMBL630295,,BAO_0000218,,
12446,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,U,A,0,Autocuration,1,,CHEMBL630296,,BAO_0000218,,
12447,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL626782,,BAO_0000218,,
12448,,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL626783,,BAO_0000218,,
12449,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,U,A,0,Autocuration,1,,CHEMBL626784,,BAO_0000218,,
12450,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,U,A,0,Autocuration,1,,CHEMBL626785,,BAO_0000218,,
12451,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL626786,,BAO_0000218,,
12452,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,A,0,Autocuration,1,,CHEMBL626787,,BAO_0000218,,
12453,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,A,0,Autocuration,1,,CHEMBL626788,,BAO_0000218,,
12454,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,A,0,Autocuration,1,,CHEMBL625927,,BAO_0000218,,
12455,,Rattus norvegicus,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL625928,,BAO_0000218,178.0,
12456,,Rattus norvegicus,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,A,1,Intermediate,1,,CHEMBL625929,,BAO_0000218,178.0,
12457,,Rattus norvegicus,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,A,1,Intermediate,1,,CHEMBL625930,,BAO_0000218,178.0,
12458,,Rattus norvegicus,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",N,A,1,Intermediate,1,,CHEMBL625931,,BAO_0000218,178.0,
12459,,Rattus norvegicus,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,N,A,1,Intermediate,1,,CHEMBL627230,,BAO_0000218,178.0,
12460,,Rattus norvegicus,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627231,,BAO_0000218,178.0,
12461,,Rattus norvegicus,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,A,1,Intermediate,1,,CHEMBL627232,,BAO_0000218,178.0,
12462,,Rattus norvegicus,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,A,1,Intermediate,1,,CHEMBL627233,,BAO_0000218,178.0,
12463,,Rattus norvegicus,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL875470,,BAO_0000218,178.0,
12464,,Rattus norvegicus,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627234,,BAO_0000218,178.0,
12465,,Rattus norvegicus,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627235,,BAO_0000218,178.0,
12466,,Rattus norvegicus,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627236,,BAO_0000218,178.0,
12467,,Rattus norvegicus,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627237,,BAO_0000218,178.0,
12468,,Rattus norvegicus,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627238,,BAO_0000218,178.0,
12469,,Rattus norvegicus,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627239,,BAO_0000218,178.0,
12470,,Rattus norvegicus,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627240,,BAO_0000218,178.0,
12471,,Rattus norvegicus,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627241,,BAO_0000218,178.0,
12472,,Rattus norvegicus,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627242,,BAO_0000218,178.0,
12473,,Rattus norvegicus,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,N,A,1,Intermediate,1,,CHEMBL627243,,BAO_0000218,178.0,
12474,,Rattus norvegicus,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,A,1,Intermediate,1,,CHEMBL627244,,BAO_0000218,178.0,
12475,,Rattus norvegicus,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627245,,BAO_0000218,178.0,
12476,,Rattus norvegicus,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627246,,BAO_0000218,178.0,
12477,,Rattus norvegicus,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627247,,BAO_0000218,178.0,
12478,,Rattus norvegicus,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627248,,BAO_0000218,178.0,
12479,,Rattus norvegicus,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627249,,BAO_0000218,178.0,
12480,,Rattus norvegicus,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL625569,,BAO_0000218,178.0,
12481,,Rattus norvegicus,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL625570,,BAO_0000218,178.0,
12482,,Rattus norvegicus,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL625571,,BAO_0000218,178.0,
12483,,Rattus norvegicus,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,A,1,Intermediate,1,,CHEMBL625572,,BAO_0000218,178.0,
12484,,Rattus norvegicus,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,A,1,Intermediate,1,,CHEMBL625573,,BAO_0000218,178.0,
12485,,Rattus norvegicus,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,N,A,1,Intermediate,1,,CHEMBL625574,,BAO_0000218,178.0,
12486,,Rattus norvegicus,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,A,1,Intermediate,1,,CHEMBL626245,,BAO_0000218,178.0,
12487,,Rattus norvegicus,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL626246,,BAO_0000218,178.0,
12488,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,A,0,Autocuration,1,,CHEMBL626247,,BAO_0000218,,
12489,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,A,0,Autocuration,1,,CHEMBL626248,,BAO_0000218,,
12490,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,A,0,Autocuration,1,,CHEMBL626249,,BAO_0000218,,
12491,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,A,0,Autocuration,1,,CHEMBL626420,,BAO_0000218,,
12492,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,A,0,Autocuration,1,,CHEMBL626421,,BAO_0000218,,
12493,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,A,0,Autocuration,1,,CHEMBL626422,,BAO_0000218,,
12494,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,A,0,Autocuration,1,,CHEMBL626423,,BAO_0000218,,
12495,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,A,0,Autocuration,1,,CHEMBL626424,,BAO_0000218,,
12496,,Canis lupus familiaris,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,N,A,1,Intermediate,1,,CHEMBL626425,,BAO_0000218,,
12497,,Rattus norvegicus,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,N,A,1,Intermediate,1,,CHEMBL875476,,BAO_0000218,,
12498,,Macaca fascicularis,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,N,A,1,Intermediate,1,,CHEMBL626426,,BAO_0000218,,
12499,,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,U,P,0,Autocuration,1,,CHEMBL626427,,BAO_0000100,,
12500,,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,U,P,0,Autocuration,1,,CHEMBL626428,,BAO_0000100,,
12501,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,U,A,0,Autocuration,1,,CHEMBL626429,,BAO_0000019,,
12502,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,U,A,0,Autocuration,1,,CHEMBL625025,,BAO_0000019,1088.0,
12503,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL625026,,BAO_0000218,178.0,
12504,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL625027,,BAO_0000218,178.0,
12505,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL874410,,BAO_0000218,178.0,
12506,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL625028,,BAO_0000218,178.0,
12507,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL625029,,BAO_0000218,178.0,
12508,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL625030,,BAO_0000218,178.0,
12509,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL625031,,BAO_0000218,178.0,
12510,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL625032,,BAO_0000218,178.0,
12511,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL625033,,BAO_0000218,178.0,
12512,,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL625034,,BAO_0000218,178.0,
12513,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624872,,BAO_0000218,948.0,
12514,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624873,,BAO_0000218,948.0,
12515,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624874,,BAO_0000218,948.0,
12516,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624875,,BAO_0000218,948.0,
12517,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624876,,BAO_0000218,948.0,
12518,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624877,,BAO_0000218,948.0,
12519,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624878,,BAO_0000218,948.0,
12520,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624879,,BAO_0000218,948.0,
12521,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624880,,BAO_0000218,948.0,
12522,,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624881,,BAO_0000218,948.0,
12523,,Rattus norvegicus,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",N,A,1,Intermediate,1,,CHEMBL624882,,BAO_0000218,948.0,
12524,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624883,,BAO_0000218,2113.0,
12525,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624884,,BAO_0000218,2113.0,
12526,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624885,,BAO_0000218,2113.0,
12527,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624886,,BAO_0000218,2113.0,
12528,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624887,,BAO_0000218,2113.0,
12529,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624888,,BAO_0000218,2113.0,
12530,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624889,,BAO_0000218,2113.0,
12531,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624890,,BAO_0000218,2113.0,
12532,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL621964,,BAO_0000218,2113.0,
12533,,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL621965,,BAO_0000218,2113.0,
12534,,Rattus norvegicus,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL621966,,BAO_0000218,2107.0,
12535,,Rattus norvegicus,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL621967,,BAO_0000218,2107.0,
12536,,Rattus norvegicus,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL622164,,BAO_0000218,2107.0,
12537,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),U,A,0,Autocuration,1,,CHEMBL623097,,BAO_0000019,,
12538,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),U,A,0,Autocuration,1,,CHEMBL623098,,BAO_0000019,,
12539,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,U,A,0,Autocuration,1,,CHEMBL623099,,BAO_0000019,,
12540,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,U,A,0,Autocuration,1,,CHEMBL623100,,BAO_0000019,,
12541,,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",N,A,1,Intermediate,1,,CHEMBL628673,,BAO_0000218,,
12542,,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",N,A,1,Intermediate,1,,CHEMBL628674,,BAO_0000218,,
12543,,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",N,A,1,Intermediate,1,,CHEMBL628675,,BAO_0000218,,
12544,,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",N,A,1,Intermediate,1,,CHEMBL627644,,BAO_0000218,,
12545,,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",N,A,1,Intermediate,1,,CHEMBL627645,,BAO_0000218,,
12546,,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",N,A,1,Intermediate,1,,CHEMBL627646,,BAO_0000218,,
12547,,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",N,A,1,Intermediate,1,,CHEMBL627647,,BAO_0000218,,
12548,,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",N,A,1,Intermediate,1,,CHEMBL627648,,BAO_0000218,,
12549,,Rattus norvegicus,Free level in rat plasma,N,A,1,Intermediate,1,,CHEMBL627649,,BAO_0000218,,
12550,,,Level reaching in blood plasma of rat or human was determined,U,A,0,Autocuration,1,,CHEMBL628313,,BAO_0000019,,
12551,,Rattus norvegicus,Log (Cbrain/Cblood) in rats,N,A,1,Intermediate,1,,CHEMBL628314,,BAO_0000218,,
12552,,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,U,A,0,Autocuration,1,,CHEMBL628315,,BAO_0000019,,
12553,,,Mean percentage of compound transport through membrane; expressed as membrane transport,U,A,0,Autocuration,1,,CHEMBL628316,,BAO_0000019,,
12554,,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,U,A,0,Autocuration,1,,CHEMBL628317,,BAO_0000218,,
12555,,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,U,A,0,Autocuration,1,,CHEMBL628473,,BAO_0000019,,
12556,,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",U,A,0,Autocuration,1,,CHEMBL628474,,BAO_0000019,,
12557,,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,U,A,0,Autocuration,1,,CHEMBL628475,,BAO_0000019,,
12558,,,Net water uptake by a carrier mediated transport (%cm) mechanism,U,A,0,Autocuration,1,,CHEMBL628476,,BAO_0000019,,
12559,,Simiiformes,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,A,0,Autocuration,1,,CHEMBL628477,,BAO_0000218,,
12560,,Mustela putorius furo,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,A,1,Intermediate,1,,CHEMBL628478,,BAO_0000218,,
12561,,Mustela putorius furo,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,A,1,Intermediate,1,,CHEMBL628479,,BAO_0000218,,
12562,,Simiiformes,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,A,0,Autocuration,1,,CHEMBL628480,,BAO_0000218,,
12563,,Simiiformes,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",U,A,0,Autocuration,1,,CHEMBL628481,,BAO_0000218,,
12564,,Rattus norvegicus,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL628482,,BAO_0000218,,
12565,,Rattus norvegicus,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,A,1,Intermediate,1,,CHEMBL628483,,BAO_0000218,,
12566,,Rattus norvegicus,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,A,1,Intermediate,1,,CHEMBL628484,,BAO_0000218,1969.0,
12567,,Rattus norvegicus,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,A,1,Intermediate,1,,CHEMBL628485,,BAO_0000218,1969.0,
12568,,Macaca fascicularis,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",N,A,1,Intermediate,1,,CHEMBL628486,,BAO_0000218,1969.0,
12569,,Homo sapiens,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",N,A,1,Intermediate,1,,CHEMBL628487,,BAO_0000218,1969.0,
12570,,Rattus norvegicus,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,A,1,Intermediate,1,,CHEMBL628488,,BAO_0000218,1969.0,
12571,,Rattus norvegicus,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,A,1,Intermediate,1,,CHEMBL628489,,BAO_0000218,1969.0,
12572,,Rattus norvegicus,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,A,1,Intermediate,1,,CHEMBL628490,,BAO_0000218,1969.0,
12573,,Macaca fascicularis,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,A,1,Intermediate,1,,CHEMBL628491,,BAO_0000218,,
12574,,Macaca fascicularis,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,A,1,Intermediate,1,,CHEMBL877507,,BAO_0000218,,
12575,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,U,A,0,Autocuration,1,,CHEMBL628492,,BAO_0000218,,
12576,,Simiiformes,% metabolized in monkey S-9 after 2 hours (10 ug/mL),U,A,0,Autocuration,1,,CHEMBL628493,,BAO_0000019,,
12577,,Simiiformes,% metabolized in monkey S-9 after 2 hours (1 ug/ml),U,A,0,Autocuration,1,,CHEMBL628494,,BAO_0000019,,
12578,,Simiiformes,% metabolized in monkey S-9 after 2 hours (10 ug/ml),U,A,0,Autocuration,1,,CHEMBL628495,,BAO_0000019,,
12579,,Homo sapiens,Permeability in Caco-2 assay at 10E-6,N,A,1,Intermediate,1,,CHEMBL628496,,BAO_0000218,,
12580,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,A,0,Autocuration,1,,CHEMBL628497,,BAO_0000218,955.0,
12581,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,A,0,Autocuration,1,,CHEMBL628498,,BAO_0000218,955.0,
12582,,,Plasma protein binding was determined,U,A,0,Autocuration,1,,CHEMBL628499,,BAO_0000019,,
12583,,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL627656,,BAO_0000218,,
12584,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,U,A,0,Autocuration,1,,CHEMBL627657,,BAO_0000218,,
12585,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,U,A,0,Autocuration,1,,CHEMBL626808,,BAO_0000218,,
12586,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL626809,,BAO_0000218,,
12587,,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL626810,,BAO_0000218,,
12588,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,U,A,0,Autocuration,1,,CHEMBL626811,,BAO_0000218,,
12589,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,U,A,0,Autocuration,1,,CHEMBL874465,,BAO_0000218,,
12590,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL626812,,BAO_0000218,,
12591,,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL626813,,BAO_0000218,,
12592,,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,U,A,0,Autocuration,1,,CHEMBL626814,,BAO_0000218,,
12593,,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,U,A,0,Autocuration,1,,CHEMBL626815,,BAO_0000019,,
12594,,,Partition coefficient (logP),U,A,0,Autocuration,1,,CHEMBL628566,,BAO_0000019,,
12595,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,P,0,Autocuration,1,,CHEMBL628567,,BAO_0000100,,
12596,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL628568,,BAO_0000100,,
12597,,Canis lupus familiaris,C max in dog,N,A,1,Intermediate,1,,CHEMBL628569,,BAO_0000218,,
12598,,Cavia porcellus,C max in guinea pig,N,A,1,Intermediate,1,,CHEMBL628570,,BAO_0000218,,
12599,,,C max value was evaluated,U,A,0,Autocuration,1,,CHEMBL628571,,BAO_0000218,,
12600,,,Cmax value after oral dose of 0.1 mg//kg,U,A,0,Autocuration,1,,CHEMBL628572,,BAO_0000218,,
12601,,,Cmax value after oral dose of 0.3 mg/kg,U,A,0,Autocuration,1,,CHEMBL628573,,BAO_0000218,,
12602,,,Cmax value after oral dose of 1 mg/kg,U,A,0,Autocuration,1,,CHEMBL628574,,BAO_0000218,,
12603,,,Cmax value after oral dose of 10 mg/kg,U,A,0,Autocuration,1,,CHEMBL628575,,BAO_0000218,,
12604,,,Cmax value after oral dose of 23.4 mg/kg,U,A,0,Autocuration,1,,CHEMBL628576,,BAO_0000218,,
12605,,,Cmax value after oral dose of 3 mg/kg,U,A,0,Autocuration,1,,CHEMBL628577,,BAO_0000218,,
12606,,,Cmax value after oral dose of 3.87 mg/kg,U,A,0,Autocuration,1,,CHEMBL628578,,BAO_0000218,,
12607,,Canis lupus familiaris,Cmax value in female Beagle dogs,N,A,1,Intermediate,1,,CHEMBL874466,,BAO_0000218,,
12608,,Rattus norvegicus,Cmax value in male rats,N,A,1,Intermediate,1,,CHEMBL628579,,BAO_0000218,,
12609,,Rattus norvegicus,Cmax value in rat plasma when administered 20 mg/kg perorally,N,A,1,Intermediate,1,,CHEMBL628580,,BAO_0000218,1969.0,
12610,,Canis lupus familiaris,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,A,1,Intermediate,1,,CHEMBL628581,,BAO_0000218,1969.0,
12611,,Canis lupus familiaris,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,A,1,Intermediate,1,,CHEMBL628582,,BAO_0000218,1969.0,
12612,,Canis lupus familiaris,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,N,A,1,Intermediate,1,,CHEMBL628583,,BAO_0000218,,
12613,,Simiiformes,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,U,A,0,Autocuration,1,,CHEMBL625782,,BAO_0000218,,
12614,,Oryctolagus cuniculus,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,N,A,1,Intermediate,1,,CHEMBL625783,,BAO_0000218,,
12615,,Rattus norvegicus,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,N,A,1,Intermediate,1,,CHEMBL625784,,BAO_0000218,,
12616,,Macaca mulatta,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,N,A,1,Intermediate,1,,CHEMBL625785,,BAO_0000218,1969.0,
12617,,Rattus norvegicus,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL625786,,BAO_0000218,,
12618,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,U,A,0,Autocuration,1,,CHEMBL874467,,BAO_0000019,,
12619,,Canis lupus familiaris,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,A,1,Intermediate,1,,CHEMBL625787,,BAO_0000218,,
12620,,Human immunodeficiency virus,cytotoxicity against HIV protease enzyme.,N,A,1,Intermediate,1,,CHEMBL625964,,BAO_0000218,,
12621,,Mus musculus,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,N,A,1,Intermediate,1,,CHEMBL625965,,BAO_0000218,,
12622,,Mus musculus,Apparent clearance in mice after oral administration of 100 mg/kg of dose,N,A,1,Intermediate,1,,CHEMBL625966,,BAO_0000218,,
12623,,Canis lupus familiaris,The plasma clearance in dog.,N,A,1,Intermediate,1,,CHEMBL625967,,BAO_0000218,1969.0,
12624,,Rattus norvegicus,The plasma clearance in rat.,N,A,1,Intermediate,1,,CHEMBL625968,,BAO_0000218,1969.0,
12625,,Rattus norvegicus,Clearance from plasma in male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL625969,,BAO_0000218,1969.0,
12626,,Macaca fascicularis,Clearance from plasma in male cynomolgus monkeys,N,A,1,Intermediate,1,,CHEMBL625970,,BAO_0000218,1969.0,
12627,,Canis lupus familiaris,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",N,A,1,Intermediate,1,,CHEMBL625971,,BAO_0000218,1969.0,
12628,,Canis lupus familiaris,Clearance of compound in dog plasma,N,A,1,Intermediate,1,,CHEMBL625972,,BAO_0000218,1969.0,
12629,,Homo sapiens,Clearance of compound in human plasma,N,A,1,Intermediate,1,,CHEMBL625973,,BAO_0000218,1969.0,
12630,,Canis lupus familiaris,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,N,A,1,Intermediate,1,,CHEMBL625974,,BAO_0000218,,
12631,,Canis lupus familiaris,Clearance of compound when administered intravenously as an individual dose to a single dog.,N,A,1,Intermediate,1,,CHEMBL625975,,BAO_0000218,,
12632,,Canis lupus familiaris,"Clearance (10 mg/kg, intravenously) in dog plasma",N,A,1,Intermediate,1,,CHEMBL625976,,BAO_0000218,1969.0,
12633,,Canis lupus familiaris,Clearance value in dog,N,A,1,Intermediate,1,,CHEMBL625977,,BAO_0000218,,
12634,,Cavia porcellus,Clearance value in guinea pig,N,A,1,Intermediate,1,,CHEMBL625978,,BAO_0000218,,
12635,,Rattus norvegicus,Clearance values in rats after iv administration.,N,A,1,Intermediate,1,,CHEMBL874468,,BAO_0000218,,
12636,,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,U,A,0,Autocuration,1,,CHEMBL625421,,BAO_0000218,1969.0,
12637,,Oryctolagus cuniculus,In vivo clearance (5 mg/kg) was determined in rabbits,N,A,1,Intermediate,1,,CHEMBL625422,,BAO_0000218,,
12638,,Rattus norvegicus,Plasma Clearance rate was determined for the compound in rats,N,A,1,Intermediate,1,,CHEMBL625423,,BAO_0000218,,
12639,,Saimiri,Plasma Clearance rate was determined for the compound in squirrel monkeys,U,A,0,Autocuration,1,,CHEMBL625424,,BAO_0000218,,
12640,,Rattus norvegicus,Plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL625425,,BAO_0000218,,
12641,,,Plasma clearance of the compound,U,A,0,Autocuration,1,,CHEMBL625426,,BAO_0000218,,
12642,,Cavia porcellus,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,N,A,1,Intermediate,1,,CHEMBL625427,,BAO_0000218,,
12643,,Cavia porcellus,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,N,A,1,Intermediate,1,,CHEMBL625428,,BAO_0000218,,
12644,,,Plasma clearance was determined,U,A,0,Autocuration,1,,CHEMBL625429,,BAO_0000218,,
12645,,Canis lupus familiaris,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,N,A,1,Intermediate,1,,CHEMBL625430,,BAO_0000218,,
12646,,Rattus norvegicus,Plasma clearance rate was determined for the compound in rats,N,A,1,Intermediate,1,,CHEMBL625431,,BAO_0000218,,
12647,,Saimiri,Plasma clearance rate was determined for the compound in squirrel monkeys,U,A,0,Autocuration,1,,CHEMBL627307,,BAO_0000218,,
12648,,,Slow clearance (CL) was determined,U,A,0,Autocuration,1,,CHEMBL627308,,BAO_0000218,,
12649,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,A,0,Autocuration,1,,CHEMBL627309,,BAO_0000218,,
12650,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,A,0,Autocuration,1,,CHEMBL627310,,BAO_0000218,,
12651,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,A,0,Autocuration,1,,CHEMBL627311,,BAO_0000218,,
12652,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,A,0,Autocuration,1,,CHEMBL627312,,BAO_0000218,,
12653,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,A,0,Autocuration,1,,CHEMBL627313,,BAO_0000218,,
12654,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,A,0,Autocuration,1,,CHEMBL627314,,BAO_0000218,,
12655,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,A,0,Autocuration,1,,CHEMBL627315,,BAO_0000218,,
12656,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,A,0,Autocuration,1,,CHEMBL627316,,BAO_0000218,,
12657,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,A,0,Autocuration,1,,CHEMBL627317,,BAO_0000218,,
12658,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,A,0,Autocuration,1,,CHEMBL627318,,BAO_0000218,,
12659,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,A,0,Autocuration,1,,CHEMBL627999,,BAO_0000218,,
12660,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,A,0,Autocuration,1,,CHEMBL628000,,BAO_0000218,,
12661,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,A,0,Autocuration,1,,CHEMBL628001,,BAO_0000218,,
12662,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,A,0,Autocuration,1,,CHEMBL628002,,BAO_0000218,,
12663,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,A,0,Autocuration,1,,CHEMBL625610,,BAO_0000218,,
12664,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,A,0,Autocuration,1,,CHEMBL625611,,BAO_0000218,,
12665,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,A,0,Autocuration,1,,CHEMBL625612,,BAO_0000218,,
12666,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,A,0,Autocuration,1,,CHEMBL625613,,BAO_0000218,,
12667,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,A,0,Autocuration,1,,CHEMBL875479,,BAO_0000218,,
12668,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,A,0,Autocuration,1,,CHEMBL625614,,BAO_0000218,,
12669,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,A,0,Autocuration,1,,CHEMBL625615,,BAO_0000218,,
12670,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,A,0,Autocuration,1,,CHEMBL626302,,BAO_0000218,,
12671,,Rattus norvegicus,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL626303,,BAO_0000218,178.0,
12672,,Rattus norvegicus,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,A,1,Intermediate,1,,CHEMBL627420,,BAO_0000218,178.0,
12673,,Rattus norvegicus,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,N,A,1,Intermediate,1,,CHEMBL627421,,BAO_0000218,,
12674,,Rattus norvegicus,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,N,A,1,Intermediate,1,,CHEMBL625695,,BAO_0000218,,
12675,,Rattus norvegicus,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,N,A,1,Intermediate,1,,CHEMBL625696,,BAO_0000218,,
12676,,Mus musculus,Distribution of compound in mice brain was measured after 1 hr,N,A,1,Intermediate,1,,CHEMBL875606,,BAO_0000218,955.0,
12677,,Mus musculus,Distribution of compound in mice brain was measured after 24 hr r,N,A,1,Intermediate,1,,CHEMBL625697,,BAO_0000218,955.0,
12678,,Mus musculus,Distribution of compound in mice brain was measured after 2 hr,N,A,1,Intermediate,1,,CHEMBL625698,,BAO_0000218,955.0,
12679,,Mus musculus,Distribution of compound in mice brain was measured after 3 hr,N,A,1,Intermediate,1,,CHEMBL625699,,BAO_0000218,955.0,
12680,,Mus musculus,Distribution of compound in mice brain was measured after 6 hr,N,A,1,Intermediate,1,,CHEMBL625700,,BAO_0000218,955.0,
12681,,Mus musculus,Distribution of compound in mice liver was measured after 1 hr,N,A,1,Intermediate,1,,CHEMBL625701,,BAO_0000218,,
12682,,Mus musculus,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,N,A,1,Intermediate,1,,CHEMBL625702,,BAO_0000218,,
12683,,Mus musculus,Distribution of compound in mice liver was measured after 2 hr,N,A,1,Intermediate,1,,CHEMBL625703,,BAO_0000218,,
12684,,Mus musculus,Distribution of compound in mice liver was measured after 3 hr,N,A,1,Intermediate,1,,CHEMBL625704,,BAO_0000218,,
12685,,Mus musculus,Distribution of compound in mice liver was measured after 6 hr,N,A,1,Intermediate,1,,CHEMBL625705,,BAO_0000218,,
12686,,Canis lupus familiaris,Distribution in dog adrenal medulla 30 min after administration.,N,A,1,Intermediate,1,,CHEMBL625706,,BAO_0000218,1236.0,
12687,,Canis lupus familiaris,Distribution in dog adrenal medulla 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL625707,,BAO_0000218,1236.0,
12688,,Canis lupus familiaris,Distribution in female dog Ovary 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL625708,,BAO_0000218,,
12689,,Canis lupus familiaris,Distribution in female dog Ovary 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL625709,,BAO_0000218,,
12690,,Canis lupus familiaris,Distribution in female dog adipose 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624180,,BAO_0000218,,
12691,,Canis lupus familiaris,Distribution in female dog adipose 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624181,,BAO_0000218,,
12692,,Canis lupus familiaris,Distribution in female dog adrenal cortex 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624182,,BAO_0000218,1235.0,
12693,,Canis lupus familiaris,Distribution in female dog adrenal cortex 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624183,,BAO_0000218,1235.0,
12694,,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624184,,BAO_0000218,2107.0,
12695,,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL877489,,BAO_0000218,2107.0,
12696,,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624185,,BAO_0000218,2107.0,
12697,,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624186,,BAO_0000218,2107.0,
12698,,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624187,,BAO_0000218,2107.0,
12699,,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624188,,BAO_0000218,2107.0,
12700,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624189,,BAO_0000218,2048.0,
12701,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624190,,BAO_0000218,2048.0,
12702,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624191,,BAO_0000218,2048.0,
12703,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624192,,BAO_0000218,2048.0,
12704,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624193,,BAO_0000218,2048.0,
12705,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624194,,BAO_0000218,2048.0,
12706,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624891,,BAO_0000218,2048.0,
12707,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL624892,,BAO_0000218,2048.0,
12708,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL624893,,BAO_0000218,2048.0,
12709,,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL627632,,BAO_0000218,2048.0,
12710,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL627633,,BAO_0000218,,
12711,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL627634,,BAO_0000218,,
12712,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL627635,,BAO_0000218,,
12713,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL627636,,BAO_0000218,,
12714,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL626816,,BAO_0000218,,
12715,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626817,,BAO_0000218,,
12716,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL626818,,BAO_0000218,,
12717,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626819,,BAO_0000218,,
12718,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL626820,,BAO_0000218,,
12719,,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626821,,BAO_0000218,,
12720,,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626822,,BAO_0000218,2046.0,
12721,,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626823,,BAO_0000218,2046.0,
12722,,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL626824,,BAO_0000218,2046.0,
12723,,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626825,,BAO_0000218,2046.0,
12724,,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL626826,,BAO_0000218,2046.0,
12725,,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626827,,BAO_0000218,2046.0,
12726,,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL626828,,BAO_0000218,2046.0,
12727,,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626829,,BAO_0000218,2046.0,
12728,,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626830,,BAO_0000218,2046.0,
12729,,Rattus norvegicus,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL627150,,BAO_0000218,,
12730,,Rattus norvegicus,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL627151,,BAO_0000218,,
12731,,Rattus norvegicus,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,A,1,Intermediate,1,,CHEMBL627152,,BAO_0000218,,
12732,,Rattus norvegicus,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL627153,,BAO_0000218,,
12733,,,Rate of acetate production by the compound was determined,U,A,0,Autocuration,1,,CHEMBL627154,,BAO_0000019,,
12734,,,Rate of acetate production by the compound was determined; Not determined,U,A,0,Autocuration,1,,CHEMBL627155,,BAO_0000019,,
12735,,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,U,A,0,Autocuration,1,,CHEMBL627156,,BAO_0000019,,
12736,,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,U,A,0,Autocuration,1,,CHEMBL627157,,BAO_0000019,,
12737,,Oryctolagus cuniculus,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,A,1,Intermediate,1,,CHEMBL627158,,BAO_0000218,,
12738,,Oryctolagus cuniculus,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,A,1,Intermediate,1,,CHEMBL627159,,BAO_0000218,1969.0,
12739,,Mus musculus,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,A,1,Intermediate,1,,CHEMBL627160,,BAO_0000218,,
12740,,Rattus norvegicus,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,A,1,Intermediate,1,,CHEMBL628540,,BAO_0000218,,
12741,,Rattus norvegicus,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,A,1,Intermediate,1,,CHEMBL628541,,BAO_0000218,1969.0,
12742,,Rattus norvegicus,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,A,1,Intermediate,1,,CHEMBL628542,,BAO_0000218,1969.0,
12743,,,Solubility after at a pH 1.2,U,P,0,Autocuration,1,,CHEMBL628543,,BAO_0000100,,
12744,,,Solubility after at pH 1.2,U,P,0,Autocuration,1,,CHEMBL628544,,BAO_0000100,,
12745,,,Solubility after injection of water,U,P,0,Autocuration,1,,CHEMBL628545,,BAO_0000100,,
12746,,,Statistical significance of IC 50 values; Expressed as R value,U,A,0,Autocuration,1,,CHEMBL628546,,BAO_0000019,,
12747,,,Systemic availability with respect to methyldopa was determined,U,A,0,Autocuration,1,,CHEMBL874455,,BAO_0000019,,
12748,,Rattus norvegicus,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,N,A,1,Intermediate,1,,CHEMBL628547,,BAO_0000218,,
12749,,Rattus norvegicus,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,N,A,1,Intermediate,1,,CHEMBL628548,,BAO_0000218,1969.0,
12750,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",N,A,1,Intermediate,1,,CHEMBL628549,,BAO_0000218,1988.0,
12751,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",N,A,1,Intermediate,1,,CHEMBL628550,,BAO_0000218,1988.0,
12752,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",N,A,1,Intermediate,1,,CHEMBL628551,,BAO_0000218,1988.0,
12753,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",N,A,1,Intermediate,1,,CHEMBL628552,,BAO_0000218,1088.0,
12754,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",N,A,1,Intermediate,1,,CHEMBL628553,,BAO_0000218,1088.0,
12755,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",N,A,1,Intermediate,1,,CHEMBL628554,,BAO_0000218,1088.0,
12756,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",N,A,1,Intermediate,1,,CHEMBL628555,,BAO_0000218,1088.0,
12757,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",N,A,1,Intermediate,1,,CHEMBL628556,,BAO_0000218,1088.0,
12758,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",N,A,1,Intermediate,1,,CHEMBL628557,,BAO_0000218,2113.0,
12759,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",N,A,1,Intermediate,1,,CHEMBL628558,,BAO_0000218,1988.0,
12760,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",N,A,1,Intermediate,1,,CHEMBL628559,,BAO_0000218,1988.0,
12761,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",N,A,1,Intermediate,1,,CHEMBL628560,,BAO_0000218,1988.0,
12762,,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",N,A,1,Intermediate,1,,CHEMBL874456,,BAO_0000218,1088.0,
12763,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",N,A,1,Intermediate,1,,CHEMBL628561,,BAO_0000218,1988.0,
12764,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",N,A,1,Intermediate,1,,CHEMBL628562,,BAO_0000218,1988.0,
12765,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",N,A,1,Intermediate,1,,CHEMBL628563,,BAO_0000218,1088.0,
12766,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",N,A,1,Intermediate,1,,CHEMBL628564,,BAO_0000218,1088.0,
12767,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",N,A,1,Intermediate,1,,CHEMBL628565,,BAO_0000218,1088.0,
12768,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",N,A,1,Intermediate,1,,CHEMBL631248,,BAO_0000218,1088.0,
12769,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",N,A,1,Intermediate,1,,CHEMBL631249,,BAO_0000218,1088.0,
12770,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",N,A,1,Intermediate,1,,CHEMBL627214,,BAO_0000218,2113.0,
12771,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",N,A,1,Intermediate,1,,CHEMBL874591,,BAO_0000218,1988.0,
12772,,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",N,A,1,Intermediate,1,,CHEMBL627215,,BAO_0000218,1988.0,
12773,,Oryctolagus cuniculus,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,N,A,1,Intermediate,1,,CHEMBL625471,,BAO_0000218,1988.0,
12774,,Oryctolagus cuniculus,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,N,A,1,Intermediate,1,,CHEMBL625472,,BAO_0000218,,
12775,,Oryctolagus cuniculus,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,N,A,1,Intermediate,1,,CHEMBL625473,,BAO_0000218,,
12776,,Canis lupus familiaris,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,N,A,1,Intermediate,1,,CHEMBL625474,,BAO_0000218,,
12777,,Canis lupus familiaris,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,N,A,1,Intermediate,1,,CHEMBL625475,,BAO_0000218,,
12778,,Rattus norvegicus,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,N,A,1,Intermediate,1,,CHEMBL625476,,BAO_0000218,,
12779,,Rattus norvegicus,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,N,A,1,Intermediate,1,,CHEMBL625477,,BAO_0000218,,
12780,,Rattus norvegicus,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,N,A,1,Intermediate,1,,CHEMBL625478,,BAO_0000218,,
12781,,Rattus norvegicus,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,N,A,1,Intermediate,1,,CHEMBL625479,,BAO_0000218,,
12782,,Rattus norvegicus,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,N,A,1,Intermediate,1,,CHEMBL625480,,BAO_0000218,,
12783,,Rattus norvegicus,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,N,A,1,Intermediate,1,,CHEMBL625481,,BAO_0000218,1969.0,
12784,,Rattus norvegicus,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL625482,,BAO_0000218,,
12785,,Rattus norvegicus,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL625483,,BAO_0000218,,
12786,,Rattus norvegicus,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL625484,,BAO_0000218,,
12787,,Rattus norvegicus,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL625485,,BAO_0000218,,
12788,,Canis lupus familiaris,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,N,A,1,Intermediate,1,,CHEMBL625486,,BAO_0000218,1969.0,
12789,,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL625487,,BAO_0000218,1969.0,
12790,,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL625488,,BAO_0000218,1969.0,
12791,,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL625489,,BAO_0000218,1969.0,
12792,,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL625490,,BAO_0000218,1969.0,
12793,,Canis lupus familiaris,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,N,A,1,Intermediate,1,,CHEMBL625491,,BAO_0000218,1969.0,
12794,,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,N,A,1,Intermediate,1,,CHEMBL625492,,BAO_0000218,1969.0,
12795,,Homo sapiens,plasma clearance in human,N,A,1,Intermediate,1,,CHEMBL625493,,BAO_0000218,1969.0,
12796,,Rattus norvegicus,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,A,1,Intermediate,1,,CHEMBL625494,,BAO_0000218,,
12797,,Rattus norvegicus,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,A,1,Intermediate,1,,CHEMBL625495,,BAO_0000218,,
12798,,Rattus norvegicus,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,A,1,Intermediate,1,,CHEMBL625496,,BAO_0000218,,
12799,,,1-Octanol/water partition coefficient measured at 7.4,U,P,0,Autocuration,1,,CHEMBL625497,,BAO_0000100,,
12800,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625498,,BAO_0000100,,
12801,,,Partition coefficient (logP),U,A,0,Autocuration,1,,CHEMBL625499,,BAO_0000019,,
12802,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625500,,BAO_0000100,,
12803,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625501,,BAO_0000100,,
12804,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625502,,BAO_0000100,,
12805,,,Calculated partition coefficient (clogP) (relative to BAY K 8644),U,P,0,Autocuration,1,,CHEMBL625503,,BAO_0000100,,
12806,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625504,,BAO_0000100,,
12807,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625505,,BAO_0000100,,
12808,,,Calculated partition coefficient of the compound,U,P,0,Autocuration,1,,CHEMBL625506,,BAO_0000100,,
12809,,,Partition coefficient (logP),U,A,0,Autocuration,1,,CHEMBL625507,,BAO_0000019,,
12810,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625508,,BAO_0000100,,
12811,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625509,,BAO_0000100,,
12812,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625510,,BAO_0000100,,
12813,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL883125,,BAO_0000100,,
12814,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625511,,BAO_0000100,,
12815,,,Partition coefficient of the compound,U,A,0,Autocuration,1,,CHEMBL874650,,BAO_0000019,,
12816,,,Partition coefficient of the compound,U,A,0,Autocuration,1,,CHEMBL625512,,BAO_0000019,,
12817,,,Partition coefficient of compound was determined,U,A,0,Autocuration,1,,CHEMBL625513,,BAO_0000019,,
12818,,,Partition coefficient was determined,U,A,0,Autocuration,1,,CHEMBL625514,,BAO_0000019,,
12819,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625515,,BAO_0000100,,
12820,,,partition coefficient of compound was determined,U,P,0,Autocuration,1,,CHEMBL625516,,BAO_0000100,,
12821,,Canis lupus familiaris,The total body administered intravenously in dog,N,A,1,Intermediate,1,,CHEMBL625517,,BAO_0000218,,
12822,,Rattus norvegicus,The total body administered intravenously in rats,N,A,1,Intermediate,1,,CHEMBL625518,,BAO_0000218,,
12823,,Mus musculus,Time taken for the administration to female NIH mice weighing 25-30 g.,N,A,1,Intermediate,1,,CHEMBL625519,,BAO_0000218,,
12824,,,Time taken for the administration,U,A,0,Autocuration,1,,CHEMBL625520,,BAO_0000019,,
12825,,Canis lupus familiaris,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,N,A,1,Intermediate,1,,CHEMBL874651,,BAO_0000218,,
12826,,Simiiformes,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,U,A,0,Autocuration,1,,CHEMBL625521,,BAO_0000218,,
12827,,Oryctolagus cuniculus,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,A,1,Intermediate,1,,CHEMBL623171,,BAO_0000218,,
12828,,Rattus norvegicus,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,N,A,1,Intermediate,1,,CHEMBL623853,,BAO_0000218,,
12829,,,Plasma clearance for the compound was determined.,U,A,0,Autocuration,1,,CHEMBL623854,,BAO_0000019,,
12830,,,CLog P value of the compound,U,P,0,Autocuration,1,,CHEMBL874405,,BAO_0000100,,
12831,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL623855,,BAO_0000100,,
12832,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL623856,,BAO_0000100,,
12833,,,ClogP value of the compound; nd ='no data',U,P,0,Autocuration,1,,CHEMBL623857,,BAO_0000100,,
12834,,,ClogP value of the compound; nd ='not determined',U,P,0,Autocuration,1,,CHEMBL623858,,BAO_0000100,,
12835,,,CLog P was determined,U,P,0,Autocuration,1,,CHEMBL623859,,BAO_0000100,,
12836,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL839829,,BAO_0000100,,
12837,,,CLogP was calculated,U,A,0,Autocuration,1,,CHEMBL623860,,BAO_0000019,,
12838,,,CLogP value was determined,U,A,0,Autocuration,1,,CHEMBL623861,,BAO_0000019,,
12839,,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,U,A,0,Autocuration,1,,CHEMBL623862,,BAO_0000019,,
12840,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL874406,,BAO_0000100,,
12841,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL623863,,BAO_0000100,,
12842,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624021,,BAO_0000100,,
12843,,Canis lupus familiaris,Distribution in female dog adrenal medulla 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624022,,BAO_0000218,1236.0,
12844,,Canis lupus familiaris,Distribution in female dog adrenal medulla 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624023,,BAO_0000218,1236.0,
12845,,Canis lupus familiaris,Distribution in female dog bile 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624024,,BAO_0000218,,
12846,,Canis lupus familiaris,Distribution in female dog bile 72 hr after administration.,N,A,1,Intermediate,1,,CHEMBL624025,,BAO_0000218,,
12847,,Canis lupus familiaris,Distribution in female dog blood 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624026,,BAO_0000218,,
12848,,Canis lupus familiaris,Distribution in female dog blood 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624027,,BAO_0000218,,
12849,,Canis lupus familiaris,Distribution in female dog heart 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624028,,BAO_0000218,,
12850,,Canis lupus familiaris,Distribution in female dog heart 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624029,,BAO_0000218,,
12851,,Canis lupus familiaris,Distribution in female dog kidney 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624030,,BAO_0000218,,
12852,,Canis lupus familiaris,Distribution in female dog kidney 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624031,,BAO_0000218,,
12853,,Canis lupus familiaris,Distribution in female dog large intestine 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624032,,BAO_0000218,160.0,
12854,,Canis lupus familiaris,Distribution in female dog large intestine 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL874407,,BAO_0000218,160.0,
12855,,Canis lupus familiaris,Distribution in female dog liver 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624033,,BAO_0000218,,
12856,,Canis lupus familiaris,Distribution in female dog liver 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624034,,BAO_0000218,,
12857,,Canis lupus familiaris,Distribution in female dog lung 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624035,,BAO_0000218,,
12858,,Canis lupus familiaris,Distribution in female dog lung 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624036,,BAO_0000218,,
12859,,Canis lupus familiaris,Distribution in female dog muscle 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624037,,BAO_0000218,2385.0,
12860,,Canis lupus familiaris,Distribution in female dog muscle 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624038,,BAO_0000218,2385.0,
12861,,Canis lupus familiaris,Distribution in female dog pancreas 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624039,,BAO_0000218,,
12862,,Canis lupus familiaris,Distribution in female dog pancreas 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624040,,BAO_0000218,,
12863,,Canis lupus familiaris,Distribution in female dog small intestine 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624041,,BAO_0000218,160.0,
12864,,Canis lupus familiaris,Distribution in female dog small intestine 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624042,,BAO_0000218,160.0,
12865,,Canis lupus familiaris,Distribution in female dog spleen 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624043,,BAO_0000218,2106.0,
12866,,Canis lupus familiaris,Distribution in female dog spleen 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624044,,BAO_0000218,2106.0,
12867,,Canis lupus familiaris,Distribution in female dog stomach 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624045,,BAO_0000218,945.0,
12868,,Canis lupus familiaris,Distribution in female dog stomach 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624046,,BAO_0000218,945.0,
12869,,Canis lupus familiaris,Distribution in female dog thyroid 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624047,,BAO_0000218,2046.0,
12870,,Canis lupus familiaris,Distribution in female dog thyroid 72 hours after administration.,N,A,1,Intermediate,1,,CHEMBL624048,,BAO_0000218,2046.0,
12871,,Canis lupus familiaris,Distribution in female dog urine 24 hours after administration.,N,A,1,Intermediate,1,,CHEMBL874408,,BAO_0000218,1088.0,
12872,,Canis lupus familiaris,Distribution in female dog urine 72 hr after administration.,N,A,1,Intermediate,1,,CHEMBL624049,,BAO_0000218,1088.0,
12873,,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,U,A,0,Autocuration,1,,CHEMBL624050,,BAO_0000218,1969.0,
12874,,,Plasma concentration at 7 hr after intravenous dosing,U,A,0,Autocuration,1,,CHEMBL624051,,BAO_0000019,,
12875,,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,N,A,1,Intermediate,1,,CHEMBL623278,,BAO_0000218,,
12876,,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,N,A,1,Intermediate,1,,CHEMBL623279,,BAO_0000218,,
12877,,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 1 hr in rats,N,A,1,Intermediate,1,,CHEMBL623280,,BAO_0000218,,
12878,,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 2 hr in rats,N,A,1,Intermediate,1,,CHEMBL623963,,BAO_0000218,,
12879,,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 4 hr in rats,N,A,1,Intermediate,1,,CHEMBL623964,,BAO_0000218,,
12880,,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 6 hr in rats,N,A,1,Intermediate,1,,CHEMBL623965,,BAO_0000218,,
12881,,Rattus norvegicus,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,N,A,1,Intermediate,1,,CHEMBL623966,,BAO_0000218,,
12882,,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,N,A,1,Intermediate,1,,CHEMBL874415,,BAO_0000218,,
12883,,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,N,A,1,Intermediate,1,,CHEMBL623967,,BAO_0000218,,
12884,,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,N,A,1,Intermediate,1,,CHEMBL623968,,BAO_0000218,,
12885,,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,N,A,1,Intermediate,1,,CHEMBL623969,,BAO_0000218,,
12886,,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,N,A,1,Intermediate,1,,CHEMBL628409,,BAO_0000218,,
12887,,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,N,A,1,Intermediate,1,,CHEMBL628410,,BAO_0000218,,
12888,,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,N,A,1,Intermediate,1,,CHEMBL628411,,BAO_0000218,,
12889,,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,N,A,1,Intermediate,1,,CHEMBL628412,,BAO_0000218,,
12890,,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,U,A,0,Autocuration,1,,CHEMBL628413,,BAO_0000019,,
12891,,,The concentration in plasmat; Not determined,U,A,0,Autocuration,1,,CHEMBL628414,,BAO_0000019,1969.0,
12892,,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in blood,N,A,1,Intermediate,1,,CHEMBL628415,,BAO_0000218,,
12893,,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in brown fat,N,A,1,Intermediate,1,,CHEMBL628416,,BAO_0000218,,
12894,,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in heart,N,A,1,Intermediate,1,,CHEMBL628417,,BAO_0000218,,
12895,,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in liver,N,A,1,Intermediate,1,,CHEMBL874908,,BAO_0000218,2107.0,
12896,,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in plasma,N,A,1,Intermediate,1,,CHEMBL628418,,BAO_0000218,,
12897,,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,N,A,1,Intermediate,1,,CHEMBL628419,,BAO_0000218,2385.0,
12898,,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,N,A,1,Intermediate,1,,CHEMBL628420,,BAO_0000218,,
12899,,,Water solubility at 37 degree C.,U,A,0,Autocuration,1,,CHEMBL628421,,BAO_0000019,,
12900,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,P,0,Autocuration,1,,CHEMBL626726,,BAO_0000100,,
12901,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,P,0,Autocuration,1,,CHEMBL626727,,BAO_0000100,,
12902,,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626728,,BAO_0000218,178.0,
12903,,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626729,,BAO_0000218,178.0,
12904,,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626730,,BAO_0000218,178.0,
12905,,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626731,,BAO_0000218,178.0,
12906,,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626732,,BAO_0000218,178.0,
12907,,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626733,,BAO_0000218,948.0,
12908,,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626734,,BAO_0000218,948.0,
12909,,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626735,,BAO_0000218,948.0,
12910,,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL874909,,BAO_0000218,948.0,
12911,,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626736,,BAO_0000218,948.0,
12912,,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL626737,,BAO_0000218,2113.0,
12913,,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630999,,BAO_0000218,2113.0,
12914,,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631000,,BAO_0000218,2113.0,
12915,,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631001,,BAO_0000218,2113.0,
12916,,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631002,,BAO_0000218,2113.0,
12917,,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631003,,BAO_0000218,2107.0,
12918,,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631004,,BAO_0000218,2107.0,
12919,,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631005,,BAO_0000218,2107.0,
12920,,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631006,,BAO_0000218,2107.0,
12921,,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631007,,BAO_0000218,2107.0,
12922,,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631008,,BAO_0000218,2048.0,
12923,,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631009,,BAO_0000218,2048.0,
12924,,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631010,,BAO_0000218,2048.0,
12925,,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631011,,BAO_0000218,2048.0,
12926,,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL631012,,BAO_0000218,2048.0,
12927,,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630271,,BAO_0000218,2046.0,
12928,,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630272,,BAO_0000218,2046.0,
12929,,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630273,,BAO_0000218,2046.0,
12930,,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630274,,BAO_0000218,2046.0,
12931,,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630275,,BAO_0000218,2046.0,
12932,,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL875782,,BAO_0000218,,
12933,,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630276,,BAO_0000218,,
12934,,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630277,,BAO_0000218,,
12935,,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630278,,BAO_0000218,,
12936,,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,N,A,1,Intermediate,1,,CHEMBL630279,,BAO_0000218,,
12937,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,U,A,0,Autocuration,1,,CHEMBL630280,,BAO_0000019,,
12938,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,A,0,Autocuration,1,,CHEMBL630281,,BAO_0000019,,
12939,,Oryctolagus cuniculus,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,N,A,1,Intermediate,1,,CHEMBL630282,,BAO_0000218,,
12940,,Oryctolagus cuniculus,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,N,A,1,Intermediate,1,,CHEMBL630283,,BAO_0000218,,
12941,,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),U,A,0,Autocuration,1,,CHEMBL630284,,BAO_0000019,,
12942,,,Alkylating activity was determined,U,A,0,Autocuration,1,,CHEMBL630285,,BAO_0000019,,
12943,Microsomes,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),U,A,0,Autocuration,1,,CHEMBL630286,,BAO_0000251,,
12944,,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",N,A,1,Intermediate,1,,CHEMBL630069,,BAO_0000218,,
12945,,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",N,A,1,Intermediate,1,,CHEMBL630070,,BAO_0000218,,
12946,,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",N,A,1,Intermediate,1,,CHEMBL630071,,BAO_0000218,,
12947,,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",N,A,1,Intermediate,1,,CHEMBL630072,,BAO_0000218,,
12948,,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",N,A,1,Intermediate,1,,CHEMBL875110,,BAO_0000218,,
12949,,Rattus norvegicus,Compound was tested for antidiuretic activity in rats,N,A,1,Intermediate,1,,CHEMBL630073,,BAO_0000218,,
12950,,,Compound was tested for inactivation kinetic values,U,A,0,Autocuration,1,,CHEMBL630074,,BAO_0000019,,
12951,,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,U,A,0,Autocuration,1,,CHEMBL630075,,BAO_0000218,,
12952,,,Dissociation rate calculated from the first-order equation using the t1/2 value,U,A,0,Autocuration,1,,CHEMBL630076,,BAO_0000019,,
12953,,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,U,P,0,Autocuration,1,,CHEMBL630077,,BAO_0000100,,
12954,,,Aqueous solubility was measured,U,P,0,Autocuration,1,,CHEMBL630078,,BAO_0000100,,
12955,,,Aqueous solubility was measured at a pH 4,U,P,0,Autocuration,1,,CHEMBL630079,,BAO_0000100,,
12956,,,Aqueous solubility (pH 7),U,P,0,Autocuration,1,,CHEMBL630080,,BAO_0000100,,
12957,,,Aqueous solubility was measured at a pH 9,U,P,0,Autocuration,1,,CHEMBL630081,,BAO_0000100,,
12958,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",U,A,0,Autocuration,1,,CHEMBL630082,,BAO_0000019,,
12959,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,A,0,Autocuration,1,,CHEMBL630083,,BAO_0000019,,
12960,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,A,0,Autocuration,1,,CHEMBL630084,,BAO_0000019,,
12961,,,Aqueous solubility of the compound,U,P,0,Autocuration,1,,CHEMBL629198,,BAO_0000100,,
12962,,,Aqueous solubility at 37 degree Celsius at pH 7.38,U,P,0,Autocuration,1,,CHEMBL629199,,BAO_0000100,,
12963,,,Aqueous solubility in pH 7.4 phosphate buffer,U,P,0,Autocuration,1,,CHEMBL629200,,BAO_0000100,,
12964,,Canis lupus familiaris,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,N,A,1,Intermediate,1,,CHEMBL629201,,BAO_0000218,,
12965,,Canis lupus familiaris,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,N,A,1,Intermediate,1,,CHEMBL629202,,BAO_0000218,,
12966,,Homo sapiens,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,N,A,1,Intermediate,1,,CHEMBL875111,,BAO_0000218,,
12967,,Homo sapiens,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,N,A,1,Intermediate,1,,CHEMBL629203,,BAO_0000218,,
12968,,Homo sapiens,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,N,A,1,Intermediate,1,,CHEMBL629204,,BAO_0000218,,
12969,,Homo sapiens,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,N,A,1,Intermediate,1,,CHEMBL629205,,BAO_0000218,,
12970,,Homo sapiens,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,N,A,1,Intermediate,1,,CHEMBL629206,,BAO_0000218,,
12971,,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,U,A,0,Autocuration,1,,CHEMBL631185,,BAO_0000019,,
12972,,Rattus norvegicus,Compound was evaluated for the average bile flow rat in rats,N,A,1,Intermediate,1,,CHEMBL631186,,BAO_0000218,,
12973,,Oryctolagus cuniculus,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,A,1,Intermediate,1,,CHEMBL631187,,BAO_0000218,,
12974,,Oryctolagus cuniculus,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,A,1,Intermediate,1,,CHEMBL631188,,BAO_0000218,,
12975,,,Average half life period was determined,U,A,0,Autocuration,1,,CHEMBL876419,,BAO_0000019,,
12976,,,Average half life period was determined,U,A,0,Autocuration,1,,CHEMBL631189,,BAO_0000019,,
12977,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL631190,,BAO_0000218,,
12978,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL631191,,BAO_0000218,,
12979,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL631192,,BAO_0000218,,
12980,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL632400,,BAO_0000218,,
12981,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL630564,,BAO_0000218,,
12982,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL630565,,BAO_0000218,,
12983,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL630566,,BAO_0000218,,
12984,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL631229,,BAO_0000218,,
12985,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL631230,,BAO_0000218,,
12986,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL876428,,BAO_0000100,,
12987,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL631231,,BAO_0000100,,
12988,,,Calculated partition coefficient (clogP) (MacLogP),U,P,0,Autocuration,1,,CHEMBL631232,,BAO_0000100,,
12989,,,Hydrophilicity was determined,U,A,0,Autocuration,1,,CHEMBL631233,,BAO_0000019,,
12990,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL631234,,BAO_0000100,,
12991,,,Increased absorption was determined,U,A,0,Autocuration,1,,CHEMBL883126,,BAO_0000019,,
12992,,,Lipophilicity value was evaluated,U,P,0,Autocuration,1,,CHEMBL631235,,BAO_0000100,,
12993,,,Log P value of the compound.,U,P,0,Autocuration,1,,CHEMBL631236,,BAO_0000100,,
12994,,,Partition coefficient of compound was determined,U,A,0,Autocuration,1,,CHEMBL631237,,BAO_0000019,,
12995,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL631238,,BAO_0000100,,
12996,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL876429,,BAO_0000100,,
12997,,,Partition coefficient was measured by medchem software; Not calculated,U,A,0,Autocuration,1,,CHEMBL631414,,BAO_0000019,,
12998,,,Partition coefficient was measured by octanol-water using standard shake-flask method,U,P,0,Autocuration,1,,CHEMBL631415,,BAO_0000100,,
12999,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL631416,,BAO_0000100,,
13000,,,Partition coefficient (logP),U,A,0,Autocuration,1,,CHEMBL631417,,BAO_0000019,,
13001,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL631418,,BAO_0000100,,
13002,,,The Octanol/Water partition coefficient CLogP,U,P,0,Autocuration,1,,CHEMBL631419,,BAO_0000100,,
13003,,,The pharmacokinetic parameter C Log p was reported,U,A,0,Autocuration,1,,CHEMBL631420,,BAO_0000019,,
13004,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL631421,,BAO_0000100,,
13005,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL631422,,BAO_0000100,,
13006,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL631423,,BAO_0000100,,
13007,,Rattus norvegicus,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL876430,,BAO_0000218,1969.0,
13008,,Rattus norvegicus,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL631424,,BAO_0000218,1969.0,
13009,,Canis lupus familiaris,Compound was administered intravenously in dog to evaluate plasma clearance values,N,A,1,Intermediate,1,,CHEMBL631425,,BAO_0000218,1969.0,
13010,,Simiiformes,Compound was administered intravenously in monkey to evaluate plasma clearance values,U,A,0,Autocuration,1,,CHEMBL631426,,BAO_0000218,1969.0,
13011,,Mus musculus,Compound was administered intravenously in mouse to evaluate plasma clearance values,N,A,1,Intermediate,1,,CHEMBL631427,,BAO_0000218,1969.0,
13012,,Canis lupus familiaris,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,N,A,1,Intermediate,1,,CHEMBL631428,,BAO_0000218,1969.0,
13013,Microsomes,Macaca mulatta,Intrinsic clearance in Rhesus liver microsome,N,A,1,Intermediate,1,,CHEMBL631429,,BAO_0000218,2107.0,
13014,Microsomes,Canis lupus familiaris,Intrinsic clearance in dog liver microsome,N,A,1,Intermediate,1,,CHEMBL631430,,BAO_0000218,2107.0,
13015,Microsomes,Rattus norvegicus,Intrinsic clearance in rat liver microsome,N,A,1,Intermediate,1,,CHEMBL631431,,BAO_0000218,2107.0,
13016,,Macaca mulatta,Low plasma clearance was calculated in rhesus monkey,N,A,1,Intermediate,1,,CHEMBL631432,,BAO_0000218,1969.0,
13017,,Canis lupus familiaris,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,N,A,1,Intermediate,1,,CHEMBL631433,,BAO_0000218,,
13018,,,Plasma clearance after intravenous dose of 0.3 mg/kg,U,A,0,Autocuration,1,,CHEMBL631434,,BAO_0000218,,
13019,,,Plasma clearance after intravenous dose of 1 mg/kg,U,A,0,Autocuration,1,,CHEMBL631435,,BAO_0000218,,
13020,,,Plasma clearance after intravenous dose of 3 mg/kg,U,A,0,Autocuration,1,,CHEMBL631436,,BAO_0000218,,
13021,,,Plasma clearance after intravenous dose of 3.87 mg/kg,U,A,0,Autocuration,1,,CHEMBL631437,,BAO_0000218,,
13022,,Rattus norvegicus,Plasma clearance after peroral administration at 10 mpk in Rat,N,A,1,Intermediate,1,,CHEMBL631438,,BAO_0000218,,
13023,,Macaca mulatta,Plasma clearance after peroral administration at 10 mpk in Rhesus,N,A,1,Intermediate,1,,CHEMBL876431,,BAO_0000218,,
13024,,Canis lupus familiaris,Plasma clearance after peroral administration at 10 mpk in dog,N,A,1,Intermediate,1,,CHEMBL631439,,BAO_0000218,,
13025,,Rattus norvegicus,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,N,A,1,Intermediate,1,,CHEMBL631440,,BAO_0000218,,
13026,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),U,A,0,Autocuration,1,,CHEMBL631441,,BAO_0000019,,
13027,,,Critical Micellar concentration was determined,U,A,0,Autocuration,1,,CHEMBL631442,,BAO_0000019,,
13028,,,Critical Micellar concentration of the compound. was determined,U,A,0,Autocuration,1,,CHEMBL626525,,BAO_0000019,,
13029,,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,U,A,0,Autocuration,1,,CHEMBL627168,,BAO_0000019,,
13030,,,Critical micellar concentration was measured in water by the dye solubilization method,U,A,0,Autocuration,1,,CHEMBL875618,,BAO_0000019,,
13031,,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,U,B,0,Autocuration,1,,CHEMBL626612,,BAO_0000019,,
13032,,,CMR value (relative to BAY K 8644),U,A,0,Autocuration,1,,CHEMBL626613,,BAO_0000019,,
13033,,,Carbamoylating activity was determined,U,A,0,Autocuration,1,,CHEMBL626614,,BAO_0000019,,
13034,,Simiiformes,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,U,A,0,Autocuration,1,,CHEMBL626615,,BAO_0000218,,
13035,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,U,A,0,Autocuration,1,,CHEMBL626616,,BAO_0000019,,
13036,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,U,A,0,Autocuration,1,,CHEMBL626617,,BAO_0000019,,
13037,,Canis lupus familiaris,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,N,A,1,Intermediate,1,,CHEMBL626618,,BAO_0000218,1969.0,
13038,,Rattus norvegicus,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,N,A,1,Intermediate,1,,CHEMBL626619,,BAO_0000218,1969.0,
13039,,Canis lupus familiaris,"Clearance rate at 0.46 mg/kg, iv, in dogs",N,A,1,Intermediate,1,,CHEMBL626620,,BAO_0000218,,
13040,,Rattus norvegicus,"Clearance rate at 5.5 mg/kg, iv, in rat",N,A,1,Intermediate,1,,CHEMBL626621,,BAO_0000218,,
13041,,Macaca fascicularis,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL626622,,BAO_0000218,,
13042,,Macaca fascicularis,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL626623,,BAO_0000218,,
13043,,Canis lupus familiaris,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL626624,,BAO_0000218,,
13044,,Rattus norvegicus,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL626625,,BAO_0000218,,
13045,,Rattus norvegicus,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,A,1,Intermediate,1,,CHEMBL626626,,BAO_0000218,2107.0,
13046,,,Tested for the total clearance of the compound,U,A,0,Autocuration,1,,CHEMBL626627,,BAO_0000218,,
13047,,Canis lupus familiaris,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL626628,,BAO_0000218,,
13048,,,Total body clearance was determined,U,A,0,Autocuration,1,,CHEMBL626629,,BAO_0000218,,
13049,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,A,1,Intermediate,1,,CHEMBL626630,,BAO_0000218,,
13050,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,A,1,Intermediate,1,,CHEMBL626631,,BAO_0000218,,
13051,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,P,0,Autocuration,1,,CHEMBL626632,,BAO_0000100,,
13052,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,P,0,Autocuration,1,,CHEMBL626633,,BAO_0000100,,
13053,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,U,P,0,Autocuration,1,,CHEMBL626634,,BAO_0000100,,
13054,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,P,0,Autocuration,1,,CHEMBL626635,,BAO_0000100,,
13055,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,P,0,Autocuration,1,,CHEMBL626636,,BAO_0000100,,
13056,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,P,0,Autocuration,1,,CHEMBL626637,,BAO_0000100,,
13057,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),N,A,1,Intermediate,1,,CHEMBL626638,,BAO_0000218,,
13058,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,N,A,1,Intermediate,1,,CHEMBL626639,,BAO_0000218,,
13059,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,N,A,1,Intermediate,1,,CHEMBL626640,,BAO_0000218,,
13060,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,N,A,1,Intermediate,1,,CHEMBL626641,,BAO_0000218,,
13061,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,N,A,1,Intermediate,1,,CHEMBL627272,,BAO_0000218,,
13062,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,N,A,1,Intermediate,1,,CHEMBL627273,,BAO_0000218,,
13063,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),N,A,1,Intermediate,1,,CHEMBL627441,,BAO_0000218,,
13064,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),N,A,1,Intermediate,1,,CHEMBL628355,,BAO_0000218,,
13065,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),N,A,1,Intermediate,1,,CHEMBL628356,,BAO_0000218,,
13066,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),N,A,1,Intermediate,1,,CHEMBL628357,,BAO_0000218,,
13067,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),N,A,1,Intermediate,1,,CHEMBL628358,,BAO_0000218,,
13068,,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),N,A,1,Intermediate,1,,CHEMBL622307,,BAO_0000218,,
13069,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,U,A,0,Autocuration,1,,CHEMBL622527,,BAO_0000019,,
13070,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,U,A,0,Autocuration,1,,CHEMBL622528,,BAO_0000019,,
13071,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,U,A,0,Autocuration,1,,CHEMBL622529,,BAO_0000019,,
13072,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,U,A,0,Autocuration,1,,CHEMBL622992,,BAO_0000019,,
13073,,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,U,A,0,Autocuration,1,,CHEMBL622993,,BAO_0000019,,
13074,,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,U,A,0,Autocuration,1,,CHEMBL622994,,BAO_0000019,,
13075,,Rattus norvegicus,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",N,A,1,Intermediate,1,,CHEMBL622995,,BAO_0000218,,
13076,,Rattus norvegicus,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",N,A,1,Intermediate,1,,CHEMBL622996,,BAO_0000218,,
13077,,Rattus norvegicus,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",N,A,1,Intermediate,1,,CHEMBL622997,,BAO_0000218,,
13078,,Rattus norvegicus,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",N,A,1,Intermediate,1,,CHEMBL622998,,BAO_0000218,,
13079,,,Cp max following ip administration at 1 mg/kg,U,A,0,Autocuration,1,,CHEMBL622999,,BAO_0000218,,
13080,,,Maximum concentration in plasma was reported at 0.5 hour,U,A,0,Autocuration,1,,CHEMBL623000,,BAO_0000218,1969.0,
13081,,,Maximum concentration in plasma was reported at 2 hour,U,A,0,Autocuration,1,,CHEMBL623001,,BAO_0000218,1969.0,
13082,,Mus musculus,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,N,A,1,Intermediate,1,,CHEMBL623002,,BAO_0000218,,
13083,,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),U,P,0,Autocuration,1,,CHEMBL623003,,BAO_0000100,,
13084,,,Steady state concentration was evaluated,U,A,0,Autocuration,1,,CHEMBL623004,,BAO_0000019,,
13085,,,Partition coefficient (logP),U,A,0,Autocuration,1,,CHEMBL623005,,BAO_0000019,,
13086,,,Partition coefficient (logD7.4),U,A,0,Autocuration,1,,CHEMBL623006,,BAO_0000019,,
13087,,Rattus norvegicus,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623007,,BAO_0000218,2107.0,
13088,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623008,,BAO_0000218,10000001.0,
13089,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,A,1,Intermediate,1,,CHEMBL876654,,BAO_0000218,2037.0,
13090,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623009,,BAO_0000218,,
13091,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623010,,BAO_0000218,,
13092,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623011,,BAO_0000218,948.0,
13093,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623012,,BAO_0000218,160.0,
13094,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,U,A,0,Autocuration,1,,CHEMBL623013,,BAO_0000019,,
13095,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,A,0,Autocuration,1,,CHEMBL623014,,BAO_0000019,,
13096,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,U,A,0,Autocuration,1,,CHEMBL623015,,BAO_0000019,1088.0,
13097,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,U,A,0,Autocuration,1,,CHEMBL623016,,BAO_0000019,1088.0,
13098,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,U,A,0,Autocuration,1,,CHEMBL624858,,BAO_0000019,1088.0,
13099,,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,N,A,1,Intermediate,1,,CHEMBL624859,,BAO_0000218,,
13100,,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,A,1,Intermediate,1,,CHEMBL624860,,BAO_0000218,,
13101,,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,A,1,Intermediate,1,,CHEMBL624861,,BAO_0000218,,
13102,,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,N,A,1,Intermediate,1,,CHEMBL624862,,BAO_0000218,,
13103,,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,N,A,1,Intermediate,1,,CHEMBL624863,,BAO_0000218,,
13104,,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,A,1,Intermediate,1,,CHEMBL876655,,BAO_0000218,,
13105,,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,A,1,Intermediate,1,,CHEMBL624864,,BAO_0000218,,
13106,,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,A,1,Intermediate,1,,CHEMBL624865,,BAO_0000218,,
13107,,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,A,1,Intermediate,1,,CHEMBL624866,,BAO_0000218,,
13108,,Canis lupus familiaris,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,N,F,1,Expert,1,,CHEMBL624867,,BAO_0000218,,
13109,,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,A,1,Intermediate,1,,CHEMBL624868,,BAO_0000218,,
13110,,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,N,A,1,Intermediate,1,,CHEMBL628450,,BAO_0000218,,
13111,,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,A,1,Intermediate,1,,CHEMBL628451,,BAO_0000218,,
13112,,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,A,1,Intermediate,1,,CHEMBL628452,,BAO_0000218,,
13113,,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,A,1,Intermediate,1,,CHEMBL628453,,BAO_0000218,,
13114,,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL628454,,BAO_0000218,,
13115,,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,A,1,Intermediate,1,,CHEMBL628455,,BAO_0000218,,
13116,,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,A,1,Intermediate,1,,CHEMBL628456,,BAO_0000218,,
13117,,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,A,1,Intermediate,1,,CHEMBL628457,,BAO_0000218,,
13118,,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,N,A,1,Intermediate,1,,CHEMBL877505,,BAO_0000218,,
13119,,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,N,A,1,Intermediate,1,,CHEMBL628458,,BAO_0000218,,
13120,,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,A,1,Intermediate,1,,CHEMBL628459,,BAO_0000218,,
13121,,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,A,1,Intermediate,1,,CHEMBL628460,,BAO_0000218,,
13122,,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,A,1,Intermediate,1,,CHEMBL628461,,BAO_0000218,,
13123,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",U,B,0,Autocuration,1,,CHEMBL628462,,BAO_0000218,,
13124,,Canis lupus familiaris,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,A,1,Intermediate,1,,CHEMBL628463,,BAO_0000218,,
13125,,Rattus norvegicus,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",N,F,1,Expert,1,,CHEMBL625666,,BAO_0000218,,
13126,,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,U,B,0,Autocuration,1,,CHEMBL625667,,BAO_0000218,,
13127,,Rattus norvegicus,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,A,1,Expert,1,,CHEMBL625668,,BAO_0000218,,
13128,,Rattus norvegicus,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,A,1,Intermediate,1,,CHEMBL625669,,BAO_0000218,,
13129,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,U,A,0,Autocuration,1,,CHEMBL625670,,BAO_0000019,,
13130,,Rattus norvegicus,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,N,A,1,Intermediate,1,,CHEMBL625671,,BAO_0000218,,
13131,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,N,A,1,Intermediate,1,,CHEMBL625672,,BAO_0000218,,
13132,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,N,A,1,Intermediate,1,,CHEMBL625673,,BAO_0000218,,
13133,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,N,A,1,Intermediate,1,,CHEMBL625674,,BAO_0000218,,
13134,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,N,A,1,Intermediate,1,,CHEMBL625675,,BAO_0000218,,
13135,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,A,1,Intermediate,1,,CHEMBL627637,,BAO_0000218,,
13136,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,N,A,1,Intermediate,1,,CHEMBL627638,,BAO_0000218,,
13137,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,N,A,1,Intermediate,1,,CHEMBL627639,,BAO_0000218,,
13138,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,N,A,1,Intermediate,1,,CHEMBL627640,,BAO_0000218,,
13139,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,N,A,1,Intermediate,1,,CHEMBL627641,,BAO_0000218,,
13140,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,A,1,Intermediate,1,,CHEMBL627642,,BAO_0000218,,
13141,,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,A,1,Intermediate,1,,CHEMBL877506,,BAO_0000218,,
13142,,Mus musculus,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,A,1,Intermediate,1,,CHEMBL627275,,BAO_0000218,,
13143,,Mustela putorius furo,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",N,A,1,Intermediate,1,,CHEMBL627643,,BAO_0000218,,
13144,,Mustela putorius furo,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,A,1,Intermediate,1,,CHEMBL631246,,BAO_0000218,,
13145,,Mustela putorius furo,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,A,1,Intermediate,1,,CHEMBL631247,,BAO_0000218,,
13146,,Mustela putorius furo,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,A,1,Intermediate,1,,CHEMBL629532,,BAO_0000218,,
13147,,Mustela putorius furo,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,N,A,1,Intermediate,1,,CHEMBL629533,,BAO_0000218,,
13148,,Mustela putorius furo,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,A,1,Intermediate,1,,CHEMBL629534,,BAO_0000218,,
13149,,Mustela putorius furo,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,N,A,1,Intermediate,1,,CHEMBL629535,,BAO_0000218,,
13150,,,Pharmacokinetic parameter :drug bound to plasma was reported,U,A,0,Autocuration,1,,CHEMBL625932,,BAO_0000019,,
13151,,,compound was evaluated for drug bound in plasma,U,A,0,Autocuration,1,,CHEMBL625933,,BAO_0000019,,
13152,,Rattus norvegicus,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,N,A,1,Intermediate,1,,CHEMBL625934,,BAO_0000218,,
13153,,Eutheria,Bioavailability,U,A,0,Autocuration,1,,CHEMBL625935,,BAO_0000218,,
13154,,Rattus norvegicus,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,N,A,1,Intermediate,1,,CHEMBL625936,,BAO_0000218,,
13155,,Rattus norvegicus,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,N,A,1,Intermediate,1,,CHEMBL625937,,BAO_0000218,,
13156,,Canis lupus familiaris,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,A,1,Intermediate,1,,CHEMBL625938,,BAO_0000218,,
13157,,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,N,A,1,Intermediate,1,,CHEMBL625939,,BAO_0000218,1970.0,
13158,,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,N,A,1,Intermediate,1,,CHEMBL625940,,BAO_0000218,1970.0,
13159,,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,N,A,1,Intermediate,1,,CHEMBL874464,,BAO_0000218,1970.0,
13160,,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,N,A,1,Intermediate,1,,CHEMBL625941,,BAO_0000218,1970.0,
13161,,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,N,A,1,Intermediate,1,,CHEMBL625942,,BAO_0000218,1970.0,
13162,,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,N,A,1,Intermediate,1,,CHEMBL625943,,BAO_0000218,1970.0,
13163,,Homo sapiens,In vitro protein binding in human serum at 5 ug/ml,N,A,1,Intermediate,1,,CHEMBL625944,,BAO_0000218,1977.0,
13164,,,Serum protein binding ability was measured,U,A,0,Autocuration,1,,CHEMBL625945,,BAO_0000019,,
13165,,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),U,A,0,Autocuration,1,,CHEMBL625946,,BAO_0000019,,
13166,,Canis lupus familiaris,Oral bioavailability in dog,U,A,0,Autocuration,1,,CHEMBL625947,,BAO_0000218,,
13167,,Rattus norvegicus,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,N,A,1,Intermediate,1,,CHEMBL625948,,BAO_0000218,,
13168,,,Absolute oral bioavailability at an iv dose of 14 mg/kg,U,A,0,Autocuration,1,,CHEMBL625949,,BAO_0000218,,
13169,,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,U,A,0,Autocuration,1,,CHEMBL625950,,BAO_0000218,,
13170,,Eutheria,Oral bioavailability (dose 15 mg/kg i.v.),U,A,0,Autocuration,1,,CHEMBL625951,,BAO_0000218,,
13171,,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,U,A,0,Autocuration,1,,CHEMBL625952,,BAO_0000218,,
13172,,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,U,A,0,Autocuration,1,,CHEMBL625953,,BAO_0000218,,
13173,,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,U,A,0,Autocuration,1,,CHEMBL625954,,BAO_0000218,,
13174,,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,U,A,0,Autocuration,1,,CHEMBL882959,,BAO_0000218,,
13175,,Canis lupus familiaris,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,N,A,1,Intermediate,1,,CHEMBL625955,,BAO_0000218,,
13176,,Mustela putorius furo,Bioavailability in ferret,U,A,0,Autocuration,1,,CHEMBL625956,,BAO_0000218,,
13177,,Macaca fascicularis,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,N,A,1,Intermediate,1,,CHEMBL625957,,BAO_0000218,,
13178,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,A,1,Intermediate,1,,CHEMBL625958,,BAO_0000218,,
13179,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,A,1,Intermediate,1,,CHEMBL625959,,BAO_0000218,,
13180,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,A,1,Intermediate,1,,CHEMBL626642,,BAO_0000218,,
13181,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,A,1,Intermediate,1,,CHEMBL631330,,BAO_0000218,,
13182,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,A,1,Intermediate,1,,CHEMBL631331,,BAO_0000218,,
13183,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,A,1,Intermediate,1,,CHEMBL631332,,BAO_0000218,,
13184,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,A,1,Intermediate,1,,CHEMBL631333,,BAO_0000218,,
13185,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,A,1,Intermediate,1,,CHEMBL632018,,BAO_0000218,,
13186,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,A,1,Intermediate,1,,CHEMBL632019,,BAO_0000218,,
13187,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,A,1,Intermediate,1,,CHEMBL632020,,BAO_0000218,,
13188,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,A,1,Intermediate,1,,CHEMBL632021,,BAO_0000218,,
13189,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,A,1,Intermediate,1,,CHEMBL632022,,BAO_0000218,,
13190,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,A,1,Intermediate,1,,CHEMBL632023,,BAO_0000218,,
13191,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,A,1,Intermediate,1,,CHEMBL632024,,BAO_0000218,,
13192,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,A,1,Intermediate,1,,CHEMBL874472,,BAO_0000218,,
13193,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,A,1,Intermediate,1,,CHEMBL632025,,BAO_0000218,,
13194,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,A,1,Intermediate,1,,CHEMBL632026,,BAO_0000218,,
13195,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,A,1,Intermediate,1,,CHEMBL632027,,BAO_0000218,,
13196,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,A,1,Intermediate,1,,CHEMBL632028,,BAO_0000218,,
13197,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,A,1,Intermediate,1,,CHEMBL626430,,BAO_0000218,,
13198,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,A,1,Intermediate,1,,CHEMBL626431,,BAO_0000218,,
13199,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,A,1,Intermediate,1,,CHEMBL626432,,BAO_0000218,,
13200,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,A,1,Intermediate,1,,CHEMBL626433,,BAO_0000218,,
13201,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,A,1,Intermediate,1,,CHEMBL626434,,BAO_0000218,,
13202,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,A,1,Intermediate,1,,CHEMBL627280,,BAO_0000218,,
13203,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,A,1,Intermediate,1,,CHEMBL627281,,BAO_0000218,,
13204,,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,A,1,Intermediate,1,,CHEMBL627282,,BAO_0000218,,
13205,,,Total body clearance was measured at given dose,U,A,0,Autocuration,1,,CHEMBL627283,,BAO_0000019,,
13206,,,Total body clearance was measured at given dose.,U,A,0,Autocuration,1,,CHEMBL627284,,BAO_0000218,,
13207,,Rattus norvegicus,Metabolic clearance from the body in rat,N,A,1,Intermediate,1,,CHEMBL627285,,BAO_0000218,,
13208,,,Renal clearance from the body,U,A,0,Autocuration,1,,CHEMBL627286,,BAO_0000218,,
13209,,Rattus norvegicus,Renal clearance from the body in rat,N,A,1,Intermediate,1,,CHEMBL875477,,BAO_0000218,,
13210,,Rattus norvegicus,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL627287,,BAO_0000218,,
13211,,Canis lupus familiaris,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,N,A,1,Intermediate,1,,CHEMBL627288,,BAO_0000218,,
13212,,Rattus norvegicus,Total clearance from the body in rat,N,A,1,Intermediate,1,,CHEMBL627289,,BAO_0000218,,
13213,,Rattus norvegicus,Clearance into cortex from rat plasma or PBS,N,A,1,Intermediate,1,,CHEMBL627290,,BAO_0000218,1969.0,
13214,,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,U,A,0,Autocuration,1,,CHEMBL627291,,BAO_0000218,,
13215,,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,U,A,0,Autocuration,1,,CHEMBL627292,,BAO_0000218,,
13216,,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,U,A,0,Autocuration,1,,CHEMBL627293,,BAO_0000218,,
13217,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,U,A,0,Autocuration,1,,CHEMBL627294,,BAO_0000218,,
13218,,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,U,A,0,Autocuration,1,,CHEMBL875478,,BAO_0000218,,
13219,,,Clearance was determined,U,A,0,Autocuration,1,,CHEMBL627295,,BAO_0000218,,
13220,,Mus musculus,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,N,A,1,Intermediate,1,,CHEMBL627296,,BAO_0000218,,
13221,,Oryctolagus cuniculus,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,N,A,1,Intermediate,1,,CHEMBL626119,,BAO_0000218,,
13222,,Rattus norvegicus,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,N,A,1,Intermediate,1,,CHEMBL626120,,BAO_0000218,,
13223,,Rattus norvegicus,Clearance in rat after iv dose (100 ug/kg),N,A,1,Intermediate,1,,CHEMBL626121,,BAO_0000218,,
13224,,Cavia porcellus,Clearance in guinea pig,U,A,0,Autocuration,1,,CHEMBL626122,,BAO_0000218,,
13225,,Rattus norvegicus,Compound was evaluated for clearance in rat,N,A,1,Intermediate,1,,CHEMBL626123,,BAO_0000218,,
13226,,Canis lupus familiaris,Compound was evaluated for the clearance in dog,N,A,1,Intermediate,1,,CHEMBL623456,,BAO_0000218,,
13227,,Rattus norvegicus,Compound was evaluated for the clearance in rat,N,A,1,Intermediate,1,,CHEMBL623457,,BAO_0000218,,
13228,,Rattus norvegicus,Compound was tested in vivo for clearance after iv administration in the rat,N,A,1,Intermediate,1,,CHEMBL623458,,BAO_0000218,,
13229,,,IV clearance determined at an iv dose of 14 mg/kg,U,A,0,Autocuration,1,,CHEMBL623459,,BAO_0000218,,
13230,,,IV clearance determined at an iv dose of 15.2 mg/kg,U,A,0,Autocuration,1,,CHEMBL875484,,BAO_0000218,,
13231,,,IV clearance determined at an iv dose of 15 mg/kg,U,A,0,Autocuration,1,,CHEMBL623460,,BAO_0000218,,
13232,,,IV clearance determined at an peroral dose of 30 mg/kg.,U,A,0,Autocuration,1,,CHEMBL623461,,BAO_0000218,,
13233,,,IV clearance determined at an peroral dose of 30.2 mg/kg.,U,A,0,Autocuration,1,,CHEMBL623462,,BAO_0000218,,
13234,,,IV clearance determined at an peroral dose of 30.3 mg/kg.,U,A,0,Autocuration,1,,CHEMBL627386,,BAO_0000218,,
13235,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627387,,BAO_0000218,2113.0,
13236,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627388,,BAO_0000218,2107.0,
13237,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627389,,BAO_0000218,2048.0,
13238,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627390,,BAO_0000218,2385.0,
13239,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627391,,BAO_0000218,1969.0,
13240,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627392,,BAO_0000218,,
13241,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627393,,BAO_0000218,2106.0,
13242,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627394,,BAO_0000218,3126.0,
13243,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627395,,BAO_0000218,10000001.0,
13244,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,A,1,Intermediate,1,,CHEMBL875485,,BAO_0000218,2037.0,
13245,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627396,,BAO_0000218,,
13246,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627397,,BAO_0000218,,
13247,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627398,,BAO_0000218,948.0,
13248,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627399,,BAO_0000218,10000001.0,
13249,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627400,,BAO_0000218,2113.0,
13250,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627401,,BAO_0000218,2107.0,
13251,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627402,,BAO_0000218,2048.0,
13252,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627403,,BAO_0000218,2385.0,
13253,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,N,A,1,Intermediate,1,,CHEMBL627404,,BAO_0000218,1969.0,
13254,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623101,,BAO_0000218,,
13255,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,N,A,1,Intermediate,1,,CHEMBL877480,,BAO_0000218,2106.0,
13256,,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623102,,BAO_0000218,3126.0,
13257,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623103,,BAO_0000218,10000001.0,
13258,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623104,,BAO_0000218,2037.0,
13259,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623105,,BAO_0000218,,
13260,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623106,,BAO_0000218,,
13261,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623107,,BAO_0000218,948.0,
13262,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623108,,BAO_0000218,160.0,
13263,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623109,,BAO_0000218,2113.0,
13264,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623110,,BAO_0000218,2107.0,
13265,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,N,A,1,Intermediate,1,,CHEMBL623111,,BAO_0000218,2048.0,
13266,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,N,A,1,Intermediate,1,,CHEMBL625060,,BAO_0000218,2385.0,
13267,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,N,A,1,Intermediate,1,,CHEMBL625061,,BAO_0000218,1969.0,
13268,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,A,1,Intermediate,1,,CHEMBL625062,,BAO_0000218,,
13269,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,N,A,1,Intermediate,1,,CHEMBL625063,,BAO_0000218,2106.0,
13270,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,N,A,1,Intermediate,1,,CHEMBL625064,,BAO_0000218,3126.0,
13271,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,N,A,1,Intermediate,1,,CHEMBL625065,,BAO_0000218,10000001.0,
13272,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,A,1,Intermediate,1,,CHEMBL625066,,BAO_0000218,2037.0,
13273,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,N,A,1,Intermediate,1,,CHEMBL625067,,BAO_0000218,,
13274,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,N,A,1,Intermediate,1,,CHEMBL625068,,BAO_0000218,,
13275,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,N,A,1,Intermediate,1,,CHEMBL622159,,BAO_0000218,948.0,
13276,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,N,A,1,Intermediate,1,,CHEMBL622160,,BAO_0000218,160.0,
13277,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,N,A,1,Intermediate,1,,CHEMBL622161,,BAO_0000218,2113.0,
13278,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,N,A,1,Intermediate,1,,CHEMBL622162,,BAO_0000218,2048.0,
13279,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,N,A,1,Intermediate,1,,CHEMBL622163,,BAO_0000218,2385.0,
13280,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,N,A,1,Intermediate,1,,CHEMBL622313,,BAO_0000218,1969.0,
13281,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,A,1,Intermediate,1,,CHEMBL622314,,BAO_0000218,,
13282,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,N,A,1,Intermediate,1,,CHEMBL622315,,BAO_0000218,2106.0,
13283,,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,N,A,1,Intermediate,1,,CHEMBL622316,,BAO_0000218,3126.0,
13284,,Escherichia coli,Normal diffusion coefficient in water for Escherichia coli,N,A,1,Intermediate,1,,CHEMBL877486,,BAO_0000218,,
13285,,,Average max percent decrease in RVR (renal vascular resistance) was determined,U,A,0,Autocuration,1,,CHEMBL622317,,BAO_0000019,,
13286,,,Average max percent decrease in RVR (renal vascular resistance) was determined.,U,A,0,Autocuration,1,,CHEMBL622318,,BAO_0000019,,
13287,,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,U,A,0,Autocuration,1,,CHEMBL622319,,BAO_0000019,,
13288,,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,U,A,0,Autocuration,1,,CHEMBL622320,,BAO_0000019,,
13289,,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,U,A,0,Autocuration,1,,CHEMBL622321,,BAO_0000019,,
13290,,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,U,A,0,Autocuration,1,,CHEMBL622322,,BAO_0000019,,
13291,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,U,A,0,Autocuration,1,,CHEMBL622323,,BAO_0000019,,
13292,,Rattus norvegicus,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,N,A,1,Intermediate,1,,CHEMBL622324,,BAO_0000218,,
13293,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,A,1,Intermediate,1,,CHEMBL622325,,BAO_0000218,1088.0,
13294,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL622326,,BAO_0000218,1088.0,
13295,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL877487,,BAO_0000218,1088.0,
13296,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL622327,,BAO_0000218,1088.0,
13297,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL622328,,BAO_0000218,1088.0,
13298,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL622329,,BAO_0000218,1088.0,
13299,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL622330,,BAO_0000218,1088.0,
13300,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,A,1,Intermediate,1,,CHEMBL622331,,BAO_0000218,1088.0,
13301,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,A,1,Intermediate,1,,CHEMBL622332,,BAO_0000218,1088.0,
13302,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL622333,,BAO_0000218,1088.0,
13303,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,A,0,Autocuration,1,,CHEMBL627658,,BAO_0000218,1088.0,
13304,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",U,A,0,Autocuration,1,,CHEMBL630428,,BAO_0000218,1088.0,
13305,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,A,0,Autocuration,1,,CHEMBL630429,,BAO_0000218,1088.0,
13306,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",U,A,0,Autocuration,1,,CHEMBL630430,,BAO_0000218,1088.0,
13307,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",U,A,0,Autocuration,1,,CHEMBL630431,,BAO_0000218,1088.0,
13308,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL630432,,BAO_0000218,1088.0,
13309,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,A,1,Intermediate,1,,CHEMBL630433,,BAO_0000218,1088.0,
13310,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL630434,,BAO_0000218,1088.0,
13311,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629372,,BAO_0000218,1088.0,
13312,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629553,,BAO_0000218,1088.0,
13313,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629554,,BAO_0000218,1088.0,
13314,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,A,1,Intermediate,1,,CHEMBL874447,,BAO_0000218,1088.0,
13315,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629555,,BAO_0000218,1088.0,
13316,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629556,,BAO_0000218,1088.0,
13317,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629557,,BAO_0000218,1088.0,
13318,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629558,,BAO_0000218,1088.0,
13319,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629559,,BAO_0000218,1088.0,
13320,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629560,,BAO_0000218,1088.0,
13321,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629561,,BAO_0000218,1088.0,
13322,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629562,,BAO_0000218,1088.0,
13323,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629563,,BAO_0000218,1088.0,
13324,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629564,,BAO_0000218,1088.0,
13325,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629565,,BAO_0000218,1088.0,
13326,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629566,,BAO_0000218,1088.0,
13327,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629567,,BAO_0000218,1088.0,
13328,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629568,,BAO_0000218,1088.0,
13329,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629569,,BAO_0000218,1088.0,
13330,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629570,,BAO_0000218,1088.0,
13331,,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,A,0,Autocuration,1,,CHEMBL629571,,BAO_0000218,1088.0,
13332,,Rattus norvegicus,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,A,0,Autocuration,1,,CHEMBL629572,,BAO_0000218,,
13333,,Rattus norvegicus,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,A,0,Autocuration,1,,CHEMBL629573,,BAO_0000218,,
13334,,Eutheria,Bioavailability (dose 20 mg/kg),U,A,0,Autocuration,1,,CHEMBL629574,,BAO_0000218,,
13335,,Canis lupus familiaris,Bioavailability in dog,U,A,0,Autocuration,1,,CHEMBL629575,,BAO_0000218,,
13336,,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (male),U,A,0,Autocuration,1,,CHEMBL874448,,BAO_0000218,,
13337,,Primates,Bioavailability in monkey (dose 10 mg/kg i.d.),U,A,0,Autocuration,1,,CHEMBL629576,,BAO_0000218,,
13338,,Rattus norvegicus,Bioavailability in rat,U,A,0,Autocuration,1,,CHEMBL629577,,BAO_0000218,,
13339,,Rattus norvegicus,Bioavailability in rat,U,A,0,Autocuration,1,,CHEMBL629578,,BAO_0000218,,
13340,,Canis lupus familiaris,Bioavailability in dog (dose 3.0 mg/kg p.o.),U,A,0,Autocuration,1,,CHEMBL629579,,BAO_0000218,,
13341,,Canis lupus familiaris,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,U,A,0,Autocuration,1,,CHEMBL882958,,BAO_0000218,,
13342,,Pan troglodytes,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,N,A,1,Intermediate,1,,CHEMBL629580,,BAO_0000218,,
13343,,Eutheria,Bioavailability,U,A,0,Autocuration,1,,CHEMBL629581,,BAO_0000218,,
13344,,Saimiri,Bioavailability in squirrel monkey,U,A,0,Autocuration,1,,CHEMBL629582,,BAO_0000218,,
13345,,Canis lupus familiaris,Bioavailability was evaluated in dog,N,A,1,Intermediate,1,,CHEMBL628522,,BAO_0000218,,
13346,,Cricetinae,Bioavailability was evaluated in hamster,N,A,1,Intermediate,1,,CHEMBL625432,,BAO_0000218,,
13347,,Rattus norvegicus,Bioavailability in rat,U,A,0,Autocuration,1,,CHEMBL625433,,BAO_0000218,,
13348,,Rattus norvegicus,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL625434,,BAO_0000218,1969.0,
13349,,Rattus norvegicus,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,N,A,1,Intermediate,1,,CHEMBL625435,,BAO_0000218,1969.0,
13350,,Rattus norvegicus,Bioavailability in rat (dose 10 mg/kg p.o.),U,A,0,Autocuration,1,,CHEMBL625436,,BAO_0000218,,
13351,,Macaca fascicularis,Bioavailability was measured in cynomolgus monkeys.,N,A,1,Intermediate,1,,CHEMBL874588,,BAO_0000218,,
13352,,Mus musculus,Bioavailability was measured in nude mice.,N,A,1,Intermediate,1,,CHEMBL625437,,BAO_0000218,,
13353,,Mustela putorius furo,Bioavailability in ferret (dose 10 mg/kg i.d.),U,A,0,Autocuration,1,,CHEMBL625438,,BAO_0000218,,
13354,,Simiiformes,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),U,A,0,Autocuration,1,,CHEMBL625439,,BAO_0000218,,
13355,,Simiiformes,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",U,A,0,Autocuration,1,,CHEMBL625440,,BAO_0000218,,
13356,,Simiiformes,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),U,A,0,Autocuration,1,,CHEMBL625441,,BAO_0000218,,
13357,,Rattus norvegicus,Bioavailability in rat (dose 10 mg/kg i.d.),U,A,0,Autocuration,1,,CHEMBL625442,,BAO_0000218,,
13358,,Rattus norvegicus,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,A,1,Intermediate,1,,CHEMBL625443,,BAO_0000218,,
13359,,,Bioavailability was determined; extremely poor,U,A,0,Autocuration,1,,CHEMBL625444,,BAO_0000218,,
13360,,Mus musculus,% bioavailability in mice after oral administration of prodrug,N,A,1,Intermediate,1,,CHEMBL625445,,BAO_0000218,,
13361,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,N,A,1,Intermediate,1,,CHEMBL625446,,BAO_0000218,,
13362,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,N,A,1,Intermediate,1,,CHEMBL882960,,BAO_0000218,,
13363,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,N,A,1,Intermediate,1,,CHEMBL625447,,BAO_0000218,,
13364,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,N,A,1,Intermediate,1,,CHEMBL625448,,BAO_0000218,,
13365,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,N,A,1,Intermediate,1,,CHEMBL625449,,BAO_0000218,,
13366,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),N,A,1,Intermediate,1,,CHEMBL874589,,BAO_0000218,,
13367,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,N,A,1,Intermediate,1,,CHEMBL625450,,BAO_0000218,,
13368,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,N,A,1,Intermediate,1,,CHEMBL625451,,BAO_0000218,,
13369,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,N,A,1,Intermediate,1,,CHEMBL626584,,BAO_0000218,,
13370,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,N,A,1,Intermediate,1,,CHEMBL626585,,BAO_0000218,,
13371,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,N,A,1,Intermediate,1,,CHEMBL626586,,BAO_0000218,,
13372,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,N,A,1,Intermediate,1,,CHEMBL626587,,BAO_0000218,,
13373,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,N,A,1,Intermediate,1,,CHEMBL626588,,BAO_0000218,,
13374,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,N,A,1,Intermediate,1,,CHEMBL626589,,BAO_0000218,,
13375,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,N,A,1,Intermediate,1,,CHEMBL626590,,BAO_0000218,,
13376,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,N,A,1,Intermediate,1,,CHEMBL626591,,BAO_0000218,,
13377,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,N,A,1,Intermediate,1,,CHEMBL627181,,BAO_0000218,,
13378,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,N,A,1,Intermediate,1,,CHEMBL628083,,BAO_0000218,,
13379,,,IV clearance determined at an peroral dose of 15 mg/kg.,U,A,0,Autocuration,1,,CHEMBL628084,,BAO_0000218,,
13380,,Hymenolepis nana,Mouse oral clearance was measured against Hymenolepiasis nana.,N,F,1,Expert,1,,CHEMBL628085,,BAO_0000218,,
13381,,Heligmosomoides polygyrus,Mouse oral clearance was measured against Nematospiroides dubius,N,F,1,Expert,1,,CHEMBL628086,,BAO_0000218,,
13382,,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,U,F,0,Autocuration,1,,CHEMBL628087,,BAO_0000218,,
13383,,Mus musculus,Mouse oral clearance was measured against N. nana; NT is Not Tested,N,A,1,Intermediate,1,,CHEMBL628088,,BAO_0000218,,
13384,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,U,B,0,Autocuration,1,,CHEMBL628089,,BAO_0000218,,
13385,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,U,A,0,Autocuration,1,,CHEMBL628090,,BAO_0000218,,
13386,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,U,A,0,Autocuration,1,,CHEMBL628091,,BAO_0000218,,
13387,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,U,A,0,Autocuration,1,,CHEMBL628092,,BAO_0000218,,
13388,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,U,A,0,Autocuration,1,,CHEMBL628093,,BAO_0000218,,
13389,,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,U,A,0,Autocuration,1,,CHEMBL875607,,BAO_0000218,,
13390,,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,U,A,0,Autocuration,1,,CHEMBL625710,,BAO_0000218,,
13391,,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,U,A,0,Autocuration,1,,CHEMBL625711,,BAO_0000218,,
13392,,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,U,A,0,Autocuration,1,,CHEMBL625712,,BAO_0000218,,
13393,,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,U,A,0,Autocuration,1,,CHEMBL625713,,BAO_0000218,,
13394,,Canis lupus familiaris,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,N,A,1,Intermediate,1,,CHEMBL625714,,BAO_0000218,,
13395,,Macaca mulatta,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,N,A,1,Intermediate,1,,CHEMBL625715,,BAO_0000218,,
13396,,Rattus norvegicus,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL625716,,BAO_0000218,,
13397,,Rattus norvegicus,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,N,A,1,Intermediate,1,,CHEMBL625717,,BAO_0000218,,
13398,,Rattus norvegicus,Plasma clearance was determined for the compound in rats,N,A,1,Intermediate,1,,CHEMBL625718,,BAO_0000218,,
13399,,Rattus norvegicus,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,N,A,1,Intermediate,1,,CHEMBL625719,,BAO_0000218,,
13400,,Rattus norvegicus,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,N,A,1,Intermediate,1,,CHEMBL625720,,BAO_0000218,,
13401,,Rattus norvegicus,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,N,A,1,Intermediate,1,,CHEMBL625721,,BAO_0000218,,
13402,,Rattus norvegicus,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,N,A,1,Intermediate,1,,CHEMBL625722,,BAO_0000218,,
13403,,Rattus norvegicus,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,N,A,1,Intermediate,1,,CHEMBL625723,,BAO_0000218,,
13404,,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,N,A,1,Intermediate,1,,CHEMBL625724,,BAO_0000218,,
13405,,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,N,A,1,Intermediate,1,,CHEMBL625725,,BAO_0000218,,
13406,,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,N,A,1,Intermediate,1,,CHEMBL625726,,BAO_0000218,,
13407,,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,N,A,1,Intermediate,1,,CHEMBL875608,,BAO_0000218,,
13408,,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,N,A,1,Intermediate,1,,CHEMBL625727,,BAO_0000218,,
13409,,Rattus norvegicus,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,U,A,0,Autocuration,1,,CHEMBL625728,,BAO_0000218,1088.0,
13410,,Rattus norvegicus,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,A,0,Autocuration,1,,CHEMBL625729,,BAO_0000218,,
13411,,Rattus norvegicus,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,U,A,0,Autocuration,1,,CHEMBL625730,,BAO_0000218,,
13412,,Rattus norvegicus,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,A,0,Autocuration,1,,CHEMBL625731,,BAO_0000218,1088.0,
13413,,Rattus norvegicus,Urinary clearance was determined in rat at 25 mg/kg os dosage,U,A,0,Autocuration,1,,CHEMBL626417,,BAO_0000218,1088.0,
13414,,Homo sapiens,Urinary clearance was determined at 100 mg/kg oral dosage in human,N,A,1,Intermediate,1,,CHEMBL626418,,BAO_0000218,1088.0,
13415,,Canis lupus familiaris,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,N,A,1,Intermediate,1,,CHEMBL626419,,BAO_0000218,1088.0,
13416,,Canis lupus familiaris,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL626592,,BAO_0000218,1969.0,
13417,,Rattus norvegicus,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,A,1,Intermediate,1,,CHEMBL626593,,BAO_0000218,1969.0,
13418,,Rattus norvegicus,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,A,1,Intermediate,1,,CHEMBL626594,,BAO_0000218,,
13419,,Canis lupus familiaris,Clearance rate in dogs,N,A,1,Intermediate,1,,CHEMBL625035,,BAO_0000218,,
13420,,,Compound was measured for intrinsic clearance,U,A,0,Autocuration,1,,CHEMBL625036,,BAO_0000019,,
13421,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625037,,BAO_0000100,,
13422,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625038,,BAO_0000100,,
13423,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625039,,BAO_0000100,,
13424,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625040,,BAO_0000100,,
13425,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625041,,BAO_0000100,,
13426,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625042,,BAO_0000100,,
13427,,,Partition coefficient of the compound,U,A,0,Autocuration,1,,CHEMBL874411,,BAO_0000019,,
13428,,,Permeability,U,A,0,Autocuration,1,,CHEMBL625043,,BAO_0000019,,
13429,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625044,,BAO_0000100,,
13430,,,Partition coefficient (logD),U,A,0,Autocuration,1,,CHEMBL625045,,BAO_0000019,,
13431,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,P,0,Autocuration,1,,CHEMBL625046,,BAO_0000100,,
13432,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,P,0,Autocuration,1,,CHEMBL625047,,BAO_0000100,,
13433,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625048,,BAO_0000100,,
13434,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625049,,BAO_0000100,,
13435,,,Calculated logarithm of partition coefficient (P) was determined,U,P,0,Autocuration,1,,CHEMBL625050,,BAO_0000100,,
13436,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625051,,BAO_0000100,,
13437,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL874412,,BAO_0000100,,
13438,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625052,,BAO_0000100,,
13439,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL625053,,BAO_0000100,,
13440,,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,U,A,0,Autocuration,1,,CHEMBL623250,,BAO_0000019,,
13441,,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,U,A,0,Autocuration,1,,CHEMBL623251,,BAO_0000019,,
13442,,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,U,A,0,Autocuration,1,,CHEMBL623252,,BAO_0000019,,
13443,,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,U,A,0,Autocuration,1,,CHEMBL623253,,BAO_0000019,,
13444,,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,U,A,0,Autocuration,1,,CHEMBL623254,,BAO_0000019,,
13445,,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,U,A,0,Autocuration,1,,CHEMBL623255,,BAO_0000019,,
13446,,,Percent degradation of compound at a pH of 1 over a 18 hr period,U,A,0,Autocuration,1,,CHEMBL626831,,BAO_0000019,,
13447,,,Percent degradation of compound at pH of 1 over an 18 hr period,U,A,0,Autocuration,1,,CHEMBL877494,,BAO_0000019,,
13448,,,Delta Logarithm of Partition Coefficient value was determined.,U,A,0,Autocuration,1,,CHEMBL626832,,BAO_0000019,,
13449,,,Delta logPoct-cyc,U,A,0,Autocuration,1,,CHEMBL626833,,BAO_0000019,,
13450,,,Lipophilicity estimated on reversed phase TLC,U,P,0,Autocuration,1,,CHEMBL626834,,BAO_0000100,,
13451,,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,U,A,0,Autocuration,1,,CHEMBL626835,,BAO_0000019,,
13452,,,Delta logPoct-cyc,U,A,0,Autocuration,1,,CHEMBL626836,,BAO_0000019,,
13453,,,Change in logarithm of partition coefficient of the compound,U,P,0,Autocuration,1,,CHEMBL626837,,BAO_0000100,,
13454,,,Delta logD (pH 6.5),U,A,0,Autocuration,1,,CHEMBL626838,,BAO_0000019,,
13455,,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",U,P,0,Autocuration,1,,CHEMBL626839,,BAO_0000100,,
13456,,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,U,A,0,Autocuration,1,,CHEMBL626840,,BAO_0000019,,
13457,,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),U,A,0,Autocuration,1,,CHEMBL626841,,BAO_0000019,,
13458,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,U,A,0,Autocuration,1,,CHEMBL626842,,BAO_0000219,,
13459,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,U,A,0,Autocuration,1,,CHEMBL626843,,BAO_0000219,,
13460,,Rattus norvegicus,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,N,A,1,Intermediate,1,,CHEMBL626844,,BAO_0000218,,
13461,,Rattus norvegicus,Amount of deuterium retained was reported after normal workup in rats,N,A,1,Intermediate,1,,CHEMBL877495,,BAO_0000218,,
13462,,Rattus norvegicus,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,N,A,1,Intermediate,1,,CHEMBL626845,,BAO_0000218,,
13463,,Rattus norvegicus,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,N,A,1,Intermediate,1,,CHEMBL626846,,BAO_0000218,,
13464,,Rattus norvegicus,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,A,1,Intermediate,1,,CHEMBL626847,,BAO_0000218,,
13465,,Rattus norvegicus,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,A,1,Intermediate,1,,CHEMBL628677,,BAO_0000218,,
13466,,Rattus norvegicus,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,N,A,1,Intermediate,1,,CHEMBL628678,,BAO_0000218,,
13467,,,Compound was subjected to electrochemical oxidation,U,A,0,Autocuration,1,,CHEMBL628679,,BAO_0000019,,
13468,,,Compound was subjected to photochemical oxidation,U,A,0,Autocuration,1,,CHEMBL628680,,BAO_0000019,,
13469,,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,U,A,0,Autocuration,1,,CHEMBL628681,,BAO_0000019,,
13470,,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,U,A,0,Autocuration,1,,CHEMBL628682,,BAO_0000019,,
13471,,,Oxidation of compound by methemoglobin in presence of hydroperoxide,U,A,0,Autocuration,1,,CHEMBL628683,,BAO_0000019,,
13472,,Rattus norvegicus,Percent diffusion through fuzzy rat skin after 48 h of incubation,N,A,1,Intermediate,1,,CHEMBL628684,,BAO_0000218,,
13473,,,Dissociation constant (pKa),U,P,0,Autocuration,1,,CHEMBL877501,,BAO_0000100,,
13474,,,Dissociation constant value of the compound; ND means not determined.,U,P,0,Autocuration,1,,CHEMBL628685,,BAO_0000100,,
13475,,Rattus norvegicus,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,N,A,1,Intermediate,1,,CHEMBL628686,,BAO_0000218,178.0,
13476,,Rattus norvegicus,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,A,1,Intermediate,1,,CHEMBL628687,,BAO_0000218,178.0,
13477,,Rattus norvegicus,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,N,A,1,Intermediate,1,,CHEMBL628688,,BAO_0000218,,
13478,,Rattus norvegicus,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,A,1,Intermediate,1,,CHEMBL628689,,BAO_0000218,,
13479,,Rattus norvegicus,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,N,A,1,Intermediate,1,,CHEMBL628690,,BAO_0000218,2107.0,
13480,,Rattus norvegicus,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,A,1,Intermediate,1,,CHEMBL629363,,BAO_0000218,2107.0,
13481,,Rattus norvegicus,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,N,A,1,Intermediate,1,,CHEMBL629364,,BAO_0000218,2106.0,
13482,,Rattus norvegicus,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,A,1,Intermediate,1,,CHEMBL629365,,BAO_0000218,2106.0,
13483,,Rattus norvegicus,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,N,A,1,Intermediate,1,,CHEMBL629366,,BAO_0000218,,
13484,,Rattus norvegicus,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,N,A,1,Intermediate,1,,CHEMBL629367,,BAO_0000218,1088.0,
13485,,Rattus norvegicus,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,A,1,Intermediate,1,,CHEMBL629368,,BAO_0000218,1988.0,
13486,,Rattus norvegicus,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,A,1,Intermediate,1,,CHEMBL877502,,BAO_0000218,1088.0,
13487,,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,N,A,1,Intermediate,1,,CHEMBL629369,,BAO_0000218,2037.0,
13488,,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,N,A,1,Intermediate,1,,CHEMBL629370,,BAO_0000218,955.0,
13489,,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",U,A,0,Autocuration,1,,CHEMBL629371,,BAO_0000218,1088.0,
13490,,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,A,0,Autocuration,1,,CHEMBL626276,,BAO_0000218,1088.0,
13491,,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,A,0,Autocuration,1,,CHEMBL626277,,BAO_0000218,1088.0,
13492,,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,A,0,Autocuration,1,,CHEMBL631250,,BAO_0000218,1088.0,
13493,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL631251,,BAO_0000218,1088.0,
13494,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,A,1,Intermediate,1,,CHEMBL631252,,BAO_0000218,1088.0,
13495,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL631253,,BAO_0000218,1088.0,
13496,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL631254,,BAO_0000218,1088.0,
13497,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL631255,,BAO_0000218,1088.0,
13498,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL631256,,BAO_0000218,1088.0,
13499,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,A,1,Intermediate,1,,CHEMBL631257,,BAO_0000218,1088.0,
13500,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628009,,BAO_0000218,1088.0,
13501,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628010,,BAO_0000218,1088.0,
13502,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628011,,BAO_0000218,1088.0,
13503,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628012,,BAO_0000218,1088.0,
13504,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628013,,BAO_0000218,1088.0,
13505,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628014,,BAO_0000218,1088.0,
13506,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628015,,BAO_0000218,1088.0,
13507,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628016,,BAO_0000218,1088.0,
13508,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL874461,,BAO_0000218,1088.0,
13509,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628017,,BAO_0000218,1088.0,
13510,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628018,,BAO_0000218,1088.0,
13511,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628019,,BAO_0000218,1088.0,
13512,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628020,,BAO_0000218,1088.0,
13513,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628021,,BAO_0000218,1088.0,
13514,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628022,,BAO_0000218,1088.0,
13515,,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628023,,BAO_0000218,1088.0,
13516,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,A,0,Autocuration,1,,CHEMBL628024,,BAO_0000218,1088.0,
13517,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",U,A,0,Autocuration,1,,CHEMBL628025,,BAO_0000218,1088.0,
13518,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,A,0,Autocuration,1,,CHEMBL628026,,BAO_0000218,1088.0,
13519,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,A,0,Autocuration,1,,CHEMBL628027,,BAO_0000218,1088.0,
13520,,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,A,0,Autocuration,1,,CHEMBL628028,,BAO_0000218,1088.0,
13521,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628029,,BAO_0000218,1088.0,
13522,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628030,,BAO_0000218,1088.0,
13523,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628031,,BAO_0000218,1088.0,
13524,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628032,,BAO_0000218,1088.0,
13525,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628033,,BAO_0000218,1088.0,
13526,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628034,,BAO_0000218,1088.0,
13527,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628035,,BAO_0000218,1088.0,
13528,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL628036,,BAO_0000218,1088.0,
13529,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,A,1,Intermediate,1,,CHEMBL874462,,BAO_0000218,1088.0,
13530,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,N,A,1,Intermediate,1,,CHEMBL628037,,BAO_0000218,,
13531,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,N,A,1,Intermediate,1,,CHEMBL628123,,BAO_0000218,,
13532,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,N,A,1,Intermediate,1,,CHEMBL628124,,BAO_0000218,,
13533,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,N,A,1,Intermediate,1,,CHEMBL628125,,BAO_0000218,,
13534,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,N,A,1,Intermediate,1,,CHEMBL628126,,BAO_0000218,,
13535,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),N,A,1,Intermediate,1,,CHEMBL628127,,BAO_0000218,,
13536,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,N,A,1,Intermediate,1,,CHEMBL628128,,BAO_0000218,,
13537,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,N,A,1,Intermediate,1,,CHEMBL628129,,BAO_0000218,,
13538,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,N,A,1,Intermediate,1,,CHEMBL628130,,BAO_0000218,,
13539,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,N,A,1,Intermediate,1,,CHEMBL628131,,BAO_0000218,,
13540,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,N,A,1,Intermediate,1,,CHEMBL628132,,BAO_0000218,,
13541,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,N,A,1,Intermediate,1,,CHEMBL628133,,BAO_0000218,,
13542,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,N,A,1,Intermediate,1,,CHEMBL628134,,BAO_0000218,,
13543,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,N,A,1,Intermediate,1,,CHEMBL628135,,BAO_0000218,,
13544,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,N,A,1,Intermediate,1,,CHEMBL628136,,BAO_0000218,,
13545,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,N,A,1,Intermediate,1,,CHEMBL628137,,BAO_0000218,,
13546,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,N,A,1,Intermediate,1,,CHEMBL628138,,BAO_0000218,,
13547,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,N,A,1,Intermediate,1,,CHEMBL628139,,BAO_0000218,,
13548,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,N,A,1,Intermediate,1,,CHEMBL628140,,BAO_0000218,,
13549,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,N,A,1,Intermediate,1,,CHEMBL628141,,BAO_0000218,,
13550,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,N,A,1,Intermediate,1,,CHEMBL628142,,BAO_0000218,,
13551,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,N,A,1,Intermediate,1,,CHEMBL628143,,BAO_0000218,,
13552,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,N,A,1,Intermediate,1,,CHEMBL628144,,BAO_0000218,,
13553,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,N,A,1,Intermediate,1,,CHEMBL628145,,BAO_0000218,,
13554,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,N,A,1,Intermediate,1,,CHEMBL628146,,BAO_0000218,,
13555,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,N,A,1,Intermediate,1,,CHEMBL625355,,BAO_0000218,,
13556,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,N,A,1,Intermediate,1,,CHEMBL625356,,BAO_0000218,,
13557,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,N,A,1,Intermediate,1,,CHEMBL625357,,BAO_0000218,,
13558,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,N,A,1,Intermediate,1,,CHEMBL625527,,BAO_0000218,,
13559,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),N,A,1,Intermediate,1,,CHEMBL875473,,BAO_0000218,,
13560,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,N,A,1,Intermediate,1,,CHEMBL625528,,BAO_0000218,,
13561,,Rattus norvegicus,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,N,A,1,Intermediate,1,,CHEMBL626304,,BAO_0000218,,
13562,,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,N,A,1,Intermediate,1,,CHEMBL624138,,BAO_0000218,1637.0,
13563,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624139,,BAO_0000100,,
13564,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624140,,BAO_0000100,,
13565,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624141,,BAO_0000100,,
13566,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624142,,BAO_0000100,,
13567,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624143,,BAO_0000100,,
13568,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624144,,BAO_0000100,,
13569,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624145,,BAO_0000100,,
13570,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624146,,BAO_0000100,,
13571,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624147,,BAO_0000100,,
13572,,,Calculated partition coefficient (clogP) (MacLogP),U,P,0,Autocuration,1,,CHEMBL883123,,BAO_0000100,,
13573,,,Partition coefficient (logP),U,A,0,Autocuration,1,,CHEMBL624148,,BAO_0000019,,
13574,,,Kinetic parameter was determined,U,A,0,Autocuration,1,,CHEMBL874416,,BAO_0000019,,
13575,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624149,,BAO_0000100,,
13576,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL624150,,BAO_0000100,,
13577,,,Lipophilicity was determined,U,P,0,Autocuration,1,,CHEMBL624151,,BAO_0000100,,
13578,,,Lipophilicity was determined,U,P,0,Autocuration,1,,CHEMBL624152,,BAO_0000100,,
13579,,,Lipophilicity was determined,U,P,0,Autocuration,1,,CHEMBL622139,,BAO_0000100,,
13580,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL622140,,BAO_0000100,,
13581,,,Lipophilicity was determined,U,P,0,Autocuration,1,,CHEMBL622141,,BAO_0000100,,
13582,,,Lipophilicity in octanol-water,U,P,0,Autocuration,1,,CHEMBL622142,,BAO_0000100,,
13583,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL622143,,BAO_0000100,,
13584,,,Octanol-water partition coefficient was determined,U,P,0,Autocuration,1,,CHEMBL622144,,BAO_0000100,,
13585,,,Partition coefficient (logP),U,A,0,Autocuration,1,,CHEMBL877473,,BAO_0000019,,
13586,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL622145,,BAO_0000100,,
13587,,,Partition coefficient was determined; ND means not determined,U,A,0,Autocuration,1,,CHEMBL622146,,BAO_0000019,,
13588,,,Calculated partition coefficient (clogP),U,P,0,Autocuration,1,,CHEMBL622147,,BAO_0000100,,
13589,,,Partition coefficient of the compound,U,A,0,Autocuration,1,,CHEMBL622148,,BAO_0000019,,
13590,,,Permeability was determined,U,A,0,Autocuration,1,,CHEMBL883124,,BAO_0000019,,
13591,,,The compound was evaluated for the partition coefficient,U,P,0,Autocuration,1,,CHEMBL622149,,BAO_0000100,,
13592,,,Partition coefficient (logP),U,A,0,Autocuration,1,,CHEMBL622150,,BAO_0000019,,
13593,,,The lipophilicity was reported,U,P,0,Autocuration,1,,CHEMBL622151,,BAO_0000100,,
13594,,,logarithm of the octanol-water partition coefficient for the compound,U,P,0,Autocuration,1,,CHEMBL622152,,BAO_0000100,,
13595,,,Clogp value was determined,U,A,0,Autocuration,1,,CHEMBL622153,,BAO_0000019,,
13596,,,Clp at a dose of 1.5 mg/kg,U,A,0,Autocuration,1,,CHEMBL877474,,BAO_0000218,,
13597,,,Clp at a dose of 2.0 mg/kg,U,A,0,Autocuration,1,,CHEMBL622154,,BAO_0000218,,
13598,,,"Clp, plasma clearance at a dose of 10 mg/kg",U,A,0,Autocuration,1,,CHEMBL622155,,BAO_0000218,1969.0,
13599,,,"Clp, plasma clearance at a dose of 50 mg/kg",U,A,0,Autocuration,1,,CHEMBL622156,,BAO_0000218,1969.0,
13600,,Rattus norvegicus,Compound was tested for plasma clearance in rat,N,A,1,Intermediate,1,,CHEMBL622157,,BAO_0000218,1969.0,
13601,,Rattus norvegicus,Compound was tested for plasma clearance in rat; Not determined,N,A,1,Intermediate,1,,CHEMBL622158,,BAO_0000218,1969.0,
13602,,Rattus norvegicus,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL622807,,BAO_0000218,,
13603,,Macaca mulatta,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,N,A,1,Intermediate,1,,CHEMBL622808,,BAO_0000218,,
13604,,,Plasma clearance by iv administration at a dose 0.003 ug/mL,U,A,0,Autocuration,1,,CHEMBL622809,,BAO_0000218,,
13605,,,Plasma clearance determined,U,A,0,Autocuration,1,,CHEMBL622810,,BAO_0000218,,
13606,,Cricetinae,Plasma clearance after iv administration at 3 mg/kg in hamster,N,A,1,Intermediate,1,,CHEMBL876653,,BAO_0000218,,
13607,,Cricetinae,Plasma clearance after iv administration at 4 mg/kg in hamster,N,A,1,Intermediate,1,,CHEMBL622811,,BAO_0000218,,
13608,,Rattus norvegicus,Rate of clearance in rat was determined,N,A,1,Intermediate,1,,CHEMBL622986,,BAO_0000218,,
13609,,Rattus norvegicus,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL622987,,BAO_0000218,1969.0,
13610,,Rattus norvegicus,Total plasma clearance after iv dose of 5.10 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL622988,,BAO_0000218,1969.0,
13611,,Rattus norvegicus,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL622989,,BAO_0000218,1969.0,
13612,,Rattus norvegicus,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,N,A,1,Intermediate,1,,CHEMBL622990,,BAO_0000218,1969.0,
13613,,Simiiformes,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,A,0,Autocuration,1,,CHEMBL622991,,BAO_0000218,1969.0,
13614,,Rattus norvegicus,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,A,1,Intermediate,1,,CHEMBL622227,,BAO_0000218,1969.0,
13615,,Canis lupus familiaris,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,A,1,Intermediate,1,,CHEMBL622228,,BAO_0000218,1969.0,
13616,,Rattus norvegicus,Clpl value in rat,N,A,1,Intermediate,1,,CHEMBL622229,,BAO_0000218,,
13617,,Cavia porcellus,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,N,A,1,Intermediate,1,,CHEMBL622230,,BAO_0000218,,
13618,,Rattus norvegicus,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,N,A,1,Intermediate,1,,CHEMBL622231,,BAO_0000218,,
13619,,Macaca fascicularis,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,N,A,1,Intermediate,1,,CHEMBL622232,,BAO_0000218,,
13620,,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,U,A,0,Autocuration,1,,CHEMBL622233,,BAO_0000218,,
13621,,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,U,A,0,Autocuration,1,,CHEMBL622234,,BAO_0000218,,
13622,,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,U,A,0,Autocuration,1,,CHEMBL622235,,BAO_0000218,,
13623,,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,U,A,0,Autocuration,1,,CHEMBL622236,,BAO_0000218,,
13624,,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,U,A,0,Autocuration,1,,CHEMBL622237,,BAO_0000218,,
13625,,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,U,A,0,Autocuration,1,,CHEMBL877482,,BAO_0000218,,
13626,,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,U,A,0,Autocuration,1,,CHEMBL622238,,BAO_0000218,,
13627,,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,U,A,0,Autocuration,1,,CHEMBL622239,,BAO_0000218,,
13628,,,Cmax was calculated as maximum concentration reached in the blood,U,A,0,Autocuration,1,,CHEMBL622240,,BAO_0000218,178.0,
13629,,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,U,A,0,Autocuration,1,,CHEMBL622241,,BAO_0000218,178.0,
13630,,Rattus norvegicus,Cmax was determine after peroral administration at 10 mpk in Rat,N,A,1,Intermediate,1,,CHEMBL631013,,BAO_0000218,,
13631,,Macaca mulatta,Cmax was determine after peroral administration at 10 mpk in Rhesus,N,A,1,Intermediate,1,,CHEMBL631014,,BAO_0000218,,
13632,,Canis lupus familiaris,Cmax was determine after peroral administration at 10 mpk in dog,N,A,1,Intermediate,1,,CHEMBL631015,,BAO_0000218,,
13633,,Rattus norvegicus,Cmax was determine after peroral administration at 160 mpk in Rat,N,A,1,Intermediate,1,,CHEMBL631016,,BAO_0000218,,
13634,,Rattus norvegicus,Cmax was determine after peroral administration at 20 mpk in Rat,N,A,1,Intermediate,1,,CHEMBL631017,,BAO_0000218,,
13635,,Rattus norvegicus,Cmax was determine after peroral administration at 50 mpk in Rat,N,A,1,Intermediate,1,,CHEMBL631018,,BAO_0000218,,
13636,,,Cmax was determined,U,A,0,Autocuration,1,,CHEMBL631019,,BAO_0000218,,
13637,,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,N,A,1,Intermediate,1,,CHEMBL875761,,BAO_0000218,955.0,
13638,,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,N,A,1,Intermediate,1,,CHEMBL631020,,BAO_0000218,955.0,
13639,,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,N,A,1,Intermediate,1,,CHEMBL631669,,BAO_0000218,955.0,
13640,,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,N,A,1,Intermediate,1,,CHEMBL631670,,BAO_0000218,955.0,
13641,,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,N,A,1,Intermediate,1,,CHEMBL631671,,BAO_0000218,2435.0,
13642,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,N,A,1,Intermediate,1,,CHEMBL631672,,BAO_0000218,178.0,
13643,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,N,A,1,Intermediate,1,,CHEMBL631673,,BAO_0000218,178.0,
13644,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,N,A,1,Intermediate,1,,CHEMBL631856,,BAO_0000218,178.0,
13645,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,N,A,1,Intermediate,1,,CHEMBL631857,,BAO_0000218,178.0,
13646,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,N,A,1,Intermediate,1,,CHEMBL631858,,BAO_0000218,178.0,
13647,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,N,A,1,Intermediate,1,,CHEMBL631859,,BAO_0000218,178.0,
13648,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,N,A,1,Intermediate,1,,CHEMBL631860,,BAO_0000218,178.0,
13649,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,N,A,1,Intermediate,1,,CHEMBL631861,,BAO_0000218,178.0,
13650,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,N,A,1,Intermediate,1,,CHEMBL631862,,BAO_0000218,178.0,
13651,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,N,A,1,Intermediate,1,,CHEMBL631863,,BAO_0000218,178.0,
13652,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,N,A,1,Intermediate,1,,CHEMBL631864,,BAO_0000218,178.0,
13653,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,N,A,1,Intermediate,1,,CHEMBL631865,,BAO_0000218,178.0,
13654,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,N,A,1,Intermediate,1,,CHEMBL631866,,BAO_0000218,178.0,
13655,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,N,A,1,Intermediate,1,,CHEMBL629360,,BAO_0000218,178.0,
13656,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,N,A,1,Intermediate,1,,CHEMBL629361,,BAO_0000218,178.0,
13657,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,N,A,1,Intermediate,1,,CHEMBL629362,,BAO_0000218,178.0,
13658,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,N,A,1,Intermediate,1,,CHEMBL630740,,BAO_0000218,178.0,
13659,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,N,A,1,Intermediate,1,,CHEMBL630741,,BAO_0000218,178.0,
13660,,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,N,A,1,Intermediate,1,,CHEMBL630742,,BAO_0000218,178.0,
13661,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,N,A,1,Intermediate,1,,CHEMBL630743,,BAO_0000218,,
13662,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,N,A,1,Intermediate,1,,CHEMBL630744,,BAO_0000218,,
13663,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,N,A,1,Intermediate,1,,CHEMBL630745,,BAO_0000218,,
13664,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,N,A,1,Intermediate,1,,CHEMBL630746,,BAO_0000218,,
13665,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,N,A,1,Intermediate,1,,CHEMBL630747,,BAO_0000218,,
13666,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,N,A,1,Intermediate,1,,CHEMBL630748,,BAO_0000218,,
13667,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,N,A,1,Intermediate,1,,CHEMBL632056,,BAO_0000218,,
13668,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,N,A,1,Intermediate,1,,CHEMBL632057,,BAO_0000218,,
13669,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,N,A,1,Intermediate,1,,CHEMBL632058,,BAO_0000218,,
13670,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,N,A,1,Intermediate,1,,CHEMBL632059,,BAO_0000218,,
13671,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,N,A,1,Intermediate,1,,CHEMBL632060,,BAO_0000218,,
13672,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,N,A,1,Intermediate,1,,CHEMBL632061,,BAO_0000218,,
13673,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,N,A,1,Intermediate,1,,CHEMBL629207,,BAO_0000218,,
13674,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,N,A,1,Intermediate,1,,CHEMBL629208,,BAO_0000218,,
13675,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,N,A,1,Intermediate,1,,CHEMBL629209,,BAO_0000218,,
13676,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,N,A,1,Intermediate,1,,CHEMBL629210,,BAO_0000218,,
13677,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,N,A,1,Intermediate,1,,CHEMBL629211,,BAO_0000218,,
13678,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,N,A,1,Intermediate,1,,CHEMBL629212,,BAO_0000218,,
13679,,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,N,A,1,Intermediate,1,,CHEMBL629213,,BAO_0000218,,
13680,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629214,,BAO_0000218,1088.0,
13681,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL629215,,BAO_0000218,1088.0,
13682,,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",N,A,1,Intermediate,1,,CHEMBL635154,,BAO_0000218,1088.0,
13683,,Rattus norvegicus,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL629216,,BAO_0000218,,
13684,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL629217,,BAO_0000218,,
13685,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL629218,,BAO_0000218,,
13686,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL629219,,BAO_0000218,,
13687,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL629220,,BAO_0000218,,
13688,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL629221,,BAO_0000218,,
13689,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL631127,,BAO_0000218,,
13690,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL631128,,BAO_0000218,,
13691,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL631129,,BAO_0000218,,
13692,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL631130,,BAO_0000218,,
13693,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL631131,,BAO_0000218,,
13694,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL631132,,BAO_0000218,,
13695,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL631133,,BAO_0000218,,
13696,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL631134,,BAO_0000218,,
13697,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL875120,,BAO_0000218,,
13698,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL631135,,BAO_0000218,,
13699,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL631136,,BAO_0000218,,
13700,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL631137,,BAO_0000218,,
13701,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL631138,,BAO_0000218,,
13702,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL631139,,BAO_0000218,,
13703,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL631140,,BAO_0000218,,
13704,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,A,1,Intermediate,1,,CHEMBL631141,,BAO_0000218,,
13705,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,A,1,Intermediate,1,,CHEMBL631142,,BAO_0000218,,
13706,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,A,1,Intermediate,1,,CHEMBL631143,,BAO_0000218,,
13707,,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,A,1,Intermediate,1,,CHEMBL631144,,BAO_0000218,,
13708,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL631145,,BAO_0000218,,
13709,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL631146,,BAO_0000218,,
13710,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL631147,,BAO_0000218,,
13711,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL631148,,BAO_0000218,,
13712,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL631149,,BAO_0000218,,
13713,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL631150,,BAO_0000218,,
13714,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL631151,,BAO_0000218,,
13715,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL631152,,BAO_0000218,,
13716,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL631443,,BAO_0000218,,
13717,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL631444,,BAO_0000218,,
13718,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,A,1,Intermediate,1,,CHEMBL631445,,BAO_0000218,,
13719,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,A,1,Intermediate,1,,CHEMBL631446,,BAO_0000218,,
13720,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL631447,,BAO_0000218,,
13721,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,A,1,Intermediate,1,,CHEMBL631448,,BAO_0000218,,
13722,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,N,A,1,Intermediate,1,,CHEMBL631449,,BAO_0000218,,
13723,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,A,1,Intermediate,1,,CHEMBL631450,,BAO_0000218,,
13724,,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,A,1,Intermediate,1,,CHEMBL629724,,BAO_0000218,,
13725,,Mus musculus,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL629725,,BAO_0000218,14.0,
13726,,Mus musculus,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL629726,,BAO_0000218,14.0,
13727,,Mus musculus,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL629727,,BAO_0000218,2106.0,
13728,,Mus musculus,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630404,,BAO_0000218,2106.0,
13729,,Mus musculus,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630405,,BAO_0000218,2106.0,
13730,,Mus musculus,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630406,,BAO_0000218,2106.0,
13731,,Mus musculus,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630407,,BAO_0000218,945.0,
13732,,Mus musculus,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630573,,BAO_0000218,945.0,
13733,,Mus musculus,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630574,,BAO_0000218,945.0,
13734,,Mus musculus,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630575,,BAO_0000218,945.0,
13735,,Mus musculus,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630576,,BAO_0000218,,
13736,,Mus musculus,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630577,,BAO_0000218,,
13737,,Mus musculus,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630578,,BAO_0000218,,
13738,,Mus musculus,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,A,1,Intermediate,1,,CHEMBL630579,,BAO_0000218,,
13739,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),N,A,1,Intermediate,1,,CHEMBL630580,,BAO_0000218,2113.0,
13740,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,N,A,1,Intermediate,1,,CHEMBL630581,,BAO_0000218,2113.0,
13741,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),N,A,1,Intermediate,1,,CHEMBL630582,,BAO_0000218,2113.0,
13742,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,N,A,1,Intermediate,1,,CHEMBL630583,,BAO_0000218,,
13743,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),N,A,1,Intermediate,1,,CHEMBL630584,,BAO_0000218,,
13744,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,N,A,1,Intermediate,1,,CHEMBL630585,,BAO_0000218,,
13745,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),N,A,1,Intermediate,1,,CHEMBL630586,,BAO_0000218,,
13746,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,N,A,1,Intermediate,1,,CHEMBL630587,,BAO_0000218,,
13747,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),N,A,1,Intermediate,1,,CHEMBL630588,,BAO_0000218,,
13748,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,N,A,1,Intermediate,1,,CHEMBL630589,,BAO_0000218,,
13749,,Mus musculus,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),N,A,1,Intermediate,1,,CHEMBL630590,,BAO_0000218,,
13750,,,Removal of 238-Plutonium(IV) in feces at 24 h,U,A,0,Autocuration,1,,CHEMBL630591,,BAO_0000019,1988.0,
13751,,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),U,A,0,Autocuration,1,,CHEMBL630592,,BAO_0000019,1988.0,
13752,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,U,A,0,Autocuration,1,,CHEMBL630593,,BAO_0000019,,
13753,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),U,A,0,Autocuration,1,,CHEMBL630594,,BAO_0000019,,
13754,,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),U,A,0,Autocuration,1,,CHEMBL630595,,BAO_0000019,1088.0,
13755,,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),U,A,0,Autocuration,1,,CHEMBL630596,,BAO_0000019,1088.0,
13756,,,Removal of 238-Plutonium(IV) in urine after 0-24 h,U,A,0,Autocuration,1,,CHEMBL630597,,BAO_0000019,1088.0,
13757,,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),U,A,0,Autocuration,1,,CHEMBL630598,,BAO_0000019,1088.0,
13758,,,Removal of 238-Plutonium(IV) in urine after 0-4 h,U,A,0,Autocuration,1,,CHEMBL630599,,BAO_0000019,1088.0,
13759,,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),U,A,0,Autocuration,1,,CHEMBL630600,,BAO_0000019,1088.0,
13760,,,Removal of 238-Plutonium(IV) in urine after 4-24 h,U,A,0,Autocuration,1,,CHEMBL630601,,BAO_0000019,1088.0,
13761,,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),U,A,0,Autocuration,1,,CHEMBL630602,,BAO_0000019,1088.0,
13762,,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),U,A,0,Autocuration,1,,CHEMBL630603,,BAO_0000019,1088.0,
13763,,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),U,A,0,Autocuration,1,,CHEMBL630604,,BAO_0000019,1088.0,
13764,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL624869,,BAO_0000218,178.0,
13765,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL624870,,BAO_0000218,178.0,
13766,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL623189,,BAO_0000218,178.0,
13767,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL623190,,BAO_0000218,178.0,
13768,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL623191,,BAO_0000218,178.0,
13769,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL623192,,BAO_0000218,,
13770,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL623193,,BAO_0000218,,
13771,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL623194,,BAO_0000218,,
13772,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL623195,,BAO_0000218,,
13773,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL623196,,BAO_0000218,,
13774,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,N,A,1,Intermediate,1,,CHEMBL623197,,BAO_0000218,,
13775,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623198,,BAO_0000218,,
13776,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,A,1,Intermediate,1,,CHEMBL623199,,BAO_0000218,,
13777,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623200,,BAO_0000218,2385.0,
13778,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623201,,BAO_0000218,2385.0,
13779,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623202,,BAO_0000218,2385.0,
13780,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623203,,BAO_0000218,2385.0,
13781,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623204,,BAO_0000218,2385.0,
13782,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,N,A,1,Intermediate,1,,CHEMBL623205,,BAO_0000218,2385.0,
13783,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623206,,BAO_0000218,2385.0,
13784,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,N,A,1,Intermediate,1,,CHEMBL623207,,BAO_0000218,2385.0,
13785,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,N,A,1,Intermediate,1,,CHEMBL623208,,BAO_0000218,2385.0,
13786,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623209,,BAO_0000218,2385.0,
13787,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,A,1,Intermediate,1,,CHEMBL623210,,BAO_0000218,2385.0,
13788,,Rattus norvegicus,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623211,,BAO_0000218,,
13789,,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,A,1,Intermediate,1,,CHEMBL623212,,BAO_0000218,995.0,
13790,,,Tested in vitro for intrinsic activity relative to quinpirole,U,A,0,Autocuration,1,,CHEMBL623213,,BAO_0000019,,
13791,,,"Relative ion enhancement, determined in pulsed ultrafiltration",U,A,0,Autocuration,1,,CHEMBL623214,,BAO_0000019,,
13792,,,% ionization at the pH 7.4 at 37 degree Centigrade,U,A,0,Autocuration,1,,CHEMBL623215,,BAO_0000019,,
13793,,,Percentage ionization was measured,U,A,0,Autocuration,1,,CHEMBL623216,,BAO_0000019,,
13794,,Bos taurus,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,N,A,1,Intermediate,1,,CHEMBL623217,,BAO_0000218,,
13795,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,U,A,0,Autocuration,1,,CHEMBL623218,,BAO_0000019,,
13796,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,U,A,0,Autocuration,1,,CHEMBL623913,,BAO_0000019,,
13797,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,U,A,0,Autocuration,1,,CHEMBL623914,,BAO_0000019,,
13798,,,Compound was evaluated for the partition coefficient in octanol/water,U,P,0,Autocuration,1,,CHEMBL623915,,BAO_0000100,,
13799,,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),U,P,0,Autocuration,1,,CHEMBL624080,,BAO_0000100,,
13800,,,Equilibrium constant measured by the pulse radiolysis at pH 7,U,A,0,Autocuration,1,,CHEMBL624081,,BAO_0000019,,
13801,,Homo sapiens,In vitro hydrolytic rate constant determined in human blood,N,A,1,Intermediate,1,,CHEMBL624082,,BAO_0000218,,
13802,,Homo sapiens,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,N,A,1,Intermediate,1,,CHEMBL625054,,BAO_0000218,,
13803,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,U,A,0,Autocuration,1,,CHEMBL877485,,BAO_0000019,,
13804,,Mus musculus,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,N,A,1,Intermediate,1,,CHEMBL625055,,BAO_0000218,,
13805,,Mus musculus,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,N,A,1,Intermediate,1,,CHEMBL625056,,BAO_0000218,,
13806,,Homo sapiens,In vitro oxidation of compound in presence of human plasma,N,A,1,Intermediate,1,,CHEMBL625057,,BAO_0000218,,
13807,,,In vitro oxidation of compound in presence of hydrogen peroxide,U,A,0,Autocuration,1,,CHEMBL625058,,BAO_0000019,,
13808,,Mus musculus,In vitro oxidation of compound in presence of mouse brain homogenate,N,A,1,Intermediate,1,,CHEMBL625059,,BAO_0000218,,
13809,,Mus musculus,In vitro oxidation of compound in presence of mouse liver homogenate,N,A,1,Intermediate,1,,CHEMBL629536,,BAO_0000218,,
13810,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,A,1,Intermediate,1,,CHEMBL629537,,BAO_0000218,,
13811,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,A,1,Intermediate,1,,CHEMBL629538,,BAO_0000218,,
13812,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,A,1,Intermediate,1,,CHEMBL629539,,BAO_0000218,,
13813,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,A,1,Intermediate,1,,CHEMBL874445,,BAO_0000218,,
13814,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,A,1,Intermediate,1,,CHEMBL629540,,BAO_0000218,,
13815,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,A,1,Intermediate,1,,CHEMBL629541,,BAO_0000218,,
13816,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,A,1,Intermediate,1,,CHEMBL629542,,BAO_0000218,,
13817,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,A,1,Intermediate,1,,CHEMBL630243,,BAO_0000218,,
13818,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,A,1,Intermediate,1,,CHEMBL630244,,BAO_0000218,,
13819,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,A,1,Intermediate,1,,CHEMBL630245,,BAO_0000218,,
13820,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,A,1,Intermediate,1,,CHEMBL630246,,BAO_0000218,,
13821,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,A,1,Intermediate,1,,CHEMBL630247,,BAO_0000218,,
13822,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,A,1,Intermediate,1,,CHEMBL630248,,BAO_0000218,,
13823,,Rattus norvegicus,Biodistribution in rat blood at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630249,,BAO_0000218,178.0,
13824,,Rattus norvegicus,Biodistribution in rat blood at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630250,,BAO_0000218,178.0,
13825,,Rattus norvegicus,Biodistribution in rat blood at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630251,,BAO_0000218,178.0,
13826,,Rattus norvegicus,Biodistribution in rat blood at 3 hr after dose administration.,N,A,1,Intermediate,1,,CHEMBL630252,,BAO_0000218,178.0,
13827,,Rattus norvegicus,Biodistribution in rat blood at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630408,,BAO_0000218,178.0,
13828,,Rattus norvegicus,Biodistribution in rat cerebellum at 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630409,,BAO_0000218,2037.0,
13829,,Rattus norvegicus,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL874446,,BAO_0000218,2037.0,
13830,,Rattus norvegicus,Biodistribution in rat cerebellum at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630410,,BAO_0000218,2037.0,
13831,,Rattus norvegicus,Biodistribution in rat cerebellum at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630411,,BAO_0000218,2037.0,
13832,,Rattus norvegicus,Biodistribution in rat cerebellum at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630412,,BAO_0000218,2037.0,
13833,,Rattus norvegicus,Biodistribution in rat cerebellum at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630413,,BAO_0000218,2037.0,
13834,,Rattus norvegicus,Biodistribution in rat cerebellum at 3 hr after dose administration.,N,A,1,Intermediate,1,,CHEMBL630414,,BAO_0000218,2037.0,
13835,,Rattus norvegicus,Biodistribution in rat cerebellum at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630415,,BAO_0000218,2037.0,
13836,,Rattus norvegicus,Biodistribution in rat cortex at 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630416,,BAO_0000218,,
13837,,Rattus norvegicus,Biodistribution in rat cortex at 1440 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630417,,BAO_0000218,,
13838,,Rattus norvegicus,Biodistribution in rat cortex at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630418,,BAO_0000218,,
13839,,Rattus norvegicus,Biodistribution in rat cortex at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630419,,BAO_0000218,,
13840,,Rattus norvegicus,Biodistribution in rat cortex at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630420,,BAO_0000218,,
13841,,Rattus norvegicus,Biodistribution in rat cortex at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630421,,BAO_0000218,,
13842,,Rattus norvegicus,Biodistribution in rat cortex at 3 hr after dose administration.,N,A,1,Intermediate,1,,CHEMBL630422,,BAO_0000218,,
13843,,Rattus norvegicus,Biodistribution in rat cortex at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630423,,BAO_0000218,,
13844,,Rattus norvegicus,Biodistribution in rat heart at 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630424,,BAO_0000218,948.0,
13845,,Rattus norvegicus,Biodistribution in rat heart at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630425,,BAO_0000218,948.0,
13846,,Rattus norvegicus,Biodistribution in rat heart at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL629462,,BAO_0000218,948.0,
13847,,Rattus norvegicus,Biodistribution in rat heart at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630426,,BAO_0000218,948.0,
13848,,Rattus norvegicus,Biodistribution in rat heart at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630427,,BAO_0000218,948.0,
13849,,Rattus norvegicus,Biodistribution in rat heart at 3 hr after dose administration.,N,A,1,Intermediate,1,,CHEMBL625877,,BAO_0000218,948.0,
13850,,Rattus norvegicus,Biodistribution in rat heart at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625878,,BAO_0000218,948.0,
13851,,Rattus norvegicus,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625879,,BAO_0000218,10000000.0,
13852,,Rattus norvegicus,Biodistribution in rat hippocampus at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625880,,BAO_0000218,10000000.0,
13853,,Rattus norvegicus,Biodistribution in rat hippocampus at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625881,,BAO_0000218,10000000.0,
13854,,Rattus norvegicus,Biodistribution in rat hippocampus at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625882,,BAO_0000218,10000000.0,
13855,,Rattus norvegicus,Biodistribution in rat hippocampus at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625883,,BAO_0000218,10000000.0,
13856,,Rattus norvegicus,Biodistribution in rat kidney at 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625884,,BAO_0000218,2113.0,
13857,,Rattus norvegicus,Biodistribution in rat kidney at 1440 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625885,,BAO_0000218,2113.0,
13858,,Rattus norvegicus,Biodistribution in rat kidney at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628649,,BAO_0000218,2113.0,
13859,,Rattus norvegicus,Biodistribution in rat kidney at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628650,,BAO_0000218,2113.0,
13860,,Rattus norvegicus,Biodistribution in rat kidney at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628651,,BAO_0000218,2113.0,
13861,,Rattus norvegicus,Biodistribution in rat kidney at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628652,,BAO_0000218,2113.0,
13862,,Rattus norvegicus,Biodistribution in rat kidney at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628653,,BAO_0000218,2113.0,
13863,,Rattus norvegicus,Biodistribution in rat liver at 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628654,,BAO_0000218,2107.0,
13864,,Rattus norvegicus,Biodistribution in rat liver at 1440 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628655,,BAO_0000218,2107.0,
13865,,Rattus norvegicus,Biodistribution in rat liver at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625238,,BAO_0000218,2107.0,
13866,,Rattus norvegicus,Biodistribution in rat liver at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625239,,BAO_0000218,2107.0,
13867,,Rattus norvegicus,Biodistribution in rat liver at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625240,,BAO_0000218,2107.0,
13868,,Rattus norvegicus,Biodistribution in rat liver at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625241,,BAO_0000218,2107.0,
13869,,Rattus norvegicus,Biodistribution in rat liver at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625242,,BAO_0000218,2107.0,
13870,,Rattus norvegicus,Biodistribution in rat lung at 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL874587,,BAO_0000218,2048.0,
13871,,Rattus norvegicus,Biodistribution in rat lung at 1440 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625405,,BAO_0000218,2048.0,
13872,,Rattus norvegicus,Biodistribution in rat lung at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625406,,BAO_0000218,2048.0,
13873,,Rattus norvegicus,Biodistribution in rat lung at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625407,,BAO_0000218,2048.0,
13874,,Rattus norvegicus,Biodistribution in rat lung at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625408,,BAO_0000218,2048.0,
13875,,Rattus norvegicus,Biodistribution in rat lung at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL625409,,BAO_0000218,2048.0,
13876,,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,N,A,1,Intermediate,1,,CHEMBL625410,,BAO_0000218,1515.0,
13877,,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,N,A,1,Intermediate,1,,CHEMBL625411,,BAO_0000218,1515.0,
13878,,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,N,A,1,Intermediate,1,,CHEMBL625412,,BAO_0000218,1515.0,
13879,,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,N,A,1,Intermediate,1,,CHEMBL625413,,BAO_0000218,1515.0,
13880,,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips v,N,A,1,Intermediate,1,,CHEMBL625414,,BAO_0000218,1515.0,
13881,,Rattus norvegicus,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,N,A,1,Intermediate,1,,CHEMBL625415,,BAO_0000218,1515.0,
13882,,Rattus norvegicus,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,N,A,1,Intermediate,1,,CHEMBL625416,,BAO_0000218,1515.0,
13883,,Rattus norvegicus,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,N,A,1,Intermediate,1,,CHEMBL625417,,BAO_0000218,1088.0,
13884,,Rattus norvegicus,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,N,A,1,Intermediate,1,,CHEMBL625418,,BAO_0000218,1988.0,
13885,,Rattus norvegicus,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,N,A,1,Intermediate,1,,CHEMBL625419,,BAO_0000218,1088.0,
13886,,Rattus norvegicus,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,N,A,1,Intermediate,1,,CHEMBL625420,,BAO_0000218,,
13887,,Rattus norvegicus,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,N,A,1,Intermediate,1,,CHEMBL626996,,BAO_0000218,,
13888,,Rattus norvegicus,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",N,A,1,Intermediate,1,,CHEMBL626997,,BAO_0000218,1988.0,
13889,,Rattus norvegicus,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",N,A,1,Intermediate,1,,CHEMBL626998,,BAO_0000218,1088.0,
13890,,Rattus norvegicus,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",N,A,1,Intermediate,1,,CHEMBL626999,,BAO_0000218,,
13891,,Mus musculus,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,N,A,1,Intermediate,1,,CHEMBL627000,,BAO_0000218,,
13892,,Mus musculus,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,N,A,1,Intermediate,1,,CHEMBL627001,,BAO_0000218,,
13893,,Mus musculus,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,N,A,1,Intermediate,1,,CHEMBL627002,,BAO_0000218,,
13894,,Mus musculus,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,N,A,1,Intermediate,1,,CHEMBL627003,,BAO_0000218,,
13895,,Mus musculus,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,N,A,1,Intermediate,1,,CHEMBL627004,,BAO_0000218,1088.0,
13896,,Mus musculus,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,N,A,1,Intermediate,1,,CHEMBL627005,,BAO_0000218,1088.0,
13897,,Mus musculus,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,N,A,1,Intermediate,1,,CHEMBL874594,,BAO_0000218,1088.0,
13898,,Mus musculus,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,N,A,1,Intermediate,1,,CHEMBL627006,,BAO_0000218,1088.0,
13899,,Mus musculus,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,N,A,1,Intermediate,1,,CHEMBL627007,,BAO_0000218,1088.0,
13900,,Mus musculus,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,N,A,1,Intermediate,1,,CHEMBL627884,,BAO_0000218,1088.0,
13901,,Mus musculus,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,N,A,1,Intermediate,1,,CHEMBL627885,,BAO_0000218,1088.0,
13902,,Mus musculus,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,N,A,1,Intermediate,1,,CHEMBL627886,,BAO_0000218,1088.0,
13903,,Mus musculus,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,N,A,1,Intermediate,1,,CHEMBL627887,,BAO_0000218,1088.0,
13904,,Mus musculus,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,N,A,1,Intermediate,1,,CHEMBL627888,,BAO_0000218,1088.0,
13905,,Mus musculus,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,N,A,1,Intermediate,1,,CHEMBL628057,,BAO_0000218,1088.0,
13906,,Mus musculus,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,N,A,1,Intermediate,1,,CHEMBL627405,,BAO_0000218,1088.0,
13907,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627406,,BAO_0000218,1088.0,
13908,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627407,,BAO_0000218,1088.0,
13909,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627408,,BAO_0000218,1088.0,
13910,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627409,,BAO_0000218,1088.0,
13911,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL875486,,BAO_0000218,1088.0,
13912,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627410,,BAO_0000218,1088.0,
13913,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627411,,BAO_0000218,1088.0,
13914,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627412,,BAO_0000218,1088.0,
13915,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627413,,BAO_0000218,1088.0,
13916,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627414,,BAO_0000218,1088.0,
13917,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627415,,BAO_0000218,1088.0,
13918,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627416,,BAO_0000218,1088.0,
13919,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627417,,BAO_0000218,1088.0,
13920,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627418,,BAO_0000218,1088.0,
13921,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627419,,BAO_0000218,1088.0,
13922,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627320,,BAO_0000218,1088.0,
13923,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627321,,BAO_0000218,1088.0,
13924,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627322,,BAO_0000218,2113.0,
13925,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627323,,BAO_0000218,2113.0,
13926,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL627491,,BAO_0000218,2113.0,
13927,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627492,,BAO_0000218,2113.0,
13928,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627493,,BAO_0000218,2113.0,
13929,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627494,,BAO_0000218,2107.0,
13930,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627495,,BAO_0000218,2107.0,
13931,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL627496,,BAO_0000218,2107.0,
13932,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627497,,BAO_0000218,2107.0,
13933,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627498,,BAO_0000218,2107.0,
13934,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627499,,BAO_0000218,2048.0,
13935,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL627500,,BAO_0000218,2048.0,
13936,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL627501,,BAO_0000218,2048.0,
13937,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL625616,,BAO_0000218,2048.0,
13938,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL625617,,BAO_0000218,2048.0,
13939,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL625618,,BAO_0000218,2385.0,
13940,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL625619,,BAO_0000218,2385.0,
13941,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL625620,,BAO_0000218,2385.0,
13942,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL625621,,BAO_0000218,2385.0,
13943,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL625622,,BAO_0000218,2385.0,
13944,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL625788,,BAO_0000218,2106.0,
13945,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL625789,,BAO_0000218,2106.0,
13946,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL625790,,BAO_0000218,2106.0,
13947,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL625791,,BAO_0000218,2106.0,
13948,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL622334,,BAO_0000218,2106.0,
13949,,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL622335,,BAO_0000218,2046.0,
13950,,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL622336,,BAO_0000218,2046.0,
13951,,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL622337,,BAO_0000218,2046.0,
13952,,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL622338,,BAO_0000218,2046.0,
13953,,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL622339,,BAO_0000218,2046.0,
13954,,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL624153,,BAO_0000218,,
13955,,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL628430,,BAO_0000218,,
13956,,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL628431,,BAO_0000218,,
13957,,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL628432,,BAO_0000218,,
13958,,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL628433,,BAO_0000218,,
13959,,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,A,1,Intermediate,1,,CHEMBL628434,,BAO_0000218,2106.0,
13960,,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,A,1,Intermediate,1,,CHEMBL626789,,BAO_0000218,2106.0,
13961,,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",N,A,1,Intermediate,1,,CHEMBL626790,,BAO_0000218,2106.0,
13962,,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,A,1,Intermediate,1,,CHEMBL626791,,BAO_0000218,2106.0,
13963,,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,A,1,Intermediate,1,,CHEMBL626792,,BAO_0000218,2106.0,
13964,,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,A,1,Intermediate,1,,CHEMBL626793,,BAO_0000218,2106.0,
13965,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,A,1,Intermediate,1,,CHEMBL627436,,BAO_0000218,,
13966,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,A,1,Intermediate,1,,CHEMBL627437,,BAO_0000218,,
13967,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,A,1,Intermediate,1,,CHEMBL627438,,BAO_0000218,,
13968,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,A,1,Intermediate,1,,CHEMBL627439,,BAO_0000218,,
13969,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,A,1,Intermediate,1,,CHEMBL627440,,BAO_0000218,,
13970,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,A,1,Intermediate,1,,CHEMBL627602,,BAO_0000218,,
13971,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,A,1,Intermediate,1,,CHEMBL627603,,BAO_0000218,,
13972,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,A,1,Intermediate,1,,CHEMBL627604,,BAO_0000218,,
13973,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,A,1,Intermediate,1,,CHEMBL627605,,BAO_0000218,,
13974,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,A,1,Intermediate,1,,CHEMBL627606,,BAO_0000218,,
13975,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,A,1,Intermediate,1,,CHEMBL627607,,BAO_0000218,,
13976,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,A,1,Intermediate,1,,CHEMBL627608,,BAO_0000218,,
13977,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,A,1,Intermediate,1,,CHEMBL627609,,BAO_0000218,,
13978,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,A,1,Intermediate,1,,CHEMBL627610,,BAO_0000218,,
13979,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,A,1,Intermediate,1,,CHEMBL627611,,BAO_0000218,,
13980,,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,A,1,Intermediate,1,,CHEMBL627612,,BAO_0000218,,
13981,,,Octanol:water partition coefficient is evaluated,U,P,0,Autocuration,1,,CHEMBL627613,,BAO_0000100,,
13982,,,Partition coefficient in 1-octanol/water system,U,P,0,Autocuration,1,,CHEMBL627614,,BAO_0000100,,
13983,,,Partition coefficient in 1-octanol/water system measured using radio active compounds,U,P,0,Autocuration,1,,CHEMBL627615,,BAO_0000100,,
13984,,,Partition coefficient in octanol/water system was determined,U,P,0,Autocuration,1,,CHEMBL627616,,BAO_0000100,,
13985,,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,U,P,0,Autocuration,1,,CHEMBL627617,,BAO_0000100,,
13986,,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,U,A,0,Autocuration,1,,CHEMBL627618,,BAO_0000019,,
13987,,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",U,A,0,Autocuration,1,,CHEMBL627619,,BAO_0000019,,
13988,,,Pseudo-first-order rate constant of the compound,U,A,0,Autocuration,1,,CHEMBL627620,,BAO_0000019,,
13989,,,Pseudo-first-order rate constant with 1-min time point,U,A,0,Autocuration,1,,CHEMBL627621,,BAO_0000019,,
13990,,,Pseudo-first-order rate constant without 1-min time point,U,A,0,Autocuration,1,,CHEMBL627622,,BAO_0000019,,
13991,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,U,A,0,Autocuration,1,,CHEMBL627623,,BAO_0000019,,
13992,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,U,A,0,Autocuration,1,,CHEMBL627624,,BAO_0000019,,
13993,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,U,A,0,Autocuration,1,,CHEMBL627625,,BAO_0000019,,
13994,,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,U,A,0,Autocuration,1,,CHEMBL628523,,BAO_0000019,,
13995,,,The alkaline hydrolysis second order rate constant(K OH) of the compound,U,A,0,Autocuration,1,,CHEMBL628524,,BAO_0000019,,
13996,,,The efflux rate constant of the compound,U,A,0,Autocuration,1,,CHEMBL628525,,BAO_0000019,,
13997,,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,A,0,Autocuration,1,,CHEMBL625732,,BAO_0000019,,
13998,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,A,0,Autocuration,1,,CHEMBL625733,,BAO_0000019,,
13999,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,F,0,Autocuration,1,,CHEMBL625734,,BAO_0000019,,
14000,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,U,A,0,Autocuration,1,,CHEMBL625913,,BAO_0000019,,
14001,,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,U,A,0,Autocuration,1,,CHEMBL625914,,BAO_0000019,,
14002,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,U,A,0,Autocuration,1,,CHEMBL625915,,BAO_0000019,,
14003,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,U,A,0,Autocuration,1,,CHEMBL625916,,BAO_0000019,,
14004,,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),U,A,0,Autocuration,1,,CHEMBL625917,,BAO_0000019,,
14005,,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL625918,,BAO_0000019,,
14006,,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL625919,,BAO_0000019,,
14007,,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL625920,,BAO_0000019,,
14008,,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL874453,,BAO_0000019,,
14009,,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL625921,,BAO_0000019,,
14010,,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,U,A,0,Autocuration,1,,CHEMBL625922,,BAO_0000019,,
14011,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL625923,,BAO_0000019,,
14012,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL625924,,BAO_0000019,,
14013,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL625925,,BAO_0000019,,
14014,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL625926,,BAO_0000019,,
14015,,Rattus norvegicus,Biodistribution in rat lung at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL627704,,BAO_0000218,2048.0,
14016,,Rattus norvegicus,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL627705,,BAO_0000218,,
14017,,Rattus norvegicus,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL627706,,BAO_0000218,,
14018,,Rattus norvegicus,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL627707,,BAO_0000218,,
14019,,Rattus norvegicus,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL627708,,BAO_0000218,,
14020,,Rattus norvegicus,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628361,,BAO_0000218,,
14021,,Rattus norvegicus,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628362,,BAO_0000218,,
14022,,Rattus norvegicus,Biodistribution in rat striatum at 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628363,,BAO_0000218,2435.0,
14023,,Rattus norvegicus,Biodistribution in rat striatum at 1440 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628364,,BAO_0000218,2435.0,
14024,,Rattus norvegicus,Biodistribution in rat striatum at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628365,,BAO_0000218,2435.0,
14025,,Rattus norvegicus,Biodistribution in rat striatum at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL874454,,BAO_0000218,2435.0,
14026,,Rattus norvegicus,Biodistribution in rat striatum at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628531,,BAO_0000218,2435.0,
14027,,Rattus norvegicus,Biodistribution in rat striatum at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628532,,BAO_0000218,2435.0,
14028,,Rattus norvegicus,Biodistribution in rat striatum at 3 hr after dose administration.,N,A,1,Intermediate,1,,CHEMBL628533,,BAO_0000218,2435.0,
14029,,Rattus norvegicus,Biodistribution in rat striatum at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628534,,BAO_0000218,2435.0,
14030,,Rattus norvegicus,Biodistribution in rat thyroid at 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628535,,BAO_0000218,2046.0,
14031,,Rattus norvegicus,Biodistribution in rat thyroid at 1440 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628536,,BAO_0000218,2046.0,
14032,,Rattus norvegicus,Biodistribution in rat thyroid at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628537,,BAO_0000218,2046.0,
14033,,Rattus norvegicus,Biodistribution in rat thyroid at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628538,,BAO_0000218,2046.0,
14034,,Rattus norvegicus,Biodistribution in rat thyroid at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628539,,BAO_0000218,2046.0,
14035,,Rattus norvegicus,Biodistribution in rat thyroid at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630297,,BAO_0000218,2046.0,
14036,,Rattus norvegicus,Biodistribution in rat thyroid at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630298,,BAO_0000218,2046.0,
14037,,Rattus norvegicus,Biodistribution in rest of brain of rat 120 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL630299,,BAO_0000218,955.0,
14038,,Rattus norvegicus,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628094,,BAO_0000218,955.0,
14039,,Rattus norvegicus,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628095,,BAO_0000218,955.0,
14040,,Rattus norvegicus,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL874648,,BAO_0000218,955.0,
14041,,Rattus norvegicus,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628096,,BAO_0000218,955.0,
14042,,Rattus norvegicus,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628097,,BAO_0000218,955.0,
14043,,Rattus norvegicus,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,N,A,1,Intermediate,1,,CHEMBL628098,,BAO_0000218,955.0,
14044,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",U,A,0,Autocuration,1,,CHEMBL628099,,BAO_0000019,,
14045,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,A,0,Autocuration,1,,CHEMBL628100,,BAO_0000019,,
14046,,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),U,A,0,Autocuration,1,,CHEMBL628101,,BAO_0000019,,
14047,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",U,A,0,Autocuration,1,,CHEMBL628102,,BAO_0000019,,
14048,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",U,A,0,Autocuration,1,,CHEMBL628103,,BAO_0000019,,
14049,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,A,0,Autocuration,1,,CHEMBL628104,,BAO_0000019,,
14050,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",U,A,0,Autocuration,1,,CHEMBL628105,,BAO_0000019,,
14051,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",U,A,0,Autocuration,1,,CHEMBL628106,,BAO_0000019,,
14052,,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,N,A,1,Intermediate,1,,CHEMBL628107,,BAO_0000218,1088.0,
14053,,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,U,F,0,Autocuration,1,,CHEMBL628108,,BAO_0000218,1088.0,
14054,,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,N,A,1,Intermediate,1,,CHEMBL628109,,BAO_0000218,1088.0,
14055,,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,U,F,0,Autocuration,1,,CHEMBL625299,,BAO_0000218,1088.0,
14056,,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,N,A,1,Intermediate,1,,CHEMBL625300,,BAO_0000218,1088.0,
14057,,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,N,A,1,Intermediate,1,,CHEMBL625301,,BAO_0000218,1088.0,
14058,,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,N,A,1,Intermediate,1,,CHEMBL625302,,BAO_0000218,1088.0,
14059,,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,N,A,1,Intermediate,1,,CHEMBL874649,,BAO_0000218,1088.0,
14060,,Rattus norvegicus,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,N,A,1,Intermediate,1,,CHEMBL625303,,BAO_0000218,,
14061,,Rattus norvegicus,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,N,A,1,Intermediate,1,,CHEMBL625463,,BAO_0000218,,
14062,,Homo sapiens,In vitro metabolism in human liver microsomes,N,A,1,Intermediate,1,,CHEMBL625464,,BAO_0000218,2107.0,
14063,,Homo sapiens,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,N,A,1,Intermediate,1,,CHEMBL625465,,BAO_0000218,,
14064,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625466,,BAO_0000218,1088.0,
14065,,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625467,,BAO_0000218,1088.0,
14066,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625468,,BAO_0000218,1088.0,
14067,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625469,,BAO_0000218,1088.0,
14068,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625470,,BAO_0000218,1088.0,
14069,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL632418,,BAO_0000218,1088.0,
14070,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627250,,BAO_0000218,1088.0,
14071,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627251,,BAO_0000218,1088.0,
14072,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627252,,BAO_0000218,1088.0,
14073,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627253,,BAO_0000218,1088.0,
14074,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627254,,BAO_0000218,1088.0,
14075,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL875471,,BAO_0000218,1088.0,
14076,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627255,,BAO_0000218,1088.0,
14077,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627256,,BAO_0000218,1088.0,
14078,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627257,,BAO_0000218,1088.0,
14079,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627258,,BAO_0000218,1088.0,
14080,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627259,,BAO_0000218,1088.0,
14081,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627260,,BAO_0000218,1088.0,
14082,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623256,,BAO_0000218,1088.0,
14083,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL874413,,BAO_0000218,1088.0,
14084,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623257,,BAO_0000218,1088.0,
14085,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623258,,BAO_0000218,1088.0,
14086,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623259,,BAO_0000218,1088.0,
14087,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623260,,BAO_0000218,1088.0,
14088,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623261,,BAO_0000218,1088.0,
14089,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623262,,BAO_0000218,1088.0,
14090,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623263,,BAO_0000218,1088.0,
14091,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623264,,BAO_0000218,1088.0,
14092,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623265,,BAO_0000218,1088.0,
14093,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623266,,BAO_0000218,1088.0,
14094,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623267,,BAO_0000218,1088.0,
14095,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623268,,BAO_0000218,1088.0,
14096,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623269,,BAO_0000218,1088.0,
14097,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623270,,BAO_0000218,1088.0,
14098,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623271,,BAO_0000218,1088.0,
14099,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623272,,BAO_0000218,1088.0,
14100,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623273,,BAO_0000218,1088.0,
14101,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623274,,BAO_0000218,1088.0,
14102,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL874414,,BAO_0000218,1088.0,
14103,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623275,,BAO_0000218,1088.0,
14104,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL629150,,BAO_0000218,1088.0,
14105,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623276,,BAO_0000218,1088.0,
14106,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623277,,BAO_0000218,1088.0,
14107,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623112,,BAO_0000218,1088.0,
14108,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623113,,BAO_0000218,1088.0,
14109,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623800,,BAO_0000218,1088.0,
14110,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623801,,BAO_0000218,1088.0,
14111,,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,A,1,Intermediate,1,,CHEMBL623802,,BAO_0000218,2106.0,
14112,,Rattus norvegicus,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL623803,,BAO_0000218,995.0,
14113,,Rattus norvegicus,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL623970,,BAO_0000218,995.0,
14114,,Rattus norvegicus,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL623971,,BAO_0000218,995.0,
14115,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623972,,BAO_0000218,178.0,
14116,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623973,,BAO_0000218,178.0,
14117,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623974,,BAO_0000218,178.0,
14118,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623975,,BAO_0000218,178.0,
14119,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623976,,BAO_0000218,955.0,
14120,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623977,,BAO_0000218,955.0,
14121,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623978,,BAO_0000218,955.0,
14122,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623979,,BAO_0000218,955.0,
14123,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623980,,BAO_0000218,,
14124,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL623981,,BAO_0000218,,
14125,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL626278,,BAO_0000218,,
14126,,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),N,A,1,Intermediate,1,,CHEMBL626279,,BAO_0000218,,
14127,,Mus musculus,Biodistribution in mice bladder plus excreted urine was determined,N,A,1,Intermediate,1,,CHEMBL626280,,BAO_0000218,,
14128,,Mus musculus,"Percentage biodistribution in mouse blood, 10 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626281,,BAO_0000218,,
14129,,Mus musculus,"Percentage biodistribution in mouse blood, 30 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626282,,BAO_0000218,,
14130,,Mus musculus,"Percentage biodistribution in mouse blood, 5 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626283,,BAO_0000218,,
14131,,Mus musculus,"Percentage biodistribution in mouse blood, 60 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626284,,BAO_0000218,,
14132,,Mus musculus,"Percentage biodistribution in mouse brain, 10 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626285,,BAO_0000218,955.0,
14133,,Mus musculus,"Percentage biodistribution in mouse brain, 30 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626286,,BAO_0000218,955.0,
14134,,Mus musculus,"Percentage biodistribution in mouse brain, 5 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626287,,BAO_0000218,955.0,
14135,,Mus musculus,"Percentage biodistribution in mouse brain, 60 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626288,,BAO_0000218,955.0,
14136,,Mus musculus,"Percentage biodistribution in mouse heart, 10 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626289,,BAO_0000218,,
14137,,Mus musculus,"Percentage biodistribution in mouse heart, 30 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626290,,BAO_0000218,,
14138,,Mus musculus,"Percentage biodistribution in mouse heart, 5 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626291,,BAO_0000218,,
14139,,Mus musculus,"Percentage biodistribution in mouse heart, 60 minutes post injection",N,A,1,Intermediate,1,,CHEMBL839888,,BAO_0000218,,
14140,,Mus musculus,"Percentage biodistribution in mouse intestine, 10 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626292,,BAO_0000218,160.0,
14141,,Mus musculus,"Percentage biodistribution in mouse intestine, 30 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626293,,BAO_0000218,160.0,
14142,,Mus musculus,"Percentage biodistribution in mouse intestine, 5 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626294,,BAO_0000218,160.0,
14143,,Mus musculus,"Percentage biodistribution in mouse intestine, 60 minutes post injection",N,A,1,Intermediate,1,,CHEMBL626295,,BAO_0000218,160.0,
14144,,Mus musculus,"Percentage biodistribution in mouse liver, 10 minutes post injection",N,A,1,Intermediate,1,,CHEMBL627659,,BAO_0000218,2107.0,
14145,,Mus musculus,"Percentage biodistribution in mouse liver, 30 minutes of post injection",N,A,1,Intermediate,1,,CHEMBL627660,,BAO_0000218,2107.0,
14146,,Mus musculus,"Percentage biodistribution in mouse liver, 5 minutes post injection",N,A,1,Intermediate,1,,CHEMBL627661,,BAO_0000218,2107.0,
14147,,Mus musculus,Biodistribution in mice liver at 60 minutes of post injection,N,A,1,Intermediate,1,,CHEMBL627662,,BAO_0000218,2107.0,
14148,,Mus musculus,Biodistribution in mice lungs at 10 min of post injection,N,A,1,Intermediate,1,,CHEMBL627663,,BAO_0000218,2048.0,
14149,,Mus musculus,"Percentage biodistribution in mouse lung, 30 minutes post injection",N,A,1,Intermediate,1,,CHEMBL627664,,BAO_0000218,,
14150,,Mus musculus,"Percentage biodistribution in mousee lung, 5 minutes post injection",N,A,1,Intermediate,1,,CHEMBL627665,,BAO_0000218,,
14151,,Mus musculus,Biodistribution in mice lungs at 60 min of post injection,N,A,1,Intermediate,1,,CHEMBL627666,,BAO_0000218,2048.0,
14152,,Mus musculus,Percentage biodistribution in mouse spleen,N,A,1,Intermediate,1,,CHEMBL627667,,BAO_0000218,2106.0,
14153,,Mus musculus,Percentage biodistribution in mouse stomach,N,A,1,Intermediate,1,,CHEMBL627668,,BAO_0000218,945.0,
14154,,Mus musculus,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,N,A,1,Intermediate,1,,CHEMBL627669,,BAO_0000218,1088.0,
14155,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,U,A,0,Autocuration,1,,CHEMBL627670,,BAO_0000218,1255.0,
14156,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,U,A,0,Autocuration,1,,CHEMBL627671,,BAO_0000218,178.0,
14157,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,U,A,0,Autocuration,1,,CHEMBL627672,,BAO_0000218,1474.0,
14158,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,U,A,0,Autocuration,1,,CHEMBL627673,,BAO_0000218,,
14159,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,U,A,0,Autocuration,1,,CHEMBL627674,,BAO_0000218,2113.0,
14160,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,U,A,0,Autocuration,1,,CHEMBL627675,,BAO_0000218,2107.0,
14161,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,U,A,0,Autocuration,1,,CHEMBL627676,,BAO_0000218,2048.0,
14162,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,U,A,0,Autocuration,1,,CHEMBL627677,,BAO_0000218,2385.0,
14163,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL627678,,BAO_0000019,,
14164,,Rattus norvegicus,Affinity for protein binding expressed as association constant in fresh rat serum,N,A,1,Intermediate,1,,CHEMBL627679,,BAO_0000218,1977.0,
14165,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,A,0,Autocuration,1,,CHEMBL627680,,BAO_0000019,,
14166,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,A,0,Autocuration,1,,CHEMBL627681,,BAO_0000019,,
14167,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,A,0,Autocuration,1,,CHEMBL627682,,BAO_0000019,,
14168,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,A,0,Autocuration,1,,CHEMBL627683,,BAO_0000019,,
14169,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,U,A,0,Autocuration,1,,CHEMBL627684,,BAO_0000019,,
14170,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,A,0,Autocuration,1,,CHEMBL874441,,BAO_0000019,,
14171,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,U,A,0,Autocuration,1,,CHEMBL627685,,BAO_0000019,,
14172,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,A,0,Autocuration,1,,CHEMBL627686,,BAO_0000019,,
14173,,,Apparent rate constant Koff for inactivation of dTMP synthase.,U,A,0,Autocuration,1,,CHEMBL627687,,BAO_0000019,,
14174,,,The irreversible inhibitor activity by second order rate equation.,U,A,0,Autocuration,1,,CHEMBL627688,,BAO_0000019,,
14175,,Rattus norvegicus,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL628038,,BAO_0000218,,
14176,,Rattus norvegicus,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,N,A,1,Intermediate,1,,CHEMBL628039,,BAO_0000218,,
14177,,Rattus norvegicus,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,N,A,1,Intermediate,1,,CHEMBL628040,,BAO_0000218,,
14178,,,Dissociation rate calculated from the first-order equation using t1/2 value,U,A,0,Autocuration,1,,CHEMBL628041,,BAO_0000019,,
14179,,,The compound was tested for Binding constant against DNA,U,A,0,Autocuration,1,,CHEMBL630226,,BAO_0000019,,
14180,,,First order rate constant for cyclization of the compound,U,A,0,Autocuration,1,,CHEMBL628042,,BAO_0000019,,
14181,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,A,0,Autocuration,1,,CHEMBL625232,,BAO_0000019,,
14182,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,A,0,Autocuration,1,,CHEMBL625233,,BAO_0000019,,
14183,,,Hydrolysis rate constant was determined,U,A,0,Autocuration,1,,CHEMBL625979,,BAO_0000019,,
14184,,,Observed first order rate constant,U,A,0,Autocuration,1,,CHEMBL625980,,BAO_0000019,,
14185,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,A,0,Autocuration,1,,CHEMBL625981,,BAO_0000019,,
14186,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,A,0,Autocuration,1,,CHEMBL625982,,BAO_0000019,,
14187,,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,U,A,0,Autocuration,1,,CHEMBL625983,,BAO_0000019,,
14188,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625984,,BAO_0000019,,
14189,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625985,,BAO_0000019,,
14190,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625986,,BAO_0000019,,
14191,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625987,,BAO_0000019,,
14192,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625988,,BAO_0000019,,
14193,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625989,,BAO_0000019,,
14194,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625990,,BAO_0000019,,
14195,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625991,,BAO_0000019,,
14196,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625992,,BAO_0000019,,
14197,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL625993,,BAO_0000019,,
14198,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL631973,,BAO_0000019,,
14199,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL632143,,BAO_0000019,,
14200,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL632144,,BAO_0000019,,
14201,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL632145,,BAO_0000019,,
14202,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL632146,,BAO_0000019,,
14203,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL632147,,BAO_0000019,,
14204,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL632148,,BAO_0000019,,
14205,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL632149,,BAO_0000019,,
14206,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL632150,,BAO_0000019,,
14207,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL632151,,BAO_0000019,,
14208,,Homo sapiens,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,N,A,1,Intermediate,1,,CHEMBL632152,,BAO_0000218,,
14209,,Homo sapiens,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,A,1,Intermediate,1,,CHEMBL632153,,BAO_0000218,,
14210,,Homo sapiens,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,A,1,Intermediate,1,,CHEMBL632154,,BAO_0000218,,
14211,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,N,A,1,Intermediate,1,,CHEMBL632155,,BAO_0000218,,
14212,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,N,A,1,Intermediate,1,,CHEMBL632156,,BAO_0000218,,
14213,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,N,A,1,Intermediate,1,,CHEMBL632157,,BAO_0000218,,
14214,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,N,A,1,Intermediate,1,,CHEMBL632158,,BAO_0000218,,
14215,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,N,A,1,Intermediate,1,,CHEMBL632159,,BAO_0000218,,
14216,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,N,A,1,Intermediate,1,,CHEMBL626305,,BAO_0000218,,
14217,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,N,A,1,Intermediate,1,,CHEMBL626306,,BAO_0000218,,
14218,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,N,A,1,Intermediate,1,,CHEMBL626307,,BAO_0000218,,
14219,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,N,A,1,Intermediate,1,,CHEMBL626308,,BAO_0000218,,
14220,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,N,A,1,Intermediate,1,,CHEMBL626479,,BAO_0000218,,
14221,,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,N,A,1,Intermediate,1,,CHEMBL626480,,BAO_0000218,,
14222,,,Calculated partition coefficient (clogP) (MlogP),U,P,0,Autocuration,1,,CHEMBL626481,,BAO_0000100,,
14223,,,Equipotent potent ratio relative to carbachol (nicotinic activity),U,A,0,Autocuration,1,,CHEMBL626482,,BAO_0000019,,
14224,,Canis lupus familiaris,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",N,A,1,Intermediate,1,,CHEMBL626483,,BAO_0000218,,
14225,,Canis lupus familiaris,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",N,A,1,Intermediate,1,,CHEMBL626484,,BAO_0000218,,
14226,,,Solubility at pH 7.4 in micro g/mL;NA denotes available,U,P,0,Autocuration,1,,CHEMBL626485,,BAO_0000100,,
14227,,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,U,P,0,Autocuration,1,,CHEMBL626486,,BAO_0000100,,
14228,,,Solubility at pH 7.4 in ug/mL;NA denotes not available,U,P,0,Autocuration,1,,CHEMBL626487,,BAO_0000100,,
14229,,Canis lupus familiaris,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,A,1,Intermediate,1,,CHEMBL626488,,BAO_0000218,1969.0,
14230,,Rattus norvegicus,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,N,A,1,Intermediate,1,,CHEMBL626489,,BAO_0000218,1977.0,
14231,,,Area under the MAP curve measured over 5 min; ND means Not determined,U,A,0,Autocuration,1,,CHEMBL626490,,BAO_0000019,,
14232,,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,U,P,0,Autocuration,1,,CHEMBL626491,,BAO_0000100,,
14233,,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,U,P,0,Autocuration,1,,CHEMBL626492,,BAO_0000100,,
14234,,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,U,A,0,Autocuration,1,,CHEMBL626493,,BAO_0000019,,
14235,,Rattus norvegicus,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,N,A,1,Intermediate,1,,CHEMBL626494,,BAO_0000218,,
14236,,,Half life after oral tested,U,A,0,Autocuration,1,,CHEMBL626495,,BAO_0000218,,
14237,,Rattus norvegicus,Half life was determined in plasma of rat; NT indicates not tested,N,A,1,Intermediate,1,,CHEMBL626496,,BAO_0000218,1969.0,
14238,,Rattus norvegicus,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,N,A,1,Intermediate,1,,CHEMBL626497,,BAO_0000218,,
14239,,,Oral bioavailability after oral tested,U,A,0,Autocuration,1,,CHEMBL626498,,BAO_0000218,,
14240,,Rattus norvegicus,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),N,A,1,Intermediate,1,,CHEMBL626499,,BAO_0000218,,
14241,,Rattus norvegicus,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),N,A,1,Intermediate,1,,CHEMBL626500,,BAO_0000218,,
14242,,Rattus norvegicus,half life was determined in plasma of rat; NT indicates not tested,N,A,1,Intermediate,1,,CHEMBL626501,,BAO_0000218,1969.0,
14243,,Rattus norvegicus,half life was determined in plasma of rat; NT means not tested,N,A,1,Intermediate,1,,CHEMBL626502,,BAO_0000218,1969.0,
14244,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,N,A,1,Intermediate,1,,CHEMBL626503,,BAO_0000218,,
14245,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); inactive,N,A,1,Intermediate,1,,CHEMBL626504,,BAO_0000218,,
14246,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,N,A,1,Intermediate,1,,CHEMBL626505,,BAO_0000218,,
14247,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,N,A,1,Intermediate,1,,CHEMBL626506,,BAO_0000218,,
14248,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,N,A,1,Intermediate,1,,CHEMBL626507,,BAO_0000218,,
14249,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,N,A,1,Intermediate,1,,CHEMBL626508,,BAO_0000218,,
14250,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,N,A,1,Intermediate,1,,CHEMBL626509,,BAO_0000218,,
14251,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,N,A,1,Intermediate,1,,CHEMBL875480,,BAO_0000218,,
14252,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,N,A,1,Intermediate,1,,CHEMBL626510,,BAO_0000218,,
14253,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,N,A,1,Intermediate,1,,CHEMBL626511,,BAO_0000218,,
14254,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,N,A,1,Intermediate,1,,CHEMBL626512,,BAO_0000218,,
14255,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,N,A,1,Intermediate,1,,CHEMBL628208,,BAO_0000218,,
14256,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,N,A,1,Intermediate,1,,CHEMBL628209,,BAO_0000218,,
14257,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,N,A,1,Intermediate,1,,CHEMBL628210,,BAO_0000218,,
14258,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,N,A,1,Intermediate,1,,CHEMBL628211,,BAO_0000218,,
14259,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,N,A,1,Intermediate,1,,CHEMBL628212,,BAO_0000218,,
14260,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,N,A,1,Intermediate,1,,CHEMBL628213,,BAO_0000218,,
14261,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628214,,BAO_0000218,1088.0,
14262,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628215,,BAO_0000218,1088.0,
14263,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628216,,BAO_0000218,1088.0,
14264,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626595,,BAO_0000218,1088.0,
14265,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626596,,BAO_0000218,1088.0,
14266,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626597,,BAO_0000218,1088.0,
14267,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626598,,BAO_0000218,1088.0,
14268,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622242,,BAO_0000218,1088.0,
14269,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622243,,BAO_0000218,1088.0,
14270,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622244,,BAO_0000218,1088.0,
14271,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622245,,BAO_0000218,1088.0,
14272,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622246,,BAO_0000218,1088.0,
14273,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622247,,BAO_0000218,1088.0,
14274,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622248,,BAO_0000218,1088.0,
14275,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL877483,,BAO_0000218,1088.0,
14276,,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622249,,BAO_0000218,1088.0,
14277,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622250,,BAO_0000218,1088.0,
14278,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622251,,BAO_0000218,1088.0,
14279,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622252,,BAO_0000218,1088.0,
14280,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622253,,BAO_0000218,1088.0,
14281,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622254,,BAO_0000218,1088.0,
14282,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622255,,BAO_0000218,1088.0,
14283,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622256,,BAO_0000218,1088.0,
14284,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622257,,BAO_0000218,1088.0,
14285,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622258,,BAO_0000218,1088.0,
14286,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622259,,BAO_0000218,1088.0,
14287,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622927,,BAO_0000218,1088.0,
14288,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622928,,BAO_0000218,1088.0,
14289,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL622929,,BAO_0000218,1088.0,
14290,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623182,,BAO_0000218,1088.0,
14291,,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623183,,BAO_0000218,1088.0,
14292,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623184,,BAO_0000218,1088.0,
14293,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623185,,BAO_0000218,1088.0,
14294,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL877484,,BAO_0000218,1088.0,
14295,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627274,,BAO_0000218,1088.0,
14296,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623186,,BAO_0000218,1088.0,
14297,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623187,,BAO_0000218,1088.0,
14298,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL623188,,BAO_0000218,1088.0,
14299,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628055,,BAO_0000218,1088.0,
14300,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628056,,BAO_0000218,1088.0,
14301,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628200,,BAO_0000218,1088.0,
14302,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628201,,BAO_0000218,1088.0,
14303,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628202,,BAO_0000218,1088.0,
14304,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628203,,BAO_0000218,1088.0,
14305,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628204,,BAO_0000218,1088.0,
14306,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628205,,BAO_0000218,1088.0,
14307,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628206,,BAO_0000218,1088.0,
14308,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),U,A,0,Autocuration,1,,CHEMBL628207,,BAO_0000218,2367.0,
14309,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,U,A,0,Autocuration,1,,CHEMBL627220,,BAO_0000218,2367.0,
14310,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,U,A,0,Autocuration,1,,CHEMBL627221,,BAO_0000218,2385.0,
14311,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),U,A,0,Autocuration,1,,CHEMBL627222,,BAO_0000218,2367.0,
14312,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,U,A,0,Autocuration,1,,CHEMBL627223,,BAO_0000218,,
14313,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,U,A,0,Autocuration,1,,CHEMBL632062,,BAO_0000218,2385.0,
14314,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,U,A,0,Autocuration,1,,CHEMBL632063,,BAO_0000218,2106.0,
14315,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,U,A,0,Autocuration,1,,CHEMBL632064,,BAO_0000218,1255.0,
14316,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,U,A,0,Autocuration,1,,CHEMBL632065,,BAO_0000218,178.0,
14317,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,U,A,0,Autocuration,1,,CHEMBL632066,,BAO_0000218,1474.0,
14318,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,U,A,0,Autocuration,1,,CHEMBL632067,,BAO_0000218,,
14319,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,U,A,0,Autocuration,1,,CHEMBL629188,,BAO_0000218,2113.0,
14320,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,U,A,0,Autocuration,1,,CHEMBL629189,,BAO_0000218,2107.0,
14321,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,U,A,0,Autocuration,1,,CHEMBL629190,,BAO_0000218,2048.0,
14322,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,U,A,0,Autocuration,1,,CHEMBL629191,,BAO_0000218,2385.0,
14323,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),U,A,0,Autocuration,1,,CHEMBL629192,,BAO_0000218,2367.0,
14324,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,U,A,0,Autocuration,1,,CHEMBL629193,,BAO_0000218,2385.0,
14325,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),U,A,0,Autocuration,1,,CHEMBL629194,,BAO_0000218,2367.0,
14326,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,U,A,0,Autocuration,1,,CHEMBL629195,,BAO_0000218,,
14327,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,U,A,0,Autocuration,1,,CHEMBL629373,,BAO_0000218,2385.0,
14328,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,U,A,0,Autocuration,1,,CHEMBL629374,,BAO_0000218,2106.0,
14329,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,U,A,0,Autocuration,1,,CHEMBL629375,,BAO_0000218,2367.0,
14330,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,U,A,0,Autocuration,1,,CHEMBL629376,,BAO_0000218,1255.0,
14331,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,U,A,0,Autocuration,1,,CHEMBL629377,,BAO_0000218,178.0,
14332,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,U,A,0,Autocuration,1,,CHEMBL629378,,BAO_0000218,1474.0,
14333,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,U,A,0,Autocuration,1,,CHEMBL629379,,BAO_0000218,,
14334,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,U,A,0,Autocuration,1,,CHEMBL629151,,BAO_0000218,2113.0,
14335,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,U,A,0,Autocuration,1,,CHEMBL629152,,BAO_0000218,2107.0,
14336,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,U,A,0,Autocuration,1,,CHEMBL629153,,BAO_0000218,2048.0,
14337,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,U,A,0,Autocuration,1,,CHEMBL629154,,BAO_0000218,2385.0,
14338,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),U,A,0,Autocuration,1,,CHEMBL629155,,BAO_0000218,2367.0,
14339,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,U,A,0,Autocuration,1,,CHEMBL629156,,BAO_0000218,2367.0,
14340,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,U,A,0,Autocuration,1,,CHEMBL629157,,BAO_0000218,2385.0,
14341,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),U,A,0,Autocuration,1,,CHEMBL629158,,BAO_0000218,2367.0,
14342,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,U,A,0,Autocuration,1,,CHEMBL629159,,BAO_0000218,,
14343,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,U,A,0,Autocuration,1,,CHEMBL629160,,BAO_0000218,2385.0,
14344,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,U,A,0,Autocuration,1,,CHEMBL629161,,BAO_0000218,2106.0,
14345,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,U,A,0,Autocuration,1,,CHEMBL629162,,BAO_0000218,1255.0,
14346,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,U,A,0,Autocuration,1,,CHEMBL629163,,BAO_0000218,178.0,
14347,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,U,A,0,Autocuration,1,,CHEMBL629164,,BAO_0000218,1474.0,
14348,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,U,A,0,Autocuration,1,,CHEMBL629165,,BAO_0000218,,
14349,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,U,A,0,Autocuration,1,,CHEMBL629166,,BAO_0000218,2107.0,
14350,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,U,A,0,Autocuration,1,,CHEMBL629167,,BAO_0000218,2048.0,
14351,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,U,A,0,Autocuration,1,,CHEMBL629168,,BAO_0000218,2385.0,
14352,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,U,A,0,Autocuration,1,,CHEMBL629169,,BAO_0000019,,
14353,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,U,A,0,Autocuration,1,,CHEMBL629170,,BAO_0000019,,
14354,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,U,A,0,Autocuration,1,,CHEMBL631153,,BAO_0000019,,
14355,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,U,A,0,Autocuration,1,,CHEMBL875121,,BAO_0000019,,
14356,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,U,A,0,Autocuration,1,,CHEMBL631154,,BAO_0000019,,
14357,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,U,A,0,Autocuration,1,,CHEMBL631155,,BAO_0000019,,
14358,,,Hydrolysis rate constant was determined,U,A,0,Autocuration,1,,CHEMBL631156,,BAO_0000019,,
14359,,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",U,A,0,Autocuration,1,,CHEMBL631157,,BAO_0000019,,
14360,,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,A,0,Autocuration,1,,CHEMBL631158,,BAO_0000019,,
14361,,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,A,0,Autocuration,1,,CHEMBL631159,,BAO_0000019,,
14362,,,Observed second order rate constant,U,A,0,Autocuration,1,,CHEMBL631160,,BAO_0000019,,
14363,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,A,0,Autocuration,1,,CHEMBL631161,,BAO_0000019,,
14364,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,A,0,Autocuration,1,,CHEMBL631162,,BAO_0000019,,
14365,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,A,0,Autocuration,1,,CHEMBL630313,,BAO_0000019,,
14366,,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,A,0,Autocuration,1,,CHEMBL630314,,BAO_0000019,,
14367,,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,A,0,Autocuration,1,,CHEMBL630315,,BAO_0000019,,
14368,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630316,,BAO_0000019,,
14369,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630986,,BAO_0000019,,
14370,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630987,,BAO_0000019,,
14371,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630988,,BAO_0000019,,
14372,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630989,,BAO_0000019,,
14373,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630990,,BAO_0000019,,
14374,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630991,,BAO_0000019,,
14375,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630992,,BAO_0000019,,
14376,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630993,,BAO_0000019,,
14377,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,A,0,Autocuration,1,,CHEMBL630994,,BAO_0000019,,
14378,,Rattus norvegicus,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,N,A,1,Intermediate,1,,CHEMBL630995,,BAO_0000218,,
14379,,,Association constant for compound at 31 degree C was determined,U,A,0,Autocuration,1,,CHEMBL629252,,BAO_0000019,,
14380,,,Calculated antagonist equilibrium dissociation constant of the compound,U,A,0,Autocuration,1,,CHEMBL629253,,BAO_0000019,,
14381,,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,U,A,0,Autocuration,1,,CHEMBL629944,,BAO_0000019,,
14382,,Cavia porcellus,Dissociation constants vs LTE4 on guinea pig trachea,N,A,1,Intermediate,1,,CHEMBL629945,,BAO_0000218,3126.0,
14383,,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",U,A,0,Autocuration,1,,CHEMBL629946,,BAO_0000019,,
14384,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",U,A,0,Autocuration,1,,CHEMBL629947,,BAO_0000019,,
14385,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",U,A,0,Autocuration,1,,CHEMBL629948,,BAO_0000019,,
14386,,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",U,A,0,Autocuration,1,,CHEMBL856024,,BAO_0000019,,
14387,,,Affinity constant KD value was derived from TMP,U,A,0,Autocuration,1,,CHEMBL629949,,BAO_0000019,,
14388,,,Apparent dissociation (binding) rate constant was evaluated,U,A,0,Autocuration,1,,CHEMBL629950,,BAO_0000019,,
14389,,,Dissociation constant (KD) of the compound,U,P,0,Autocuration,1,,CHEMBL630127,,BAO_0000100,,
14390,,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,U,P,0,Autocuration,1,,CHEMBL630128,,BAO_0000100,,
14391,,,Dissociation constant from ESR titration experiments,U,P,0,Autocuration,1,,CHEMBL630129,,BAO_0000100,,
14392,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),U,,0,Autocuration,1,,CHEMBL630130,,BAO_0000019,,
14393,,,Dissociation constant was evaluated.,U,P,0,Autocuration,1,,CHEMBL875234,,BAO_0000100,,
14394,,,Dissociation constant was reported,U,P,0,Autocuration,1,,CHEMBL630131,,BAO_0000100,,
14395,,Rattus norvegicus,Dissociation constant was determined in rat pituitary cells.,N,A,1,Intermediate,1,,CHEMBL630132,,BAO_0000218,,
14396,,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,U,A,0,Autocuration,1,,CHEMBL630133,,BAO_0000019,,
14397,,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,U,A,0,Autocuration,1,,CHEMBL630134,,BAO_0000019,,
14398,,,Equilibrium dissociation constant of the compound,U,A,0,Autocuration,1,,CHEMBL630135,,BAO_0000019,,
14399,,,Equilibrium dissociation constant was determined,U,A,0,Autocuration,1,,CHEMBL630136,,BAO_0000019,,
14400,,,Kinetic constant KD was evaluated,U,A,0,Autocuration,1,,CHEMBL630137,,BAO_0000019,,
14401,,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,U,A,0,Autocuration,1,,CHEMBL630138,,BAO_0000019,,
14402,,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,U,A,0,Autocuration,1,,CHEMBL630139,,BAO_0000019,,
14403,,,Rate constant for hydrolysis in aqueous acetone.,U,A,0,Autocuration,1,,CHEMBL630140,,BAO_0000019,,
14404,,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,U,A,0,Autocuration,1,,CHEMBL875235,,BAO_0000019,,
14405,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,N,A,1,Intermediate,1,,CHEMBL876439,,BAO_0000218,,
14406,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,N,A,1,Intermediate,1,,CHEMBL630605,,BAO_0000218,,
14407,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,N,A,1,Intermediate,1,,CHEMBL630606,,BAO_0000218,,
14408,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,N,A,1,Intermediate,1,,CHEMBL630607,,BAO_0000218,,
14409,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,N,A,1,Intermediate,1,,CHEMBL630608,,BAO_0000218,,
14410,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,N,A,1,Intermediate,1,,CHEMBL630609,,BAO_0000218,,
14411,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,N,A,1,Intermediate,1,,CHEMBL630610,,BAO_0000218,,
14412,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,N,A,1,Intermediate,1,,CHEMBL630611,,BAO_0000218,,
14413,,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,N,A,1,Intermediate,1,,CHEMBL629552,,BAO_0000218,,
14414,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,A,1,Intermediate,1,,CHEMBL629733,,BAO_0000218,,
14415,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,A,1,Intermediate,1,,CHEMBL629734,,BAO_0000218,,
14416,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,A,1,Intermediate,1,,CHEMBL629735,,BAO_0000218,,
14417,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,A,1,Intermediate,1,,CHEMBL629736,,BAO_0000218,,
14418,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,A,1,Intermediate,1,,CHEMBL629737,,BAO_0000218,,
14419,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,A,1,Intermediate,1,,CHEMBL629738,,BAO_0000218,,
14420,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,A,1,Intermediate,1,,CHEMBL629739,,BAO_0000218,,
14421,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,A,1,Intermediate,1,,CHEMBL629740,,BAO_0000218,,
14422,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,A,1,Intermediate,1,,CHEMBL629741,,BAO_0000218,,
14423,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,A,1,Intermediate,1,,CHEMBL629742,,BAO_0000218,,
14424,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,A,1,Intermediate,1,,CHEMBL629743,,BAO_0000218,,
14425,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,A,1,Intermediate,1,,CHEMBL629744,,BAO_0000218,,
14426,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,A,1,Intermediate,1,,CHEMBL629745,,BAO_0000218,,
14427,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,A,1,Intermediate,1,,CHEMBL629746,,BAO_0000218,,
14428,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,A,1,Intermediate,1,,CHEMBL629747,,BAO_0000218,,
14429,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,A,1,Intermediate,1,,CHEMBL629748,,BAO_0000218,,
14430,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,A,1,Intermediate,1,,CHEMBL629749,,BAO_0000218,,
14431,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,A,1,Intermediate,1,,CHEMBL629750,,BAO_0000218,,
14432,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,A,1,Intermediate,1,,CHEMBL629751,,BAO_0000218,,
14433,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,A,1,Intermediate,1,,CHEMBL629752,,BAO_0000218,,
14434,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,A,1,Intermediate,1,,CHEMBL629753,,BAO_0000218,,
14435,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,A,1,Intermediate,1,,CHEMBL629754,,BAO_0000218,,
14436,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,A,1,Intermediate,1,,CHEMBL629755,,BAO_0000218,,
14437,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,A,1,Intermediate,1,,CHEMBL629756,,BAO_0000218,,
14438,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,A,1,Intermediate,1,,CHEMBL629757,,BAO_0000218,,
14439,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,A,1,Intermediate,1,,CHEMBL629758,,BAO_0000218,,
14440,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,A,1,Intermediate,1,,CHEMBL629759,,BAO_0000218,,
14441,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,A,1,Intermediate,1,,CHEMBL629760,,BAO_0000218,,
14442,,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,A,1,Intermediate,1,,CHEMBL876443,,BAO_0000218,,
14443,,Canis lupus familiaris,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,N,A,1,Intermediate,1,,CHEMBL629761,,BAO_0000218,,
14444,,Canis lupus familiaris,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,N,A,1,Intermediate,1,,CHEMBL629762,,BAO_0000218,,
14445,,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL629763,,BAO_0000218,,
14446,,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL629764,,BAO_0000218,,
14447,,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL629765,,BAO_0000218,,
14448,,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL629766,,BAO_0000218,,
14449,,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL629767,,BAO_0000218,,
14450,,Canis lupus familiaris,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,N,A,1,Intermediate,1,,CHEMBL629768,,BAO_0000218,,
14451,,Mus musculus,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL629769,,BAO_0000218,,
14452,,Canis lupus familiaris,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,N,A,1,Intermediate,1,,CHEMBL629770,,BAO_0000218,,
14453,,Canis lupus familiaris,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL629771,,BAO_0000218,,
14454,,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL629772,,BAO_0000218,,
14455,,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL629773,,BAO_0000218,,
14456,,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL625455,,BAO_0000218,,
14457,,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL625456,,BAO_0000218,,
14458,,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,N,A,1,Intermediate,1,,CHEMBL625457,,BAO_0000218,,
14459,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625458,,BAO_0000218,1088.0,
14460,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625459,,BAO_0000218,1088.0,
14461,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL875483,,BAO_0000218,1088.0,
14462,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL634779,,BAO_0000218,1088.0,
14463,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625460,,BAO_0000218,1088.0,
14464,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626117,,BAO_0000218,1088.0,
14465,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626118,,BAO_0000218,1088.0,
14466,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628342,,BAO_0000218,1088.0,
14467,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628343,,BAO_0000218,1088.0,
14468,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628344,,BAO_0000218,1088.0,
14469,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628345,,BAO_0000218,1088.0,
14470,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628346,,BAO_0000218,1088.0,
14471,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628347,,BAO_0000218,1088.0,
14472,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628348,,BAO_0000218,1088.0,
14473,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628349,,BAO_0000218,1088.0,
14474,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL875611,,BAO_0000218,1088.0,
14475,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628350,,BAO_0000218,1088.0,
14476,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628351,,BAO_0000218,1088.0,
14477,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628352,,BAO_0000218,1088.0,
14478,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628353,,BAO_0000218,1088.0,
14479,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628354,,BAO_0000218,1088.0,
14480,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626667,,BAO_0000218,1088.0,
14481,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626668,,BAO_0000218,1088.0,
14482,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626669,,BAO_0000218,1088.0,
14483,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626670,,BAO_0000218,1088.0,
14484,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626671,,BAO_0000218,1088.0,
14485,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626672,,BAO_0000218,1088.0,
14486,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626673,,BAO_0000218,1088.0,
14487,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626674,,BAO_0000218,1088.0,
14488,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626675,,BAO_0000218,1088.0,
14489,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626676,,BAO_0000218,1088.0,
14490,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626677,,BAO_0000218,1088.0,
14491,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626678,,BAO_0000218,1088.0,
14492,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626679,,BAO_0000218,1088.0,
14493,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL875612,,BAO_0000218,1088.0,
14494,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626680,,BAO_0000218,1088.0,
14495,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626681,,BAO_0000218,1088.0,
14496,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626682,,BAO_0000218,1088.0,
14497,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626683,,BAO_0000218,1088.0,
14498,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626684,,BAO_0000218,1088.0,
14499,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626685,,BAO_0000218,1088.0,
14500,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626686,,BAO_0000218,1088.0,
14501,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626687,,BAO_0000218,1088.0,
14502,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL624978,,BAO_0000218,1088.0,
14503,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL624979,,BAO_0000218,1088.0,
14504,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL624980,,BAO_0000218,1088.0,
14505,,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL624981,,BAO_0000218,1088.0,
14506,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL624982,,BAO_0000218,1088.0,
14507,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),U,A,0,Autocuration,1,,CHEMBL627564,,BAO_0000218,2367.0,
14508,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),U,A,0,Autocuration,1,,CHEMBL627565,,BAO_0000218,2367.0,
14509,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,U,A,0,Autocuration,1,,CHEMBL627566,,BAO_0000218,,
14510,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,U,A,0,Autocuration,1,,CHEMBL627567,,BAO_0000218,2385.0,
14511,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,U,A,0,Autocuration,1,,CHEMBL627568,,BAO_0000218,2106.0,
14512,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,U,A,0,Autocuration,1,,CHEMBL627569,,BAO_0000218,2113.0,
14513,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,U,A,0,Autocuration,1,,CHEMBL627570,,BAO_0000218,1255.0,
14514,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,U,A,0,Autocuration,1,,CHEMBL627571,,BAO_0000218,178.0,
14515,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,U,A,0,Autocuration,1,,CHEMBL627572,,BAO_0000218,1474.0,
14516,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,U,A,0,Autocuration,1,,CHEMBL627573,,BAO_0000218,,
14517,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,U,A,0,Autocuration,1,,CHEMBL627574,,BAO_0000218,2113.0,
14518,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,U,A,0,Autocuration,1,,CHEMBL627575,,BAO_0000218,2107.0,
14519,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,U,A,0,Autocuration,1,,CHEMBL627576,,BAO_0000218,2048.0,
14520,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,U,A,0,Autocuration,1,,CHEMBL627577,,BAO_0000218,2385.0,
14521,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),U,A,0,Autocuration,1,,CHEMBL627578,,BAO_0000218,2367.0,
14522,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,U,A,0,Autocuration,1,,CHEMBL627579,,BAO_0000218,2367.0,
14523,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,U,A,0,Autocuration,1,,CHEMBL627580,,BAO_0000218,2385.0,
14524,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),U,A,0,Autocuration,1,,CHEMBL627581,,BAO_0000218,2367.0,
14525,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,U,A,0,Autocuration,1,,CHEMBL627582,,BAO_0000218,,
14526,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,U,A,0,Autocuration,1,,CHEMBL627583,,BAO_0000218,2385.0,
14527,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,U,A,0,Autocuration,1,,CHEMBL627584,,BAO_0000218,2106.0,
14528,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,U,A,0,Autocuration,1,,CHEMBL627585,,BAO_0000218,2367.0,
14529,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,U,A,0,Autocuration,1,,CHEMBL627586,,BAO_0000218,2385.0,
14530,,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL627587,,BAO_0000218,,
14531,,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL627588,,BAO_0000218,,
14532,,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628250,,BAO_0000218,,
14533,,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628251,,BAO_0000218,,
14534,,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628252,,BAO_0000218,10000000.0,
14535,,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628253,,BAO_0000218,10000000.0,
14536,,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628254,,BAO_0000218,1898.0,
14537,,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL877493,,BAO_0000218,1898.0,
14538,,Rattus norvegicus,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628255,,BAO_0000218,,
14539,,Rattus norvegicus,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628256,,BAO_0000218,,
14540,,Rattus norvegicus,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628257,,BAO_0000218,10000000.0,
14541,,Rattus norvegicus,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628258,,BAO_0000218,1898.0,
14542,,Rattus norvegicus,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628259,,BAO_0000218,,
14543,,Rattus norvegicus,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL628429,,BAO_0000218,,
14544,,Rattus norvegicus,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,A,1,Intermediate,1,,CHEMBL626862,,BAO_0000218,10000000.0,
14545,,Rattus norvegicus,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,N,A,1,Intermediate,1,,CHEMBL626863,,BAO_0000218,1898.0,
14546,,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,N,A,1,Intermediate,1,,CHEMBL625886,,BAO_0000218,2037.0,
14547,,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,N,A,1,Intermediate,1,,CHEMBL625887,,BAO_0000218,2037.0,
14548,,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat cortex,N,A,1,Intermediate,1,,CHEMBL625888,,BAO_0000218,,
14549,,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,N,A,1,Intermediate,1,,CHEMBL625889,,BAO_0000218,,
14550,,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,N,A,1,Intermediate,1,,CHEMBL625890,,BAO_0000218,10000000.0,
14551,,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,N,A,1,Intermediate,1,,CHEMBL625891,,BAO_0000218,10000000.0,
14552,,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,N,A,1,Intermediate,1,,CHEMBL625892,,BAO_0000218,1898.0,
14553,,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,N,A,1,Intermediate,1,,CHEMBL625893,,BAO_0000218,1898.0,
14554,,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,N,A,1,Intermediate,1,,CHEMBL625894,,BAO_0000218,2037.0,
14555,,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat cortex,N,A,1,Intermediate,1,,CHEMBL625895,,BAO_0000218,,
14556,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,A,0,Autocuration,1,,CHEMBL625896,,BAO_0000019,,
14557,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",U,A,0,Autocuration,1,,CHEMBL625897,,BAO_0000019,,
14558,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,A,0,Autocuration,1,,CHEMBL625898,,BAO_0000019,,
14559,,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,A,0,Autocuration,1,,CHEMBL625899,,BAO_0000019,,
14560,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,A,0,Autocuration,1,,CHEMBL626124,,BAO_0000019,,
14561,,Escherichia coli,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,N,A,1,Intermediate,1,,CHEMBL628500,,BAO_0000218,,
14562,,Rattus norvegicus,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",N,A,1,Intermediate,1,,CHEMBL857856,,BAO_0000218,,
14563,,Rattus norvegicus,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",N,A,1,Intermediate,1,,CHEMBL628501,,BAO_0000218,,
14564,,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",U,A,0,Autocuration,1,,CHEMBL628502,,BAO_0000019,,
14565,,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,U,A,0,Autocuration,1,,CHEMBL628503,,BAO_0000019,,
14566,,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,U,A,0,Autocuration,1,,CHEMBL628504,,BAO_0000019,,
14567,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,A,0,Autocuration,1,,CHEMBL628505,,BAO_0000019,,
14568,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",U,A,0,Autocuration,1,,CHEMBL874452,,BAO_0000019,,
14569,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",U,A,0,Autocuration,1,,CHEMBL628506,,BAO_0000019,,
14570,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,A,0,Autocuration,1,,CHEMBL628507,,BAO_0000019,,
14571,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",U,A,0,Autocuration,1,,CHEMBL628508,,BAO_0000019,,
14572,,,Michaelis constant (KM) was evaluated,U,A,0,Autocuration,1,,CHEMBL628509,,BAO_0000019,,
14573,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,A,0,Autocuration,1,,CHEMBL628510,,BAO_0000019,,
14574,,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,U,B,0,Autocuration,1,,CHEMBL628511,,BAO_0000019,,
14575,,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,U,B,0,Autocuration,1,,CHEMBL628512,,BAO_0000019,,
14576,,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,U,B,0,Autocuration,1,,CHEMBL628513,,BAO_0000019,,
14577,,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,U,B,0,Autocuration,1,,CHEMBL628514,,BAO_0000019,,
14578,,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,U,A,0,Autocuration,1,,CHEMBL628515,,BAO_0000019,,
14579,,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,U,A,0,Autocuration,1,,CHEMBL628516,,BAO_0000019,,
14580,,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,A,0,Autocuration,1,,CHEMBL628517,,BAO_0000019,,
14581,,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,A,0,Autocuration,1,,CHEMBL628518,,BAO_0000019,,
14582,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,U,A,0,Autocuration,1,,CHEMBL628519,,BAO_0000019,,
14583,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,U,A,0,Autocuration,1,,CHEMBL628520,,BAO_0000019,,
14584,,,Binding constant was determined,U,A,0,Autocuration,1,,CHEMBL628521,,BAO_0000019,,
14585,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,U,A,0,Autocuration,1,,CHEMBL630443,,BAO_0000019,,
14586,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,U,A,0,Autocuration,1,,CHEMBL630444,,BAO_0000019,,
14587,,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,U,A,0,Autocuration,1,,CHEMBL857732,,BAO_0000019,,
14588,,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,U,P,0,Autocuration,1,,CHEMBL630445,,BAO_0000100,,
14589,,,Catalytic rate constant of the compound,U,A,0,Autocuration,1,,CHEMBL630446,,BAO_0000019,,
14590,,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,U,B,0,Autocuration,1,,CHEMBL630447,,BAO_0000019,,
14591,,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),U,A,0,Autocuration,1,,CHEMBL630448,,BAO_0000019,,
14592,,,Catalytic rate constant against phospholipase A2 was determined,U,A,0,Autocuration,1,,CHEMBL630449,,BAO_0000019,,
14593,,,"Compound was evaluated for catalytic constant, Kcat",U,A,0,Autocuration,1,,CHEMBL630450,,BAO_0000019,,
14594,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,U,A,0,Autocuration,1,,CHEMBL630451,,BAO_0000019,,
14595,,,Kcat calculated from 0.693/T1/2,U,A,0,Autocuration,1,,CHEMBL630452,,BAO_0000019,,
14596,,,Kcat was determined,U,A,0,Autocuration,1,,CHEMBL630453,,BAO_0000019,,
14597,,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,U,A,0,Autocuration,1,,CHEMBL630454,,BAO_0000019,,
14598,,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,U,A,0,Autocuration,1,,CHEMBL630455,,BAO_0000019,,
14599,,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,U,A,0,Autocuration,1,,CHEMBL631487,,BAO_0000019,,
14600,,,Kcat value was determined,U,A,0,Autocuration,1,,CHEMBL631488,,BAO_0000019,,
14601,,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,U,A,0,Autocuration,1,,CHEMBL876440,,BAO_0000019,,
14602,,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,U,A,0,Autocuration,1,,CHEMBL631489,,BAO_0000019,,
14603,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,A,0,Autocuration,1,,CHEMBL857742,,BAO_0000019,,
14604,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,A,0,Autocuration,1,,CHEMBL631490,,BAO_0000019,,
14605,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",U,A,0,Autocuration,1,,CHEMBL631491,,BAO_0000019,,
14606,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,A,0,Autocuration,1,,CHEMBL631492,,BAO_0000019,,
14607,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,A,0,Autocuration,1,,CHEMBL631493,,BAO_0000019,,
14608,,,Kinetic parameter for rate of conversion to PABA was determined,U,A,0,Autocuration,1,,CHEMBL631494,,BAO_0000019,,
14609,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,A,0,Autocuration,1,,CHEMBL631495,,BAO_0000019,,
14610,,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,A,1,Intermediate,1,,CHEMBL631496,,BAO_0000218,1988.0,
14611,,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,A,1,Intermediate,1,,CHEMBL631497,,BAO_0000218,1088.0,
14612,,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,A,1,Intermediate,1,,CHEMBL631498,,BAO_0000218,1088.0,
14613,,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,A,1,Intermediate,1,,CHEMBL629776,,BAO_0000218,1088.0,
14614,,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,A,1,Intermediate,1,,CHEMBL629777,,BAO_0000218,1088.0,
14615,,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,A,1,Intermediate,1,,CHEMBL629778,,BAO_0000218,1088.0,
14616,,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,N,A,1,Intermediate,1,,CHEMBL630456,,BAO_0000218,,
14617,,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,N,A,1,Intermediate,1,,CHEMBL630457,,BAO_0000218,,
14618,,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,N,A,1,Intermediate,1,,CHEMBL630458,,BAO_0000218,,
14619,,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,N,A,1,Intermediate,1,,CHEMBL630459,,BAO_0000218,,
14620,,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,N,A,1,Intermediate,1,,CHEMBL630460,,BAO_0000218,,
14621,,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,N,A,1,Intermediate,1,,CHEMBL876550,,BAO_0000218,,
14622,,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,N,A,1,Intermediate,1,,CHEMBL630461,,BAO_0000218,,
14623,,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,N,A,1,Intermediate,1,,CHEMBL630462,,BAO_0000218,,
14624,,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,N,A,1,Intermediate,1,,CHEMBL630463,,BAO_0000218,,
14625,,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,N,A,1,Intermediate,1,,CHEMBL630464,,BAO_0000218,,
14626,,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,N,A,1,Intermediate,1,,CHEMBL630465,,BAO_0000218,,
14627,,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,N,A,1,Intermediate,1,,CHEMBL630466,,BAO_0000218,,
14628,,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,N,A,1,Intermediate,1,,CHEMBL630467,,BAO_0000218,,
14629,,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,N,A,1,Intermediate,1,,CHEMBL630633,,BAO_0000218,,
14630,,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,N,A,1,Intermediate,1,,CHEMBL630634,,BAO_0000218,,
14631,,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,N,A,1,Intermediate,1,,CHEMBL630635,,BAO_0000218,,
14632,,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,N,A,1,Intermediate,1,,CHEMBL630636,,BAO_0000218,,
14633,,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,N,A,1,Intermediate,1,,CHEMBL630637,,BAO_0000218,,
14634,,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,A,1,Intermediate,1,,CHEMBL630638,,BAO_0000218,1988.0,
14635,,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,A,1,Intermediate,1,,CHEMBL630639,,BAO_0000218,1988.0,
14636,,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,A,1,Intermediate,1,,CHEMBL630640,,BAO_0000218,1988.0,
14637,,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,A,1,Intermediate,1,,CHEMBL876551,,BAO_0000218,1988.0,
14638,,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",N,A,1,Intermediate,1,,CHEMBL630641,,BAO_0000218,1088.0,
14639,,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,A,1,Intermediate,1,,CHEMBL630642,,BAO_0000218,1088.0,
14640,,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,A,1,Intermediate,1,,CHEMBL630643,,BAO_0000218,1088.0,
14641,,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,A,1,Intermediate,1,,CHEMBL630644,,BAO_0000218,1088.0,
14642,,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,A,1,Intermediate,1,,CHEMBL630645,,BAO_0000218,1088.0,
14643,,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,A,1,Intermediate,1,,CHEMBL625599,,BAO_0000218,1988.0,
14644,,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,A,1,Intermediate,1,,CHEMBL625600,,BAO_0000218,1988.0,
14645,,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,A,1,Intermediate,1,,CHEMBL625601,,BAO_0000218,1988.0,
14646,,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,A,1,Intermediate,1,,CHEMBL625602,,BAO_0000218,1988.0,
14647,,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",N,A,1,Intermediate,1,,CHEMBL627470,,BAO_0000218,1088.0,
14648,,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,A,1,Intermediate,1,,CHEMBL627471,,BAO_0000218,1088.0,
14649,,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,A,1,Intermediate,1,,CHEMBL627472,,BAO_0000218,1088.0,
14650,,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,A,1,Intermediate,1,,CHEMBL627473,,BAO_0000218,1088.0,
14651,,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,A,1,Intermediate,1,,CHEMBL627474,,BAO_0000218,1088.0,
14652,,Rattus norvegicus,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL627475,,BAO_0000218,178.0,
14653,,Rattus norvegicus,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL627476,,BAO_0000218,178.0,
14654,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627477,,BAO_0000218,1088.0,
14655,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627478,,BAO_0000218,1088.0,
14656,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627479,,BAO_0000218,1088.0,
14657,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627480,,BAO_0000218,1088.0,
14658,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627481,,BAO_0000218,1088.0,
14659,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627482,,BAO_0000218,1088.0,
14660,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL627483,,BAO_0000218,1088.0,
14661,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL875636,,BAO_0000218,1088.0,
14662,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625764,,BAO_0000218,1088.0,
14663,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625765,,BAO_0000218,1088.0,
14664,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625766,,BAO_0000218,1088.0,
14665,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625767,,BAO_0000218,1088.0,
14666,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625768,,BAO_0000218,1088.0,
14667,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625769,,BAO_0000218,1088.0,
14668,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625770,,BAO_0000218,1088.0,
14669,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625771,,BAO_0000218,1088.0,
14670,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625772,,BAO_0000218,1088.0,
14671,,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625773,,BAO_0000218,1088.0,
14672,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625774,,BAO_0000218,1088.0,
14673,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625775,,BAO_0000218,1088.0,
14674,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625776,,BAO_0000218,1088.0,
14675,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625777,,BAO_0000218,1088.0,
14676,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625778,,BAO_0000218,1088.0,
14677,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625779,,BAO_0000218,1088.0,
14678,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625780,,BAO_0000218,1088.0,
14679,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL625781,,BAO_0000218,1088.0,
14680,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL875637,,BAO_0000218,1088.0,
14681,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626473,,BAO_0000218,1088.0,
14682,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626474,,BAO_0000218,1088.0,
14683,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626475,,BAO_0000218,1088.0,
14684,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626476,,BAO_0000218,1088.0,
14685,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL634397,,BAO_0000218,1088.0,
14686,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL626477,,BAO_0000218,1088.0,
14687,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631069,,BAO_0000218,1088.0,
14688,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631070,,BAO_0000218,1088.0,
14689,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631071,,BAO_0000218,1088.0,
14690,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631072,,BAO_0000218,1088.0,
14691,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631073,,BAO_0000218,1088.0,
14692,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631074,,BAO_0000218,1088.0,
14693,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631075,,BAO_0000218,1088.0,
14694,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631725,,BAO_0000218,1088.0,
14695,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631726,,BAO_0000218,1088.0,
14696,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631727,,BAO_0000218,1088.0,
14697,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631728,,BAO_0000218,1088.0,
14698,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631729,,BAO_0000218,1088.0,
14699,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631730,,BAO_0000218,1088.0,
14700,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631731,,BAO_0000218,1088.0,
14701,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631910,,BAO_0000218,1088.0,
14702,,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,N,A,1,Intermediate,1,,CHEMBL631911,,BAO_0000218,10000000.0,
14703,,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,N,A,1,Intermediate,1,,CHEMBL631912,,BAO_0000218,1898.0,
14704,,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,N,A,1,Intermediate,1,,CHEMBL631913,,BAO_0000218,1898.0,
14705,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631914,,BAO_0000218,178.0,
14706,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631915,,BAO_0000218,178.0,
14707,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL875778,,BAO_0000218,178.0,
14708,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631916,,BAO_0000218,178.0,
14709,,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631917,,BAO_0000218,178.0,
14710,,Rattus norvegicus,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631918,,BAO_0000218,178.0,
14711,,Rattus norvegicus,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631919,,BAO_0000218,178.0,
14712,,Rattus norvegicus,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL631920,,BAO_0000218,178.0,
14713,,Rattus norvegicus,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631921,,BAO_0000218,178.0,
14714,,Rattus norvegicus,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631922,,BAO_0000218,178.0,
14715,,Rattus norvegicus,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL631923,,BAO_0000218,178.0,
14716,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631924,,BAO_0000218,,
14717,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630234,,BAO_0000218,,
14718,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL630235,,BAO_0000218,,
14719,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630236,,BAO_0000218,,
14720,,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630237,,BAO_0000218,,
14721,,Rattus norvegicus,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630238,,BAO_0000218,,
14722,,Rattus norvegicus,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630239,,BAO_0000218,,
14723,,Rattus norvegicus,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL630303,,BAO_0000218,,
14724,,Rattus norvegicus,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630304,,BAO_0000218,,
14725,,Rattus norvegicus,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630305,,BAO_0000218,,
14726,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630306,,BAO_0000218,2113.0,
14727,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630307,,BAO_0000218,2113.0,
14728,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL630308,,BAO_0000218,2113.0,
14729,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630309,,BAO_0000218,2113.0,
14730,,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL629309,,BAO_0000218,2113.0,
14731,,Rattus norvegicus,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL629993,,BAO_0000218,2113.0,
14732,,Rattus norvegicus,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL629994,,BAO_0000218,2113.0,
14733,,Rattus norvegicus,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL629995,,BAO_0000218,2113.0,
14734,,Rattus norvegicus,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631993,,BAO_0000218,2113.0,
14735,,Rattus norvegicus,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631994,,BAO_0000218,2113.0,
14736,,Rattus norvegicus,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631995,,BAO_0000218,2113.0,
14737,,Rattus norvegicus,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL631996,,BAO_0000218,2107.0,
14738,,Rattus norvegicus,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631997,,BAO_0000218,2107.0,
14739,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631998,,BAO_0000218,2107.0,
14740,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631999,,BAO_0000218,2107.0,
14741,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL632000,,BAO_0000218,2107.0,
14742,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL632001,,BAO_0000218,2107.0,
14743,,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL874424,,BAO_0000218,2107.0,
14744,,Rattus norvegicus,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL632002,,BAO_0000218,2107.0,
14745,,Rattus norvegicus,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL632003,,BAO_0000218,2107.0,
14746,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,A,0,Autocuration,1,,CHEMBL632004,,BAO_0000019,,
14747,,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,U,A,0,Autocuration,1,,CHEMBL632005,,BAO_0000019,,
14748,,,Compound was tested for amidase rate in the presence of N62C screen enzyme,U,A,0,Autocuration,1,,CHEMBL632006,,BAO_0000019,,
14749,,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,U,A,0,Autocuration,1,,CHEMBL632007,,BAO_0000019,,
14750,,,Compound was tested for amidase rate in the presence of S166C screen enzyme,U,A,0,Autocuration,1,,CHEMBL632008,,BAO_0000019,,
14751,,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,U,A,0,Autocuration,1,,CHEMBL632009,,BAO_0000019,,
14752,,,Compound was tested for esterase rate in the presence of N62C screen enzyme,U,A,0,Autocuration,1,,CHEMBL632010,,BAO_0000019,,
14753,,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,U,A,0,Autocuration,1,,CHEMBL857750,,BAO_0000019,,
14754,,,Compound was tested for esterase rate in the presence of S166C screen enzyme,U,A,0,Autocuration,1,,CHEMBL632011,,BAO_0000019,,
14755,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,A,0,Autocuration,1,,CHEMBL632012,,BAO_0000019,,
14756,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,A,0,Autocuration,1,,CHEMBL632013,,BAO_0000019,,
14757,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",U,A,0,Autocuration,1,,CHEMBL632014,,BAO_0000019,,
14758,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,A,0,Autocuration,1,,CHEMBL629622,,BAO_0000019,,
14759,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,A,0,Autocuration,1,,CHEMBL629623,,BAO_0000019,,
14760,,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",U,A,0,Autocuration,1,,CHEMBL629624,,BAO_0000019,,
14761,,,Ratio of Kcat to that of Km was determined,U,A,0,Autocuration,1,,CHEMBL629625,,BAO_0000019,,
14762,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,A,0,Autocuration,1,,CHEMBL629626,,BAO_0000019,,
14763,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,A,0,Autocuration,1,,CHEMBL629627,,BAO_0000019,,
14764,,,"Compound was evaluated for constant, Kd",U,A,0,Autocuration,1,,CHEMBL629628,,BAO_0000019,,
14765,,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,U,A,0,Autocuration,1,,CHEMBL629629,,BAO_0000019,,
14766,,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,U,A,0,Autocuration,1,,CHEMBL629630,,BAO_0000019,,
14767,,,Dissociation Constant of compound determined,U,A,0,Autocuration,1,,CHEMBL856030,,BAO_0000019,,
14768,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,U,B,0,Autocuration,1,,CHEMBL629631,,BAO_0000019,,
14769,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,U,B,0,Autocuration,1,,CHEMBL629632,,BAO_0000019,,
14770,,,Dissociation constant of compound with Fructose was determined,U,P,0,Autocuration,1,,CHEMBL629633,,BAO_0000100,,
14771,,,Dissociation constant of compound with Fructose was determined; Not determined,U,P,0,Autocuration,1,,CHEMBL629634,,BAO_0000100,,
14772,,,Dissociation constant of compound with Lactulose was determined,U,P,0,Autocuration,1,,CHEMBL629635,,BAO_0000100,,
14773,,,Dissociation constant of compound with Lactulose was determined; Not determined,U,P,0,Autocuration,1,,CHEMBL629636,,BAO_0000100,,
14774,,,Dissociation constant of the Compound,U,P,0,Autocuration,1,,CHEMBL629637,,BAO_0000100,,
14775,,,Dissociation constant by non-linear regression analysis,U,P,0,Autocuration,1,,CHEMBL629638,,BAO_0000100,,
14776,,,Dissociation constant was determined,U,P,0,Autocuration,1,,CHEMBL629639,,BAO_0000100,,
14777,,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,U,P,0,Autocuration,1,,CHEMBL629640,,BAO_0000100,,
14778,,,Dissociation constant was determined,U,P,0,Autocuration,1,,CHEMBL629641,,BAO_0000100,,
14779,,,Dissociation constant was determined,U,P,0,Autocuration,1,,CHEMBL631344,,BAO_0000100,,
14780,,Rattus norvegicus,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,N,A,1,Intermediate,1,,CHEMBL631345,,BAO_0000218,2385.0,
14781,,,The dissociation constant determined by fluorescence displacement assay,U,A,0,Autocuration,1,,CHEMBL631346,,BAO_0000019,,
14782,,,kd value surface plasmon resonance (SPR) method,U,A,0,Autocuration,1,,CHEMBL631524,,BAO_0000019,,
14783,,Rattus norvegicus,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,N,A,1,Intermediate,1,,CHEMBL631525,,BAO_0000218,2385.0,
14784,,,First dissociation constant of the binding of compound to V30M TTR,U,F,0,Autocuration,1,,CHEMBL631526,,BAO_0000019,,
14785,,,Second dissociation constant of the binding of compound to V30M TTR,U,F,0,Autocuration,1,,CHEMBL631527,,BAO_0000019,,
14786,,,"Compound was evaluated for equilibrium constant, Ke",U,A,0,Autocuration,1,,CHEMBL631528,,BAO_0000019,,
14787,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,U,A,0,Autocuration,1,,CHEMBL631529,,BAO_0000019,1898.0,
14788,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,U,A,0,Autocuration,1,,CHEMBL631530,,BAO_0000019,1898.0,
14789,,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,U,A,0,Autocuration,1,,CHEMBL631531,,BAO_0000019,,
14790,,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,U,A,0,Autocuration,1,,CHEMBL631532,,BAO_0000019,,
14791,,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,U,A,0,Autocuration,1,,CHEMBL631533,,BAO_0000019,,
14792,,Mus musculus,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,A,1,Intermediate,1,,CHEMBL876552,,BAO_0000218,,
14793,,Mus musculus,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,A,1,Intermediate,1,,CHEMBL631534,,BAO_0000218,,
14794,,Mus musculus,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,A,1,Intermediate,1,,CHEMBL631535,,BAO_0000218,,
14795,,Mus musculus,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,A,1,Intermediate,1,,CHEMBL631536,,BAO_0000218,,
14796,,Mus musculus,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,N,A,1,Intermediate,1,,CHEMBL631537,,BAO_0000218,,
14797,,Mus musculus,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,A,1,Intermediate,1,,CHEMBL631538,,BAO_0000218,,
14798,,Mus musculus,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,N,A,1,Intermediate,1,,CHEMBL631539,,BAO_0000218,,
14799,,Mus musculus,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,A,1,Intermediate,1,,CHEMBL631540,,BAO_0000218,,
14800,,Rattus norvegicus,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,A,1,Intermediate,1,,CHEMBL625637,,BAO_0000218,,
14801,,Rattus norvegicus,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,A,1,Intermediate,1,,CHEMBL625638,,BAO_0000218,,
14802,,Rattus norvegicus,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,A,1,Intermediate,1,,CHEMBL625639,,BAO_0000218,,
14803,,Rattus norvegicus,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625640,,BAO_0000218,955.0,
14804,,Rattus norvegicus,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625641,,BAO_0000218,955.0,
14805,,Rattus norvegicus,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625642,,BAO_0000218,948.0,
14806,,Rattus norvegicus,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625643,,BAO_0000218,948.0,
14807,,Rattus norvegicus,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625644,,BAO_0000218,2113.0,
14808,,Rattus norvegicus,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625645,,BAO_0000218,2113.0,
14809,,Rattus norvegicus,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625646,,BAO_0000218,2107.0,
14810,,Rattus norvegicus,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625647,,BAO_0000218,2107.0,
14811,,Rattus norvegicus,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625648,,BAO_0000218,2048.0,
14812,,Rattus norvegicus,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625649,,BAO_0000218,2048.0,
14813,,Rattus norvegicus,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625650,,BAO_0000218,2385.0,
14814,,Rattus norvegicus,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625651,,BAO_0000218,2385.0,
14815,,Rattus norvegicus,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625652,,BAO_0000218,14.0,
14816,,Rattus norvegicus,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625653,,BAO_0000218,14.0,
14817,,Rattus norvegicus,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625654,,BAO_0000218,2106.0,
14818,,Rattus norvegicus,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,A,1,Intermediate,1,,CHEMBL625655,,BAO_0000218,2106.0,
14819,,Rattus norvegicus,Biodistribution of Compound in rat blood after 15 minutes of administration,N,A,1,Intermediate,1,,CHEMBL625656,,BAO_0000218,178.0,
14820,,Rattus norvegicus,Biodistribution of Compound in rat blood after 2 minutes of administration,N,A,1,Intermediate,1,,CHEMBL625657,,BAO_0000218,178.0,
14821,,Rattus norvegicus,Biodistribution of Compound in rat brain after 15 minutes of administration,N,A,1,Intermediate,1,,CHEMBL625658,,BAO_0000218,955.0,
14822,,Rattus norvegicus,Biodistribution of Compound in rat brain after 2 minutes of administration,N,A,1,Intermediate,1,,CHEMBL625659,,BAO_0000218,955.0,
14823,,Rattus norvegicus,Biodistribution of Compound in rat heart after 15 minutes of administration,N,A,1,Intermediate,1,,CHEMBL625660,,BAO_0000218,948.0,
14824,,Rattus norvegicus,Biodistribution of Compound in rat heart after 2 minutes of administration,N,A,1,Intermediate,1,,CHEMBL625661,,BAO_0000218,948.0,
14825,,Rattus norvegicus,Biodistribution of Compound in rat liver after 15 minutes of administration,N,A,1,Intermediate,1,,CHEMBL625662,,BAO_0000218,2107.0,
14826,,Rattus norvegicus,Biodistribution of Compound in rat liver after 2 minutes of administration,N,A,1,Intermediate,1,,CHEMBL625663,,BAO_0000218,2107.0,
14827,,Rattus norvegicus,Biodistribution of Compound in rat lung after 15 minutes of administration,N,A,1,Intermediate,1,,CHEMBL875621,,BAO_0000218,2048.0,
14828,,Rattus norvegicus,Biodistribution of Compound in rat lung after 2 minutes of administration,N,A,1,Intermediate,1,,CHEMBL628382,,BAO_0000218,2048.0,
14829,,Rattus norvegicus,Biodistribution of Compound in rat muscle after 15 minutes of administration,N,A,1,Intermediate,1,,CHEMBL628383,,BAO_0000218,2385.0,
14830,,Rattus norvegicus,Biodistribution of Compound in rat muscle after 2 minutes of administration,N,A,1,Intermediate,1,,CHEMBL628384,,BAO_0000218,2385.0,
14831,,Rattus norvegicus,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,N,A,1,Intermediate,1,,CHEMBL628385,,BAO_0000218,,
14832,,Rattus norvegicus,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,N,A,1,Intermediate,1,,CHEMBL875753,,BAO_0000218,,
14833,,Rattus norvegicus,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,N,A,1,Intermediate,1,,CHEMBL628386,,BAO_0000218,,
14834,,Rattus norvegicus,Organ distribution in rat blood 2 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL628387,,BAO_0000218,,
14835,,Rattus norvegicus,Organ distribution in rat blood 2 hr after intravenous injection,N,A,1,Intermediate,1,,CHEMBL628388,,BAO_0000218,,
14836,,Rattus norvegicus,Organ distribution in rat blood 30 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL628389,,BAO_0000218,,
14837,,Rattus norvegicus,Organ distribution in rat blood 30 min after intravenous injection,N,A,1,Intermediate,1,,CHEMBL632756,,BAO_0000218,,
14838,,Rattus norvegicus,Organ distribution in rat brain 2 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL628390,,BAO_0000218,,
14839,,Rattus norvegicus,Organ distribution in rat brain 2 hr after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631811,,BAO_0000218,,
14840,,Rattus norvegicus,Organ distribution in rat brain 30 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631812,,BAO_0000218,,
14841,,Rattus norvegicus,Organ distribution in rat heart 2 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631813,,BAO_0000218,,
14842,,Rattus norvegicus,Organ distribution in rat heart 2 hr after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631814,,BAO_0000218,,
14843,,Rattus norvegicus,Organ distribution in rat heart 30 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631815,,BAO_0000218,,
14844,,Rattus norvegicus,Organ distribution in rat kidney 2 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631816,,BAO_0000218,,
14845,,Rattus norvegicus,Organ distribution in rat kidney 2 hr after intravenous injection,N,A,1,Intermediate,1,,CHEMBL875758,,BAO_0000218,,
14846,,Rattus norvegicus,Organ distribution in rat kidney 30 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631817,,BAO_0000218,,
14847,,Rattus norvegicus,Organ distribution in rat liver 2 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631818,,BAO_0000218,2107.0,
14848,,Rattus norvegicus,Organ distribution in rat liver 2 hr after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631819,,BAO_0000218,2107.0,
14849,,Rattus norvegicus,Organ distribution in rat liver 30 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631820,,BAO_0000218,2107.0,
14850,,Rattus norvegicus,Organ distribution in rat lung 2 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631821,,BAO_0000218,,
14851,,Rattus norvegicus,Organ distribution in rat lung 2 hr after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631822,,BAO_0000218,,
14852,,Rattus norvegicus,Organ distribution in rat lung 30 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631823,,BAO_0000218,,
14853,,Rattus norvegicus,Organ distribution in rat muscle 2 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631824,,BAO_0000218,2385.0,
14854,,Rattus norvegicus,Organ distribution in rat muscle 2 hr after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631825,,BAO_0000218,2385.0,
14855,,Rattus norvegicus,Organ distribution in rat muscle 30 minutes after intravenous injection,N,A,1,Intermediate,1,,CHEMBL631826,,BAO_0000218,2385.0,
14856,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),N,A,1,Intermediate,1,,CHEMBL631827,,BAO_0000218,,
14857,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),N,A,1,Intermediate,1,,CHEMBL631828,,BAO_0000218,,
14858,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),N,A,1,Intermediate,1,,CHEMBL631829,,BAO_0000218,,
14859,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL875759,,BAO_0000218,1088.0,
14860,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631830,,BAO_0000218,1088.0,
14861,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631831,,BAO_0000218,1088.0,
14862,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631832,,BAO_0000218,1088.0,
14863,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631833,,BAO_0000218,1088.0,
14864,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631834,,BAO_0000218,1088.0,
14865,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631835,,BAO_0000218,1088.0,
14866,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631836,,BAO_0000218,1088.0,
14867,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631837,,BAO_0000218,1088.0,
14868,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631838,,BAO_0000218,1088.0,
14869,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631839,,BAO_0000218,1088.0,
14870,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631840,,BAO_0000218,1088.0,
14871,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631841,,BAO_0000218,1088.0,
14872,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631842,,BAO_0000218,1088.0,
14873,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631843,,BAO_0000218,1088.0,
14874,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631844,,BAO_0000218,1088.0,
14875,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631845,,BAO_0000218,1088.0,
14876,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631846,,BAO_0000218,1088.0,
14877,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL875760,,BAO_0000218,1088.0,
14878,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL632199,,BAO_0000218,1088.0,
14879,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631847,,BAO_0000218,1088.0,
14880,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL631848,,BAO_0000218,1088.0,
14881,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628707,,BAO_0000218,1088.0,
14882,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628708,,BAO_0000218,1088.0,
14883,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628709,,BAO_0000218,1088.0,
14884,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628710,,BAO_0000218,1088.0,
14885,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628711,,BAO_0000218,1088.0,
14886,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628712,,BAO_0000218,1088.0,
14887,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628713,,BAO_0000218,1088.0,
14888,,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,A,1,Intermediate,1,,CHEMBL628714,,BAO_0000218,1088.0,
14889,,Rattus norvegicus,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",N,A,1,Intermediate,1,,CHEMBL628715,,BAO_0000218,,
14890,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,U,A,0,Autocuration,1,,CHEMBL629179,,BAO_0000019,,
14891,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,U,A,0,Autocuration,1,,CHEMBL629180,,BAO_0000019,,
14892,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,U,A,0,Autocuration,1,,CHEMBL875108,,BAO_0000019,,
14893,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629181,,BAO_0000019,1235.0,
14894,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629182,,BAO_0000019,1235.0,
14895,,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629183,,BAO_0000019,,
14896,,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629184,,BAO_0000019,,
14897,,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629185,,BAO_0000019,1235.0,
14898,,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629186,,BAO_0000019,1235.0,
14899,,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629187,,BAO_0000019,,
14900,,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629887,,BAO_0000019,,
14901,,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629888,,BAO_0000019,,
14902,,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629889,,BAO_0000019,,
14903,,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629890,,BAO_0000019,1235.0,
14904,,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629891,,BAO_0000019,,
14905,,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629892,,BAO_0000019,,
14906,,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629893,,BAO_0000019,1235.0,
14907,,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629894,,BAO_0000019,,
14908,,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,U,A,0,Autocuration,1,,CHEMBL629895,,BAO_0000019,,
14909,,Canis lupus familiaris,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",U,A,0,Autocuration,1,,CHEMBL875109,,BAO_0000218,,
14910,,Macaca fascicularis,Absolute bioavailability in male cynomolgus monkeys,U,A,0,Autocuration,1,,CHEMBL629896,,BAO_0000218,,
14911,,Rattus norvegicus,Absolute bioavailability in maleSprague-Dawley rats,U,A,0,Autocuration,1,,CHEMBL629897,,BAO_0000218,,
14912,,Rattus norvegicus,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL629898,,BAO_0000218,2107.0,
14913,,Rattus norvegicus,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630057,,BAO_0000218,2107.0,
14914,,Rattus norvegicus,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630058,,BAO_0000218,2107.0,
14915,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630059,,BAO_0000218,2048.0,
14916,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630060,,BAO_0000218,2048.0,
14917,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL630061,,BAO_0000218,2048.0,
14918,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630062,,BAO_0000218,2048.0,
14919,,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630063,,BAO_0000218,2048.0,
14920,,Rattus norvegicus,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630064,,BAO_0000218,2048.0,
14921,,Rattus norvegicus,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630065,,BAO_0000218,2048.0,
14922,,Rattus norvegicus,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL630066,,BAO_0000218,2048.0,
14923,,Rattus norvegicus,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630067,,BAO_0000218,2048.0,
14924,,Rattus norvegicus,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630068,,BAO_0000218,2048.0,
14925,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631113,,BAO_0000218,2385.0,
14926,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631114,,BAO_0000218,2385.0,
14927,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL631115,,BAO_0000218,2385.0,
14928,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL631116,,BAO_0000218,2385.0,
14929,,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630528,,BAO_0000218,2385.0,
14930,,Rattus norvegicus,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630529,,BAO_0000218,2385.0,
14931,,Rattus norvegicus,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630530,,BAO_0000218,2385.0,
14932,,Rattus norvegicus,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL630531,,BAO_0000218,2385.0,
14933,,Rattus norvegicus,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630532,,BAO_0000218,2385.0,
14934,,Rattus norvegicus,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630533,,BAO_0000218,2385.0,
14935,,Mus musculus,Biodistribution in normal mice blood after 120 hr,N,A,1,Intermediate,1,,CHEMBL630534,,BAO_0000218,178.0,
14936,,Mus musculus,Biodistribution in normal mice blood after 24 hr,N,A,1,Intermediate,1,,CHEMBL630535,,BAO_0000218,178.0,
14937,,Mus musculus,Biodistribution in normal mice blood after 4 hr,N,A,1,Intermediate,1,,CHEMBL630536,,BAO_0000218,178.0,
14938,,Mus musculus,Biodistribution in normal mice bone after 120 hr,N,A,1,Intermediate,1,,CHEMBL630537,,BAO_0000218,10000001.0,
14939,,Mus musculus,Biodistribution in normal mice bone after 24 hr,N,A,1,Intermediate,1,,CHEMBL630538,,BAO_0000218,10000001.0,
14940,,Mus musculus,Biodistribution in normal mice bone after 4 hr,N,A,1,Intermediate,1,,CHEMBL630539,,BAO_0000218,10000001.0,
14941,,Mus musculus,Biodistribution in normal mice heart after 120 hr,N,A,1,Intermediate,1,,CHEMBL630540,,BAO_0000218,948.0,
14942,,Mus musculus,Biodistribution in normal mice heart after 24 hr,N,A,1,Intermediate,1,,CHEMBL630541,,BAO_0000218,948.0,
14943,,Mus musculus,Biodistribution in normal mice heart after 4 hr,N,A,1,Intermediate,1,,CHEMBL630542,,BAO_0000218,948.0,
14944,,Mus musculus,Biodistribution in normal mice kidney after 120 hr,N,A,1,Intermediate,1,,CHEMBL630543,,BAO_0000218,2113.0,
14945,,Mus musculus,Biodistribution in normal mice kidney after 24 hr,N,A,1,Intermediate,1,,CHEMBL630544,,BAO_0000218,2113.0,
14946,,Mus musculus,Biodistribution in normal mice kidney after 4 hr,N,A,1,Intermediate,1,,CHEMBL630545,,BAO_0000218,2113.0,
14947,,Mus musculus,Biodistribution in normal mice liver after 120 hr,N,A,1,Intermediate,1,,CHEMBL630546,,BAO_0000218,2107.0,
14948,,Mus musculus,Biodistribution in normal mice liver after 24 hr,N,A,1,Intermediate,1,,CHEMBL630547,,BAO_0000218,2107.0,
14949,,Mus musculus,Biodistribution in normal mice liver after 4 hr,N,A,1,Intermediate,1,,CHEMBL630548,,BAO_0000218,2107.0,
14950,,Mus musculus,Biodistribution in normal mice spleen after 120 hr,N,A,1,Intermediate,1,,CHEMBL630549,,BAO_0000218,2106.0,
14951,,Mus musculus,Biodistribution in normal mice spleen after 24 hr,N,A,1,Intermediate,1,,CHEMBL630550,,BAO_0000218,2106.0,
14952,,Mus musculus,Biodistribution in normal mice spleen after 4 hr,N,A,1,Intermediate,1,,CHEMBL876426,,BAO_0000218,2106.0,
14953,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630551,,BAO_0000218,2106.0,
14954,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630552,,BAO_0000218,2106.0,
14955,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL630553,,BAO_0000218,2106.0,
14956,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630554,,BAO_0000218,2106.0,
14957,,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630555,,BAO_0000218,2106.0,
14958,,Rattus norvegicus,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630556,,BAO_0000218,2106.0,
14959,,Rattus norvegicus,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630557,,BAO_0000218,2106.0,
14960,,Rattus norvegicus,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,A,1,Intermediate,1,,CHEMBL630558,,BAO_0000218,2106.0,
14961,,Rattus norvegicus,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630559,,BAO_0000218,2106.0,
14962,,Rattus norvegicus,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL630560,,BAO_0000218,2106.0,
14963,,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,A,1,Intermediate,1,,CHEMBL876427,,BAO_0000218,2046.0,
14964,,Rattus norvegicus,The Kel values in female wistar rats.,N,A,1,Intermediate,1,,CHEMBL630561,,BAO_0000218,,
14965,,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,U,A,0,Autocuration,1,,CHEMBL630562,,BAO_0000019,,
14966,,,Hydrolysis rate constant of the compound,U,A,0,Autocuration,1,,CHEMBL630563,,BAO_0000019,,
14967,,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,U,P,0,Autocuration,1,,CHEMBL629673,,BAO_0000100,,
14968,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",U,A,0,Autocuration,1,,CHEMBL629674,,BAO_0000019,,
14969,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",U,A,0,Autocuration,1,,CHEMBL629675,,BAO_0000019,,
14970,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",U,A,0,Autocuration,1,,CHEMBL629676,,BAO_0000019,,
14971,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",U,A,0,Autocuration,1,,CHEMBL629677,,BAO_0000019,,
14972,,,Apparent inactivation rate constant was evaluated,U,A,0,Autocuration,1,,CHEMBL629678,,BAO_0000019,,
14973,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,U,A,0,Autocuration,1,,CHEMBL629679,,BAO_0000019,,
14974,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,U,A,0,Autocuration,1,,CHEMBL629680,,BAO_0000019,,
14975,,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,U,A,0,Autocuration,1,,CHEMBL629681,,BAO_0000019,,
14976,,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,U,A,0,Autocuration,1,,CHEMBL629682,,BAO_0000019,,
14977,,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,U,A,0,Autocuration,1,,CHEMBL629683,,BAO_0000019,,
14978,,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,U,F,0,Autocuration,1,,CHEMBL629684,,BAO_0000019,,
14979,,,Dissociation constant was determined,U,P,0,Autocuration,1,,CHEMBL629685,,BAO_0000100,,
14980,,,Dissociation constant was determined,U,P,0,Autocuration,1,,CHEMBL629686,,BAO_0000100,,
14981,,,Dissociation constant at pH 7.4,U,P,0,Autocuration,1,,CHEMBL872932,,BAO_0000100,,
14982,,,Dissociation constant in presence of 1 mM dithiothreitol,U,P,0,Autocuration,1,,CHEMBL629687,,BAO_0000100,,
14983,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,A,0,Autocuration,1,,CHEMBL872931,,BAO_0000019,,
14984,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,A,0,Autocuration,1,,CHEMBL628151,,BAO_0000019,,
14985,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,A,0,Autocuration,1,,CHEMBL628152,,BAO_0000019,,
14986,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,A,0,Autocuration,1,,CHEMBL628153,,BAO_0000019,,
14987,,,Kinetic constant for aromatization of androstenedione,U,A,0,Autocuration,1,,CHEMBL628154,,BAO_0000019,,
14988,,,Kinetic constant for aromatization of testosterone,U,A,0,Autocuration,1,,CHEMBL628155,,BAO_0000019,,
14989,,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,U,A,0,Autocuration,1,,CHEMBL628156,,BAO_0000019,,
14990,,,Local inhibition constant was determined,U,A,0,Autocuration,1,,CHEMBL628157,,BAO_0000019,,
14991,,Saccharomyces cerevisiae,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,N,A,1,Intermediate,1,,CHEMBL857533,,BAO_0000218,,
14992,,,Dissociation constant value of the compound,U,P,0,Autocuration,1,,CHEMBL628158,,BAO_0000100,,
14993,,,In vitro permeability through cornea without epithelium,U,A,0,Autocuration,1,,CHEMBL628159,,BAO_0000019,964.0,
14994,,,In vitro permeability through intact cornea,U,A,0,Autocuration,1,,CHEMBL875616,,BAO_0000019,964.0,
14995,,Oryctolagus cuniculus,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,N,A,1,Intermediate,1,,CHEMBL628160,,BAO_0000218,964.0,
14996,,,Rate of enzyme inactivation for the compound was determined,U,A,0,Autocuration,1,,CHEMBL628161,,BAO_0000019,,
14997,,,In vitro permeability through cornea without epithelium,U,A,0,Autocuration,1,,CHEMBL628162,,BAO_0000019,964.0,
14998,,,In vitro permeability through intact cornea,U,A,0,Autocuration,1,,CHEMBL628163,,BAO_0000019,964.0,
14999,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628164,,BAO_0000019,,
15000,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628165,,BAO_0000019,,
15001,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628166,,BAO_0000019,,
15002,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628167,,BAO_0000019,,
15003,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628168,,BAO_0000019,,
15004,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628169,,BAO_0000019,,
15005,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628170,,BAO_0000019,,
15006,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628171,,BAO_0000019,,
15007,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL627434,,BAO_0000019,,
15008,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL627435,,BAO_0000019,,
15009,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628110,,BAO_0000019,,
15010,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628111,,BAO_0000019,,
15011,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628112,,BAO_0000019,,
15012,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628260,,BAO_0000019,,
15013,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,A,0,Autocuration,1,,CHEMBL628261,,BAO_0000019,,
15014,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),N,A,1,Intermediate,1,,CHEMBL628262,,BAO_0000218,,
15015,,Homo sapiens,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,N,A,1,Intermediate,1,,CHEMBL628263,,BAO_0000218,,
15016,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),N,A,1,Intermediate,1,,CHEMBL628264,,BAO_0000218,,
15017,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),N,A,1,Intermediate,1,,CHEMBL628265,,BAO_0000218,,
15018,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),N,A,1,Intermediate,1,,CHEMBL628266,,BAO_0000218,,
15019,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),N,A,1,Intermediate,1,,CHEMBL628267,,BAO_0000218,,
15020,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,N,A,1,Intermediate,1,,CHEMBL628268,,BAO_0000218,,
15021,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),N,A,1,Intermediate,1,,CHEMBL628269,,BAO_0000218,,
15022,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),N,A,1,Intermediate,1,,CHEMBL628270,,BAO_0000218,,
15023,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),N,A,1,Intermediate,1,,CHEMBL628271,,BAO_0000218,,
15024,,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),N,A,1,Intermediate,1,,CHEMBL628272,,BAO_0000218,,
